id	sid	tid	token	lemma	pos
ghmj-1044	1	1	ghmj	ghmj	PROPN
ghmj-1044	1	2	(	(	PUNCT
ghmj-1044	1	3	global	global	ADJ
ghmj-1044	1	4	health	health	PROPN
ghmj-1044	1	5	management	management	NOUN
ghmj-1044	1	6	journal	journal	PROPN
ghmj-1044	1	7	)	)	PUNCT
ghmj-1044	1	8	2024	2024	NUM
ghmj-1044	1	9	,	,	PUNCT
ghmj-1044	1	10	vol	vol	NOUN
ghmj-1044	1	11	.	.	PROPN
ghmj-1044	1	12	7	7	NUM
ghmj-1044	1	13	,	,	PUNCT
ghmj-1044	1	14	no	no	INTJ
ghmj-1044	1	15	.	.	NOUN
ghmj-1044	1	16	4	4	NUM
ghmj-1044	1	17	indonesian	indonesian	ADJ
ghmj-1044	1	18	scholars	scholar	NOUN
ghmj-1044	1	19	’	'	PUNCT
ghmj-1044	1	20	alliance	alliance	NOUN
ghmj-1044	1	21	open	open	ADJ
ghmj-1044	1	22	access	access	NOUN
ghmj-1044	1	23	research	research	NOUN
ghmj-1044	1	24	article	article	NOUN
ghmj-1044	1	25	the	the	DET
ghmj-1044	1	26	1st	1st	ADJ
ghmj-1044	1	27	cirebon	cirebon	PROPN
ghmj-1044	1	28	international	international	PROPN
ghmj-1044	1	29	health	health	NOUN
ghmj-1044	1	30	symposium	symposium	NOUN
ghmj-1044	1	31	:	:	PUNCT
ghmj-1044	1	32	faculty	faculty	NOUN
ghmj-1044	1	33	of	of	ADP
ghmj-1044	1	34	medicine	medicine	NOUN
ghmj-1044	1	35	,	,	PUNCT
ghmj-1044	1	36	universitas	universita	NOUN
ghmj-1044	1	37	swadaya	swadaya	NOUN
ghmj-1044	1	38	gunung	gunung	NOUN
ghmj-1044	1	39	jati	jati	PROPN
ghmj-1044	1	40	update	update	NOUN
ghmj-1044	1	41	on	on	ADP
ghmj-1044	1	42	non	non	ADJ
ghmj-1044	1	43	-	-	ADJ
ghmj-1044	1	44	communicable	communicable	ADJ
ghmj-1044	1	45	diseases	disease	NOUN
ghmj-1044	1	46	:	:	PUNCT
ghmj-1044	1	47	global	global	ADJ
ghmj-1044	1	48	perspective	perspective	NOUN
ghmj-1044	1	49	on	on	ADP
ghmj-1044	1	50	health	health	NOUN
ghmj-1044	1	51	challenges	challenge	NOUN
ghmj-1044	1	52	and	and	CCONJ
ghmj-1044	1	53	innovation	innovation	NOUN
ghmj-1044	1	54	angiotensin	angiotensin	NOUN
ghmj-1044	1	55	-	-	PUNCT
ghmj-1044	1	56	converting	convert	VERB
ghmj-1044	1	57	enzyme	enzyme	NOUN
ghmj-1044	1	58	insertion	insertion	NOUN
ghmj-1044	1	59	/	/	SYM
ghmj-1044	1	60	deletion	deletion	NOUN
ghmj-1044	1	61	(	(	PUNCT
ghmj-1044	1	62	ace	ace	VERB
ghmj-1044	1	63	i	i	PROPN
ghmj-1044	1	64	/	/	SYM
ghmj-1044	1	65	d	d	NOUN
ghmj-1044	1	66	)	)	PUNCT
ghmj-1044	1	67	gene	gene	NOUN
ghmj-1044	1	68	polymorphism	polymorphism	NOUN
ghmj-1044	1	69	as	as	ADP
ghmj-1044	1	70	a	a	DET
ghmj-1044	1	71	risk	risk	NOUN
ghmj-1044	1	72	factor	factor	NOUN
ghmj-1044	1	73	for	for	ADP
ghmj-1044	1	74	essential	essential	ADJ
ghmj-1044	1	75	hypertension	hypertension	NOUN
ghmj-1044	1	76	hasna	hasna	PROPN
ghmj-1044	1	77	nurazizah	nurazizah	PROPN
ghmj-1044	1	78	kuswara	kuswara	PROPN
ghmj-1044	1	79	*	*	PUNCT
ghmj-1044	1	80	,	,	PUNCT
ghmj-1044	1	81	donny	donny	PROPN
ghmj-1044	1	82	nauphar	nauphar	PROPN
ghmj-1044	1	83	#	#	PROPN
ghmj-1044	1	84	,	,	PUNCT
ghmj-1044	1	85	ariestya	ariestya	ADJ
ghmj-1044	1	86	indah	indah	PROPN
ghmj-1044	1	87	permata	permata	PROPN
ghmj-1044	1	88	sari	sari	ADJ
ghmj-1044	1	89	department	department	PROPN
ghmj-1044	1	90	of	of	ADP
ghmj-1044	1	91	genetics	genetic	NOUN
ghmj-1044	1	92	,	,	PUNCT
ghmj-1044	1	93	faculty	faculty	NOUN
ghmj-1044	1	94	of	of	ADP
ghmj-1044	1	95	medicine	medicine	NOUN
ghmj-1044	1	96	,	,	PUNCT
ghmj-1044	1	97	universitas	universita	NOUN
ghmj-1044	1	98	swadaya	swadaya	NOUN
ghmj-1044	1	99	gunung	gunung	PROPN
ghmj-1044	1	100	jati	jati	PROPN
ghmj-1044	1	101	,	,	PUNCT
ghmj-1044	1	102	indonesia	indonesia	PROPN
ghmj-1044	1	103	.	.	PUNCT
ghmj-1044	2	1	*	*	PUNCT
ghmj-1044	2	2	corresponding	correspond	VERB
ghmj-1044	2	3	author	author	NOUN
ghmj-1044	2	4	’s	’s	PART
ghmj-1044	2	5	e	e	NOUN
ghmj-1044	2	6	-	-	NOUN
ghmj-1044	2	7	mail	mail	NOUN
ghmj-1044	2	8	:	:	PUNCT
ghmj-1044	3	1	kuswarahasnanurazizah@gmail.com	kuswarahasnanurazizah@gmail.com	X
ghmj-1044	3	2	*	*	PUNCT
ghmj-1044	3	3	;	;	PUNCT
ghmj-1044	3	4	dnauphar@yahoo.com	dnauphar@yahoo.com	X
ghmj-1044	3	5	#	#	NOUN
ghmj-1044	3	6	doi	doi	NOUN
ghmj-1044	3	7	:	:	PUNCT
ghmj-1044	3	8	10.35898	10.35898	NUM
ghmj-1044	3	9	/	/	SYM
ghmj-1044	3	10	ghmj-741044	ghmj-741044	ADJ
ghmj-1044	3	11	abstract	abstract	ADJ
ghmj-1044	3	12	background	background	NOUN
ghmj-1044	3	13	:	:	PUNCT
ghmj-1044	3	14	hypertension	hypertension	NOUN
ghmj-1044	3	15	is	be	AUX
ghmj-1044	3	16	the	the	DET
ghmj-1044	3	17	leading	lead	VERB
ghmj-1044	3	18	cause	cause	NOUN
ghmj-1044	3	19	of	of	ADP
ghmj-1044	3	20	death	death	NOUN
ghmj-1044	3	21	globally	globally	ADV
ghmj-1044	3	22	due	due	ADP
ghmj-1044	3	23	to	to	ADP
ghmj-1044	3	24	its	its	PRON
ghmj-1044	3	25	complications	complication	NOUN
ghmj-1044	3	26	,	,	PUNCT
ghmj-1044	3	27	including	include	VERB
ghmj-1044	3	28	coronary	coronary	ADJ
ghmj-1044	3	29	heart	heart	NOUN
ghmj-1044	3	30	disease	disease	NOUN
ghmj-1044	3	31	and	and	CCONJ
ghmj-1044	3	32	stroke	stroke	NOUN
ghmj-1044	3	33	.	.	PUNCT
ghmj-1044	4	1	in	in	ADP
ghmj-1044	4	2	2018	2018	NUM
ghmj-1044	4	3	,	,	PUNCT
ghmj-1044	4	4	hypertension	hypertension	NOUN
ghmj-1044	4	5	cases	case	NOUN
ghmj-1044	4	6	in	in	ADP
ghmj-1044	4	7	west	west	PROPN
ghmj-1044	4	8	java	java	PROPN
ghmj-1044	4	9	were	be	AUX
ghmj-1044	4	10	the	the	DET
ghmj-1044	4	11	second	second	ADJ
ghmj-1044	4	12	highest	high	ADJ
ghmj-1044	4	13	among	among	ADP
ghmj-1044	4	14	all	all	DET
ghmj-1044	4	15	populations	population	NOUN
ghmj-1044	4	16	in	in	ADP
ghmj-1044	4	17	indonesia	indonesia	PROPN
ghmj-1044	4	18	.	.	PUNCT
ghmj-1044	5	1	genetics	genetics	PROPN
ghmj-1044	5	2	is	be	AUX
ghmj-1044	5	3	one	one	NUM
ghmj-1044	5	4	of	of	ADP
ghmj-1044	5	5	the	the	DET
ghmj-1044	5	6	unmodifiable	unmodifiable	ADJ
ghmj-1044	5	7	risk	risk	NOUN
ghmj-1044	5	8	factors	factor	NOUN
ghmj-1044	5	9	for	for	ADP
ghmj-1044	5	10	hypertension	hypertension	NOUN
ghmj-1044	5	11	.	.	PUNCT
ghmj-1044	6	1	angiotensin	angiotensin	NOUN
ghmj-1044	6	2	-	-	PUNCT
ghmj-1044	6	3	converting	convert	VERB
ghmj-1044	6	4	enzyme	enzyme	NOUN
ghmj-1044	6	5	insertion	insertion	NOUN
ghmj-1044	6	6	/	/	SYM
ghmj-1044	6	7	deletion	deletion	NOUN
ghmj-1044	6	8	(	(	PUNCT
ghmj-1044	6	9	ace	ace	VERB
ghmj-1044	6	10	i	i	PROPN
ghmj-1044	6	11	/	/	SYM
ghmj-1044	6	12	d	d	NOUN
ghmj-1044	6	13	)	)	PUNCT
ghmj-1044	6	14	gene	gene	NOUN
ghmj-1044	6	15	polymorphism	polymorphism	NOUN
ghmj-1044	6	16	could	could	AUX
ghmj-1044	6	17	affect	affect	VERB
ghmj-1044	6	18	ace	ace	NOUN
ghmj-1044	6	19	production	production	NOUN
ghmj-1044	6	20	in	in	ADP
ghmj-1044	6	21	the	the	DET
ghmj-1044	6	22	renin	renin	ADJ
ghmj-1044	6	23	-	-	PUNCT
ghmj-1044	6	24	angiotensin	angiotensin	NOUN
ghmj-1044	6	25	-	-	PUNCT
ghmj-1044	6	26	aldosterone	aldosterone	NOUN
ghmj-1044	6	27	system	system	NOUN
ghmj-1044	6	28	(	(	PUNCT
ghmj-1044	6	29	raas	raas	NOUN
ghmj-1044	6	30	)	)	PUNCT
ghmj-1044	6	31	,	,	PUNCT
ghmj-1044	6	32	which	which	PRON
ghmj-1044	6	33	is	be	AUX
ghmj-1044	6	34	linked	link	VERB
ghmj-1044	6	35	to	to	ADP
ghmj-1044	6	36	the	the	DET
ghmj-1044	6	37	blood	blood	NOUN
ghmj-1044	6	38	pressure	pressure	NOUN
ghmj-1044	6	39	regulation	regulation	NOUN
ghmj-1044	6	40	.	.	PUNCT
ghmj-1044	7	1	aims	aim	NOUN
ghmj-1044	7	2	:	:	PUNCT
ghmj-1044	7	3	to	to	PART
ghmj-1044	7	4	analyze	analyze	VERB
ghmj-1044	7	5	ace	ace	VERB
ghmj-1044	7	6	i	i	PRON
ghmj-1044	7	7	/	/	SYM
ghmj-1044	7	8	d	d	PROPN
ghmj-1044	7	9	gene	gene	NOUN
ghmj-1044	7	10	polymorphism	polymorphism	NOUN
ghmj-1044	7	11	as	as	ADP
ghmj-1044	7	12	a	a	DET
ghmj-1044	7	13	risk	risk	NOUN
ghmj-1044	7	14	factor	factor	NOUN
ghmj-1044	7	15	for	for	ADP
ghmj-1044	7	16	hypertension	hypertension	NOUN
ghmj-1044	7	17	in	in	ADP
ghmj-1044	7	18	cirebon	cirebon	NOUN
ghmj-1044	7	19	.	.	PUNCT
ghmj-1044	8	1	methods	method	NOUN
ghmj-1044	8	2	:	:	PUNCT
ghmj-1044	8	3	an	an	DET
ghmj-1044	8	4	observational	observational	ADJ
ghmj-1044	8	5	analysis	analysis	NOUN
ghmj-1044	8	6	with	with	ADP
ghmj-1044	8	7	a	a	DET
ghmj-1044	8	8	case	case	NOUN
ghmj-1044	8	9	-	-	PUNCT
ghmj-1044	8	10	control	control	NOUN
ghmj-1044	8	11	design	design	NOUN
ghmj-1044	8	12	was	be	AUX
ghmj-1044	8	13	used	use	VERB
ghmj-1044	8	14	in	in	ADP
ghmj-1044	8	15	this	this	DET
ghmj-1044	8	16	study	study	NOUN
ghmj-1044	8	17	.	.	PUNCT
ghmj-1044	9	1	blood	blood	NOUN
ghmj-1044	9	2	samples	sample	NOUN
ghmj-1044	9	3	were	be	AUX
ghmj-1044	9	4	collected	collect	VERB
ghmj-1044	9	5	from	from	ADP
ghmj-1044	9	6	30	30	NUM
ghmj-1044	9	7	hypertensive	hypertensive	ADJ
ghmj-1044	9	8	patients	patient	NOUN
ghmj-1044	9	9	and	and	CCONJ
ghmj-1044	9	10	30	30	NUM
ghmj-1044	9	11	healthy	healthy	ADJ
ghmj-1044	9	12	individuals	individual	NOUN
ghmj-1044	9	13	at	at	ADP
ghmj-1044	9	14	talun	talun	PROPN
ghmj-1044	9	15	health	health	NOUN
ghmj-1044	9	16	center	center	NOUN
ghmj-1044	9	17	.	.	PUNCT
ghmj-1044	10	1	dna	dna	PROPN
ghmj-1044	10	2	extraction	extraction	NOUN
ghmj-1044	10	3	was	be	AUX
ghmj-1044	10	4	performed	perform	VERB
ghmj-1044	10	5	to	to	PART
ghmj-1044	10	6	evaluate	evaluate	VERB
ghmj-1044	10	7	polymorphisms	polymorphism	NOUN
ghmj-1044	10	8	using	use	VERB
ghmj-1044	10	9	arms	arm	NOUN
ghmj-1044	10	10	-	-	PUNCT
ghmj-1044	10	11	pcr	pcr	NOUN
ghmj-1044	10	12	.	.	PUNCT
ghmj-1044	11	1	statistical	statistical	ADJ
ghmj-1044	11	2	analyses	analysis	NOUN
ghmj-1044	11	3	,	,	PUNCT
ghmj-1044	11	4	including	include	VERB
ghmj-1044	11	5	the	the	DET
ghmj-1044	11	6	chi	chi	ADJ
ghmj-1044	11	7	-	-	PUNCT
ghmj-1044	11	8	square	square	ADJ
ghmj-1044	11	9	test	test	NOUN
ghmj-1044	11	10	,	,	PUNCT
ghmj-1044	11	11	fisher	fisher	PROPN
ghmj-1044	11	12	’s	’s	PART
ghmj-1044	11	13	exact	exact	ADJ
ghmj-1044	11	14	test	test	NOUN
ghmj-1044	11	15	,	,	PUNCT
ghmj-1044	11	16	mann	mann	PROPN
ghmj-1044	11	17	-	-	PUNCT
ghmj-1044	11	18	whitney	whitney	PROPN
ghmj-1044	11	19	test	test	NOUN
ghmj-1044	11	20	,	,	PUNCT
ghmj-1044	11	21	and	and	CCONJ
ghmj-1044	11	22	kruskal	kruskal	PROPN
ghmj-1044	11	23	-	-	PUNCT
ghmj-1044	11	24	wallis	wallis	PROPN
ghmj-1044	11	25	test	test	NOUN
ghmj-1044	11	26	,	,	PUNCT
ghmj-1044	11	27	were	be	AUX
ghmj-1044	11	28	conducted	conduct	VERB
ghmj-1044	11	29	to	to	PART
ghmj-1044	11	30	compare	compare	VERB
ghmj-1044	11	31	the	the	DET
ghmj-1044	11	32	case	case	NOUN
ghmj-1044	11	33	and	and	CCONJ
ghmj-1044	11	34	control	control	NOUN
ghmj-1044	11	35	groups	group	NOUN
ghmj-1044	11	36	.	.	PUNCT
ghmj-1044	12	1	the	the	DET
ghmj-1044	12	2	odds	odd	NOUN
ghmj-1044	12	3	ratio	ratio	NOUN
ghmj-1044	12	4	was	be	AUX
ghmj-1044	12	5	calculated	calculate	VERB
ghmj-1044	12	6	to	to	PART
ghmj-1044	12	7	see	see	VERB
ghmj-1044	12	8	the	the	DET
ghmj-1044	12	9	risk	risk	NOUN
ghmj-1044	12	10	of	of	ADP
ghmj-1044	12	11	the	the	DET
ghmj-1044	12	12	assessed	assessed	ADJ
ghmj-1044	12	13	variables	variable	NOUN
ghmj-1044	12	14	,	,	PUNCT
ghmj-1044	12	15	including	include	VERB
ghmj-1044	12	16	genotype	genotype	NOUN
ghmj-1044	12	17	,	,	PUNCT
ghmj-1044	12	18	allele	allele	NOUN
ghmj-1044	12	19	frequency	frequency	NOUN
ghmj-1044	12	20	,	,	PUNCT
ghmj-1044	12	21	and	and	CCONJ
ghmj-1044	12	22	the	the	DET
ghmj-1044	12	23	presence	presence	NOUN
ghmj-1044	12	24	of	of	ADP
ghmj-1044	12	25	ace	ace	PROPN
ghmj-1044	12	26	i	i	PROPN
ghmj-1044	12	27	/	/	SYM
ghmj-1044	12	28	d	d	PROPN
ghmj-1044	12	29	gene	gene	NOUN
ghmj-1044	12	30	polymorphism	polymorphism	NOUN
ghmj-1044	12	31	.	.	PUNCT
ghmj-1044	13	1	results	result	NOUN
ghmj-1044	13	2	:	:	PUNCT
ghmj-1044	13	3	in	in	ADP
ghmj-1044	13	4	the	the	DET
ghmj-1044	13	5	case	case	NOUN
ghmj-1044	13	6	group	group	NOUN
ghmj-1044	13	7	,	,	PUNCT
ghmj-1044	13	8	the	the	DET
ghmj-1044	13	9	frequency	frequency	NOUN
ghmj-1044	13	10	of	of	ADP
ghmj-1044	13	11	the	the	DET
ghmj-1044	13	12	ii	ii	PROPN
ghmj-1044	13	13	genotype	genotype	NOUN
ghmj-1044	13	14	was	be	AUX
ghmj-1044	13	15	2	2	NUM
ghmj-1044	13	16	(	(	PUNCT
ghmj-1044	13	17	6.7	6.7	NUM
ghmj-1044	13	18	%	%	NOUN
ghmj-1044	13	19	)	)	PUNCT
ghmj-1044	13	20	,	,	PUNCT
ghmj-1044	13	21	the	the	DET
ghmj-1044	13	22	i	i	PROPN
ghmj-1044	13	23	d	d	PROPN
ghmj-1044	13	24	genotype	genotype	NOUN
ghmj-1044	13	25	was	be	AUX
ghmj-1044	13	26	25	25	NUM
ghmj-1044	13	27	(	(	PUNCT
ghmj-1044	13	28	83.3	83.3	NUM
ghmj-1044	13	29	%	%	NOUN
ghmj-1044	13	30	)	)	PUNCT
ghmj-1044	13	31	,	,	PUNCT
ghmj-1044	13	32	and	and	CCONJ
ghmj-1044	13	33	the	the	DET
ghmj-1044	13	34	dd	dd	NOUN
ghmj-1044	13	35	genotype	genotype	NOUN
ghmj-1044	13	36	was	be	AUX
ghmj-1044	13	37	3	3	NUM
ghmj-1044	13	38	(	(	PUNCT
ghmj-1044	13	39	10.0	10.0	NUM
ghmj-1044	13	40	%	%	NOUN
ghmj-1044	13	41	)	)	PUNCT
ghmj-1044	13	42	.	.	PUNCT
ghmj-1044	14	1	in	in	ADP
ghmj-1044	14	2	the	the	DET
ghmj-1044	14	3	control	control	NOUN
ghmj-1044	14	4	group	group	NOUN
ghmj-1044	14	5	,	,	PUNCT
ghmj-1044	14	6	the	the	DET
ghmj-1044	14	7	frequency	frequency	NOUN
ghmj-1044	14	8	of	of	ADP
ghmj-1044	14	9	the	the	DET
ghmj-1044	14	10	ii	ii	PROPN
ghmj-1044	14	11	genotype	genotype	NOUN
ghmj-1044	14	12	was	be	AUX
ghmj-1044	14	13	2	2	NUM
ghmj-1044	14	14	(	(	PUNCT
ghmj-1044	14	15	6.7	6.7	NUM
ghmj-1044	14	16	%	%	NOUN
ghmj-1044	14	17	)	)	PUNCT
ghmj-1044	14	18	,	,	PUNCT
ghmj-1044	14	19	the	the	DET
ghmj-1044	14	20	i	i	PROPN
ghmj-1044	14	21	d	d	PROPN
ghmj-1044	14	22	genotype	genotype	NOUN
ghmj-1044	14	23	was	be	AUX
ghmj-1044	14	24	26	26	NUM
ghmj-1044	14	25	(	(	PUNCT
ghmj-1044	14	26	86.7	86.7	NUM
ghmj-1044	14	27	%	%	NOUN
ghmj-1044	14	28	)	)	PUNCT
ghmj-1044	14	29	,	,	PUNCT
ghmj-1044	14	30	and	and	CCONJ
ghmj-1044	14	31	the	the	DET
ghmj-1044	14	32	dd	dd	NOUN
ghmj-1044	14	33	genotype	genotype	NOUN
ghmj-1044	14	34	was	be	AUX
ghmj-1044	14	35	2	2	NUM
ghmj-1044	14	36	(	(	PUNCT
ghmj-1044	14	37	6.7	6.7	NUM
ghmj-1044	14	38	%	%	NOUN
ghmj-1044	14	39	)	)	PUNCT
ghmj-1044	14	40	.	.	PUNCT
ghmj-1044	15	1	statistically	statistically	ADV
ghmj-1044	15	2	,	,	PUNCT
ghmj-1044	15	3	there	there	PRON
ghmj-1044	15	4	was	be	VERB
ghmj-1044	15	5	no	no	DET
ghmj-1044	15	6	significant	significant	ADJ
ghmj-1044	15	7	association	association	NOUN
ghmj-1044	15	8	between	between	ADP
ghmj-1044	15	9	ace	ace	PROPN
ghmj-1044	16	1	i	i	PROPN
ghmj-1044	16	2	/	/	SYM
ghmj-1044	16	3	d	d	NOUN
ghmj-1044	16	4	gene	gene	NOUN
ghmj-1044	16	5	polymorphisms	polymorphism	NOUN
ghmj-1044	16	6	in	in	ADP
ghmj-1044	16	7	essential	essential	ADJ
ghmj-1044	16	8	hypertension	hypertension	NOUN
ghmj-1044	16	9	patients	patient	NOUN
ghmj-1044	16	10	and	and	CCONJ
ghmj-1044	16	11	healthy	healthy	ADJ
ghmj-1044	16	12	people	people	NOUN
ghmj-1044	16	13	(	(	PUNCT
ghmj-1044	16	14	p=0.500	p=0.500	NUM
ghmj-1044	16	15	;	;	PUNCT
ghmj-1044	16	16	or=1.556	or=1.556	X
ghmj-1044	16	17	;	;	PUNCT
ghmj-1044	16	18	95	95	NUM
ghmj-1044	16	19	%	%	NOUN
ghmj-1044	16	20	ci=0.241	ci=0.241	NOUN
ghmj-1044	16	21	-	-	PUNCT
ghmj-1044	16	22	10.049	10.049	NUM
ghmj-1044	16	23	)	)	PUNCT
ghmj-1044	16	24	.	.	PUNCT
ghmj-1044	17	1	conclusion	conclusion	NOUN
ghmj-1044	17	2	:	:	PUNCT
ghmj-1044	17	3	ace	ace	VERB
ghmj-1044	17	4	i	i	PRON
ghmj-1044	17	5	/	/	SYM
ghmj-1044	17	6	d	d	NOUN
ghmj-1044	17	7	gene	gene	NOUN
ghmj-1044	17	8	polymorphism	polymorphism	NOUN
ghmj-1044	17	9	was	be	AUX
ghmj-1044	17	10	not	not	PART
ghmj-1044	17	11	significantly	significantly	ADV
ghmj-1044	17	12	associated	associate	VERB
ghmj-1044	17	13	with	with	ADP
ghmj-1044	17	14	essential	essential	ADJ
ghmj-1044	17	15	hypertension	hypertension	NOUN
ghmj-1044	17	16	in	in	ADP
ghmj-1044	17	17	cirebon	cirebon	NOUN
ghmj-1044	17	18	,	,	PUNCT
ghmj-1044	17	19	west	west	PROPN
ghmj-1044	17	20	java	java	PROPN
ghmj-1044	17	21	,	,	PUNCT
ghmj-1044	17	22	indonesia	indonesia	PROPN
ghmj-1044	17	23	.	.	PUNCT
ghmj-1044	18	1	keywords	keyword	NOUN
ghmj-1044	18	2	:	:	PUNCT
ghmj-1044	18	3	polymorphism	polymorphism	NOUN
ghmj-1044	18	4	,	,	PUNCT
ghmj-1044	18	5	ace	ace	NOUN
ghmj-1044	18	6	gene	gene	NOUN
ghmj-1044	18	7	,	,	PUNCT
ghmj-1044	18	8	insertion	insertion	NOUN
ghmj-1044	18	9	-	-	PUNCT
ghmj-1044	18	10	deletion	deletion	NOUN
ghmj-1044	18	11	mutation	mutation	NOUN
ghmj-1044	18	12	,	,	PUNCT
ghmj-1044	18	13	blood	blood	NOUN
ghmj-1044	18	14	pressure	pressure	NOUN
ghmj-1044	18	15	,	,	PUNCT
ghmj-1044	18	16	hypertension	hypertension	NOUN
ghmj-1044	18	17	.	.	PUNCT
ghmj-1044	19	1	received	receive	VERB
ghmj-1044	19	2	:	:	PUNCT
ghmj-1044	19	3	25	25	NUM
ghmj-1044	19	4	september	september	PROPN
ghmj-1044	19	5	2024	2024	NUM
ghmj-1044	19	6	reviewed	review	VERB
ghmj-1044	19	7	:	:	PUNCT
ghmj-1044	19	8	21	21	NUM
ghmj-1044	19	9	october	october	NOUN
ghmj-1044	19	10	2024	2024	NUM
ghmj-1044	19	11	revised	revise	VERB
ghmj-1044	19	12	:	:	PUNCT
ghmj-1044	19	13	23	23	NUM
ghmj-1044	19	14	november	november	NOUN
ghmj-1044	19	15	2024	2024	NUM
ghmj-1044	19	16	accepted	accept	VERB
ghmj-1044	19	17	:	:	PUNCT
ghmj-1044	19	18	30	30	NUM
ghmj-1044	19	19	november	november	NOUN
ghmj-1044	19	20	2024	2024	NUM
ghmj-1044	19	21	©	©	PROPN
ghmj-1044	19	22	yayasan	yayasan	PROPN
ghmj-1044	19	23	aliansi	aliansi	PROPN
ghmj-1044	19	24	cendekiawan	cendekiawan	PROPN
ghmj-1044	19	25	indonesia	indonesia	PROPN
ghmj-1044	19	26	thailand	thailand	PROPN
ghmj-1044	19	27	(	(	PUNCT
ghmj-1044	19	28	indonesian	indonesian	ADJ
ghmj-1044	19	29	scholars	scholar	NOUN
ghmj-1044	19	30	’	’	PART
ghmj-1044	19	31	alliance	alliance	NOUN
ghmj-1044	19	32	)	)	PUNCT
ghmj-1044	19	33	.	.	PUNCT
ghmj-1044	20	1	this	this	PRON
ghmj-1044	20	2	is	be	AUX
ghmj-1044	20	3	an	an	DET
ghmj-1044	20	4	open	open	ADJ
ghmj-1044	20	5	-	-	PUNCT
ghmj-1044	20	6	access	access	NOUN
ghmj-1044	20	7	following	follow	VERB
ghmj-1044	20	8	creative	creative	ADJ
ghmj-1044	20	9	commons	common	NOUN
ghmj-1044	20	10	license	license	NOUN
ghmj-1044	20	11	deed	deed	NOUN
ghmj-1044	20	12	attribution	attribution	NOUN
ghmj-1044	20	13	-	-	PUNCT
ghmj-1044	20	14	noncommercial	noncommercial	ADJ
ghmj-1044	20	15	-	-	PUNCT
ghmj-1044	20	16	sharealike	sharealike	ADJ
ghmj-1044	20	17	4.0	4.0	NUM
ghmj-1044	20	18	international	international	ADJ
ghmj-1044	20	19	(	(	PUNCT
ghmj-1044	20	20	cc	cc	NOUN
ghmj-1044	20	21	by	by	ADP
ghmj-1044	20	22	-	-	PUNCT
ghmj-1044	20	23	nc	nc	PROPN
ghmj-1044	20	24	-	-	PUNCT
ghmj-1044	20	25	sa	sa	PROPN
ghmj-1044	20	26	4.0	4.0	NUM
ghmj-1044	20	27	)	)	PUNCT
ghmj-1044	20	28	mailto:kuswarahasnanurazizah@gmail.com	mailto:kuswarahasnanurazizah@gmail.com	PROPN
ghmj-1044	20	29	mailto:dnauphar@yahoo.com	mailto:dnauphar@yahoo.com	PROPN
ghmj-1044	20	30	https://doi.org/10.35898/ghmj-741044	https://doi.org/10.35898/ghmj-741044	PROPN
ghmj-1044	20	31	https://orcid.org/0009-0008-2203-1824	https://orcid.org/0009-0008-2203-1824	PROPN
ghmj-1044	20	32	https://orcid.org/0000-0002-8708-4715	https://orcid.org/0000-0002-8708-4715	NOUN
ghmj-1044	20	33	https://orcid.org/0000-0003-4037-937x	https://orcid.org/0000-0003-4037-937x	PROPN
ghmj-1044	20	34	181	181	NUM
ghmj-1044	20	35	ghmj	ghmj	NOUN
ghmj-1044	20	36	(	(	PUNCT
ghmj-1044	20	37	global	global	ADJ
ghmj-1044	20	38	health	health	PROPN
ghmj-1044	20	39	management	management	NOUN
ghmj-1044	20	40	journal	journal	PROPN
ghmj-1044	20	41	)	)	PUNCT
ghmj-1044	20	42	2024	2024	NUM
ghmj-1044	20	43	,	,	PUNCT
ghmj-1044	20	44	vol	vol	NOUN
ghmj-1044	20	45	.	.	PROPN
ghmj-1044	20	46	7	7	NUM
ghmj-1044	20	47	,	,	PUNCT
ghmj-1044	20	48	no	no	INTJ
ghmj-1044	20	49	.	.	NOUN
ghmj-1044	20	50	4	4	NUM
ghmj-1044	20	51	kuswara	kuswara	NOUN
ghmj-1044	20	52	,	,	PUNCT
ghmj-1044	20	53	et	et	PROPN
ghmj-1044	20	54	.	.	PUNCT
ghmj-1044	21	1	al	al	PROPN
ghmj-1044	21	2	.	.	PROPN
ghmj-1044	21	3	1	1	NUM
ghmj-1044	21	4	.	.	X
ghmj-1044	21	5	introduction	introduction	NOUN
ghmj-1044	21	6	one	one	NUM
ghmj-1044	21	7	of	of	ADP
ghmj-1044	21	8	the	the	DET
ghmj-1044	21	9	risk	risk	NOUN
ghmj-1044	21	10	factors	factor	NOUN
ghmj-1044	21	11	for	for	ADP
ghmj-1044	21	12	diseases	disease	NOUN
ghmj-1044	21	13	that	that	PRON
ghmj-1044	21	14	cause	cause	VERB
ghmj-1044	21	15	death	death	NOUN
ghmj-1044	21	16	globally	globally	ADV
ghmj-1044	21	17	is	be	AUX
ghmj-1044	21	18	hypertension	hypertension	NOUN
ghmj-1044	21	19	,	,	PUNCT
ghmj-1044	21	20	including	include	VERB
ghmj-1044	21	21	coronary	coronary	ADJ
ghmj-1044	21	22	heart	heart	NOUN
ghmj-1044	21	23	disease	disease	NOUN
ghmj-1044	21	24	,	,	PUNCT
ghmj-1044	21	25	ischemic	ischemic	ADJ
ghmj-1044	21	26	stroke	stroke	NOUN
ghmj-1044	21	27	,	,	PUNCT
ghmj-1044	21	28	and	and	CCONJ
ghmj-1044	21	29	hemorrhagic	hemorrhagic	NOUN
ghmj-1044	21	30	stroke	stroke	NOUN
ghmj-1044	21	31	(	(	PUNCT
ghmj-1044	21	32	world	world	NOUN
ghmj-1044	21	33	health	health	NOUN
ghmj-1044	21	34	organization	organization	NOUN
ghmj-1044	21	35	,	,	PUNCT
ghmj-1044	21	36	2023	2023	NUM
ghmj-1044	21	37	,	,	PUNCT
ghmj-1044	21	38	2024	2024	NUM
ghmj-1044	21	39	)	)	PUNCT
ghmj-1044	21	40	.	.	PUNCT
ghmj-1044	22	1	hypertension	hypertension	NOUN
ghmj-1044	22	2	is	be	AUX
ghmj-1044	22	3	a	a	DET
ghmj-1044	22	4	condition	condition	NOUN
ghmj-1044	22	5	in	in	ADP
ghmj-1044	22	6	which	which	PRON
ghmj-1044	22	7	systolic	systolic	ADJ
ghmj-1044	22	8	blood	blood	NOUN
ghmj-1044	22	9	pressure	pressure	NOUN
ghmj-1044	22	10	≥140	≥140	ADJ
ghmj-1044	22	11	mmhg	mmhg	NOUN
ghmj-1044	22	12	and/or	and/or	CCONJ
ghmj-1044	22	13	diastolic	diastolic	ADJ
ghmj-1044	22	14	blood	blood	NOUN
ghmj-1044	22	15	pressure	pressure	NOUN
ghmj-1044	22	16	≥90	≥90	PROPN
ghmj-1044	22	17	mmhg	mmhg	NOUN
ghmj-1044	22	18	(	(	PUNCT
ghmj-1044	22	19	world	world	NOUN
ghmj-1044	22	20	health	health	NOUN
ghmj-1044	22	21	organization	organization	NOUN
ghmj-1044	22	22	,	,	PUNCT
ghmj-1044	22	23	2023	2023	NUM
ghmj-1044	22	24	)	)	PUNCT
ghmj-1044	22	25	.	.	PUNCT
ghmj-1044	23	1	according	accord	VERB
ghmj-1044	23	2	to	to	ADP
ghmj-1044	23	3	the	the	DET
ghmj-1044	23	4	world	world	PROPN
ghmj-1044	23	5	health	health	NOUN
ghmj-1044	23	6	organization	organization	NOUN
ghmj-1044	23	7	(	(	PUNCT
ghmj-1044	23	8	who	who	PRON
ghmj-1044	23	9	)	)	PUNCT
ghmj-1044	23	10	,	,	PUNCT
ghmj-1044	23	11	an	an	DET
ghmj-1044	23	12	estimated	estimate	VERB
ghmj-1044	23	13	1.13	1.13	NUM
ghmj-1044	23	14	billion	billion	NUM
ghmj-1044	23	15	people	people	NOUN
ghmj-1044	23	16	in	in	ADP
ghmj-1044	23	17	the	the	DET
ghmj-1044	23	18	world	world	NOUN
ghmj-1044	23	19	suffer	suffer	VERB
ghmj-1044	23	20	from	from	ADP
ghmj-1044	23	21	hypertension	hypertension	NOUN
ghmj-1044	23	22	.	.	PUNCT
ghmj-1044	24	1	hypertension	hypertension	NOUN
ghmj-1044	24	2	accounts	account	VERB
ghmj-1044	24	3	for	for	ADP
ghmj-1044	24	4	about	about	ADV
ghmj-1044	24	5	12.8	12.8	NUM
ghmj-1044	24	6	%	%	NOUN
ghmj-1044	24	7	(	(	PUNCT
ghmj-1044	24	8	estimated	estimate	VERB
ghmj-1044	24	9	7.5	7.5	NUM
ghmj-1044	24	10	million	million	NUM
ghmj-1044	24	11	)	)	PUNCT
ghmj-1044	24	12	of	of	ADP
ghmj-1044	24	13	all	all	DET
ghmj-1044	24	14	deaths	death	NOUN
ghmj-1044	24	15	in	in	ADP
ghmj-1044	24	16	the	the	DET
ghmj-1044	24	17	world	world	NOUN
ghmj-1044	24	18	(	(	PUNCT
ghmj-1044	24	19	world	world	NOUN
ghmj-1044	24	20	health	health	NOUN
ghmj-1044	24	21	organization	organization	NOUN
ghmj-1044	24	22	,	,	PUNCT
ghmj-1044	24	23	2023	2023	NUM
ghmj-1044	24	24	)	)	PUNCT
ghmj-1044	24	25	.	.	PUNCT
ghmj-1044	25	1	the	the	DET
ghmj-1044	25	2	prevalence	prevalence	NOUN
ghmj-1044	25	3	of	of	ADP
ghmj-1044	25	4	hypertension	hypertension	NOUN
ghmj-1044	25	5	in	in	ADP
ghmj-1044	25	6	indonesia	indonesia	PROPN
ghmj-1044	25	7	is	be	AUX
ghmj-1044	25	8	34.11	34.11	NUM
ghmj-1044	25	9	%	%	NOUN
ghmj-1044	25	10	of	of	ADP
ghmj-1044	25	11	individuals	individual	NOUN
ghmj-1044	25	12	aged	age	VERB
ghmj-1044	25	13	≥18	≥18	NUM
ghmj-1044	25	14	years	year	NOUN
ghmj-1044	25	15	,	,	PUNCT
ghmj-1044	25	16	while	while	SCONJ
ghmj-1044	25	17	in	in	ADP
ghmj-1044	25	18	west	west	PROPN
ghmj-1044	25	19	java	java	PROPN
ghmj-1044	25	20	province	province	PROPN
ghmj-1044	25	21	,	,	PUNCT
ghmj-1044	25	22	the	the	DET
ghmj-1044	25	23	prevalence	prevalence	NOUN
ghmj-1044	25	24	of	of	ADP
ghmj-1044	25	25	hypertension	hypertension	NOUN
ghmj-1044	25	26	is	be	AUX
ghmj-1044	25	27	39.6	39.6	NUM
ghmj-1044	25	28	%	%	NOUN
ghmj-1044	25	29	(	(	PUNCT
ghmj-1044	25	30	badan	badan	PROPN
ghmj-1044	25	31	penelitian	penelitian	PROPN
ghmj-1044	25	32	dan	dan	PROPN
ghmj-1044	25	33	pengembangan	pengembangan	PROPN
ghmj-1044	25	34	kesehatan	kesehatan	PROPN
ghmj-1044	25	35	kementerian	kementerian	PROPN
ghmj-1044	25	36	kesehatan	kesehatan	PROPN
ghmj-1044	25	37	ri	ri	PROPN
ghmj-1044	25	38	,	,	PUNCT
ghmj-1044	25	39	2019	2019	NUM
ghmj-1044	25	40	)	)	PUNCT
ghmj-1044	25	41	.	.	PUNCT
ghmj-1044	26	1	the	the	DET
ghmj-1044	26	2	estimated	estimate	VERB
ghmj-1044	26	3	number	number	NOUN
ghmj-1044	26	4	of	of	ADP
ghmj-1044	26	5	hypertension	hypertension	NOUN
ghmj-1044	26	6	patients	patient	NOUN
ghmj-1044	26	7	in	in	ADP
ghmj-1044	26	8	cirebon	cirebon	PROPN
ghmj-1044	26	9	regency	regency	PROPN
ghmj-1044	26	10	in	in	ADP
ghmj-1044	26	11	2021	2021	NUM
ghmj-1044	26	12	is	be	AUX
ghmj-1044	26	13	648.030	648.030	NUM
ghmj-1044	26	14	,	,	PUNCT
ghmj-1044	26	15	and	and	CCONJ
ghmj-1044	26	16	73.173	73.173	NUM
ghmj-1044	26	17	,	,	PUNCT
ghmj-1044	26	18	or	or	CCONJ
ghmj-1044	26	19	11.3	11.3	NUM
ghmj-1044	26	20	%	%	NOUN
ghmj-1044	26	21	of	of	ADP
ghmj-1044	26	22	the	the	DET
ghmj-1044	26	23	total	total	ADJ
ghmj-1044	26	24	number	number	NOUN
ghmj-1044	26	25	of	of	ADP
ghmj-1044	26	26	hypertension	hypertension	NOUN
ghmj-1044	26	27	patients	patient	NOUN
ghmj-1044	26	28	,	,	PUNCT
ghmj-1044	26	29	have	have	AUX
ghmj-1044	26	30	received	receive	VERB
ghmj-1044	26	31	medical	medical	ADJ
ghmj-1044	26	32	treatment	treatment	NOUN
ghmj-1044	26	33	according	accord	VERB
ghmj-1044	26	34	to	to	ADP
ghmj-1044	26	35	standards	standard	NOUN
ghmj-1044	26	36	(	(	PUNCT
ghmj-1044	26	37	dinas	dinas	PROPN
ghmj-1044	26	38	kesehatan	kesehatan	PROPN
ghmj-1044	26	39	kabupaten	kabupaten	PROPN
ghmj-1044	26	40	cirebon	cirebon	NOUN
ghmj-1044	26	41	,	,	PUNCT
ghmj-1044	26	42	2021	2021	NUM
ghmj-1044	26	43	)	)	PUNCT
ghmj-1044	26	44	.	.	PUNCT
ghmj-1044	27	1	the	the	DET
ghmj-1044	27	2	estimated	estimate	VERB
ghmj-1044	27	3	number	number	NOUN
ghmj-1044	27	4	of	of	ADP
ghmj-1044	27	5	hypertension	hypertension	NOUN
ghmj-1044	27	6	patients	patient	NOUN
ghmj-1044	27	7	aged	age	VERB
ghmj-1044	27	8	≥15	≥15	VERB
ghmj-1044	27	9	years	year	NOUN
ghmj-1044	27	10	at	at	ADP
ghmj-1044	27	11	the	the	DET
ghmj-1044	27	12	talun	talun	PROPN
ghmj-1044	27	13	health	health	NOUN
ghmj-1044	27	14	center	center	NOUN
ghmj-1044	27	15	is	be	AUX
ghmj-1044	27	16	12.182	12.182	NUM
ghmj-1044	27	17	(	(	PUNCT
ghmj-1044	27	18	dinas	dinas	PROPN
ghmj-1044	27	19	kesehatan	kesehatan	PROPN
ghmj-1044	27	20	kabupaten	kabupaten	PROPN
ghmj-1044	27	21	cirebon	cirebon	NOUN
ghmj-1044	27	22	,	,	PUNCT
ghmj-1044	27	23	2021	2021	NUM
ghmj-1044	27	24	)	)	PUNCT
ghmj-1044	27	25	.	.	PUNCT
ghmj-1044	28	1	essential	essential	ADJ
ghmj-1044	28	2	hypertension	hypertension	NOUN
ghmj-1044	28	3	and	and	CCONJ
ghmj-1044	28	4	secondary	secondary	ADJ
ghmj-1044	28	5	hypertension	hypertension	NOUN
ghmj-1044	28	6	are	be	AUX
ghmj-1044	28	7	the	the	DET
ghmj-1044	28	8	two	two	NUM
ghmj-1044	28	9	types	type	NOUN
ghmj-1044	28	10	of	of	ADP
ghmj-1044	28	11	hypertensions	hypertension	NOUN
ghmj-1044	28	12	that	that	PRON
ghmj-1044	28	13	are	be	AUX
ghmj-1044	28	14	classified	classify	VERB
ghmj-1044	28	15	according	accord	VERB
ghmj-1044	28	16	to	to	ADP
ghmj-1044	28	17	their	their	PRON
ghmj-1044	28	18	causes	cause	NOUN
ghmj-1044	28	19	.	.	PUNCT
ghmj-1044	29	1	essential	essential	ADJ
ghmj-1044	29	2	hypertension	hypertension	NOUN
ghmj-1044	29	3	is	be	AUX
ghmj-1044	29	4	hypertension	hypertension	NOUN
ghmj-1044	29	5	of	of	ADP
ghmj-1044	29	6	unknown	unknown	ADJ
ghmj-1044	29	7	cause	cause	NOUN
ghmj-1044	29	8	.	.	PUNCT
ghmj-1044	30	1	the	the	DET
ghmj-1044	30	2	percentage	percentage	NOUN
ghmj-1044	30	3	of	of	ADP
ghmj-1044	30	4	essential	essential	ADJ
ghmj-1044	30	5	hypertension	hypertension	NOUN
ghmj-1044	30	6	is	be	AUX
ghmj-1044	30	7	90	90	NUM
ghmj-1044	30	8	%	%	NOUN
ghmj-1044	30	9	,	,	PUNCT
ghmj-1044	30	10	while	while	SCONJ
ghmj-1044	30	11	the	the	DET
ghmj-1044	30	12	percentage	percentage	NOUN
ghmj-1044	30	13	of	of	ADP
ghmj-1044	30	14	secondary	secondary	ADJ
ghmj-1044	30	15	hypertension	hypertension	NOUN
ghmj-1044	30	16	,	,	PUNCT
ghmj-1044	30	17	whose	whose	DET
ghmj-1044	30	18	cause	cause	NOUN
ghmj-1044	30	19	is	be	AUX
ghmj-1044	30	20	known	know	VERB
ghmj-1044	30	21	to	to	PART
ghmj-1044	30	22	be	be	AUX
ghmj-1044	30	23	10	10	NUM
ghmj-1044	30	24	%	%	NOUN
ghmj-1044	30	25	(	(	PUNCT
ghmj-1044	30	26	kumar	kumar	PROPN
ghmj-1044	30	27	&	&	CCONJ
ghmj-1044	30	28	clark	clark	PROPN
ghmj-1044	30	29	,	,	PUNCT
ghmj-1044	30	30	2021	2021	NUM
ghmj-1044	30	31	;	;	PUNCT
ghmj-1044	30	32	tortora	tortora	PROPN
ghmj-1044	30	33	&	&	CCONJ
ghmj-1044	30	34	derrickson	derrickson	PROPN
ghmj-1044	30	35	,	,	PUNCT
ghmj-1044	30	36	2014	2014	NUM
ghmj-1044	30	37	)	)	PUNCT
ghmj-1044	30	38	.	.	PUNCT
ghmj-1044	31	1	among	among	ADP
ghmj-1044	31	2	the	the	DET
ghmj-1044	31	3	factors	factor	NOUN
ghmj-1044	31	4	that	that	PRON
ghmj-1044	31	5	cause	cause	VERB
ghmj-1044	31	6	essential	essential	ADJ
ghmj-1044	31	7	hypertension	hypertension	NOUN
ghmj-1044	31	8	are	be	AUX
ghmj-1044	31	9	genetic	genetic	ADJ
ghmj-1044	31	10	factors	factor	NOUN
ghmj-1044	31	11	.	.	PUNCT
ghmj-1044	32	1	an	an	DET
ghmj-1044	32	2	example	example	NOUN
ghmj-1044	32	3	is	be	AUX
ghmj-1044	32	4	the	the	DET
ghmj-1044	32	5	polymorphism	polymorphism	NOUN
ghmj-1044	32	6	of	of	ADP
ghmj-1044	32	7	genes	gene	NOUN
ghmj-1044	32	8	that	that	PRON
ghmj-1044	32	9	regulate	regulate	VERB
ghmj-1044	32	10	blood	blood	NOUN
ghmj-1044	32	11	pressure	pressure	NOUN
ghmj-1044	32	12	,	,	PUNCT
ghmj-1044	32	13	such	such	ADJ
ghmj-1044	32	14	as	as	ADP
ghmj-1044	32	15	angiotensin	angiotensin	NOUN
ghmj-1044	32	16	-	-	PUNCT
ghmj-1044	32	17	converting	convert	VERB
ghmj-1044	32	18	enzyme	enzyme	NOUN
ghmj-1044	32	19	(	(	PUNCT
ghmj-1044	32	20	ace	ace	NOUN
ghmj-1044	32	21	)	)	PUNCT
ghmj-1044	32	22	.	.	PUNCT
ghmj-1044	33	1	(	(	PUNCT
ghmj-1044	33	2	setiati	setiati	NOUN
ghmj-1044	33	3	et	et	PROPN
ghmj-1044	33	4	al	al	PROPN
ghmj-1044	33	5	.	.	PROPN
ghmj-1044	33	6	,	,	PUNCT
ghmj-1044	33	7	2014	2014	NUM
ghmj-1044	33	8	)	)	PUNCT
ghmj-1044	33	9	.	.	PUNCT
ghmj-1044	34	1	the	the	DET
ghmj-1044	34	2	ace	ace	PROPN
ghmj-1044	34	3	gene	gene	NOUN
ghmj-1044	34	4	plays	play	VERB
ghmj-1044	34	5	a	a	DET
ghmj-1044	34	6	crucial	crucial	ADJ
ghmj-1044	34	7	role	role	NOUN
ghmj-1044	34	8	in	in	ADP
ghmj-1044	34	9	the	the	DET
ghmj-1044	34	10	renin	renin	ADJ
ghmj-1044	34	11	-	-	PUNCT
ghmj-1044	34	12	angiotensin	angiotensin	NOUN
ghmj-1044	34	13	-	-	PUNCT
ghmj-1044	34	14	aldosterone	aldosterone	NOUN
ghmj-1044	34	15	system	system	NOUN
ghmj-1044	34	16	(	(	PUNCT
ghmj-1044	34	17	raas	raas	NOUN
ghmj-1044	34	18	)	)	PUNCT
ghmj-1044	34	19	,	,	PUNCT
ghmj-1044	34	20	which	which	PRON
ghmj-1044	34	21	raises	raise	VERB
ghmj-1044	34	22	blood	blood	NOUN
ghmj-1044	34	23	pressure	pressure	NOUN
ghmj-1044	34	24	by	by	ADP
ghmj-1044	34	25	converting	convert	VERB
ghmj-1044	34	26	the	the	DET
ghmj-1044	34	27	inert	inert	ADJ
ghmj-1044	34	28	peptide	peptide	NOUN
ghmj-1044	34	29	angiotensin	angiotensin	NOUN
ghmj-1044	34	30	i	i	PRON
ghmj-1044	34	31	into	into	ADP
ghmj-1044	34	32	the	the	DET
ghmj-1044	34	33	potent	potent	ADJ
ghmj-1044	34	34	vasoconstrictor	vasoconstrictor	NOUN
ghmj-1044	34	35	angiotensin	angiotensin	PROPN
ghmj-1044	34	36	ii	ii	PROPN
ghmj-1044	34	37	.	.	PUNCT
ghmj-1044	35	1	it	it	PRON
ghmj-1044	35	2	also	also	ADV
ghmj-1044	35	3	deactivates	deactivate	VERB
ghmj-1044	35	4	the	the	DET
ghmj-1044	35	5	vasodilator	vasodilator	NOUN
ghmj-1044	35	6	bradykinin	bradykinin	NOUN
ghmj-1044	35	7	(	(	PUNCT
ghmj-1044	35	8	sayed	say	VERB
ghmj-1044	35	9	-	-	PUNCT
ghmj-1044	35	10	tabatabaei	tabatabaei	NOUN
ghmj-1044	35	11	,	,	PUNCT
ghmj-1044	35	12	oostra	oostra	PROPN
ghmj-1044	35	13	,	,	PUNCT
ghmj-1044	35	14	isaacs	isaacs	PROPN
ghmj-1044	35	15	,	,	PUNCT
ghmj-1044	35	16	duijn	duijn	PROPN
ghmj-1044	35	17	,	,	PUNCT
ghmj-1044	35	18	&	&	CCONJ
ghmj-1044	35	19	witteman	witteman	NOUN
ghmj-1044	35	20	,	,	PUNCT
ghmj-1044	35	21	2006	2006	NUM
ghmj-1044	35	22	)	)	PUNCT
ghmj-1044	35	23	.	.	PUNCT
ghmj-1044	36	1	differences	difference	NOUN
ghmj-1044	36	2	in	in	ADP
ghmj-1044	36	3	the	the	DET
ghmj-1044	36	4	ace	ace	NOUN
ghmj-1044	36	5	enzymes	enzyme	NOUN
ghmj-1044	36	6	produced	produce	VERB
ghmj-1044	36	7	can	can	AUX
ghmj-1044	36	8	be	be	AUX
ghmj-1044	36	9	caused	cause	VERB
ghmj-1044	36	10	by	by	ADP
ghmj-1044	36	11	mutations	mutation	NOUN
ghmj-1044	36	12	in	in	ADP
ghmj-1044	36	13	the	the	DET
ghmj-1044	36	14	ace	ace	NOUN
ghmj-1044	36	15	gene	gene	NOUN
ghmj-1044	36	16	.	.	PUNCT
ghmj-1044	37	1	one	one	NUM
ghmj-1044	37	2	of	of	ADP
ghmj-1044	37	3	the	the	DET
ghmj-1044	37	4	most	most	ADV
ghmj-1044	37	5	common	common	ADJ
ghmj-1044	37	6	variations	variation	NOUN
ghmj-1044	37	7	is	be	AUX
ghmj-1044	37	8	the	the	DET
ghmj-1044	37	9	insertion	insertion	NOUN
ghmj-1044	37	10	/	/	SYM
ghmj-1044	37	11	deletion	deletion	NOUN
ghmj-1044	37	12	(	(	PUNCT
ghmj-1044	37	13	i	i	NOUN
ghmj-1044	37	14	/	/	SYM
ghmj-1044	37	15	d	d	NOUN
ghmj-1044	37	16	)	)	PUNCT
ghmj-1044	37	17	of	of	ADP
ghmj-1044	37	18	ace	ace	ADJ
ghmj-1044	37	19	gene	gene	NOUN
ghmj-1044	37	20	.	.	PUNCT
ghmj-1044	38	1	insertion	insertion	NOUN
ghmj-1044	38	2	(	(	PUNCT
ghmj-1044	38	3	i	i	NOUN
ghmj-1044	38	4	)	)	PUNCT
ghmj-1044	38	5	refers	refer	VERB
ghmj-1044	38	6	to	to	ADP
ghmj-1044	38	7	additional	additional	ADJ
ghmj-1044	38	8	deoxyribonucleic	deoxyribonucleic	ADJ
ghmj-1044	38	9	acid	acid	NOUN
ghmj-1044	38	10	(	(	PUNCT
ghmj-1044	38	11	dna	dna	NOUN
ghmj-1044	38	12	)	)	PUNCT
ghmj-1044	38	13	segments	segment	NOUN
ghmj-1044	38	14	in	in	ADP
ghmj-1044	38	15	the	the	DET
ghmj-1044	38	16	ace	ace	NOUN
ghmj-1044	38	17	gene	gene	NOUN
ghmj-1044	38	18	.	.	PUNCT
ghmj-1044	39	1	on	on	ADP
ghmj-1044	39	2	the	the	DET
ghmj-1044	39	3	other	other	ADJ
ghmj-1044	39	4	hand	hand	NOUN
ghmj-1044	39	5	,	,	PUNCT
ghmj-1044	39	6	deletion	deletion	NOUN
ghmj-1044	39	7	(	(	PUNCT
ghmj-1044	39	8	d	d	X
ghmj-1044	39	9	)	)	PUNCT
ghmj-1044	39	10	denotes	denote	VERB
ghmj-1044	39	11	the	the	DET
ghmj-1044	39	12	absence	absence	NOUN
ghmj-1044	39	13	of	of	ADP
ghmj-1044	39	14	specific	specific	ADJ
ghmj-1044	39	15	segments	segment	NOUN
ghmj-1044	39	16	in	in	ADP
ghmj-1044	39	17	the	the	DET
ghmj-1044	39	18	ace	ace	NOUN
ghmj-1044	39	19	gene	gene	NOUN
ghmj-1044	39	20	.	.	PUNCT
ghmj-1044	40	1	possible	possible	ADJ
ghmj-1044	40	2	genotype	genotype	NOUN
ghmj-1044	40	3	combinations	combination	NOUN
ghmj-1044	40	4	are	be	AUX
ghmj-1044	40	5	ii	ii	NUM
ghmj-1044	40	6	,	,	PUNCT
ghmj-1044	40	7	i	i	PROPN
ghmj-1044	40	8	d	d	PROPN
ghmj-1044	40	9	,	,	PUNCT
ghmj-1044	40	10	and	and	CCONJ
ghmj-1044	40	11	dd	dd	X
ghmj-1044	40	12	(	(	PUNCT
ghmj-1044	40	13	eleni	eleni	PROPN
ghmj-1044	40	14	et	et	PROPN
ghmj-1044	40	15	al	al	PROPN
ghmj-1044	40	16	.	.	PROPN
ghmj-1044	40	17	,	,	PUNCT
ghmj-1044	40	18	2008	2008	NUM
ghmj-1044	40	19	;	;	PUNCT
ghmj-1044	40	20	sayed	say	VERB
ghmj-1044	40	21	-	-	PUNCT
ghmj-1044	40	22	tabatabaei	tabatabaei	NOUN
ghmj-1044	40	23	et	et	PROPN
ghmj-1044	40	24	al	al	PROPN
ghmj-1044	40	25	.	.	PROPN
ghmj-1044	40	26	,	,	PUNCT
ghmj-1044	40	27	2006	2006	NUM
ghmj-1044	40	28	)	)	PUNCT
ghmj-1044	40	29	.	.	PUNCT
ghmj-1044	41	1	the	the	DET
ghmj-1044	41	2	alu	alu	NOUN
ghmj-1044	41	3	287	287	NUM
ghmj-1044	41	4	bp	bp	PROPN
ghmj-1044	41	5	sequence	sequence	NOUN
ghmj-1044	41	6	in	in	ADP
ghmj-1044	41	7	intron	intron	ADJ
ghmj-1044	41	8	16	16	NUM
ghmj-1044	41	9	is	be	AUX
ghmj-1044	41	10	where	where	SCONJ
ghmj-1044	41	11	the	the	DET
ghmj-1044	41	12	ace	ace	NOUN
ghmj-1044	41	13	i	i	PROPN
ghmj-1044	41	14	/	/	SYM
ghmj-1044	41	15	d	d	NOUN
ghmj-1044	41	16	polymorphism	polymorphism	NOUN
ghmj-1044	41	17	is	be	AUX
ghmj-1044	41	18	found	find	VERB
ghmj-1044	41	19	(	(	PUNCT
ghmj-1044	41	20	sayed	say	VERB
ghmj-1044	41	21	-	-	PUNCT
ghmj-1044	41	22	tabatabaei	tabatabaei	NOUN
ghmj-1044	41	23	et	et	PROPN
ghmj-1044	41	24	al	al	PROPN
ghmj-1044	41	25	.	.	PROPN
ghmj-1044	41	26	,	,	PUNCT
ghmj-1044	41	27	2006	2006	NUM
ghmj-1044	41	28	)	)	PUNCT
ghmj-1044	41	29	.	.	PUNCT
ghmj-1044	42	1	ace	ace	VERB
ghmj-1044	42	2	i	i	PRON
ghmj-1044	42	3	/	/	SYM
ghmj-1044	42	4	d	d	NOUN
ghmj-1044	42	5	variants	variant	NOUN
ghmj-1044	42	6	have	have	AUX
ghmj-1044	42	7	been	be	AUX
ghmj-1044	42	8	associated	associate	VERB
ghmj-1044	42	9	in	in	ADP
ghmj-1044	42	10	multiple	multiple	ADJ
ghmj-1044	42	11	studies	study	NOUN
ghmj-1044	42	12	with	with	ADP
ghmj-1044	42	13	an	an	DET
ghmj-1044	42	14	increased	increase	VERB
ghmj-1044	42	15	risk	risk	NOUN
ghmj-1044	42	16	of	of	ADP
ghmj-1044	42	17	cardiovascular	cardiovascular	ADJ
ghmj-1044	42	18	diseases	disease	NOUN
ghmj-1044	42	19	such	such	ADJ
ghmj-1044	42	20	as	as	ADP
ghmj-1044	42	21	hypertension	hypertension	NOUN
ghmj-1044	42	22	,	,	PUNCT
ghmj-1044	42	23	stroke	stroke	NOUN
ghmj-1044	42	24	,	,	PUNCT
ghmj-1044	42	25	kidney	kidney	NOUN
ghmj-1044	42	26	disease	disease	NOUN
ghmj-1044	42	27	,	,	PUNCT
ghmj-1044	42	28	psoriasis	psoriasis	NOUN
ghmj-1044	42	29	,	,	PUNCT
ghmj-1044	42	30	and	and	CCONJ
ghmj-1044	42	31	alzheimer	alzheimer	PROPN
ghmj-1044	42	32	's	's	PART
ghmj-1044	42	33	disease	disease	NOUN
ghmj-1044	42	34	.	.	PUNCT
ghmj-1044	43	1	(	(	PUNCT
ghmj-1044	43	2	sayed	say	VERB
ghmj-1044	43	3	-	-	PUNCT
ghmj-1044	43	4	tabatabaei	tabatabaei	NOUN
ghmj-1044	43	5	et	et	PROPN
ghmj-1044	43	6	al	al	PROPN
ghmj-1044	43	7	.	.	PROPN
ghmj-1044	43	8	,	,	PUNCT
ghmj-1044	43	9	2006	2006	NUM
ghmj-1044	43	10	;	;	PUNCT
ghmj-1044	43	11	x.	x.	PROPN
ghmj-1044	43	12	wang	wang	PROPN
ghmj-1044	43	13	et	et	PROPN
ghmj-1044	43	14	al	al	PROPN
ghmj-1044	43	15	.	.	PROPN
ghmj-1044	43	16	,	,	PUNCT
ghmj-1044	43	17	2004	2004	NUM
ghmj-1044	43	18	)	)	PUNCT
ghmj-1044	43	19	.	.	PUNCT
ghmj-1044	44	1	individuals	individual	NOUN
ghmj-1044	44	2	carrying	carry	VERB
ghmj-1044	44	3	the	the	DET
ghmj-1044	44	4	d	d	PROPN
ghmj-1044	44	5	allele	allele	NOUN
ghmj-1044	44	6	tend	tend	VERB
ghmj-1044	44	7	to	to	PART
ghmj-1044	44	8	have	have	VERB
ghmj-1044	44	9	higher	high	ADJ
ghmj-1044	44	10	ace	ace	NOUN
ghmj-1044	44	11	enzyme	enzyme	NOUN
ghmj-1044	44	12	activity	activity	NOUN
ghmj-1044	44	13	,	,	PUNCT
ghmj-1044	44	14	resulting	result	VERB
ghmj-1044	44	15	in	in	ADP
ghmj-1044	44	16	increased	increase	VERB
ghmj-1044	44	17	angiotensin	angiotensin	NOUN
ghmj-1044	44	18	ii	ii	PROPN
ghmj-1044	44	19	production	production	NOUN
ghmj-1044	44	20	,	,	PUNCT
ghmj-1044	44	21	which	which	PRON
ghmj-1044	44	22	can	can	AUX
ghmj-1044	44	23	cause	cause	VERB
ghmj-1044	44	24	vasoconstriction	vasoconstriction	NOUN
ghmj-1044	44	25	and	and	CCONJ
ghmj-1044	44	26	elevated	elevated	ADJ
ghmj-1044	44	27	blood	blood	NOUN
ghmj-1044	44	28	pressure	pressure	NOUN
ghmj-1044	44	29	,	,	PUNCT
ghmj-1044	44	30	thereby	thereby	ADV
ghmj-1044	44	31	increasing	increase	VERB
ghmj-1044	44	32	the	the	DET
ghmj-1044	44	33	risk	risk	NOUN
ghmj-1044	44	34	of	of	ADP
ghmj-1044	44	35	essential	essential	ADJ
ghmj-1044	44	36	hypertension	hypertension	NOUN
ghmj-1044	44	37	(	(	PUNCT
ghmj-1044	44	38	eleni	eleni	PROPN
ghmj-1044	44	39	et	et	PROPN
ghmj-1044	44	40	al	al	PROPN
ghmj-1044	44	41	.	.	PROPN
ghmj-1044	44	42	,	,	PUNCT
ghmj-1044	44	43	2008	2008	NUM
ghmj-1044	44	44	;	;	PUNCT
ghmj-1044	44	45	qadar	qadar	PROPN
ghmj-1044	44	46	pasha	pasha	PROPN
ghmj-1044	44	47	et	et	PROPN
ghmj-1044	44	48	al	al	PROPN
ghmj-1044	44	49	.	.	PROPN
ghmj-1044	44	50	,	,	PUNCT
ghmj-1044	44	51	2002	2002	NUM
ghmj-1044	44	52	;	;	PUNCT
ghmj-1044	44	53	l.	l.	PROPN
ghmj-1044	44	54	wang	wang	PROPN
ghmj-1044	44	55	,	,	PUNCT
ghmj-1044	44	56	song	song	NOUN
ghmj-1044	44	57	,	,	PUNCT
ghmj-1044	44	58	&	&	CCONJ
ghmj-1044	44	59	dong	dong	PROPN
ghmj-1044	44	60	,	,	PUNCT
ghmj-1044	44	61	2023	2023	NUM
ghmj-1044	44	62	)	)	PUNCT
ghmj-1044	44	63	.	.	PUNCT
ghmj-1044	45	1	studies	study	NOUN
ghmj-1044	45	2	on	on	ADP
ghmj-1044	45	3	ace	ace	PROPN
ghmj-1044	45	4	i	i	PROPN
ghmj-1044	45	5	/	/	SYM
ghmj-1044	45	6	d	d	NOUN
ghmj-1044	45	7	polymorphisms	polymorphism	NOUN
ghmj-1044	45	8	have	have	AUX
ghmj-1044	45	9	produced	produce	VERB
ghmj-1044	45	10	conflicting	conflicting	ADJ
ghmj-1044	45	11	results	result	NOUN
ghmj-1044	45	12	,	,	PUNCT
ghmj-1044	45	13	possibly	possibly	ADV
ghmj-1044	45	14	due	due	ADP
ghmj-1044	45	15	to	to	ADP
ghmj-1044	45	16	population	population	NOUN
ghmj-1044	45	17	differences	difference	NOUN
ghmj-1044	45	18	and	and	CCONJ
ghmj-1044	45	19	other	other	ADJ
ghmj-1044	45	20	risk	risk	NOUN
ghmj-1044	45	21	factors	factor	NOUN
ghmj-1044	45	22	.	.	PUNCT
ghmj-1044	46	1	for	for	ADP
ghmj-1044	46	2	instance	instance	NOUN
ghmj-1044	46	3	,	,	PUNCT
ghmj-1044	46	4	research	research	NOUN
ghmj-1044	46	5	conducted	conduct	VERB
ghmj-1044	46	6	on	on	ADP
ghmj-1044	46	7	the	the	DET
ghmj-1044	46	8	ethiopian	ethiopian	ADJ
ghmj-1044	46	9	population	population	NOUN
ghmj-1044	46	10	found	find	VERB
ghmj-1044	46	11	a	a	DET
ghmj-1044	46	12	significant	significant	ADJ
ghmj-1044	46	13	association	association	NOUN
ghmj-1044	46	14	between	between	ADP
ghmj-1044	46	15	the	the	DET
ghmj-1044	46	16	ace	ace	NOUN
ghmj-1044	46	17	i	i	PROPN
ghmj-1044	46	18	/	/	SYM
ghmj-1044	46	19	d	d	NOUN
ghmj-1044	46	20	polymorphism	polymorphism	NOUN
ghmj-1044	46	21	and	and	CCONJ
ghmj-1044	46	22	the	the	DET
ghmj-1044	46	23	risk	risk	NOUN
ghmj-1044	46	24	of	of	ADP
ghmj-1044	46	25	hypertension	hypertension	NOUN
ghmj-1044	46	26	(	(	PUNCT
ghmj-1044	46	27	birhan	birhan	PROPN
ghmj-1044	46	28	,	,	PUNCT
ghmj-1044	46	29	molla	molla	NOUN
ghmj-1044	46	30	,	,	PUNCT
ghmj-1044	46	31	abdulkadir	abdulkadir	NOUN
ghmj-1044	46	32	,	,	PUNCT
ghmj-1044	46	33	&	&	CCONJ
ghmj-1044	46	34	tesfa	tesfa	PROPN
ghmj-1044	46	35	,	,	PUNCT
ghmj-1044	46	36	2022	2022	NUM
ghmj-1044	46	37	)	)	PUNCT
ghmj-1044	46	38	.	.	PUNCT
ghmj-1044	47	1	a	a	DET
ghmj-1044	47	2	correlation	correlation	NOUN
ghmj-1044	47	3	between	between	ADP
ghmj-1044	47	4	hypertension	hypertension	NOUN
ghmj-1044	47	5	and	and	CCONJ
ghmj-1044	47	6	the	the	DET
ghmj-1044	47	7	ace	ace	NOUN
ghmj-1044	47	8	i	i	PROPN
ghmj-1044	47	9	/	/	SYM
ghmj-1044	47	10	d	d	NOUN
ghmj-1044	47	11	gene	gene	NOUN
ghmj-1044	47	12	polymorphism	polymorphism	NOUN
ghmj-1044	47	13	was	be	AUX
ghmj-1044	47	14	discovered	discover	VERB
ghmj-1044	47	15	in	in	ADP
ghmj-1044	47	16	studies	study	NOUN
ghmj-1044	47	17	conducted	conduct	VERB
ghmj-1044	47	18	on	on	ADP
ghmj-1044	47	19	the	the	DET
ghmj-1044	47	20	chinese	chinese	PROPN
ghmj-1044	47	21	steelworker	steelworker	PROPN
ghmj-1044	47	22	community	community	PROPN
ghmj-1044	47	23	(	(	PUNCT
ghmj-1044	47	24	x.	x.	NOUN
ghmj-1044	47	25	zhang	zhang	PROPN
ghmj-1044	47	26	et	et	PROPN
ghmj-1044	47	27	al	al	PROPN
ghmj-1044	47	28	.	.	PROPN
ghmj-1044	47	29	,	,	PUNCT
ghmj-1044	47	30	2022	2022	NUM
ghmj-1044	47	31	)	)	PUNCT
ghmj-1044	47	32	.	.	PUNCT
ghmj-1044	48	1	meanwhile	meanwhile	ADV
ghmj-1044	48	2	,	,	PUNCT
ghmj-1044	48	3	a	a	DET
ghmj-1044	48	4	study	study	NOUN
ghmj-1044	48	5	in	in	ADP
ghmj-1044	48	6	the	the	DET
ghmj-1044	48	7	hefei	hefei	PROPN
ghmj-1044	48	8	region	region	PROPN
ghmj-1044	48	9	of	of	ADP
ghmj-1044	48	10	anhui	anhui	PROPN
ghmj-1044	48	11	,	,	PUNCT
ghmj-1044	48	12	china	china	PROPN
ghmj-1044	48	13	,	,	PUNCT
ghmj-1044	48	14	found	find	VERB
ghmj-1044	48	15	no	no	DET
ghmj-1044	48	16	relationship	relationship	NOUN
ghmj-1044	48	17	between	between	ADP
ghmj-1044	48	18	ace	ace	NOUN
ghmj-1044	48	19	i	i	PROPN
ghmj-1044	48	20	/	/	SYM
ghmj-1044	48	21	d	d	PROPN
ghmj-1044	48	22	gene	gene	NOUN
ghmj-1044	48	23	polymorphism	polymorphism	NOUN
ghmj-1044	48	24	and	and	CCONJ
ghmj-1044	48	25	hypertension	hypertension	NOUN
ghmj-1044	48	26	in	in	ADP
ghmj-1044	48	27	the	the	DET
ghmj-1044	48	28	hefei	hefei	PROPN
ghmj-1044	48	29	region	region	PROPN
ghmj-1044	48	30	of	of	ADP
ghmj-1044	48	31	anhui	anhui	PROPN
ghmj-1044	48	32	,	,	PUNCT
ghmj-1044	48	33	china	china	PROPN
ghmj-1044	48	34	(	(	PUNCT
ghmj-1044	48	35	l.	l.	PROPN
ghmj-1044	48	36	wang	wang	PROPN
ghmj-1044	48	37	et	et	PROPN
ghmj-1044	48	38	al	al	PROPN
ghmj-1044	48	39	.	.	PROPN
ghmj-1044	48	40	,	,	PUNCT
ghmj-1044	48	41	2023	2023	NUM
ghmj-1044	48	42	)	)	PUNCT
ghmj-1044	48	43	.	.	PUNCT
ghmj-1044	49	1	the	the	DET
ghmj-1044	49	2	ace	ace	NOUN
ghmj-1044	49	3	i	i	PROPN
ghmj-1044	49	4	/	/	SYM
ghmj-1044	49	5	d	d	NOUN
ghmj-1044	49	6	polymorphism	polymorphism	NOUN
ghmj-1044	49	7	was	be	AUX
ghmj-1044	49	8	not	not	PART
ghmj-1044	49	9	significantly	significantly	ADV
ghmj-1044	49	10	associated	associate	VERB
ghmj-1044	49	11	with	with	ADP
ghmj-1044	49	12	hypertension	hypertension	NOUN
ghmj-1044	49	13	in	in	ADP
ghmj-1044	49	14	a	a	DET
ghmj-1044	49	15	research	research	NOUN
ghmj-1044	49	16	conducted	conduct	VERB
ghmj-1044	49	17	in	in	ADP
ghmj-1044	49	18	south	south	ADJ
ghmj-1044	49	19	sulawesi	sulawesi	PROPN
ghmj-1044	49	20	,	,	PUNCT
ghmj-1044	49	21	indonesia	indonesia	PROPN
ghmj-1044	49	22	,	,	PUNCT
ghmj-1044	49	23	involving	involve	VERB
ghmj-1044	49	24	99	99	NUM
ghmj-1044	49	25	non	non	ADJ
ghmj-1044	49	26	-	-	ADJ
ghmj-1044	49	27	hypertensive	hypertensive	ADJ
ghmj-1044	49	28	and	and	CCONJ
ghmj-1044	49	29	104	104	NUM
ghmj-1044	49	30	hypertensive	hypertensive	ADJ
ghmj-1044	49	31	patients	patient	NOUN
ghmj-1044	49	32	.	.	PUNCT
ghmj-1044	50	1	(	(	PUNCT
ghmj-1044	50	2	rasyid	rasyid	NOUN
ghmj-1044	50	3	,	,	PUNCT
ghmj-1044	50	4	bakri	bakri	NOUN
ghmj-1044	50	5	,	,	PUNCT
ghmj-1044	50	6	&	&	CCONJ
ghmj-1044	50	7	yusuf	yusuf	PROPN
ghmj-1044	50	8	,	,	PUNCT
ghmj-1044	50	9	2012	2012	NUM
ghmj-1044	50	10	)	)	PUNCT
ghmj-1044	50	11	.	.	PUNCT
ghmj-1044	51	1	to	to	ADP
ghmj-1044	51	2	date	date	NOUN
ghmj-1044	51	3	,	,	PUNCT
ghmj-1044	51	4	no	no	DET
ghmj-1044	51	5	studies	study	NOUN
ghmj-1044	51	6	have	have	AUX
ghmj-1044	51	7	examined	examine	VERB
ghmj-1044	51	8	the	the	DET
ghmj-1044	51	9	connection	connection	NOUN
ghmj-1044	51	10	between	between	ADP
ghmj-1044	51	11	ace	ace	PROPN
ghmj-1044	51	12	i	i	PROPN
ghmj-1044	51	13	/	/	SYM
ghmj-1044	51	14	d	d	NOUN
ghmj-1044	51	15	polymorphisms	polymorphism	NOUN
ghmj-1044	51	16	and	and	CCONJ
ghmj-1044	51	17	risk	risk	NOUN
ghmj-1044	51	18	factors	factor	NOUN
ghmj-1044	51	19	for	for	ADP
ghmj-1044	51	20	hypertension	hypertension	NOUN
ghmj-1044	51	21	in	in	ADP
ghmj-1044	51	22	the	the	DET
ghmj-1044	51	23	population	population	NOUN
ghmj-1044	51	24	of	of	ADP
ghmj-1044	51	25	cirebon	cirebon	PROPN
ghmj-1044	51	26	,	,	PUNCT
ghmj-1044	51	27	west	west	PROPN
ghmj-1044	51	28	java	java	PROPN
ghmj-1044	51	29	,	,	PUNCT
ghmj-1044	51	30	indonesia	indonesia	PROPN
ghmj-1044	51	31	,	,	PUNCT
ghmj-1044	51	32	in	in	ADP
ghmj-1044	51	33	2024	2024	NUM
ghmj-1044	51	34	.	.	PUNCT
ghmj-1044	52	1	therefore	therefore	ADV
ghmj-1044	52	2	,	,	PUNCT
ghmj-1044	52	3	this	this	DET
ghmj-1044	52	4	study	study	NOUN
ghmj-1044	52	5	aims	aim	VERB
ghmj-1044	52	6	to	to	PART
ghmj-1044	52	7	investigate	investigate	VERB
ghmj-1044	52	8	the	the	DET
ghmj-1044	52	9	role	role	NOUN
ghmj-1044	52	10	of	of	ADP
ghmj-1044	52	11	the	the	DET
ghmj-1044	52	12	ace	ace	NOUN
ghmj-1044	52	13	i	i	PROPN
ghmj-1044	52	14	/	/	SYM
ghmj-1044	52	15	d	d	NOUN
ghmj-1044	52	16	polymorphism	polymorphism	NOUN
ghmj-1044	52	17	as	as	ADP
ghmj-1044	52	18	a	a	DET
ghmj-1044	52	19	risk	risk	NOUN
ghmj-1044	52	20	factor	factor	NOUN
ghmj-1044	52	21	for	for	ADP
ghmj-1044	52	22	hypertension	hypertension	NOUN
ghmj-1044	52	23	in	in	ADP
ghmj-1044	52	24	the	the	DET
ghmj-1044	52	25	population	population	NOUN
ghmj-1044	52	26	of	of	ADP
ghmj-1044	52	27	cirebon	cirebon	PROPN
ghmj-1044	52	28	,	,	PUNCT
ghmj-1044	52	29	west	west	PROPN
ghmj-1044	52	30	java	java	PROPN
ghmj-1044	52	31	,	,	PUNCT
ghmj-1044	52	32	indonesia	indonesia	PROPN
ghmj-1044	52	33	,	,	PUNCT
ghmj-1044	52	34	in	in	ADP
ghmj-1044	52	35	2024	2024	NUM
ghmj-1044	52	36	.	.	PUNCT
ghmj-1044	53	1	kuswara	kuswara	PROPN
ghmj-1044	53	2	,	,	PUNCT
ghmj-1044	53	3	et	et	PROPN
ghmj-1044	53	4	.	.	PUNCT
ghmj-1044	54	1	al	al	PROPN
ghmj-1044	54	2	.	.	PROPN
ghmj-1044	54	3	ghmj	ghmj	PROPN
ghmj-1044	54	4	(	(	PUNCT
ghmj-1044	54	5	global	global	ADJ
ghmj-1044	54	6	health	health	PROPN
ghmj-1044	54	7	management	management	NOUN
ghmj-1044	54	8	journal	journal	PROPN
ghmj-1044	54	9	)	)	PUNCT
ghmj-1044	54	10	2024	2024	NUM
ghmj-1044	54	11	,	,	PUNCT
ghmj-1044	54	12	vol	vol	NOUN
ghmj-1044	54	13	.	.	PROPN
ghmj-1044	54	14	7	7	NUM
ghmj-1044	54	15	,	,	PUNCT
ghmj-1044	54	16	no	no	INTJ
ghmj-1044	54	17	.	.	NOUN
ghmj-1044	54	18	4	4	NUM
ghmj-1044	54	19	182	182	NUM
ghmj-1044	54	20	2	2	NUM
ghmj-1044	54	21	.	.	PUNCT
ghmj-1044	55	1	methods	method	NOUN
ghmj-1044	55	2	study	study	VERB
ghmj-1044	55	3	design	design	NOUN
ghmj-1044	55	4	and	and	CCONJ
ghmj-1044	55	5	research	research	NOUN
ghmj-1044	55	6	procedures	procedure	NOUN
ghmj-1044	55	7	this	this	DET
ghmj-1044	55	8	observational	observational	ADJ
ghmj-1044	55	9	analytical	analytical	ADJ
ghmj-1044	55	10	study	study	NOUN
ghmj-1044	55	11	employed	employ	VERB
ghmj-1044	55	12	a	a	DET
ghmj-1044	55	13	case	case	NOUN
ghmj-1044	55	14	-	-	PUNCT
ghmj-1044	55	15	control	control	NOUN
ghmj-1044	55	16	design	design	NOUN
ghmj-1044	55	17	to	to	PART
ghmj-1044	55	18	investigate	investigate	VERB
ghmj-1044	55	19	the	the	DET
ghmj-1044	55	20	relationship	relationship	NOUN
ghmj-1044	55	21	between	between	ADP
ghmj-1044	55	22	ace	ace	PROPN
ghmj-1044	55	23	i	i	PROPN
ghmj-1044	55	24	/	/	SYM
ghmj-1044	55	25	d	d	NOUN
ghmj-1044	55	26	polymorphism	polymorphism	NOUN
ghmj-1044	55	27	and	and	CCONJ
ghmj-1044	55	28	essential	essential	ADJ
ghmj-1044	55	29	hypertension	hypertension	NOUN
ghmj-1044	55	30	in	in	ADP
ghmj-1044	55	31	cirebon	cirebon	NOUN
ghmj-1044	55	32	,	,	PUNCT
ghmj-1044	55	33	west	west	PROPN
ghmj-1044	55	34	java	java	PROPN
ghmj-1044	55	35	,	,	PUNCT
ghmj-1044	55	36	indonesia	indonesia	PROPN
ghmj-1044	55	37	.	.	PUNCT
ghmj-1044	56	1	this	this	DET
ghmj-1044	56	2	study	study	NOUN
ghmj-1044	56	3	compared	compare	VERB
ghmj-1044	56	4	hypertensive	hypertensive	ADJ
ghmj-1044	56	5	patients	patient	NOUN
ghmj-1044	56	6	,	,	PUNCT
ghmj-1044	56	7	who	who	PRON
ghmj-1044	56	8	represented	represent	VERB
ghmj-1044	56	9	the	the	DET
ghmj-1044	56	10	affected	affected	ADJ
ghmj-1044	56	11	individuals	individual	NOUN
ghmj-1044	56	12	(	(	PUNCT
ghmj-1044	56	13	cases	case	NOUN
ghmj-1044	56	14	)	)	PUNCT
ghmj-1044	56	15	,	,	PUNCT
ghmj-1044	56	16	and	and	CCONJ
ghmj-1044	56	17	healthy	healthy	ADJ
ghmj-1044	56	18	individuals	individual	NOUN
ghmj-1044	56	19	as	as	ADP
ghmj-1044	56	20	the	the	DET
ghmj-1044	56	21	unaffected	unaffected	ADJ
ghmj-1044	56	22	controls	control	NOUN
ghmj-1044	56	23	.	.	PUNCT
ghmj-1044	57	1	participants	participant	NOUN
ghmj-1044	57	2	were	be	AUX
ghmj-1044	57	3	selected	select	VERB
ghmj-1044	57	4	through	through	ADP
ghmj-1044	57	5	purposive	purposive	ADJ
ghmj-1044	57	6	sampling	sampling	NOUN
ghmj-1044	57	7	based	base	VERB
ghmj-1044	57	8	on	on	ADP
ghmj-1044	57	9	predefined	predefine	VERB
ghmj-1044	57	10	inclusion	inclusion	NOUN
ghmj-1044	57	11	and	and	CCONJ
ghmj-1044	57	12	exclusion	exclusion	NOUN
ghmj-1044	57	13	criteria	criterion	NOUN
ghmj-1044	57	14	.	.	PUNCT
ghmj-1044	58	1	the	the	DET
ghmj-1044	58	2	case	case	NOUN
ghmj-1044	58	3	-	-	PUNCT
ghmj-1044	58	4	control	control	NOUN
ghmj-1044	58	5	approach	approach	NOUN
ghmj-1044	58	6	determined	determine	VERB
ghmj-1044	58	7	a	a	DET
ghmj-1044	58	8	total	total	ADJ
ghmj-1044	58	9	sample	sample	NOUN
ghmj-1044	58	10	size	size	NOUN
ghmj-1044	58	11	of	of	ADP
ghmj-1044	58	12	60	60	NUM
ghmj-1044	58	13	participants	participant	NOUN
ghmj-1044	58	14	,	,	PUNCT
ghmj-1044	58	15	comprising	comprise	VERB
ghmj-1044	58	16	30	30	NUM
ghmj-1044	58	17	individuals	individual	NOUN
ghmj-1044	58	18	in	in	ADP
ghmj-1044	58	19	the	the	DET
ghmj-1044	58	20	case	case	NOUN
ghmj-1044	58	21	group	group	NOUN
ghmj-1044	58	22	and	and	CCONJ
ghmj-1044	58	23	30	30	NUM
ghmj-1044	58	24	individuals	individual	NOUN
ghmj-1044	58	25	in	in	ADP
ghmj-1044	58	26	the	the	DET
ghmj-1044	58	27	control	control	NOUN
ghmj-1044	58	28	group	group	NOUN
ghmj-1044	58	29	.	.	PUNCT
ghmj-1044	59	1	the	the	DET
ghmj-1044	59	2	subjects	subject	NOUN
ghmj-1044	59	3	were	be	AUX
ghmj-1044	59	4	categorized	categorize	VERB
ghmj-1044	59	5	into	into	ADP
ghmj-1044	59	6	two	two	NUM
ghmj-1044	59	7	groups	group	NOUN
ghmj-1044	59	8	:	:	PUNCT
ghmj-1044	59	9	the	the	DET
ghmj-1044	59	10	case	case	NOUN
ghmj-1044	59	11	group	group	NOUN
ghmj-1044	59	12	,	,	PUNCT
ghmj-1044	59	13	which	which	PRON
ghmj-1044	59	14	included	include	VERB
ghmj-1044	59	15	patients	patient	NOUN
ghmj-1044	59	16	diagnosed	diagnose	VERB
ghmj-1044	59	17	with	with	ADP
ghmj-1044	59	18	essential	essential	ADJ
ghmj-1044	59	19	hypertension	hypertension	NOUN
ghmj-1044	59	20	according	accord	VERB
ghmj-1044	59	21	to	to	ADP
ghmj-1044	59	22	jnc	jnc	PROPN
ghmj-1044	59	23	viii	viii	PROPN
ghmj-1044	59	24	criteria	criterion	NOUN
ghmj-1044	59	25	,	,	PUNCT
ghmj-1044	59	26	and	and	CCONJ
ghmj-1044	59	27	those	those	PRON
ghmj-1044	59	28	with	with	ADP
ghmj-1044	59	29	a	a	DET
ghmj-1044	59	30	history	history	NOUN
ghmj-1044	59	31	of	of	ADP
ghmj-1044	59	32	essential	essential	ADJ
ghmj-1044	59	33	hypertension	hypertension	NOUN
ghmj-1044	59	34	,	,	PUNCT
ghmj-1044	59	35	receiving	receive	VERB
ghmj-1044	59	36	antihypertensive	antihypertensive	ADJ
ghmj-1044	59	37	medications	medication	NOUN
ghmj-1044	59	38	for	for	ADP
ghmj-1044	59	39	more	more	ADJ
ghmj-1044	59	40	than	than	ADP
ghmj-1044	59	41	3	3	NUM
ghmj-1044	59	42	months	month	NOUN
ghmj-1044	59	43	.	.	PUNCT
ghmj-1044	60	1	the	the	DET
ghmj-1044	60	2	control	control	PROPN
ghmj-1044	60	3	group	group	NOUN
ghmj-1044	60	4	consisted	consist	VERB
ghmj-1044	60	5	of	of	ADP
ghmj-1044	60	6	healthy	healthy	ADJ
ghmj-1044	60	7	individuals	individual	NOUN
ghmj-1044	60	8	without	without	ADP
ghmj-1044	60	9	a	a	DET
ghmj-1044	60	10	history	history	NOUN
ghmj-1044	60	11	of	of	ADP
ghmj-1044	60	12	essential	essential	ADJ
ghmj-1044	60	13	or	or	CCONJ
ghmj-1044	60	14	secondary	secondary	ADJ
ghmj-1044	60	15	hypertension	hypertension	NOUN
ghmj-1044	60	16	,	,	PUNCT
ghmj-1044	60	17	and	and	CCONJ
ghmj-1044	60	18	who	who	PRON
ghmj-1044	60	19	were	be	AUX
ghmj-1044	60	20	not	not	PART
ghmj-1044	60	21	taking	take	VERB
ghmj-1044	60	22	antihypertensive	antihypertensive	ADJ
ghmj-1044	60	23	medications	medication	NOUN
ghmj-1044	60	24	.	.	PUNCT
ghmj-1044	61	1	control	control	NOUN
ghmj-1044	61	2	subjects	subject	NOUN
ghmj-1044	61	3	were	be	AUX
ghmj-1044	61	4	matched	match	VERB
ghmj-1044	61	5	with	with	ADP
ghmj-1044	61	6	case	case	NOUN
ghmj-1044	61	7	subjects	subject	NOUN
ghmj-1044	61	8	by	by	ADP
ghmj-1044	61	9	age	age	NOUN
ghmj-1044	61	10	(	(	PUNCT
ghmj-1044	61	11	±	±	NOUN
ghmj-1044	61	12	2	2	NUM
ghmj-1044	61	13	years	year	NOUN
ghmj-1044	61	14	)	)	PUNCT
ghmj-1044	61	15	.	.	PUNCT
ghmj-1044	62	1	to	to	PART
ghmj-1044	62	2	reduce	reduce	VERB
ghmj-1044	62	3	bias	bias	NOUN
ghmj-1044	62	4	,	,	PUNCT
ghmj-1044	62	5	patients	patient	NOUN
ghmj-1044	62	6	who	who	PRON
ghmj-1044	62	7	were	be	AUX
ghmj-1044	62	8	pregnant	pregnant	ADJ
ghmj-1044	62	9	or	or	CCONJ
ghmj-1044	62	10	breastfeeding	breastfeeding	NOUN
ghmj-1044	62	11	,	,	PUNCT
ghmj-1044	62	12	or	or	CCONJ
ghmj-1044	62	13	had	have	VERB
ghmj-1044	62	14	a	a	DET
ghmj-1044	62	15	history	history	NOUN
ghmj-1044	62	16	of	of	ADP
ghmj-1044	62	17	diabetes	diabetes	NOUN
ghmj-1044	62	18	mellitus	mellitus	NOUN
ghmj-1044	62	19	,	,	PUNCT
ghmj-1044	62	20	renal	renal	ADJ
ghmj-1044	62	21	disease	disease	NOUN
ghmj-1044	62	22	,	,	PUNCT
ghmj-1044	62	23	coronary	coronary	ADJ
ghmj-1044	62	24	heart	heart	NOUN
ghmj-1044	62	25	disease	disease	NOUN
ghmj-1044	62	26	,	,	PUNCT
ghmj-1044	62	27	or	or	CCONJ
ghmj-1044	62	28	other	other	ADJ
ghmj-1044	62	29	cardiovascular	cardiovascular	ADJ
ghmj-1044	62	30	disease	disease	NOUN
ghmj-1044	62	31	were	be	AUX
ghmj-1044	62	32	excluded	exclude	VERB
ghmj-1044	62	33	from	from	ADP
ghmj-1044	62	34	the	the	DET
ghmj-1044	62	35	case	case	NOUN
ghmj-1044	62	36	group	group	NOUN
ghmj-1044	62	37	.	.	PUNCT
ghmj-1044	63	1	measurements	measurement	NOUN
ghmj-1044	63	2	screening	screen	VERB
ghmj-1044	63	3	and	and	CCONJ
ghmj-1044	63	4	blood	blood	NOUN
ghmj-1044	63	5	collection	collection	NOUN
ghmj-1044	63	6	of	of	ADP
ghmj-1044	63	7	subjects	subject	NOUN
ghmj-1044	63	8	data	datum	NOUN
ghmj-1044	63	9	collection	collection	NOUN
ghmj-1044	63	10	and	and	CCONJ
ghmj-1044	63	11	sample	sample	NOUN
ghmj-1044	63	12	acquisition	acquisition	NOUN
ghmj-1044	63	13	were	be	AUX
ghmj-1044	63	14	conducted	conduct	VERB
ghmj-1044	63	15	between	between	ADP
ghmj-1044	63	16	march	march	PROPN
ghmj-1044	63	17	and	and	CCONJ
ghmj-1044	63	18	august	august	PROPN
ghmj-1044	63	19	2024	2024	NUM
ghmj-1044	63	20	at	at	ADP
ghmj-1044	63	21	the	the	DET
ghmj-1044	63	22	talun	talun	ADJ
ghmj-1044	63	23	public	public	ADJ
ghmj-1044	63	24	health	health	NOUN
ghmj-1044	63	25	center	center	NOUN
ghmj-1044	63	26	in	in	ADP
ghmj-1044	63	27	cirebon	cirebon	NOUN
ghmj-1044	63	28	.	.	PUNCT
ghmj-1044	64	1	genetic	genetic	ADJ
ghmj-1044	64	2	analysis	analysis	NOUN
ghmj-1044	64	3	was	be	AUX
ghmj-1044	64	4	performed	perform	VERB
ghmj-1044	64	5	at	at	ADP
ghmj-1044	64	6	the	the	DET
ghmj-1044	64	7	research	research	NOUN
ghmj-1044	64	8	laboratory	laboratory	NOUN
ghmj-1044	64	9	of	of	ADP
ghmj-1044	64	10	the	the	DET
ghmj-1044	64	11	faculty	faculty	NOUN
ghmj-1044	64	12	of	of	ADP
ghmj-1044	64	13	medicine	medicine	NOUN
ghmj-1044	64	14	at	at	ADP
ghmj-1044	64	15	universitas	universita	NOUN
ghmj-1044	64	16	swadaya	swadaya	VERB
ghmj-1044	64	17	gunung	gunung	PROPN
ghmj-1044	64	18	jati	jati	PROPN
ghmj-1044	64	19	.	.	PUNCT
ghmj-1044	65	1	after	after	ADP
ghmj-1044	65	2	obtaining	obtain	VERB
ghmj-1044	65	3	informed	informed	ADJ
ghmj-1044	65	4	consent	consent	NOUN
ghmj-1044	65	5	,	,	PUNCT
ghmj-1044	65	6	participants	participant	NOUN
ghmj-1044	65	7	who	who	PRON
ghmj-1044	65	8	met	meet	VERB
ghmj-1044	65	9	the	the	DET
ghmj-1044	65	10	study	study	NOUN
ghmj-1044	65	11	criteria	criterion	NOUN
ghmj-1044	65	12	were	be	AUX
ghmj-1044	65	13	screened	screen	VERB
ghmj-1044	65	14	using	use	VERB
ghmj-1044	65	15	a	a	DET
ghmj-1044	65	16	questionnaire	questionnaire	NOUN
ghmj-1044	65	17	.	.	PUNCT
ghmj-1044	66	1	clinical	clinical	ADJ
ghmj-1044	66	2	characteristics	characteristic	NOUN
ghmj-1044	66	3	collected	collect	VERB
ghmj-1044	66	4	during	during	ADP
ghmj-1044	66	5	screening	screen	VERB
ghmj-1044	66	6	included	include	VERB
ghmj-1044	66	7	age	age	NOUN
ghmj-1044	66	8	,	,	PUNCT
ghmj-1044	66	9	gender	gender	NOUN
ghmj-1044	66	10	,	,	PUNCT
ghmj-1044	66	11	occupation	occupation	NOUN
ghmj-1044	66	12	,	,	PUNCT
ghmj-1044	66	13	ethnicity	ethnicity	NOUN
ghmj-1044	66	14	,	,	PUNCT
ghmj-1044	66	15	body	body	NOUN
ghmj-1044	66	16	mass	mass	NOUN
ghmj-1044	66	17	index	index	NOUN
ghmj-1044	66	18	(	(	PUNCT
ghmj-1044	66	19	bmi	bmi	PROPN
ghmj-1044	66	20	)	)	PUNCT
ghmj-1044	66	21	,	,	PUNCT
ghmj-1044	66	22	smoking	smoking	NOUN
ghmj-1044	66	23	status	status	NOUN
ghmj-1044	66	24	,	,	PUNCT
ghmj-1044	66	25	dietary	dietary	ADJ
ghmj-1044	66	26	habits	habit	NOUN
ghmj-1044	66	27	,	,	PUNCT
ghmj-1044	66	28	and	and	CCONJ
ghmj-1044	66	29	family	family	NOUN
ghmj-1044	66	30	history	history	NOUN
ghmj-1044	66	31	of	of	ADP
ghmj-1044	66	32	hypertension	hypertension	NOUN
ghmj-1044	66	33	.	.	PUNCT
ghmj-1044	67	1	furthermore	furthermore	ADV
ghmj-1044	67	2	,	,	PUNCT
ghmj-1044	67	3	blood	blood	NOUN
ghmj-1044	67	4	pressure	pressure	NOUN
ghmj-1044	67	5	was	be	AUX
ghmj-1044	67	6	measured	measure	VERB
ghmj-1044	67	7	three	three	NUM
ghmj-1044	67	8	times	time	NOUN
ghmj-1044	67	9	,	,	PUNCT
ghmj-1044	67	10	with	with	ADP
ghmj-1044	67	11	3	3	NUM
ghmj-1044	67	12	to	to	PART
ghmj-1044	67	13	5	5	NUM
ghmj-1044	67	14	minutes	minute	NOUN
ghmj-1044	67	15	between	between	ADP
ghmj-1044	67	16	each	each	DET
ghmj-1044	67	17	measurement	measurement	NOUN
ghmj-1044	67	18	.	.	PUNCT
ghmj-1044	68	1	blood	blood	NOUN
ghmj-1044	68	2	samples	sample	NOUN
ghmj-1044	68	3	(	(	PUNCT
ghmj-1044	68	4	3–5	3–5	NUM
ghmj-1044	68	5	cc	cc	NOUN
ghmj-1044	68	6	)	)	PUNCT
ghmj-1044	68	7	were	be	AUX
ghmj-1044	68	8	collected	collect	VERB
ghmj-1044	68	9	at	at	ADP
ghmj-1044	68	10	the	the	DET
ghmj-1044	68	11	talun	talun	ADJ
ghmj-1044	68	12	public	public	ADJ
ghmj-1044	68	13	health	health	NOUN
ghmj-1044	68	14	center	center	NOUN
ghmj-1044	68	15	,	,	PUNCT
ghmj-1044	68	16	placed	place	VERB
ghmj-1044	68	17	in	in	ADP
ghmj-1044	68	18	edta	edta	NOUN
ghmj-1044	68	19	tubes	tube	NOUN
ghmj-1044	68	20	,	,	PUNCT
ghmj-1044	68	21	and	and	CCONJ
ghmj-1044	68	22	sent	send	VERB
ghmj-1044	68	23	to	to	ADP
ghmj-1044	68	24	the	the	DET
ghmj-1044	68	25	research	research	NOUN
ghmj-1044	68	26	laboratory	laboratory	NOUN
ghmj-1044	68	27	at	at	ADP
ghmj-1044	68	28	universitas	universita	NOUN
ghmj-1044	68	29	swadaya	swadaya	VERB
ghmj-1044	68	30	gunung	gunung	NOUN
ghmj-1044	68	31	jati	jati	NOUN
ghmj-1044	68	32	cirebon	cirebon	NOUN
ghmj-1044	68	33	for	for	ADP
ghmj-1044	68	34	genetic	genetic	ADJ
ghmj-1044	68	35	analysis	analysis	NOUN
ghmj-1044	68	36	.	.	PUNCT
ghmj-1044	69	1	dna	dna	PROPN
ghmj-1044	69	2	extraction	extraction	VERB
ghmj-1044	69	3	the	the	DET
ghmj-1044	69	4	dna	dna	PROPN
ghmj-1044	69	5	extraction	extraction	NOUN
ghmj-1044	69	6	was	be	AUX
ghmj-1044	69	7	performed	perform	VERB
ghmj-1044	69	8	using	use	VERB
ghmj-1044	69	9	the	the	DET
ghmj-1044	69	10	salting	salting	NOUN
ghmj-1044	69	11	-	-	PUNCT
ghmj-1044	69	12	out	out	ADP
ghmj-1044	69	13	method	method	NOUN
ghmj-1044	69	14	with	with	ADP
ghmj-1044	69	15	the	the	DET
ghmj-1044	69	16	tiangen	tiangen	NOUN
ghmj-1044	69	17	tianamp	tianamp	PROPN
ghmj-1044	69	18	dna	dna	PROPN
ghmj-1044	69	19	/	/	SYM
ghmj-1044	69	20	rna	rna	NOUN
ghmj-1044	69	21	extraction	extraction	NOUN
ghmj-1044	69	22	kit	kit	NOUN
ghmj-1044	69	23	.	.	PUNCT
ghmj-1044	70	1	upon	upon	SCONJ
ghmj-1044	70	2	completion	completion	NOUN
ghmj-1044	70	3	of	of	ADP
ghmj-1044	70	4	the	the	DET
ghmj-1044	70	5	extraction	extraction	NOUN
ghmj-1044	70	6	process	process	NOUN
ghmj-1044	70	7	,	,	PUNCT
ghmj-1044	70	8	the	the	DET
ghmj-1044	70	9	dna	dna	NOUN
ghmj-1044	70	10	was	be	AUX
ghmj-1044	70	11	stored	store	VERB
ghmj-1044	70	12	at	at	ADP
ghmj-1044	70	13	-20	-20	PUNCT
ghmj-1044	70	14	℃	℃	PROPN
ghmj-1044	70	15	in	in	ADP
ghmj-1044	70	16	the	the	DET
ghmj-1044	70	17	freezer	freezer	NOUN
ghmj-1044	70	18	.	.	PUNCT
ghmj-1044	71	1	dna	dna	PROPN
ghmj-1044	71	2	amplification	amplification	NOUN
ghmj-1044	71	3	the	the	DET
ghmj-1044	71	4	extracted	extract	VERB
ghmj-1044	71	5	genomic	genomic	ADJ
ghmj-1044	71	6	dna	dna	NOUN
ghmj-1044	71	7	from	from	ADP
ghmj-1044	71	8	hypertensive	hypertensive	ADJ
ghmj-1044	71	9	patients	patient	NOUN
ghmj-1044	71	10	was	be	AUX
ghmj-1044	71	11	amplified	amplify	VERB
ghmj-1044	71	12	using	use	VERB
ghmj-1044	71	13	the	the	DET
ghmj-1044	71	14	arms	arm	NOUN
ghmj-1044	71	15	-	-	PUNCT
ghmj-1044	71	16	pcr	pcr	NOUN
ghmj-1044	71	17	technique	technique	NOUN
ghmj-1044	71	18	.	.	PUNCT
ghmj-1044	72	1	the	the	DET
ghmj-1044	72	2	forward	forward	ADJ
ghmj-1044	72	3	primer	primer	NOUN
ghmj-1044	72	4	used	use	VERB
ghmj-1044	72	5	was	be	AUX
ghmj-1044	72	6	5’–ctggagaccactcccatcctttct–3	5’–ctggagaccactcccatcctttct–3	NUM
ghmj-1044	72	7	’	'	PUNCT
ghmj-1044	72	8	,	,	PUNCT
ghmj-1044	72	9	and	and	CCONJ
ghmj-1044	72	10	the	the	DET
ghmj-1044	72	11	reverse	reverse	ADJ
ghmj-1044	72	12	primer	primer	NOUN
ghmj-1044	72	13	was	be	AUX
ghmj-1044	72	14	5	5	NUM
ghmj-1044	72	15	’	'	PUNCT
ghmj-1044	72	16	–	–	PUNCT
ghmj-1044	72	17	gatgtggccatcacattcgtcagat–3	gatgtggccatcacattcgtcagat–3	PROPN
ghmj-1044	72	18	’	'	PUNCT
ghmj-1044	72	19	.	.	PUNCT
ghmj-1044	73	1	the	the	DET
ghmj-1044	73	2	total	total	ADJ
ghmj-1044	73	3	volume	volume	NOUN
ghmj-1044	73	4	for	for	ADP
ghmj-1044	73	5	the	the	DET
ghmj-1044	73	6	amplification	amplification	NOUN
ghmj-1044	73	7	reaction	reaction	NOUN
ghmj-1044	73	8	was	be	AUX
ghmj-1044	73	9	25	25	NUM
ghmj-1044	73	10	μl	μl	NUM
ghmj-1044	73	11	,	,	PUNCT
ghmj-1044	73	12	which	which	PRON
ghmj-1044	73	13	included	include	VERB
ghmj-1044	73	14	12.5	12.5	NUM
ghmj-1044	73	15	μl	μl	ADP
ghmj-1044	73	16	of	of	ADP
ghmj-1044	73	17	pcr	pcr	NOUN
ghmj-1044	73	18	taq	taq	NOUN
ghmj-1044	73	19	master	master	NOUN
ghmj-1044	73	20	mix	mix	NOUN
ghmj-1044	73	21	,	,	PUNCT
ghmj-1044	73	22	1.0	1.0	NUM
ghmj-1044	73	23	μl	μl	ADP
ghmj-1044	73	24	each	each	PRON
ghmj-1044	73	25	of	of	ADP
ghmj-1044	73	26	upstream	upstream	ADJ
ghmj-1044	73	27	and	and	CCONJ
ghmj-1044	73	28	downstream	downstream	ADJ
ghmj-1044	73	29	primers	primer	NOUN
ghmj-1044	73	30	,	,	PUNCT
ghmj-1044	73	31	1.0	1.0	NUM
ghmj-1044	73	32	μl	μl	NOUN
ghmj-1044	73	33	of	of	ADP
ghmj-1044	73	34	dna	dna	PROPN
ghmj-1044	73	35	template	template	NOUN
ghmj-1044	73	36	,	,	PUNCT
ghmj-1044	73	37	and	and	CCONJ
ghmj-1044	73	38	9.5	9.5	NUM
ghmj-1044	73	39	μl	μl	ADP
ghmj-1044	73	40	of	of	ADP
ghmj-1044	73	41	deionized	deionize	VERB
ghmj-1044	73	42	water	water	NOUN
ghmj-1044	73	43	.	.	PUNCT
ghmj-1044	74	1	the	the	DET
ghmj-1044	74	2	arms	arm	NOUN
ghmj-1044	74	3	-	-	PUNCT
ghmj-1044	74	4	pcr	pcr	NOUN
ghmj-1044	74	5	condition	condition	NOUN
ghmj-1044	74	6	included	include	VERB
ghmj-1044	74	7	an	an	DET
ghmj-1044	74	8	initial	initial	ADJ
ghmj-1044	74	9	pre	pre	ADJ
ghmj-1044	74	10	-	-	ADJ
ghmj-1044	74	11	denaturation	denaturation	ADJ
ghmj-1044	74	12	step	step	NOUN
ghmj-1044	74	13	at	at	ADP
ghmj-1044	74	14	95	95	NUM
ghmj-1044	74	15	°	°	ADP
ghmj-1044	74	16	c	c	NOUN
ghmj-1044	74	17	for	for	ADP
ghmj-1044	74	18	5	5	NUM
ghmj-1044	74	19	minutes	minute	NOUN
ghmj-1044	74	20	,	,	PUNCT
ghmj-1044	74	21	followed	follow	VERB
ghmj-1044	74	22	by	by	ADP
ghmj-1044	74	23	denaturation	denaturation	NOUN
ghmj-1044	74	24	at	at	ADP
ghmj-1044	74	25	94	94	NUM
ghmj-1044	74	26	°	°	ADP
ghmj-1044	74	27	c	c	NOUN
ghmj-1044	74	28	for	for	ADP
ghmj-1044	74	29	30	30	NUM
ghmj-1044	74	30	seconds	second	NOUN
ghmj-1044	74	31	,	,	PUNCT
ghmj-1044	74	32	annealing	anneal	VERB
ghmj-1044	74	33	at	at	ADP
ghmj-1044	74	34	58	58	NUM
ghmj-1044	74	35	°	°	ADP
ghmj-1044	74	36	c	c	NOUN
ghmj-1044	74	37	for	for	ADP
ghmj-1044	74	38	30	30	NUM
ghmj-1044	74	39	seconds	second	NOUN
ghmj-1044	74	40	,	,	PUNCT
ghmj-1044	74	41	and	and	CCONJ
ghmj-1044	74	42	extension	extension	NOUN
ghmj-1044	74	43	at	at	ADP
ghmj-1044	74	44	72	72	NUM
ghmj-1044	74	45	°	°	ADP
ghmj-1044	74	46	c	c	NOUN
ghmj-1044	74	47	for	for	ADP
ghmj-1044	74	48	40	40	NUM
ghmj-1044	74	49	seconds	second	NOUN
ghmj-1044	74	50	.	.	PUNCT
ghmj-1044	75	1	starting	start	VERB
ghmj-1044	75	2	from	from	ADP
ghmj-1044	75	3	denaturation	denaturation	NOUN
ghmj-1044	75	4	to	to	ADP
ghmj-1044	75	5	extension	extension	NOUN
ghmj-1044	75	6	,	,	PUNCT
ghmj-1044	75	7	the	the	DET
ghmj-1044	75	8	cycle	cycle	NOUN
ghmj-1044	75	9	was	be	AUX
ghmj-1044	75	10	repeated	repeat	VERB
ghmj-1044	75	11	35	35	NUM
ghmj-1044	75	12	times	time	NOUN
ghmj-1044	75	13	.	.	PUNCT
ghmj-1044	76	1	a	a	DET
ghmj-1044	76	2	final	final	ADJ
ghmj-1044	76	3	terminal	terminal	ADJ
ghmj-1044	76	4	extension	extension	NOUN
ghmj-1044	76	5	was	be	AUX
ghmj-1044	76	6	performed	perform	VERB
ghmj-1044	76	7	at	at	ADP
ghmj-1044	76	8	72	72	NUM
ghmj-1044	76	9	°	°	ADP
ghmj-1044	76	10	c	c	NOUN
ghmj-1044	76	11	for	for	ADP
ghmj-1044	76	12	5	5	NUM
ghmj-1044	76	13	minutes	minute	NOUN
ghmj-1044	76	14	(	(	PUNCT
ghmj-1044	76	15	x.	x.	NOUN
ghmj-1044	76	16	zhang	zhang	PROPN
ghmj-1044	76	17	et	et	PROPN
ghmj-1044	76	18	al	al	PROPN
ghmj-1044	76	19	.	.	PROPN
ghmj-1044	76	20	,	,	PUNCT
ghmj-1044	76	21	2022	2022	NUM
ghmj-1044	76	22	)	)	PUNCT
ghmj-1044	76	23	.	.	PUNCT
ghmj-1044	77	1	pcr	pcr	ADJ
ghmj-1044	77	2	visualization	visualization	NOUN
ghmj-1044	77	3	an	an	DET
ghmj-1044	77	4	insertion	insertion	NOUN
ghmj-1044	77	5	/	/	SYM
ghmj-1044	77	6	deletion	deletion	NOUN
ghmj-1044	77	7	site	site	NOUN
ghmj-1044	77	8	characterized	characterize	VERB
ghmj-1044	77	9	the	the	DET
ghmj-1044	77	10	ace	ace	NOUN
ghmj-1044	77	11	i	i	PROPN
ghmj-1044	77	12	/	/	SYM
ghmj-1044	77	13	d	d	NOUN
ghmj-1044	77	14	polymorphism	polymorphism	NOUN
ghmj-1044	77	15	,	,	PUNCT
ghmj-1044	77	16	and	and	CCONJ
ghmj-1044	77	17	genotypes	genotype	NOUN
ghmj-1044	77	18	were	be	AUX
ghmj-1044	77	19	identified	identify	VERB
ghmj-1044	77	20	by	by	ADP
ghmj-1044	77	21	visualizing	visualize	VERB
ghmj-1044	77	22	arms	arm	NOUN
ghmj-1044	77	23	-	-	PUNCT
ghmj-1044	77	24	pcr	pcr	NOUN
ghmj-1044	77	25	amplification	amplification	NOUN
ghmj-1044	77	26	products	product	NOUN
ghmj-1044	77	27	under	under	ADP
ghmj-1044	77	28	an	an	DET
ghmj-1044	77	29	ultraviolet	ultraviolet	NOUN
ghmj-1044	77	30	analyzer	analyzer	NOUN
ghmj-1044	77	31	.	.	PUNCT
ghmj-1044	78	1	the	the	DET
ghmj-1044	78	2	dna	dna	PROPN
ghmj-1044	78	3	fragments	fragment	NOUN
ghmj-1044	78	4	were	be	AUX
ghmj-1044	78	5	stained	stain	VERB
ghmj-1044	78	6	with	with	ADP
ghmj-1044	78	7	gelred	gelre	VERB
ghmj-1044	78	8	and	and	CCONJ
ghmj-1044	78	9	subjected	subject	VERB
ghmj-1044	78	10	to	to	ADP
ghmj-1044	78	11	electrophoresis	electrophoresis	NOUN
ghmj-1044	78	12	on	on	ADP
ghmj-1044	78	13	a	a	DET
ghmj-1044	78	14	1.5	1.5	NUM
ghmj-1044	78	15	%	%	NOUN
ghmj-1044	78	16	agarose	agarose	NOUN
ghmj-1044	78	17	gel	gel	NOUN
ghmj-1044	78	18	in	in	ADP
ghmj-1044	78	19	tae	tae	NOUN
ghmj-1044	78	20	buffer	buffer	NOUN
ghmj-1044	78	21	for	for	ADP
ghmj-1044	78	22	30	30	NUM
ghmj-1044	78	23	minutes	minute	NOUN
ghmj-1044	78	24	at	at	ADP
ghmj-1044	78	25	100	100	NUM
ghmj-1044	78	26	volts	volt	NOUN
ghmj-1044	78	27	.	.	PUNCT
ghmj-1044	79	1	the	the	DET
ghmj-1044	79	2	expected	expect	VERB
ghmj-1044	79	3	results	result	NOUN
ghmj-1044	79	4	were	be	AUX
ghmj-1044	79	5	ii	ii	NUM
ghmj-1044	79	6	genotype	genotype	NOUN
ghmj-1044	79	7	(	(	PUNCT
ghmj-1044	79	8	490	490	NUM
ghmj-1044	79	9	bp	bp	NOUN
ghmj-1044	79	10	)	)	PUNCT
ghmj-1044	79	11	;	;	PUNCT
ghmj-1044	80	1	i	i	PROPN
ghmj-1044	80	2	d	d	PROPN
ghmj-1044	80	3	genotype	genotype	NOUN
ghmj-1044	80	4	(	(	PUNCT
ghmj-1044	80	5	190	190	NUM
ghmj-1044	80	6	bp	bp	NOUN
ghmj-1044	80	7	,	,	PUNCT
ghmj-1044	80	8	490	490	NUM
ghmj-1044	80	9	bp	bp	NOUN
ghmj-1044	80	10	)	)	PUNCT
ghmj-1044	80	11	;	;	PUNCT
ghmj-1044	80	12	and	and	CCONJ
ghmj-1044	80	13	dd	dd	VERB
ghmj-1044	80	14	genotype	genotype	NOUN
ghmj-1044	80	15	(	(	PUNCT
ghmj-1044	80	16	190	190	NUM
ghmj-1044	80	17	bp	bp	NOUN
ghmj-1044	80	18	)	)	PUNCT
ghmj-1044	80	19	.	.	PUNCT
ghmj-1044	81	1	183	183	NUM
ghmj-1044	81	2	ghmj	ghmj	NOUN
ghmj-1044	81	3	(	(	PUNCT
ghmj-1044	81	4	global	global	ADJ
ghmj-1044	81	5	health	health	PROPN
ghmj-1044	81	6	management	management	NOUN
ghmj-1044	81	7	journal	journal	PROPN
ghmj-1044	81	8	)	)	PUNCT
ghmj-1044	81	9	2024	2024	NUM
ghmj-1044	81	10	,	,	PUNCT
ghmj-1044	81	11	vol	vol	NOUN
ghmj-1044	81	12	.	.	PROPN
ghmj-1044	81	13	7	7	NUM
ghmj-1044	81	14	,	,	PUNCT
ghmj-1044	81	15	no	no	INTJ
ghmj-1044	81	16	.	.	NOUN
ghmj-1044	81	17	4	4	NUM
ghmj-1044	81	18	kuswara	kuswara	NOUN
ghmj-1044	81	19	,	,	PUNCT
ghmj-1044	81	20	et	et	NOUN
ghmj-1044	81	21	.	.	PUNCT
ghmj-1044	82	1	al	al	PROPN
ghmj-1044	82	2	.	.	PUNCT
ghmj-1044	83	1	statistical	statistical	ADJ
ghmj-1044	83	2	techniques	technique	NOUN
ghmj-1044	83	3	statistical	statistical	ADJ
ghmj-1044	83	4	analysis	analysis	NOUN
ghmj-1044	83	5	was	be	AUX
ghmj-1044	83	6	performed	perform	VERB
ghmj-1044	83	7	using	use	VERB
ghmj-1044	83	8	chi	chi	ADJ
ghmj-1044	83	9	-	-	PUNCT
ghmj-1044	83	10	square	square	ADJ
ghmj-1044	83	11	,	,	PUNCT
ghmj-1044	83	12	fisher	fisher	PROPN
ghmj-1044	83	13	’s	’s	PART
ghmj-1044	83	14	exact	exact	ADJ
ghmj-1044	83	15	test	test	NOUN
ghmj-1044	83	16	,	,	PUNCT
ghmj-1044	83	17	mann	mann	PROPN
ghmj-1044	83	18	-	-	PUNCT
ghmj-1044	83	19	whitney	whitney	PROPN
ghmj-1044	83	20	,	,	PUNCT
ghmj-1044	83	21	and	and	CCONJ
ghmj-1044	83	22	kruskal	kruskal	PROPN
ghmj-1044	83	23	-	-	PUNCT
ghmj-1044	83	24	wallis	wallis	PROPN
ghmj-1044	83	25	tests	test	NOUN
ghmj-1044	83	26	to	to	PART
ghmj-1044	83	27	compare	compare	VERB
ghmj-1044	83	28	case	case	NOUN
ghmj-1044	83	29	and	and	CCONJ
ghmj-1044	83	30	control	control	NOUN
ghmj-1044	83	31	groups	group	NOUN
ghmj-1044	83	32	.	.	PUNCT
ghmj-1044	84	1	odds	odd	NOUN
ghmj-1044	84	2	ratios	ratio	NOUN
ghmj-1044	84	3	(	(	PUNCT
ghmj-1044	84	4	or	or	CCONJ
ghmj-1044	84	5	)	)	PUNCT
ghmj-1044	84	6	with	with	ADP
ghmj-1044	84	7	95	95	NUM
ghmj-1044	84	8	%	%	NOUN
ghmj-1044	84	9	confidence	confidence	NOUN
ghmj-1044	84	10	intervals	interval	NOUN
ghmj-1044	84	11	(	(	PUNCT
ghmj-1044	84	12	ci	ci	NOUN
ghmj-1044	84	13	)	)	PUNCT
ghmj-1044	84	14	were	be	AUX
ghmj-1044	84	15	calculated	calculate	VERB
ghmj-1044	84	16	to	to	PART
ghmj-1044	84	17	assess	assess	VERB
ghmj-1044	84	18	the	the	DET
ghmj-1044	84	19	risk	risk	NOUN
ghmj-1044	84	20	associated	associate	VERB
ghmj-1044	84	21	with	with	ADP
ghmj-1044	84	22	the	the	DET
ghmj-1044	84	23	variables	variable	NOUN
ghmj-1044	84	24	such	such	ADJ
ghmj-1044	84	25	as	as	ADP
ghmj-1044	84	26	genotype	genotype	NOUN
ghmj-1044	84	27	,	,	PUNCT
ghmj-1044	84	28	allele	allele	NOUN
ghmj-1044	84	29	frequency	frequency	NOUN
ghmj-1044	84	30	,	,	PUNCT
ghmj-1044	84	31	and	and	CCONJ
ghmj-1044	84	32	the	the	DET
ghmj-1044	84	33	presence	presence	NOUN
ghmj-1044	84	34	of	of	ADP
ghmj-1044	84	35	ace	ace	PROPN
ghmj-1044	84	36	i	i	PROPN
ghmj-1044	84	37	/	/	SYM
ghmj-1044	84	38	d	d	PROPN
ghmj-1044	84	39	gene	gene	NOUN
ghmj-1044	84	40	polymorphism	polymorphism	NOUN
ghmj-1044	84	41	,	,	PUNCT
ghmj-1044	84	42	with	with	ADP
ghmj-1044	84	43	significance	significance	NOUN
ghmj-1044	84	44	set	set	VERB
ghmj-1044	84	45	at	at	ADP
ghmj-1044	84	46	p<0.05	p<0.05	NOUN
ghmj-1044	84	47	.	.	PUNCT
ghmj-1044	85	1	ethical	ethical	ADJ
ghmj-1044	85	2	clearance	clearance	NOUN
ghmj-1044	85	3	this	this	DET
ghmj-1044	85	4	study	study	NOUN
ghmj-1044	85	5	was	be	AUX
ghmj-1044	85	6	conducted	conduct	VERB
ghmj-1044	85	7	after	after	ADP
ghmj-1044	85	8	receiving	receive	VERB
ghmj-1044	85	9	ethical	ethical	ADJ
ghmj-1044	85	10	clearance	clearance	NOUN
ghmj-1044	85	11	from	from	ADP
ghmj-1044	85	12	the	the	DET
ghmj-1044	85	13	medical	medical	ADJ
ghmj-1044	85	14	research	research	PROPN
ghmj-1044	85	15	ethics	ethic	NOUN
ghmj-1044	85	16	committee	committee	PROPN
ghmj-1044	85	17	of	of	ADP
ghmj-1044	85	18	universitas	universita	NOUN
ghmj-1044	85	19	swadaya	swadaya	VERB
ghmj-1044	85	20	gunung	gunung	NOUN
ghmj-1044	85	21	jati	jati	NOUN
ghmj-1044	85	22	on	on	ADP
ghmj-1044	85	23	april	april	PROPN
ghmj-1044	85	24	30	30	NUM
ghmj-1044	85	25	,	,	PUNCT
ghmj-1044	85	26	2024	2024	NUM
ghmj-1044	85	27	,	,	PUNCT
ghmj-1044	85	28	under	under	ADP
ghmj-1044	85	29	approval	approval	NOUN
ghmj-1044	85	30	number	number	NOUN
ghmj-1044	85	31	29	29	NUM
ghmj-1044	85	32	/	/	SYM
ghmj-1044	85	33	ec	ec	PROPN
ghmj-1044	85	34	/	/	SYM
ghmj-1044	85	35	fkugj	fkugj	NOUN
ghmj-1044	85	36	/	/	SYM
ghmj-1044	85	37	iv/2024	iv/2024	NOUN
ghmj-1044	85	38	.	.	PROPN
ghmj-1044	85	39	3	3	NUM
ghmj-1044	85	40	.	.	NOUN
ghmj-1044	85	41	results	result	NOUN
ghmj-1044	85	42	overview	overview	NOUN
ghmj-1044	85	43	of	of	ADP
ghmj-1044	85	44	the	the	DET
ghmj-1044	85	45	characteristics	characteristic	NOUN
ghmj-1044	85	46	of	of	ADP
ghmj-1044	85	47	the	the	DET
ghmj-1044	85	48	research	research	NOUN
ghmj-1044	85	49	subject	subject	NOUN
ghmj-1044	85	50	based	base	VERB
ghmj-1044	85	51	on	on	ADP
ghmj-1044	85	52	the	the	DET
ghmj-1044	85	53	results	result	NOUN
ghmj-1044	85	54	of	of	ADP
ghmj-1044	85	55	the	the	DET
ghmj-1044	85	56	analysis	analysis	NOUN
ghmj-1044	85	57	of	of	ADP
ghmj-1044	85	58	60	60	NUM
ghmj-1044	85	59	respondents	respondent	NOUN
ghmj-1044	85	60	in	in	ADP
ghmj-1044	85	61	table	table	NOUN
ghmj-1044	85	62	1	1	NUM
ghmj-1044	85	63	,	,	PUNCT
ghmj-1044	85	64	it	it	PRON
ghmj-1044	85	65	was	be	AUX
ghmj-1044	85	66	found	find	VERB
ghmj-1044	85	67	that	that	SCONJ
ghmj-1044	85	68	the	the	DET
ghmj-1044	85	69	frequency	frequency	NOUN
ghmj-1044	85	70	of	of	ADP
ghmj-1044	85	71	the	the	DET
ghmj-1044	85	72	highest	high	ADJ
ghmj-1044	85	73	age	age	NOUN
ghmj-1044	85	74	characteristics	characteristic	NOUN
ghmj-1044	85	75	was	be	AUX
ghmj-1044	85	76	around	around	ADV
ghmj-1044	85	77	23	23	NUM
ghmj-1044	85	78	(	(	PUNCT
ghmj-1044	85	79	76.7	76.7	NUM
ghmj-1044	85	80	%	%	NOUN
ghmj-1044	85	81	)	)	PUNCT
ghmj-1044	85	82	subjects	subject	NOUN
ghmj-1044	85	83	in	in	ADP
ghmj-1044	85	84	the	the	DET
ghmj-1044	85	85	age	age	NOUN
ghmj-1044	85	86	range	range	NOUN
ghmj-1044	85	87	of	of	ADP
ghmj-1044	85	88	40	40	NUM
ghmj-1044	85	89	-	-	SYM
ghmj-1044	85	90	59	59	NUM
ghmj-1044	85	91	years	year	NOUN
ghmj-1044	85	92	in	in	ADP
ghmj-1044	85	93	the	the	DET
ghmj-1044	85	94	control	control	NOUN
ghmj-1044	85	95	group	group	NOUN
ghmj-1044	85	96	and	and	CCONJ
ghmj-1044	85	97	22	22	NUM
ghmj-1044	85	98	(	(	PUNCT
ghmj-1044	85	99	73.3	73.3	NUM
ghmj-1044	85	100	%	%	NOUN
ghmj-1044	85	101	)	)	PUNCT
ghmj-1044	85	102	in	in	ADP
ghmj-1044	85	103	the	the	DET
ghmj-1044	85	104	case	case	NOUN
ghmj-1044	85	105	group	group	NOUN
ghmj-1044	85	106	.	.	PUNCT
ghmj-1044	86	1	the	the	DET
ghmj-1044	86	2	most	most	ADV
ghmj-1044	86	3	dominant	dominant	ADJ
ghmj-1044	86	4	frequency	frequency	NOUN
ghmj-1044	86	5	of	of	ADP
ghmj-1044	86	6	ethnic	ethnic	ADJ
ghmj-1044	86	7	characteristics	characteristic	NOUN
ghmj-1044	86	8	was	be	AUX
ghmj-1044	86	9	javanese	javanese	PROPN
ghmj-1044	86	10	,	,	PUNCT
ghmj-1044	86	11	with	with	ADP
ghmj-1044	86	12	26	26	NUM
ghmj-1044	86	13	(	(	PUNCT
ghmj-1044	86	14	57.8	57.8	NUM
ghmj-1044	86	15	%	%	NOUN
ghmj-1044	86	16	)	)	PUNCT
ghmj-1044	86	17	in	in	ADP
ghmj-1044	86	18	the	the	DET
ghmj-1044	86	19	control	control	NOUN
ghmj-1044	86	20	group	group	NOUN
ghmj-1044	86	21	and	and	CCONJ
ghmj-1044	86	22	19	19	NUM
ghmj-1044	86	23	(	(	PUNCT
ghmj-1044	86	24	42.2	42.2	NUM
ghmj-1044	86	25	%	%	NOUN
ghmj-1044	86	26	)	)	PUNCT
ghmj-1044	86	27	in	in	ADP
ghmj-1044	86	28	the	the	DET
ghmj-1044	86	29	case	case	NOUN
ghmj-1044	86	30	group	group	NOUN
ghmj-1044	86	31	.	.	PUNCT
ghmj-1044	87	1	the	the	DET
ghmj-1044	87	2	highest	high	ADJ
ghmj-1044	87	3	frequency	frequency	NOUN
ghmj-1044	87	4	of	of	ADP
ghmj-1044	87	5	subjects	subject	NOUN
ghmj-1044	87	6	with	with	ADP
ghmj-1044	87	7	a	a	DET
ghmj-1044	87	8	family	family	NOUN
ghmj-1044	87	9	history	history	NOUN
ghmj-1044	87	10	of	of	ADP
ghmj-1044	87	11	hypertension	hypertension	NOUN
ghmj-1044	87	12	was	be	AUX
ghmj-1044	87	13	observed	observe	VERB
ghmj-1044	87	14	in	in	ADP
ghmj-1044	87	15	the	the	DET
ghmj-1044	87	16	control	control	NOUN
ghmj-1044	87	17	group	group	NOUN
ghmj-1044	87	18	,	,	PUNCT
ghmj-1044	87	19	with	with	ADP
ghmj-1044	87	20	27	27	NUM
ghmj-1044	87	21	individuals	individual	NOUN
ghmj-1044	87	22	(	(	PUNCT
ghmj-1044	87	23	90.0	90.0	NUM
ghmj-1044	87	24	%	%	NOUN
ghmj-1044	87	25	)	)	PUNCT
ghmj-1044	87	26	categorized	categorize	VERB
ghmj-1044	87	27	as	as	ADP
ghmj-1044	87	28	having	have	VERB
ghmj-1044	87	29	no	no	DET
ghmj-1044	87	30	history	history	NOUN
ghmj-1044	87	31	of	of	ADP
ghmj-1044	87	32	hypertension	hypertension	NOUN
ghmj-1044	87	33	.	.	PUNCT
ghmj-1044	88	1	the	the	DET
ghmj-1044	88	2	highest	high	ADJ
ghmj-1044	88	3	frequency	frequency	NOUN
ghmj-1044	88	4	of	of	ADP
ghmj-1044	88	5	bmi	bmi	PROPN
ghmj-1044	88	6	characteristics	characteristic	NOUN
ghmj-1044	88	7	in	in	ADP
ghmj-1044	88	8	both	both	CCONJ
ghmj-1044	88	9	the	the	DET
ghmj-1044	88	10	case	case	NOUN
ghmj-1044	88	11	and	and	CCONJ
ghmj-1044	88	12	control	control	NOUN
ghmj-1044	88	13	groups	group	NOUN
ghmj-1044	88	14	was	be	AUX
ghmj-1044	88	15	obesity	obesity	NOUN
ghmj-1044	88	16	i	i	PRON
ghmj-1044	88	17	,	,	PUNCT
ghmj-1044	88	18	followed	follow	VERB
ghmj-1044	88	19	by	by	ADP
ghmj-1044	88	20	overweight	overweight	ADJ
ghmj-1044	88	21	,	,	PUNCT
ghmj-1044	88	22	obesity	obesity	NOUN
ghmj-1044	88	23	ii	ii	NOUN
ghmj-1044	88	24	,	,	PUNCT
ghmj-1044	88	25	and	and	CCONJ
ghmj-1044	88	26	normal	normal	ADJ
ghmj-1044	88	27	.	.	PUNCT
ghmj-1044	89	1	in	in	ADP
ghmj-1044	89	2	the	the	DET
ghmj-1044	89	3	case	case	NOUN
ghmj-1044	89	4	group	group	NOUN
ghmj-1044	89	5	,	,	PUNCT
ghmj-1044	89	6	the	the	DET
ghmj-1044	89	7	frequencies	frequency	NOUN
ghmj-1044	89	8	were	be	AUX
ghmj-1044	89	9	13	13	NUM
ghmj-1044	89	10	(	(	PUNCT
ghmj-1044	89	11	43.3	43.3	NUM
ghmj-1044	89	12	%	%	NOUN
ghmj-1044	89	13	)	)	PUNCT
ghmj-1044	89	14	,	,	PUNCT
ghmj-1044	89	15	6	6	NUM
ghmj-1044	89	16	(	(	PUNCT
ghmj-1044	89	17	20.0	20.0	NUM
ghmj-1044	89	18	%	%	NOUN
ghmj-1044	89	19	)	)	PUNCT
ghmj-1044	89	20	,	,	PUNCT
ghmj-1044	89	21	6	6	NUM
ghmj-1044	89	22	(	(	PUNCT
ghmj-1044	89	23	20.0	20.0	NUM
ghmj-1044	89	24	%	%	NOUN
ghmj-1044	89	25	)	)	PUNCT
ghmj-1044	89	26	,	,	PUNCT
ghmj-1044	89	27	4	4	NUM
ghmj-1044	89	28	(	(	PUNCT
ghmj-1044	89	29	13.3	13.3	NUM
ghmj-1044	89	30	%	%	NOUN
ghmj-1044	89	31	)	)	PUNCT
ghmj-1044	89	32	,	,	PUNCT
ghmj-1044	89	33	and	and	CCONJ
ghmj-1044	89	34	1	1	NUM
ghmj-1044	89	35	(	(	PUNCT
ghmj-1044	89	36	3.3	3.3	NUM
ghmj-1044	89	37	%	%	NOUN
ghmj-1044	89	38	)	)	PUNCT
ghmj-1044	89	39	subjects	subject	NOUN
ghmj-1044	89	40	,	,	PUNCT
ghmj-1044	89	41	respectively	respectively	ADV
ghmj-1044	89	42	.	.	PUNCT
ghmj-1044	90	1	in	in	ADP
ghmj-1044	90	2	contrast	contrast	NOUN
ghmj-1044	90	3	,	,	PUNCT
ghmj-1044	90	4	the	the	DET
ghmj-1044	90	5	bmi	bmi	NOUN
ghmj-1044	90	6	distribution	distribution	NOUN
ghmj-1044	90	7	in	in	ADP
ghmj-1044	90	8	the	the	DET
ghmj-1044	90	9	control	control	NOUN
ghmj-1044	90	10	group	group	NOUN
ghmj-1044	90	11	was	be	AUX
ghmj-1044	90	12	as	as	SCONJ
ghmj-1044	90	13	follows	follow	VERB
ghmj-1044	90	14	:	:	PUNCT
ghmj-1044	90	15	12	12	NUM
ghmj-1044	90	16	(	(	PUNCT
ghmj-1044	90	17	40.0	40.0	NUM
ghmj-1044	90	18	%	%	NOUN
ghmj-1044	90	19	)	)	PUNCT
ghmj-1044	90	20	subjects	subject	NOUN
ghmj-1044	90	21	had	have	VERB
ghmj-1044	90	22	obesity	obesity	NOUN
ghmj-1044	90	23	i	i	PRON
ghmj-1044	90	24	,	,	PUNCT
ghmj-1044	90	25	10	10	NUM
ghmj-1044	90	26	(	(	PUNCT
ghmj-1044	90	27	33.3	33.3	NUM
ghmj-1044	90	28	%	%	NOUN
ghmj-1044	90	29	)	)	PUNCT
ghmj-1044	90	30	had	have	AUX
ghmj-1044	90	31	overweight	overweight	ADJ
ghmj-1044	90	32	,	,	PUNCT
ghmj-1044	90	33	4	4	NUM
ghmj-1044	90	34	(	(	PUNCT
ghmj-1044	90	35	13.3	13.3	NUM
ghmj-1044	90	36	%	%	NOUN
ghmj-1044	90	37	)	)	PUNCT
ghmj-1044	90	38	had	have	VERB
ghmj-1044	90	39	obesity	obesity	NOUN
ghmj-1044	90	40	ii	ii	NOUN
ghmj-1044	90	41	,	,	PUNCT
ghmj-1044	90	42	4	4	NUM
ghmj-1044	90	43	(	(	PUNCT
ghmj-1044	90	44	13.3	13.3	NUM
ghmj-1044	90	45	%	%	NOUN
ghmj-1044	90	46	)	)	PUNCT
ghmj-1044	90	47	had	have	VERB
ghmj-1044	90	48	normal	normal	ADJ
ghmj-1044	90	49	bmi	bmi	NOUN
ghmj-1044	90	50	,	,	PUNCT
ghmj-1044	90	51	and	and	CCONJ
ghmj-1044	90	52	0	0	NUM
ghmj-1044	90	53	(	(	PUNCT
ghmj-1044	90	54	0.0	0.0	NUM
ghmj-1044	90	55	%	%	NOUN
ghmj-1044	90	56	)	)	PUNCT
ghmj-1044	90	57	subjects	subject	NOUN
ghmj-1044	90	58	had	have	VERB
ghmj-1044	90	59	other	other	ADJ
ghmj-1044	90	60	bmi	bmi	NOUN
ghmj-1044	90	61	categories	category	NOUN
ghmj-1044	90	62	.	.	PUNCT
ghmj-1044	91	1	table	table	NOUN
ghmj-1044	91	2	1	1	NUM
ghmj-1044	91	3	.	.	PUNCT
ghmj-1044	91	4	frequency	frequency	NOUN
ghmj-1044	91	5	distribution	distribution	NOUN
ghmj-1044	91	6	of	of	ADP
ghmj-1044	91	7	characteristics	characteristic	NOUN
ghmj-1044	91	8	of	of	ADP
ghmj-1044	91	9	research	research	NOUN
ghmj-1044	91	10	subjects	subject	NOUN
ghmj-1044	91	11	characteristics	characteristic	NOUN
ghmj-1044	91	12	n	n	PRON
ghmj-1044	91	13	(	(	PUNCT
ghmj-1044	91	14	%	%	INTJ
ghmj-1044	91	15	)	)	PUNCT
ghmj-1044	91	16	pvalue	pvalue	NOUN
ghmj-1044	91	17	or	or	CCONJ
ghmj-1044	91	18	(	(	PUNCT
ghmj-1044	91	19	95	95	NUM
ghmj-1044	91	20	%	%	NOUN
ghmj-1044	91	21	ci	ci	NOUN
ghmj-1044	91	22	)	)	PUNCT
ghmj-1044	91	23	case	case	NOUN
ghmj-1044	91	24	control	control	NOUN
ghmj-1044	91	25	total	total	VERB
ghmj-1044	91	26	30	30	NUM
ghmj-1044	91	27	(	(	PUNCT
ghmj-1044	91	28	100	100	NUM
ghmj-1044	91	29	)	)	PUNCT
ghmj-1044	91	30	30	30	NUM
ghmj-1044	91	31	(	(	PUNCT
ghmj-1044	91	32	100	100	NUM
ghmj-1044	91	33	)	)	PUNCT
ghmj-1044	91	34	age	age	NOUN
ghmj-1044	91	35	18	18	NUM
ghmj-1044	91	36	-	-	SYM
ghmj-1044	91	37	39	39	NUM
ghmj-1044	91	38	40	40	NUM
ghmj-1044	91	39	-	-	SYM
ghmj-1044	91	40	59	59	NUM
ghmj-1044	91	41	≥60	≥60	NUM
ghmj-1044	91	42	4	4	NUM
ghmj-1044	91	43	(	(	PUNCT
ghmj-1044	91	44	13.3	13.3	NUM
ghmj-1044	91	45	)	)	PUNCT
ghmj-1044	91	46	22	22	NUM
ghmj-1044	91	47	(	(	PUNCT
ghmj-1044	91	48	73.3	73.3	NUM
ghmj-1044	91	49	)	)	PUNCT
ghmj-1044	91	50	4	4	NUM
ghmj-1044	91	51	(	(	PUNCT
ghmj-1044	91	52	13.3	13.3	NUM
ghmj-1044	91	53	)	)	PUNCT
ghmj-1044	91	54	3	3	NUM
ghmj-1044	91	55	(	(	PUNCT
ghmj-1044	91	56	10.0	10.0	NUM
ghmj-1044	91	57	)	)	PUNCT
ghmj-1044	91	58	23	23	NUM
ghmj-1044	91	59	(	(	PUNCT
ghmj-1044	91	60	76.7	76.7	NUM
ghmj-1044	91	61	)	)	PUNCT
ghmj-1044	91	62	4	4	NUM
ghmj-1044	91	63	(	(	PUNCT
ghmj-1044	91	64	13.3	13.3	NUM
ghmj-1044	91	65	)	)	PUNCT
ghmj-1044	91	66	0.800a	0.800a	NOUN
ghmj-1044	91	67	na	na	ADP
ghmj-1044	91	68	sex	sex	NOUN
ghmj-1044	91	69	male	male	ADJ
ghmj-1044	91	70	female	female	ADJ
ghmj-1044	91	71	15	15	NUM
ghmj-1044	91	72	(	(	PUNCT
ghmj-1044	91	73	50.0	50.0	NUM
ghmj-1044	91	74	)	)	SYM
ghmj-1044	91	75	15	15	NUM
ghmj-1044	91	76	(	(	PUNCT
ghmj-1044	91	77	50.0	50.0	NUM
ghmj-1044	91	78	)	)	SYM
ghmj-1044	91	79	15	15	NUM
ghmj-1044	91	80	(	(	PUNCT
ghmj-1044	91	81	50.0	50.0	NUM
ghmj-1044	91	82	)	)	SYM
ghmj-1044	91	83	15	15	NUM
ghmj-1044	91	84	(	(	PUNCT
ghmj-1044	91	85	50.0	50.0	NUM
ghmj-1044	91	86	)	)	PUNCT
ghmj-1044	91	87	1.000b	1.000b	NUM
ghmj-1044	91	88	1.00	1.00	NUM
ghmj-1044	91	89	(	(	PUNCT
ghmj-1044	91	90	0.363	0.363	NUM
ghmj-1044	91	91	-	-	PUNCT
ghmj-1044	91	92	2.751	2.751	NUM
ghmj-1044	91	93	)	)	PUNCT
ghmj-1044	91	94	ethnicity	ethnicity	NOUN
ghmj-1044	91	95	javanese	javanese	PROPN
ghmj-1044	91	96	non	non	PROPN
ghmj-1044	91	97	-	-	ADJ
ghmj-1044	91	98	javanese	javanese	ADJ
ghmj-1044	91	99	19	19	NUM
ghmj-1044	91	100	(	(	PUNCT
ghmj-1044	91	101	42.2	42.2	NUM
ghmj-1044	91	102	)	)	PUNCT
ghmj-1044	91	103	11	11	NUM
ghmj-1044	91	104	(	(	PUNCT
ghmj-1044	91	105	73.3	73.3	NUM
ghmj-1044	91	106	)	)	PUNCT
ghmj-1044	91	107	26	26	NUM
ghmj-1044	91	108	(	(	PUNCT
ghmj-1044	91	109	57.8	57.8	NUM
ghmj-1044	91	110	)	)	SYM
ghmj-1044	91	111	4	4	NUM
ghmj-1044	91	112	(	(	PUNCT
ghmj-1044	91	113	26.7	26.7	NUM
ghmj-1044	91	114	)	)	PUNCT
ghmj-1044	91	115	0.037*b	0.037*b	NOUN
ghmj-1044	91	116	0.266	0.266	NUM
ghmj-1044	91	117	(	(	PUNCT
ghmj-1044	91	118	0.073	0.073	NUM
ghmj-1044	91	119	-	-	PUNCT
ghmj-1044	91	120	0.964	0.964	NUM
ghmj-1044	91	121	)	)	PUNCT
ghmj-1044	91	122	family	family	NOUN
ghmj-1044	91	123	history	history	NOUN
ghmj-1044	91	124	of	of	ADP
ghmj-1044	91	125	hypertension	hypertension	NOUN
ghmj-1044	92	1	yes	yes	INTJ
ghmj-1044	92	2	no	no	DET
ghmj-1044	92	3	19	19	NUM
ghmj-1044	92	4	(	(	PUNCT
ghmj-1044	92	5	63.3	63.3	NUM
ghmj-1044	92	6	)	)	PUNCT
ghmj-1044	92	7	11	11	NUM
ghmj-1044	92	8	(	(	PUNCT
ghmj-1044	92	9	36.7	36.7	NUM
ghmj-1044	92	10	)	)	PUNCT
ghmj-1044	92	11	3	3	NUM
ghmj-1044	92	12	(	(	PUNCT
ghmj-1044	92	13	10.0	10.0	NUM
ghmj-1044	92	14	)	)	PUNCT
ghmj-1044	92	15	27	27	NUM
ghmj-1044	92	16	(	(	PUNCT
ghmj-1044	92	17	90.0	90.0	NUM
ghmj-1044	92	18	)	)	PUNCT
ghmj-1044	92	19	0.000*b	0.000*b	NOUN
ghmj-1044	92	20	15.545	15.545	NUM
ghmj-1044	92	21	(	(	PUNCT
ghmj-1044	92	22	3.814	3.814	NUM
ghmj-1044	92	23	-	-	SYM
ghmj-1044	92	24	63.359	63.359	NUM
ghmj-1044	92	25	)	)	PUNCT
ghmj-1044	92	26	bmi	bmi	VERB
ghmj-1044	92	27	underweight	underweight	PROPN
ghmj-1044	92	28	normal	normal	ADJ
ghmj-1044	92	29	overweight	overweight	NOUN
ghmj-1044	92	30	obesity	obesity	NOUN
ghmj-1044	92	31	i	i	PRON
ghmj-1044	92	32	obesity	obesity	VERB
ghmj-1044	92	33	ii	ii	PROPN
ghmj-1044	92	34	1	1	NUM
ghmj-1044	92	35	(	(	PUNCT
ghmj-1044	92	36	3.3	3.3	NUM
ghmj-1044	92	37	)	)	PUNCT
ghmj-1044	92	38	4	4	NUM
ghmj-1044	92	39	(	(	PUNCT
ghmj-1044	92	40	13.3	13.3	NUM
ghmj-1044	92	41	)	)	PUNCT
ghmj-1044	92	42	6	6	NUM
ghmj-1044	92	43	(	(	PUNCT
ghmj-1044	92	44	20.0	20.0	NUM
ghmj-1044	92	45	)	)	PUNCT
ghmj-1044	92	46	13	13	NUM
ghmj-1044	92	47	(	(	PUNCT
ghmj-1044	92	48	43.3	43.3	NUM
ghmj-1044	92	49	)	)	PUNCT
ghmj-1044	92	50	6	6	NUM
ghmj-1044	92	51	(	(	PUNCT
ghmj-1044	92	52	20.0	20.0	NUM
ghmj-1044	92	53	)	)	PUNCT
ghmj-1044	92	54	0	0	NUM
ghmj-1044	93	1	(	(	PUNCT
ghmj-1044	93	2	0.0	0.0	NUM
ghmj-1044	93	3	)	)	PUNCT
ghmj-1044	93	4	4	4	NUM
ghmj-1044	93	5	(	(	PUNCT
ghmj-1044	93	6	13.3	13.3	NUM
ghmj-1044	93	7	)	)	PUNCT
ghmj-1044	93	8	10	10	NUM
ghmj-1044	93	9	(	(	PUNCT
ghmj-1044	93	10	33.3	33.3	NUM
ghmj-1044	93	11	)	)	PUNCT
ghmj-1044	93	12	12	12	NUM
ghmj-1044	93	13	(	(	PUNCT
ghmj-1044	93	14	40.0	40.0	NUM
ghmj-1044	93	15	)	)	SYM
ghmj-1044	93	16	4	4	NUM
ghmj-1044	93	17	(	(	PUNCT
ghmj-1044	93	18	13.3	13.3	NUM
ghmj-1044	93	19	)	)	PUNCT
ghmj-1044	93	20	0.533c	0.533c	NOUN
ghmj-1044	93	21	na	na	NOUN
ghmj-1044	93	22	smoking	smoking	NOUN
ghmj-1044	94	1	yes	yes	INTJ
ghmj-1044	94	2	no	no	DET
ghmj-1044	94	3	9	9	NUM
ghmj-1044	94	4	(	(	PUNCT
ghmj-1044	94	5	30.0	30.0	NUM
ghmj-1044	94	6	)	)	PUNCT
ghmj-1044	94	7	21	21	NUM
ghmj-1044	94	8	(	(	PUNCT
ghmj-1044	94	9	70.0	70.0	NUM
ghmj-1044	94	10	)	)	PUNCT
ghmj-1044	94	11	6	6	NUM
ghmj-1044	94	12	(	(	PUNCT
ghmj-1044	94	13	20.0	20.0	NUM
ghmj-1044	94	14	)	)	SYM
ghmj-1044	94	15	24	24	NUM
ghmj-1044	94	16	(	(	PUNCT
ghmj-1044	94	17	80.0	80.0	NUM
ghmj-1044	94	18	)	)	PUNCT
ghmj-1044	94	19	0.371b	0.371b	NOUN
ghmj-1044	94	20	1.714	1.714	NUM
ghmj-1044	94	21	(	(	PUNCT
ghmj-1044	94	22	0.523	0.523	NUM
ghmj-1044	94	23	-	-	NUM
ghmj-1044	94	24	5.621	5.621	NUM
ghmj-1044	94	25	)	)	PUNCT
ghmj-1044	94	26	*	*	PUNCT
ghmj-1044	94	27	significant	significant	ADJ
ghmj-1044	94	28	(	(	PUNCT
ghmj-1044	94	29	p<0.05	p<0.05	NOUN
ghmj-1044	94	30	)	)	PUNCT
ghmj-1044	94	31	amann	amann	PROPN
ghmj-1044	94	32	-	-	PUNCT
ghmj-1044	94	33	whitney	whitney	PROPN
ghmj-1044	94	34	test	test	NOUN
ghmj-1044	94	35	.	.	PUNCT
ghmj-1044	95	1	bchi	bchi	ADJ
ghmj-1044	95	2	-	-	PUNCT
ghmj-1044	95	3	square	square	NOUN
ghmj-1044	95	4	test	test	NOUN
ghmj-1044	95	5	.	.	PUNCT
ghmj-1044	96	1	ckruskal	ckruskal	PROPN
ghmj-1044	96	2	-	-	PUNCT
ghmj-1044	96	3	wallis	wallis	PROPN
ghmj-1044	96	4	test	test	NOUN
ghmj-1044	96	5	.	.	PUNCT
ghmj-1044	97	1	kuswara	kuswara	PROPN
ghmj-1044	97	2	,	,	PUNCT
ghmj-1044	97	3	et	et	PROPN
ghmj-1044	97	4	.	.	PUNCT
ghmj-1044	98	1	al	al	PROPN
ghmj-1044	98	2	.	.	PROPN
ghmj-1044	98	3	ghmj	ghmj	PROPN
ghmj-1044	98	4	(	(	PUNCT
ghmj-1044	98	5	global	global	ADJ
ghmj-1044	98	6	health	health	PROPN
ghmj-1044	98	7	management	management	NOUN
ghmj-1044	98	8	journal	journal	PROPN
ghmj-1044	98	9	)	)	PUNCT
ghmj-1044	98	10	2024	2024	NUM
ghmj-1044	98	11	,	,	PUNCT
ghmj-1044	98	12	vol	vol	NOUN
ghmj-1044	98	13	.	.	PROPN
ghmj-1044	98	14	7	7	NUM
ghmj-1044	98	15	,	,	PUNCT
ghmj-1044	98	16	no	no	INTJ
ghmj-1044	98	17	.	.	NOUN
ghmj-1044	98	18	4	4	NUM
ghmj-1044	98	19	184	184	NUM
ghmj-1044	98	20	the	the	DET
ghmj-1044	98	21	highest	high	ADJ
ghmj-1044	98	22	frequency	frequency	NOUN
ghmj-1044	98	23	of	of	ADP
ghmj-1044	98	24	smoking	smoking	NOUN
ghmj-1044	98	25	status	status	NOUN
ghmj-1044	98	26	was	be	AUX
ghmj-1044	98	27	observed	observe	VERB
ghmj-1044	98	28	in	in	ADP
ghmj-1044	98	29	the	the	DET
ghmj-1044	98	30	non	non	ADJ
ghmj-1044	98	31	-	-	ADJ
ghmj-1044	98	32	smoking	smoking	ADJ
ghmj-1044	98	33	category	category	NOUN
ghmj-1044	98	34	,	,	PUNCT
ghmj-1044	98	35	with	with	ADP
ghmj-1044	98	36	24	24	NUM
ghmj-1044	98	37	(	(	PUNCT
ghmj-1044	98	38	80.0	80.0	NUM
ghmj-1044	98	39	%	%	NOUN
ghmj-1044	98	40	)	)	PUNCT
ghmj-1044	98	41	subjects	subject	NOUN
ghmj-1044	98	42	in	in	ADP
ghmj-1044	98	43	the	the	DET
ghmj-1044	98	44	control	control	NOUN
ghmj-1044	98	45	group	group	NOUN
ghmj-1044	98	46	and	and	CCONJ
ghmj-1044	98	47	21	21	NUM
ghmj-1044	98	48	(	(	PUNCT
ghmj-1044	98	49	70.0	70.0	NUM
ghmj-1044	98	50	%	%	NOUN
ghmj-1044	98	51	)	)	PUNCT
ghmj-1044	98	52	in	in	ADP
ghmj-1044	98	53	the	the	DET
ghmj-1044	98	54	case	case	NOUN
ghmj-1044	98	55	group	group	NOUN
ghmj-1044	98	56	.	.	PUNCT
ghmj-1044	99	1	the	the	DET
ghmj-1044	99	2	p	p	NOUN
ghmj-1044	99	3	-	-	PUNCT
ghmj-1044	99	4	value	value	NOUN
ghmj-1044	99	5	for	for	ADP
ghmj-1044	99	6	ethnicity	ethnicity	NOUN
ghmj-1044	99	7	and	and	CCONJ
ghmj-1044	99	8	family	family	NOUN
ghmj-1044	99	9	history	history	NOUN
ghmj-1044	99	10	of	of	ADP
ghmj-1044	99	11	hypertension	hypertension	NOUN
ghmj-1044	99	12	showed	show	VERB
ghmj-1044	99	13	statistical	statistical	ADJ
ghmj-1044	99	14	significance	significance	NOUN
ghmj-1044	99	15	(	(	PUNCT
ghmj-1044	99	16	p=0.037	p=0.037	NOUN
ghmj-1044	99	17	;	;	PUNCT
ghmj-1044	99	18	p=0.000	p=0.000	NUM
ghmj-1044	99	19	)	)	PUNCT
ghmj-1044	99	20	,	,	PUNCT
ghmj-1044	99	21	while	while	SCONJ
ghmj-1044	99	22	age	age	NOUN
ghmj-1044	99	23	,	,	PUNCT
ghmj-1044	99	24	gender	gender	NOUN
ghmj-1044	99	25	,	,	PUNCT
ghmj-1044	99	26	bmi	bmi	NOUN
ghmj-1044	99	27	,	,	PUNCT
ghmj-1044	99	28	and	and	CCONJ
ghmj-1044	99	29	smoking	smoking	NOUN
ghmj-1044	99	30	did	do	AUX
ghmj-1044	99	31	not	not	PART
ghmj-1044	99	32	demonstrate	demonstrate	VERB
ghmj-1044	99	33	significant	significant	ADJ
ghmj-1044	99	34	associations	association	NOUN
ghmj-1044	99	35	with	with	ADP
ghmj-1044	99	36	the	the	DET
ghmj-1044	99	37	incidence	incidence	NOUN
ghmj-1044	99	38	of	of	ADP
ghmj-1044	99	39	hypertension	hypertension	NOUN
ghmj-1044	99	40	(	(	PUNCT
ghmj-1044	99	41	p=0.800	p=0.800	ADJ
ghmj-1044	99	42	;	;	PUNCT
ghmj-1044	99	43	p=1.000	p=1.000	X
ghmj-1044	99	44	;	;	PUNCT
ghmj-1044	99	45	p=0.533	p=0.533	X
ghmj-1044	99	46	;	;	PUNCT
ghmj-1044	99	47	p=0.371	p=0.371	X
ghmj-1044	99	48	)	)	PUNCT
ghmj-1044	99	49	.	.	PUNCT
ghmj-1044	100	1	the	the	DET
ghmj-1044	100	2	or	or	CCONJ
ghmj-1044	100	3	(	(	PUNCT
ghmj-1044	100	4	95	95	NUM
ghmj-1044	100	5	%	%	NOUN
ghmj-1044	100	6	ci	ci	NOUN
ghmj-1044	100	7	)	)	PUNCT
ghmj-1044	100	8	value	value	NOUN
ghmj-1044	100	9	for	for	ADP
ghmj-1044	100	10	ethnicity	ethnicity	NOUN
ghmj-1044	100	11	was	be	AUX
ghmj-1044	100	12	0.266	0.266	NUM
ghmj-1044	100	13	(	(	PUNCT
ghmj-1044	100	14	0.073	0.073	NUM
ghmj-1044	100	15	-	-	PUNCT
ghmj-1044	100	16	0.964	0.964	NUM
ghmj-1044	100	17	)	)	PUNCT
ghmj-1044	100	18	,	,	PUNCT
ghmj-1044	100	19	while	while	SCONJ
ghmj-1044	100	20	for	for	ADP
ghmj-1044	100	21	family	family	NOUN
ghmj-1044	100	22	history	history	NOUN
ghmj-1044	100	23	of	of	ADP
ghmj-1044	100	24	hypertension	hypertension	NOUN
ghmj-1044	100	25	was	be	AUX
ghmj-1044	100	26	15.545	15.545	NUM
ghmj-1044	100	27	(	(	PUNCT
ghmj-1044	100	28	3.81463.359	3.81463.359	NUM
ghmj-1044	100	29	)	)	PUNCT
ghmj-1044	100	30	.	.	PUNCT
ghmj-1044	101	1	the	the	DET
ghmj-1044	101	2	or	or	CCONJ
ghmj-1044	101	3	(	(	PUNCT
ghmj-1044	101	4	95	95	NUM
ghmj-1044	101	5	%	%	NOUN
ghmj-1044	101	6	ci	ci	NOUN
ghmj-1044	101	7	)	)	PUNCT
ghmj-1044	101	8	value	value	NOUN
ghmj-1044	101	9	for	for	ADP
ghmj-1044	101	10	smoking	smoking	NOUN
ghmj-1044	101	11	status	status	NOUN
ghmj-1044	101	12	was	be	AUX
ghmj-1044	101	13	1.714	1.714	NUM
ghmj-1044	101	14	(	(	PUNCT
ghmj-1044	101	15	0.523	0.523	NUM
ghmj-1044	101	16	-	-	NUM
ghmj-1044	101	17	5.621	5.621	NUM
ghmj-1044	101	18	)	)	PUNCT
ghmj-1044	101	19	.	.	PUNCT
ghmj-1044	102	1	standard	standard	ADJ
ghmj-1044	102	2	descriptive	descriptive	ADJ
ghmj-1044	102	3	analysis	analysis	NOUN
ghmj-1044	102	4	of	of	ADP
ghmj-1044	102	5	research	research	NOUN
ghmj-1044	102	6	subjects	subject	NOUN
ghmj-1044	102	7	descriptive	descriptive	ADJ
ghmj-1044	102	8	analysis	analysis	NOUN
ghmj-1044	102	9	(	(	PUNCT
ghmj-1044	102	10	table	table	NOUN
ghmj-1044	102	11	2	2	NUM
ghmj-1044	102	12	)	)	PUNCT
ghmj-1044	102	13	reveals	reveal	VERB
ghmj-1044	102	14	that	that	SCONJ
ghmj-1044	102	15	the	the	DET
ghmj-1044	102	16	case	case	NOUN
ghmj-1044	102	17	and	and	CCONJ
ghmj-1044	102	18	control	control	NOUN
ghmj-1044	102	19	groups	group	NOUN
ghmj-1044	102	20	had	have	VERB
ghmj-1044	102	21	the	the	DET
ghmj-1044	102	22	same	same	ADJ
ghmj-1044	102	23	age	age	NOUN
ghmj-1044	102	24	range	range	NOUN
ghmj-1044	102	25	and	and	CCONJ
ghmj-1044	102	26	median	median	ADJ
ghmj-1044	102	27	age	age	NOUN
ghmj-1044	102	28	,	,	PUNCT
ghmj-1044	102	29	with	with	ADP
ghmj-1044	102	30	a	a	DET
ghmj-1044	102	31	range	range	NOUN
ghmj-1044	102	32	of	of	ADP
ghmj-1044	102	33	42	42	NUM
ghmj-1044	102	34	years	year	NOUN
ghmj-1044	102	35	and	and	CCONJ
ghmj-1044	102	36	a	a	DET
ghmj-1044	102	37	median	median	NOUN
ghmj-1044	102	38	of	of	ADP
ghmj-1044	102	39	51	51	NUM
ghmj-1044	102	40	years	year	NOUN
ghmj-1044	102	41	.	.	PUNCT
ghmj-1044	103	1	the	the	DET
ghmj-1044	103	2	standard	standard	ADJ
ghmj-1044	103	3	deviation	deviation	NOUN
ghmj-1044	103	4	of	of	ADP
ghmj-1044	103	5	the	the	DET
ghmj-1044	103	6	case	case	NOUN
ghmj-1044	103	7	group	group	NOUN
ghmj-1044	103	8	was	be	AUX
ghmj-1044	103	9	9.640	9.640	NUM
ghmj-1044	103	10	,	,	PUNCT
ghmj-1044	103	11	whereas	whereas	SCONJ
ghmj-1044	103	12	that	that	PRON
ghmj-1044	103	13	of	of	ADP
ghmj-1044	103	14	the	the	DET
ghmj-1044	103	15	control	control	NOUN
ghmj-1044	103	16	group	group	NOUN
ghmj-1044	103	17	was	be	AUX
ghmj-1044	103	18	9.481	9.481	NUM
ghmj-1044	103	19	.	.	PUNCT
ghmj-1044	104	1	table	table	NOUN
ghmj-1044	104	2	2	2	NUM
ghmj-1044	104	3	.	.	X
ghmj-1044	104	4	standard	standard	ADJ
ghmj-1044	104	5	descriptive	descriptive	ADJ
ghmj-1044	104	6	analysis	analysis	NOUN
ghmj-1044	104	7	of	of	ADP
ghmj-1044	104	8	research	research	NOUN
ghmj-1044	104	9	subjects	subject	NOUN
ghmj-1044	104	10	range	range	VERB
ghmj-1044	104	11	median	median	ADJ
ghmj-1044	104	12	std	std	PROPN
ghmj-1044	104	13	.	.	PUNCT
ghmj-1044	105	1	deviation	deviation	NOUN
ghmj-1044	105	2	control	control	NOUN
ghmj-1044	105	3	age	age	NOUN
ghmj-1044	105	4	42	42	NUM
ghmj-1044	105	5	51	51	NUM
ghmj-1044	105	6	9.413	9.413	NUM
ghmj-1044	105	7	case	case	NOUN
ghmj-1044	105	8	age	age	NOUN
ghmj-1044	105	9	42	42	NUM
ghmj-1044	105	10	51	51	NUM
ghmj-1044	105	11	9.640	9.640	NUM
ghmj-1044	105	12	total	total	ADJ
ghmj-1044	105	13	age	age	NOUN
ghmj-1044	105	14	42	42	NUM
ghmj-1044	105	15	51	51	NUM
ghmj-1044	105	16	9.448	9.448	NUM
ghmj-1044	105	17	genotype	genotype	NOUN
ghmj-1044	105	18	and	and	CCONJ
ghmj-1044	105	19	allele	allele	NOUN
ghmj-1044	105	20	frequency	frequency	NOUN
ghmj-1044	105	21	distribution	distribution	NOUN
ghmj-1044	105	22	the	the	DET
ghmj-1044	105	23	genotype	genotype	NOUN
ghmj-1044	105	24	frequency	frequency	NOUN
ghmj-1044	105	25	distribution	distribution	NOUN
ghmj-1044	105	26	of	of	ADP
ghmj-1044	105	27	the	the	DET
ghmj-1044	105	28	ace	ace	NOUN
ghmj-1044	105	29	i	i	PROPN
ghmj-1044	105	30	/	/	SYM
ghmj-1044	106	1	d	d	NOUN
ghmj-1044	106	2	gene	gene	NOUN
ghmj-1044	106	3	was	be	AUX
ghmj-1044	106	4	determined	determine	VERB
ghmj-1044	106	5	using	use	VERB
ghmj-1044	106	6	arms	arm	NOUN
ghmj-1044	106	7	-	-	PUNCT
ghmj-1044	106	8	pcr	pcr	NOUN
ghmj-1044	106	9	,	,	PUNCT
ghmj-1044	106	10	yielding	yield	VERB
ghmj-1044	106	11	three	three	NUM
ghmj-1044	106	12	possible	possible	ADJ
ghmj-1044	106	13	outcomes	outcome	NOUN
ghmj-1044	106	14	:	:	PUNCT
ghmj-1044	106	15	ii	ii	NOUN
ghmj-1044	106	16	(	(	PUNCT
ghmj-1044	106	17	490	490	NUM
ghmj-1044	106	18	bp	bp	NOUN
ghmj-1044	106	19	)	)	PUNCT
ghmj-1044	106	20	,	,	PUNCT
ghmj-1044	106	21	i	i	PROPN
ghmj-1044	106	22	d	d	PROPN
ghmj-1044	106	23	(	(	PUNCT
ghmj-1044	106	24	190	190	NUM
ghmj-1044	106	25	bp	bp	PROPN
ghmj-1044	106	26	,	,	PUNCT
ghmj-1044	106	27	490	490	NUM
ghmj-1044	106	28	bp	bp	NOUN
ghmj-1044	106	29	)	)	PUNCT
ghmj-1044	106	30	,	,	PUNCT
ghmj-1044	106	31	and	and	CCONJ
ghmj-1044	106	32	dd	dd	VERB
ghmj-1044	106	33	(	(	PUNCT
ghmj-1044	106	34	190	190	NUM
ghmj-1044	106	35	bp	bp	NOUN
ghmj-1044	106	36	)	)	PUNCT
ghmj-1044	106	37	.	.	PUNCT
ghmj-1044	107	1	the	the	DET
ghmj-1044	107	2	allele	allele	NOUN
ghmj-1044	107	3	frequency	frequency	NOUN
ghmj-1044	107	4	distribution	distribution	NOUN
ghmj-1044	107	5	of	of	ADP
ghmj-1044	107	6	the	the	DET
ghmj-1044	107	7	ace	ace	NOUN
ghmj-1044	107	8	i	i	PROPN
ghmj-1044	107	9	/	/	SYM
ghmj-1044	107	10	d	d	NOUN
ghmj-1044	107	11	gene	gene	NOUN
ghmj-1044	107	12	consisted	consist	VERB
ghmj-1044	107	13	of	of	ADP
ghmj-1044	107	14	allele	allele	NOUN
ghmj-1044	107	15	i	i	PRON
ghmj-1044	107	16	and	and	CCONJ
ghmj-1044	107	17	allele	allele	NOUN
ghmj-1044	107	18	d	d	PROPN
ghmj-1044	107	19	,	,	PUNCT
ghmj-1044	107	20	as	as	SCONJ
ghmj-1044	107	21	shown	show	VERB
ghmj-1044	107	22	in	in	ADP
ghmj-1044	107	23	table	table	NOUN
ghmj-1044	107	24	3	3	NUM
ghmj-1044	107	25	.	.	PUNCT
ghmj-1044	108	1	according	accord	VERB
ghmj-1044	108	2	to	to	ADP
ghmj-1044	108	3	the	the	DET
ghmj-1044	108	4	table	table	NOUN
ghmj-1044	108	5	,	,	PUNCT
ghmj-1044	108	6	the	the	DET
ghmj-1044	108	7	most	most	ADV
ghmj-1044	108	8	common	common	ADJ
ghmj-1044	108	9	genotype	genotype	NOUN
ghmj-1044	108	10	was	be	AUX
ghmj-1044	108	11	i	i	PROPN
ghmj-1044	108	12	d	d	PROPN
ghmj-1044	108	13	,	,	PUNCT
ghmj-1044	108	14	found	find	VERB
ghmj-1044	108	15	in	in	ADP
ghmj-1044	108	16	25	25	NUM
ghmj-1044	108	17	subjects	subject	NOUN
ghmj-1044	108	18	(	(	PUNCT
ghmj-1044	108	19	83.3	83.3	NUM
ghmj-1044	108	20	%	%	NOUN
ghmj-1044	108	21	)	)	PUNCT
ghmj-1044	108	22	in	in	ADP
ghmj-1044	108	23	both	both	CCONJ
ghmj-1044	108	24	the	the	DET
ghmj-1044	108	25	case	case	NOUN
ghmj-1044	108	26	and	and	CCONJ
ghmj-1044	108	27	control	control	NOUN
ghmj-1044	108	28	groups	group	NOUN
ghmj-1044	108	29	.	.	PUNCT
ghmj-1044	109	1	the	the	DET
ghmj-1044	109	2	least	least	ADV
ghmj-1044	109	3	common	common	ADJ
ghmj-1044	109	4	genotype	genotype	NOUN
ghmj-1044	109	5	was	be	AUX
ghmj-1044	109	6	ii	ii	PROPN
ghmj-1044	109	7	,	,	PUNCT
ghmj-1044	109	8	identified	identify	VERB
ghmj-1044	109	9	in	in	ADP
ghmj-1044	109	10	only	only	ADV
ghmj-1044	109	11	2	2	NUM
ghmj-1044	109	12	subjects	subject	NOUN
ghmj-1044	109	13	(	(	PUNCT
ghmj-1044	109	14	6.7	6.7	NUM
ghmj-1044	109	15	%	%	NOUN
ghmj-1044	109	16	)	)	PUNCT
ghmj-1044	109	17	in	in	ADP
ghmj-1044	109	18	the	the	DET
ghmj-1044	109	19	case	case	NOUN
ghmj-1044	109	20	group	group	NOUN
ghmj-1044	109	21	.	.	PUNCT
ghmj-1044	110	1	the	the	DET
ghmj-1044	110	2	most	most	ADV
ghmj-1044	110	3	frequent	frequent	ADJ
ghmj-1044	110	4	allele	allele	NOUN
ghmj-1044	110	5	in	in	ADP
ghmj-1044	110	6	the	the	DET
ghmj-1044	110	7	case	case	NOUN
ghmj-1044	110	8	group	group	NOUN
ghmj-1044	110	9	was	be	AUX
ghmj-1044	110	10	allele	allele	NOUN
ghmj-1044	110	11	i	i	PRON
ghmj-1044	110	12	(	(	PUNCT
ghmj-1044	110	13	51.7	51.7	NUM
ghmj-1044	110	14	%	%	NOUN
ghmj-1044	110	15	)	)	PUNCT
ghmj-1044	110	16	,	,	PUNCT
ghmj-1044	110	17	while	while	SCONJ
ghmj-1044	110	18	in	in	ADP
ghmj-1044	110	19	the	the	DET
ghmj-1044	110	20	control	control	NOUN
ghmj-1044	110	21	group	group	NOUN
ghmj-1044	110	22	,	,	PUNCT
ghmj-1044	110	23	allele	allele	PROPN
ghmj-1044	110	24	d	d	PROPN
ghmj-1044	110	25	was	be	AUX
ghmj-1044	110	26	more	more	ADV
ghmj-1044	110	27	prevalent	prevalent	ADJ
ghmj-1044	110	28	(	(	PUNCT
ghmj-1044	110	29	51.7	51.7	NUM
ghmj-1044	110	30	%	%	NOUN
ghmj-1044	110	31	)	)	PUNCT
ghmj-1044	110	32	.	.	PUNCT
ghmj-1044	111	1	the	the	DET
ghmj-1044	111	2	p	p	NOUN
ghmj-1044	111	3	-	-	PUNCT
ghmj-1044	111	4	value	value	NOUN
ghmj-1044	111	5	for	for	ADP
ghmj-1044	111	6	genotype	genotype	NOUN
ghmj-1044	111	7	(	(	PUNCT
ghmj-1044	111	8	kruskalwallis	kruskalwalli	VERB
ghmj-1044	111	9	test	test	NOUN
ghmj-1044	111	10	)	)	PUNCT
ghmj-1044	111	11	and	and	CCONJ
ghmj-1044	111	12	allele	allele	NOUN
ghmj-1044	111	13	(	(	PUNCT
ghmj-1044	111	14	fisher	fisher	PROPN
ghmj-1044	111	15	’s	’s	PART
ghmj-1044	111	16	exact	exact	ADJ
ghmj-1044	111	17	test	test	NOUN
ghmj-1044	111	18	)	)	PUNCT
ghmj-1044	111	19	did	do	AUX
ghmj-1044	111	20	not	not	PART
ghmj-1044	111	21	show	show	VERB
ghmj-1044	111	22	significance	significance	NOUN
ghmj-1044	111	23	(	(	PUNCT
ghmj-1044	111	24	p=0.531	p=0.531	X
ghmj-1044	111	25	;	;	PUNCT
ghmj-1044	111	26	p=0.715	p=0.715	NUM
ghmj-1044	111	27	)	)	PUNCT
ghmj-1044	111	28	.	.	PUNCT
ghmj-1044	112	1	the	the	DET
ghmj-1044	112	2	or	or	CCONJ
ghmj-1044	112	3	(	(	PUNCT
ghmj-1044	112	4	95	95	NUM
ghmj-1044	112	5	%	%	NOUN
ghmj-1044	112	6	ci	ci	NOUN
ghmj-1044	112	7	)	)	PUNCT
ghmj-1044	112	8	for	for	ADP
ghmj-1044	112	9	the	the	DET
ghmj-1044	112	10	alleles	allele	NOUN
ghmj-1044	112	11	was	be	AUX
ghmj-1044	112	12	1.143	1.143	NUM
ghmj-1044	112	13	(	(	PUNCT
ghmj-1044	112	14	0.558	0.558	NUM
ghmj-1044	112	15	-	-	SYM
ghmj-1044	112	16	2.338	2.338	NUM
ghmj-1044	112	17	)	)	PUNCT
ghmj-1044	112	18	.	.	PUNCT
ghmj-1044	113	1	table	table	NOUN
ghmj-1044	113	2	3	3	NUM
ghmj-1044	113	3	.	.	X
ghmj-1044	113	4	genotype	genotype	NOUN
ghmj-1044	113	5	and	and	CCONJ
ghmj-1044	113	6	allele	allele	NOUN
ghmj-1044	113	7	frequency	frequency	NOUN
ghmj-1044	113	8	distribution	distribution	NOUN
ghmj-1044	113	9	n	n	CCONJ
ghmj-1044	113	10	(	(	PUNCT
ghmj-1044	113	11	%	%	NOUN
ghmj-1044	113	12	)	)	PUNCT
ghmj-1044	113	13	p	p	NOUN
ghmj-1044	113	14	-	-	PUNCT
ghmj-1044	113	15	value	value	NOUN
ghmj-1044	113	16	or	or	CCONJ
ghmj-1044	113	17	(	(	PUNCT
ghmj-1044	113	18	95	95	NUM
ghmj-1044	113	19	%	%	NOUN
ghmj-1044	113	20	ci	ci	NOUN
ghmj-1044	113	21	)	)	PUNCT
ghmj-1044	113	22	case	case	NOUN
ghmj-1044	113	23	control	control	NOUN
ghmj-1044	113	24	genotype	genotype	PROPN
ghmj-1044	113	25	ii	ii	PROPN
ghmj-1044	114	1	i	i	PROPN
ghmj-1044	114	2	d	d	PROPN
ghmj-1044	114	3	dd	dd	NOUN
ghmj-1044	114	4	2	2	NUM
ghmj-1044	114	5	(	(	PUNCT
ghmj-1044	114	6	6.7	6.7	NUM
ghmj-1044	114	7	)	)	PUNCT
ghmj-1044	114	8	25	25	NUM
ghmj-1044	114	9	(	(	PUNCT
ghmj-1044	114	10	83.3	83.3	NUM
ghmj-1044	114	11	)	)	PUNCT
ghmj-1044	114	12	3	3	NUM
ghmj-1044	114	13	(	(	PUNCT
ghmj-1044	114	14	10.0	10.0	NUM
ghmj-1044	114	15	)	)	PUNCT
ghmj-1044	114	16	3	3	NUM
ghmj-1044	114	17	(	(	PUNCT
ghmj-1044	114	18	10.0	10.0	NUM
ghmj-1044	114	19	)	)	PUNCT
ghmj-1044	114	20	25	25	NUM
ghmj-1044	114	21	(	(	PUNCT
ghmj-1044	114	22	83.3	83.3	NUM
ghmj-1044	114	23	)	)	SYM
ghmj-1044	114	24	2	2	NUM
ghmj-1044	114	25	(	(	PUNCT
ghmj-1044	114	26	6.7	6.7	NUM
ghmj-1044	114	27	)	)	PUNCT
ghmj-1044	114	28	0.531a	0.531a	NOUN
ghmj-1044	114	29	1.00	1.00	NUM
ghmj-1044	114	30	(	(	PUNCT
ghmj-1044	114	31	ref	ref	NOUN
ghmj-1044	114	32	)	)	PUNCT
ghmj-1044	114	33	0.667	0.667	NUM
ghmj-1044	114	34	(	(	PUNCT
ghmj-1044	114	35	0.102	0.102	NUM
ghmj-1044	114	36	-	-	SYM
ghmj-1044	114	37	4.339	4.339	NUM
ghmj-1044	114	38	)	)	PUNCT
ghmj-1044	114	39	2.25	2.25	NUM
ghmj-1044	114	40	(	(	PUNCT
ghmj-1044	114	41	0.179	0.179	NUM
ghmj-1044	114	42	-	-	PUNCT
ghmj-1044	114	43	28.254	28.254	NUM
ghmj-1044	114	44	)	)	PUNCT
ghmj-1044	114	45	allele	allele	NOUN
ghmj-1044	115	1	i	i	NOUN
ghmj-1044	115	2	d	d	PROPN
ghmj-1044	115	3	31	31	NUM
ghmj-1044	115	4	(	(	PUNCT
ghmj-1044	115	5	51.7	51.7	NUM
ghmj-1044	115	6	)	)	PUNCT
ghmj-1044	115	7	29	29	NUM
ghmj-1044	115	8	(	(	PUNCT
ghmj-1044	115	9	48.3	48.3	NUM
ghmj-1044	115	10	)	)	PUNCT
ghmj-1044	115	11	29	29	NUM
ghmj-1044	115	12	(	(	PUNCT
ghmj-1044	115	13	48.3	48.3	NUM
ghmj-1044	115	14	)	)	PUNCT
ghmj-1044	115	15	31	31	NUM
ghmj-1044	115	16	(	(	PUNCT
ghmj-1044	115	17	51.7	51.7	NUM
ghmj-1044	115	18	)	)	PUNCT
ghmj-1044	115	19	0.715b	0.715b	NOUN
ghmj-1044	115	20	1.00	1.00	NUM
ghmj-1044	115	21	(	(	PUNCT
ghmj-1044	115	22	ref	ref	NOUN
ghmj-1044	115	23	)	)	PUNCT
ghmj-1044	115	24	1.143	1.143	NUM
ghmj-1044	115	25	(	(	PUNCT
ghmj-1044	115	26	0.558	0.558	NUM
ghmj-1044	115	27	-	-	SYM
ghmj-1044	115	28	2.338	2.338	NUM
ghmj-1044	115	29	)	)	PUNCT
ghmj-1044	115	30	akruskal	akruskal	PROPN
ghmj-1044	115	31	-	-	PUNCT
ghmj-1044	115	32	wallis	wallis	PROPN
ghmj-1044	115	33	test	test	NOUN
ghmj-1044	115	34	.	.	PUNCT
ghmj-1044	116	1	bchi	bchi	ADJ
ghmj-1044	116	2	-	-	PUNCT
ghmj-1044	116	3	square	square	NOUN
ghmj-1044	116	4	test	test	NOUN
ghmj-1044	116	5	.	.	PUNCT
ghmj-1044	117	1	moreover	moreover	ADV
ghmj-1044	117	2	,	,	PUNCT
ghmj-1044	117	3	table	table	NOUN
ghmj-1044	117	4	4	4	NUM
ghmj-1044	117	5	demonstrates	demonstrate	VERB
ghmj-1044	117	6	that	that	SCONJ
ghmj-1044	117	7	there	there	PRON
ghmj-1044	117	8	is	be	VERB
ghmj-1044	117	9	no	no	DET
ghmj-1044	117	10	significant	significant	ADJ
ghmj-1044	117	11	association	association	NOUN
ghmj-1044	117	12	between	between	ADP
ghmj-1044	117	13	hypertension	hypertension	NOUN
ghmj-1044	117	14	and	and	CCONJ
ghmj-1044	117	15	the	the	DET
ghmj-1044	117	16	ace	ace	NOUN
ghmj-1044	117	17	i	i	PROPN
ghmj-1044	117	18	/	/	SYM
ghmj-1044	117	19	d	d	NOUN
ghmj-1044	117	20	genotype	genotype	NOUN
ghmj-1044	117	21	when	when	SCONJ
ghmj-1044	117	22	fisher	fisher	PROPN
ghmj-1044	117	23	's	's	PART
ghmj-1044	117	24	exact	exact	ADJ
ghmj-1044	117	25	test	test	NOUN
ghmj-1044	117	26	is	be	AUX
ghmj-1044	117	27	applied	apply	VERB
ghmj-1044	117	28	.	.	PUNCT
ghmj-1044	118	1	the	the	DET
ghmj-1044	118	2	id+dd	id+dd	NOUN
ghmj-1044	118	3	vs.	vs.	ADP
ghmj-1044	118	4	ii	ii	PROPN
ghmj-1044	118	5	(	(	PUNCT
ghmj-1044	118	6	reference	reference	NOUN
ghmj-1044	118	7	)	)	PUNCT
ghmj-1044	118	8	comparison	comparison	NOUN
ghmj-1044	118	9	yielded	yield	VERB
ghmj-1044	118	10	an	an	DET
ghmj-1044	118	11	odds	odd	NOUN
ghmj-1044	118	12	ratio	ratio	NOUN
ghmj-1044	118	13	(	(	PUNCT
ghmj-1044	118	14	or	or	CCONJ
ghmj-1044	118	15	)	)	PUNCT
ghmj-1044	118	16	of	of	ADP
ghmj-1044	118	17	0.643	0.643	NUM
ghmj-1044	118	18	and	and	CCONJ
ghmj-1044	118	19	a	a	DET
ghmj-1044	118	20	95	95	NUM
ghmj-1044	118	21	%	%	NOUN
ghmj-1044	118	22	ci	ci	NOUN
ghmj-1044	118	23	of	of	ADP
ghmj-1044	118	24	0.100–4.153	0.100–4.153	PROPN
ghmj-1044	118	25	.	.	PROPN
ghmj-1044	118	26	185	185	NUM
ghmj-1044	118	27	ghmj	ghmj	NOUN
ghmj-1044	118	28	(	(	PUNCT
ghmj-1044	118	29	global	global	ADJ
ghmj-1044	118	30	health	health	PROPN
ghmj-1044	118	31	management	management	NOUN
ghmj-1044	118	32	journal	journal	PROPN
ghmj-1044	118	33	)	)	PUNCT
ghmj-1044	118	34	2024	2024	NUM
ghmj-1044	118	35	,	,	PUNCT
ghmj-1044	118	36	vol	vol	NOUN
ghmj-1044	118	37	.	.	PROPN
ghmj-1044	118	38	7	7	NUM
ghmj-1044	118	39	,	,	PUNCT
ghmj-1044	118	40	no	no	INTJ
ghmj-1044	118	41	.	.	NOUN
ghmj-1044	118	42	4	4	NUM
ghmj-1044	118	43	kuswara	kuswara	NOUN
ghmj-1044	118	44	,	,	PUNCT
ghmj-1044	118	45	et	et	PROPN
ghmj-1044	118	46	.	.	PUNCT
ghmj-1044	119	1	al	al	PROPN
ghmj-1044	119	2	.	.	PROPN
ghmj-1044	119	3	table	table	PROPN
ghmj-1044	119	4	4	4	NUM
ghmj-1044	119	5	.	.	PUNCT
ghmj-1044	119	6	compound	compound	NOUN
ghmj-1044	119	7	allele	allele	PROPN
ghmj-1044	119	8	analysis	analysis	NOUN
ghmj-1044	119	9	n	n	PRON
ghmj-1044	119	10	(	(	PUNCT
ghmj-1044	119	11	%	%	NOUN
ghmj-1044	119	12	)	)	PUNCT
ghmj-1044	119	13	p	p	NOUN
ghmj-1044	119	14	-	-	PUNCT
ghmj-1044	119	15	value	value	NOUN
ghmj-1044	119	16	or	or	CCONJ
ghmj-1044	119	17	(	(	PUNCT
ghmj-1044	119	18	95	95	NUM
ghmj-1044	119	19	%	%	NOUN
ghmj-1044	119	20	ci	ci	NOUN
ghmj-1044	119	21	)	)	PUNCT
ghmj-1044	119	22	case	case	NOUN
ghmj-1044	119	23	control	control	NOUN
ghmj-1044	119	24	total	total	VERB
ghmj-1044	119	25	30	30	NUM
ghmj-1044	119	26	(	(	PUNCT
ghmj-1044	119	27	100	100	NUM
ghmj-1044	119	28	)	)	PUNCT
ghmj-1044	119	29	30	30	NUM
ghmj-1044	119	30	(	(	PUNCT
ghmj-1044	119	31	100	100	NUM
ghmj-1044	119	32	)	)	PUNCT
ghmj-1044	119	33	dd	dd	NOUN
ghmj-1044	119	34	3	3	NUM
ghmj-1044	119	35	(	(	PUNCT
ghmj-1044	119	36	10.7	10.7	NUM
ghmj-1044	119	37	)	)	SYM
ghmj-1044	119	38	2	2	NUM
ghmj-1044	119	39	(	(	PUNCT
ghmj-1044	119	40	7.4	7.4	NUM
ghmj-1044	119	41	)	)	PUNCT
ghmj-1044	119	42	1.00	1.00	NUM
ghmj-1044	119	43	(	(	PUNCT
ghmj-1044	119	44	ref	ref	NOUN
ghmj-1044	119	45	)	)	PUNCT
ghmj-1044	119	46	•	•	ADP
ghmj-1044	120	1	i	i	PROPN
ghmj-1044	120	2	d	d	PROPN
ghmj-1044	120	3	25	25	NUM
ghmj-1044	120	4	(	(	PUNCT
ghmj-1044	120	5	89.3	89.3	NUM
ghmj-1044	120	6	)	)	PUNCT
ghmj-1044	120	7	25	25	NUM
ghmj-1044	120	8	(	(	PUNCT
ghmj-1044	120	9	93.6	93.6	NUM
ghmj-1044	120	10	)	)	PUNCT
ghmj-1044	120	11	0.518a	0.518a	NOUN
ghmj-1044	120	12	1.500	1.500	NUM
ghmj-1044	120	13	(	(	PUNCT
ghmj-1044	120	14	0.230	0.230	NUM
ghmj-1044	120	15	-	-	SYM
ghmj-1044	120	16	9.763	9.763	NUM
ghmj-1044	120	17	)	)	PUNCT
ghmj-1044	120	18	dd	dd	NOUN
ghmj-1044	120	19	3	3	NUM
ghmj-1044	120	20	(	(	PUNCT
ghmj-1044	120	21	60.0	60.0	NUM
ghmj-1044	120	22	)	)	SYM
ghmj-1044	120	23	2	2	NUM
ghmj-1044	120	24	(	(	PUNCT
ghmj-1044	120	25	40.0	40.0	NUM
ghmj-1044	120	26	)	)	PUNCT
ghmj-1044	120	27	1.00	1.00	NUM
ghmj-1044	120	28	(	(	PUNCT
ghmj-1044	120	29	ref	ref	NOUN
ghmj-1044	120	30	)	)	PUNCT
ghmj-1044	120	31	•	•	ADP
ghmj-1044	120	32	ii	ii	PROPN
ghmj-1044	120	33	2	2	NUM
ghmj-1044	120	34	(	(	PUNCT
ghmj-1044	120	35	40.0	40.0	NUM
ghmj-1044	120	36	)	)	PUNCT
ghmj-1044	120	37	3	3	NUM
ghmj-1044	120	38	(	(	PUNCT
ghmj-1044	120	39	60.0	60.0	NUM
ghmj-1044	120	40	)	)	PUNCT
ghmj-1044	120	41	0.500a	0.500a	NOUN
ghmj-1044	120	42	2.250	2.250	NUM
ghmj-1044	120	43	(	(	PUNCT
ghmj-1044	120	44	0.179	0.179	NUM
ghmj-1044	120	45	-	-	SYM
ghmj-1044	120	46	28.254	28.254	NUM
ghmj-1044	120	47	)	)	PUNCT
ghmj-1044	120	48	dd	dd	NOUN
ghmj-1044	120	49	3	3	NUM
ghmj-1044	120	50	(	(	PUNCT
ghmj-1044	120	51	10.0	10.0	NUM
ghmj-1044	120	52	)	)	SYM
ghmj-1044	120	53	2	2	NUM
ghmj-1044	120	54	(	(	PUNCT
ghmj-1044	120	55	6.7	6.7	NUM
ghmj-1044	120	56	)	)	PUNCT
ghmj-1044	120	57	1.00	1.00	NUM
ghmj-1044	120	58	(	(	PUNCT
ghmj-1044	120	59	ref	ref	NOUN
ghmj-1044	120	60	)	)	PUNCT
ghmj-1044	120	61	•	•	ADP
ghmj-1044	121	1	id+ii	id+ii	NOUN
ghmj-1044	121	2	27	27	NUM
ghmj-1044	121	3	(	(	PUNCT
ghmj-1044	121	4	90.0	90.0	NUM
ghmj-1044	121	5	)	)	SYM
ghmj-1044	121	6	28	28	NUM
ghmj-1044	121	7	(	(	PUNCT
ghmj-1044	121	8	93.3	93.3	NUM
ghmj-1044	121	9	)	)	PUNCT
ghmj-1044	121	10	0.500a	0.500a	NOUN
ghmj-1044	121	11	1.556	1.556	NUM
ghmj-1044	121	12	(	(	PUNCT
ghmj-1044	121	13	0.241	0.241	NUM
ghmj-1044	121	14	-	-	SYM
ghmj-1044	121	15	10.049	10.049	NUM
ghmj-1044	121	16	)	)	PUNCT
ghmj-1044	121	17	ii	ii	NOUN
ghmj-1044	121	18	2	2	NUM
ghmj-1044	121	19	(	(	PUNCT
ghmj-1044	121	20	6.7	6.7	NUM
ghmj-1044	121	21	)	)	PUNCT
ghmj-1044	121	22	3	3	NUM
ghmj-1044	121	23	(	(	PUNCT
ghmj-1044	121	24	10.0	10.0	NUM
ghmj-1044	121	25	)	)	PUNCT
ghmj-1044	121	26	1.00	1.00	NUM
ghmj-1044	121	27	(	(	PUNCT
ghmj-1044	121	28	ref	ref	NOUN
ghmj-1044	121	29	)	)	PUNCT
ghmj-1044	121	30	•	•	NOUN
ghmj-1044	121	31	id+dd	id+dd	NOUN
ghmj-1044	121	32	28	28	NUM
ghmj-1044	121	33	(	(	PUNCT
ghmj-1044	121	34	93.3	93.3	NUM
ghmj-1044	121	35	)	)	PUNCT
ghmj-1044	121	36	27	27	NUM
ghmj-1044	121	37	(	(	PUNCT
ghmj-1044	121	38	90.0	90.0	NUM
ghmj-1044	121	39	)	)	PUNCT
ghmj-1044	121	40	0.500a	0.500a	NOUN
ghmj-1044	121	41	0.643	0.643	NUM
ghmj-1044	121	42	(	(	PUNCT
ghmj-1044	121	43	0.100	0.100	NUM
ghmj-1044	121	44	-	-	PUNCT
ghmj-1044	121	45	4.153	4.153	NUM
ghmj-1044	121	46	)	)	PUNCT
ghmj-1044	121	47	afisher	afisher	PROPN
ghmj-1044	121	48	’s	’s	PART
ghmj-1044	121	49	exact	exact	ADJ
ghmj-1044	121	50	test	test	NOUN
ghmj-1044	121	51	gel	gel	NOUN
ghmj-1044	121	52	electrophoresis	electrophoresis	NOUN
ghmj-1044	121	53	visualization	visualization	NOUN
ghmj-1044	121	54	results	result	NOUN
ghmj-1044	121	55	figure	figure	VERB
ghmj-1044	121	56	1	1	NUM
ghmj-1044	121	57	illustrates	illustrate	VERB
ghmj-1044	121	58	the	the	DET
ghmj-1044	121	59	results	result	NOUN
ghmj-1044	121	60	of	of	ADP
ghmj-1044	121	61	gel	gel	NOUN
ghmj-1044	121	62	electrophoresis	electrophoresis	NOUN
ghmj-1044	121	63	conducted	conduct	VERB
ghmj-1044	121	64	on	on	ADP
ghmj-1044	121	65	1.5	1.5	NUM
ghmj-1044	121	66	%	%	NOUN
ghmj-1044	121	67	agarose	agarose	X
ghmj-1044	121	68	gel	gel	NOUN
ghmj-1044	121	69	,	,	PUNCT
ghmj-1044	121	70	run	run	VERB
ghmj-1044	121	71	for	for	ADP
ghmj-1044	121	72	30	30	NUM
ghmj-1044	121	73	minutes	minute	NOUN
ghmj-1044	121	74	at	at	ADP
ghmj-1044	121	75	100	100	NUM
ghmj-1044	121	76	volts	volt	NOUN
ghmj-1044	121	77	.	.	PUNCT
ghmj-1044	122	1	bands	band	NOUN
ghmj-1044	122	2	labeled	label	VERB
ghmj-1044	122	3	3	3	NUM
ghmj-1044	122	4	,	,	PUNCT
ghmj-1044	122	5	5	5	NUM
ghmj-1044	122	6	,	,	PUNCT
ghmj-1044	122	7	8	8	NUM
ghmj-1044	122	8	,	,	PUNCT
ghmj-1044	122	9	and	and	CCONJ
ghmj-1044	122	10	11	11	NUM
ghmj-1044	122	11	showed	show	VERB
ghmj-1044	122	12	a	a	DET
ghmj-1044	122	13	single	single	ADJ
ghmj-1044	122	14	band	band	NOUN
ghmj-1044	122	15	representing	represent	VERB
ghmj-1044	122	16	ii	ii	PROPN
ghmj-1044	122	17	(	(	PUNCT
ghmj-1044	122	18	490	490	NUM
ghmj-1044	122	19	bp	bp	NOUN
ghmj-1044	122	20	)	)	PUNCT
ghmj-1044	122	21	,	,	PUNCT
ghmj-1044	122	22	while	while	SCONJ
ghmj-1044	122	23	bands	band	NOUN
ghmj-1044	122	24	labeled	label	VERB
ghmj-1044	122	25	1	1	NUM
ghmj-1044	122	26	,	,	PUNCT
ghmj-1044	122	27	4	4	NUM
ghmj-1044	122	28	,	,	PUNCT
ghmj-1044	122	29	6	6	NUM
ghmj-1044	122	30	,	,	PUNCT
ghmj-1044	122	31	7	7	NUM
ghmj-1044	122	32	,	,	PUNCT
ghmj-1044	122	33	and	and	CCONJ
ghmj-1044	122	34	9	9	NUM
ghmj-1044	122	35	showed	show	VERB
ghmj-1044	122	36	two	two	NUM
ghmj-1044	122	37	bands	band	NOUN
ghmj-1044	122	38	corresponding	correspond	VERB
ghmj-1044	122	39	to	to	ADP
ghmj-1044	122	40	i	i	PROPN
ghmj-1044	122	41	d	d	PROPN
ghmj-1044	122	42	(	(	PUNCT
ghmj-1044	122	43	190	190	NUM
ghmj-1044	122	44	bp	bp	PROPN
ghmj-1044	122	45	,	,	PUNCT
ghmj-1044	122	46	490	490	NUM
ghmj-1044	122	47	bp	bp	NOUN
ghmj-1044	122	48	)	)	PUNCT
ghmj-1044	122	49	,	,	PUNCT
ghmj-1044	122	50	and	and	CCONJ
ghmj-1044	122	51	bands	band	NOUN
ghmj-1044	122	52	2	2	NUM
ghmj-1044	122	53	and	and	CCONJ
ghmj-1044	122	54	10	10	NUM
ghmj-1044	122	55	indicated	indicate	VERB
ghmj-1044	122	56	a	a	DET
ghmj-1044	122	57	single	single	ADJ
ghmj-1044	122	58	band	band	NOUN
ghmj-1044	122	59	for	for	ADP
ghmj-1044	122	60	dd	dd	PROPN
ghmj-1044	122	61	(	(	PUNCT
ghmj-1044	122	62	190	190	NUM
ghmj-1044	122	63	bp	bp	NOUN
ghmj-1044	122	64	)	)	PUNCT
ghmj-1044	122	65	.	.	PUNCT
ghmj-1044	123	1	figure	figure	NOUN
ghmj-1044	123	2	1	1	NUM
ghmj-1044	123	3	.	.	PUNCT
ghmj-1044	123	4	gel	gel	NOUN
ghmj-1044	123	5	electrophoresis	electrophoresis	NOUN
ghmj-1044	123	6	of	of	ADP
ghmj-1044	123	7	ace	ace	NOUN
ghmj-1044	123	8	i	i	PROPN
ghmj-1044	123	9	/	/	SYM
ghmj-1044	123	10	d	d	PROPN
ghmj-1044	123	11	relationship	relationship	NOUN
ghmj-1044	123	12	between	between	ADP
ghmj-1044	123	13	ace	ace	NOUN
ghmj-1044	123	14	i	i	PROPN
ghmj-1044	123	15	/	/	SYM
ghmj-1044	123	16	d	d	NOUN
ghmj-1044	123	17	polymorphism	polymorphism	NOUN
ghmj-1044	123	18	and	and	CCONJ
ghmj-1044	123	19	essential	essential	ADJ
ghmj-1044	123	20	hypertension	hypertension	NOUN
ghmj-1044	123	21	table	table	NOUN
ghmj-1044	123	22	5	5	NUM
ghmj-1044	123	23	reveals	reveal	VERB
ghmj-1044	123	24	that	that	SCONJ
ghmj-1044	123	25	28	28	NUM
ghmj-1044	123	26	(	(	PUNCT
ghmj-1044	123	27	93.3	93.3	NUM
ghmj-1044	123	28	%	%	NOUN
ghmj-1044	123	29	)	)	PUNCT
ghmj-1044	123	30	subjects	subject	NOUN
ghmj-1044	123	31	in	in	ADP
ghmj-1044	123	32	the	the	DET
ghmj-1044	123	33	case	case	NOUN
ghmj-1044	123	34	group	group	NOUN
ghmj-1044	123	35	had	have	VERB
ghmj-1044	123	36	the	the	DET
ghmj-1044	123	37	ace	ace	NOUN
ghmj-1044	123	38	i	i	PROPN
ghmj-1044	123	39	/	/	SYM
ghmj-1044	123	40	d	d	NOUN
ghmj-1044	123	41	polymorphism	polymorphism	NOUN
ghmj-1044	123	42	,	,	PUNCT
ghmj-1044	123	43	while	while	SCONJ
ghmj-1044	123	44	only	only	ADV
ghmj-1044	123	45	2	2	NUM
ghmj-1044	123	46	(	(	PUNCT
ghmj-1044	123	47	6.7	6.7	NUM
ghmj-1044	123	48	%	%	NOUN
ghmj-1044	123	49	)	)	PUNCT
ghmj-1044	123	50	did	do	VERB
ghmj-1044	123	51	not	not	PART
ghmj-1044	123	52	.	.	PUNCT
ghmj-1044	124	1	in	in	ADP
ghmj-1044	124	2	the	the	DET
ghmj-1044	124	3	control	control	NOUN
ghmj-1044	124	4	group	group	NOUN
ghmj-1044	124	5	,	,	PUNCT
ghmj-1044	124	6	27	27	NUM
ghmj-1044	124	7	(	(	PUNCT
ghmj-1044	124	8	90.0	90.0	NUM
ghmj-1044	124	9	%	%	NOUN
ghmj-1044	124	10	)	)	PUNCT
ghmj-1044	124	11	subjects	subject	NOUN
ghmj-1044	124	12	had	have	VERB
ghmj-1044	124	13	the	the	DET
ghmj-1044	124	14	polymorphism	polymorphism	NOUN
ghmj-1044	124	15	,	,	PUNCT
ghmj-1044	124	16	while	while	SCONJ
ghmj-1044	124	17	3	3	NUM
ghmj-1044	124	18	(	(	PUNCT
ghmj-1044	124	19	10.0	10.0	NUM
ghmj-1044	124	20	%	%	NOUN
ghmj-1044	124	21	)	)	PUNCT
ghmj-1044	124	22	did	do	VERB
ghmj-1044	124	23	not	not	PART
ghmj-1044	124	24	.	.	PUNCT
ghmj-1044	125	1	due	due	ADP
ghmj-1044	125	2	to	to	ADP
ghmj-1044	125	3	the	the	DET
ghmj-1044	125	4	small	small	ADJ
ghmj-1044	125	5	number	number	NOUN
ghmj-1044	125	6	of	of	ADP
ghmj-1044	125	7	subjects	subject	NOUN
ghmj-1044	125	8	in	in	ADP
ghmj-1044	125	9	each	each	DET
ghmj-1044	125	10	category	category	NOUN
ghmj-1044	125	11	,	,	PUNCT
ghmj-1044	125	12	the	the	DET
ghmj-1044	125	13	data	datum	NOUN
ghmj-1044	125	14	did	do	AUX
ghmj-1044	125	15	not	not	PART
ghmj-1044	125	16	meet	meet	VERB
ghmj-1044	125	17	the	the	DET
ghmj-1044	125	18	minimum	minimum	NOUN
ghmj-1044	125	19	expected	expect	VERB
ghmj-1044	125	20	count	count	NOUN
ghmj-1044	125	21	for	for	ADP
ghmj-1044	125	22	the	the	DET
ghmj-1044	125	23	chi	chi	ADJ
ghmj-1044	125	24	-	-	PUNCT
ghmj-1044	125	25	square	square	ADJ
ghmj-1044	125	26	test	test	NOUN
ghmj-1044	125	27	.	.	PUNCT
ghmj-1044	126	1	therefore	therefore	ADV
ghmj-1044	126	2	,	,	PUNCT
ghmj-1044	126	3	fisher	fisher	PROPN
ghmj-1044	126	4	's	's	PART
ghmj-1044	126	5	exact	exact	ADJ
ghmj-1044	126	6	test	test	NOUN
ghmj-1044	126	7	yielded	yield	VERB
ghmj-1044	126	8	a	a	DET
ghmj-1044	126	9	p	p	NOUN
ghmj-1044	126	10	-	-	PUNCT
ghmj-1044	126	11	value	value	NOUN
ghmj-1044	126	12	of	of	ADP
ghmj-1044	126	13	0.500	0.500	NUM
ghmj-1044	126	14	,	,	PUNCT
ghmj-1044	126	15	indicating	indicate	VERB
ghmj-1044	126	16	no	no	DET
ghmj-1044	126	17	statistical	statistical	ADJ
ghmj-1044	126	18	significance	significance	NOUN
ghmj-1044	126	19	(	(	PUNCT
ghmj-1044	126	20	p>0.05	p>0.05	NOUN
ghmj-1044	126	21	)	)	PUNCT
ghmj-1044	126	22	.	.	PUNCT
ghmj-1044	127	1	the	the	DET
ghmj-1044	127	2	or	or	CCONJ
ghmj-1044	127	3	(	(	PUNCT
ghmj-1044	127	4	95	95	NUM
ghmj-1044	127	5	%	%	NOUN
ghmj-1044	127	6	ci	ci	NOUN
ghmj-1044	127	7	)	)	PUNCT
ghmj-1044	127	8	was	be	AUX
ghmj-1044	127	9	1.556	1.556	NUM
ghmj-1044	127	10	(	(	PUNCT
ghmj-1044	127	11	0.241	0.241	NUM
ghmj-1044	127	12	-	-	SYM
ghmj-1044	127	13	10.049	10.049	NUM
ghmj-1044	127	14	)	)	PUNCT
ghmj-1044	127	15	,	,	PUNCT
ghmj-1044	127	16	suggesting	suggest	VERB
ghmj-1044	127	17	that	that	SCONJ
ghmj-1044	127	18	subjects	subject	NOUN
ghmj-1044	127	19	with	with	ADP
ghmj-1044	127	20	the	the	DET
ghmj-1044	127	21	ace	ace	NOUN
ghmj-1044	127	22	i	i	PROPN
ghmj-1044	127	23	/	/	SYM
ghmj-1044	127	24	d	d	NOUN
ghmj-1044	127	25	polymorphism	polymorphism	NOUN
ghmj-1044	127	26	were	be	AUX
ghmj-1044	127	27	1.556	1.556	NUM
ghmj-1044	127	28	times	time	NOUN
ghmj-1044	127	29	more	more	ADV
ghmj-1044	127	30	likely	likely	ADJ
ghmj-1044	127	31	to	to	PART
ghmj-1044	127	32	develop	develop	VERB
ghmj-1044	127	33	essential	essential	ADJ
ghmj-1044	127	34	hypertension	hypertension	NOUN
ghmj-1044	127	35	than	than	ADP
ghmj-1044	127	36	those	those	PRON
ghmj-1044	127	37	without	without	ADP
ghmj-1044	127	38	the	the	DET
ghmj-1044	127	39	polymorphism	polymorphism	NOUN
ghmj-1044	127	40	.	.	PUNCT
ghmj-1044	128	1	in	in	ADP
ghmj-1044	128	2	this	this	DET
ghmj-1044	128	3	study	study	NOUN
ghmj-1044	128	4	,	,	PUNCT
ghmj-1044	128	5	the	the	DET
ghmj-1044	128	6	ace	ace	NOUN
ghmj-1044	128	7	i	i	PROPN
ghmj-1044	128	8	/	/	SYM
ghmj-1044	128	9	d	d	NOUN
ghmj-1044	128	10	polymorphism	polymorphism	NOUN
ghmj-1044	128	11	was	be	AUX
ghmj-1044	128	12	considered	consider	VERB
ghmj-1044	128	13	a	a	DET
ghmj-1044	128	14	risk	risk	NOUN
ghmj-1044	128	15	factor	factor	NOUN
ghmj-1044	128	16	for	for	ADP
ghmj-1044	128	17	essential	essential	ADJ
ghmj-1044	128	18	hypertension	hypertension	NOUN
ghmj-1044	128	19	.	.	PUNCT
ghmj-1044	129	1	kuswara	kuswara	PROPN
ghmj-1044	129	2	,	,	PUNCT
ghmj-1044	129	3	et	et	PROPN
ghmj-1044	129	4	.	.	PUNCT
ghmj-1044	130	1	al	al	PROPN
ghmj-1044	130	2	.	.	PROPN
ghmj-1044	130	3	ghmj	ghmj	PROPN
ghmj-1044	130	4	(	(	PUNCT
ghmj-1044	130	5	global	global	ADJ
ghmj-1044	130	6	health	health	PROPN
ghmj-1044	130	7	management	management	NOUN
ghmj-1044	130	8	journal	journal	PROPN
ghmj-1044	130	9	)	)	PUNCT
ghmj-1044	130	10	2024	2024	NUM
ghmj-1044	130	11	,	,	PUNCT
ghmj-1044	130	12	vol	vol	NOUN
ghmj-1044	130	13	.	.	PROPN
ghmj-1044	130	14	7	7	NUM
ghmj-1044	130	15	,	,	PUNCT
ghmj-1044	130	16	no	no	INTJ
ghmj-1044	130	17	.	.	NOUN
ghmj-1044	130	18	4	4	NUM
ghmj-1044	130	19	186	186	NUM
ghmj-1044	130	20	table	table	NOUN
ghmj-1044	130	21	5	5	NUM
ghmj-1044	130	22	.	.	PUNCT
ghmj-1044	130	23	association	association	NOUN
ghmj-1044	130	24	of	of	ADP
ghmj-1044	130	25	ace	ace	PROPN
ghmj-1044	130	26	i	i	PROPN
ghmj-1044	130	27	/	/	SYM
ghmj-1044	130	28	d	d	PROPN
ghmj-1044	130	29	gene	gene	NOUN
ghmj-1044	130	30	polymorphism	polymorphism	NOUN
ghmj-1044	130	31	with	with	ADP
ghmj-1044	130	32	essential	essential	ADJ
ghmj-1044	130	33	hypertension	hypertension	NOUN
ghmj-1044	130	34	polymorphism	polymorphism	NOUN
ghmj-1044	130	35	n	n	PROPN
ghmj-1044	130	36	(	(	PUNCT
ghmj-1044	130	37	%	%	NOUN
ghmj-1044	130	38	)	)	PUNCT
ghmj-1044	130	39	p	p	NOUN
ghmj-1044	130	40	-	-	PUNCT
ghmj-1044	130	41	value	value	NOUN
ghmj-1044	130	42	or	or	CCONJ
ghmj-1044	130	43	(	(	PUNCT
ghmj-1044	130	44	95	95	NUM
ghmj-1044	130	45	%	%	NOUN
ghmj-1044	130	46	ci	ci	NOUN
ghmj-1044	130	47	)	)	PUNCT
ghmj-1044	130	48	case	case	NOUN
ghmj-1044	130	49	control	control	NOUN
ghmj-1044	130	50	yes	yes	INTJ
ghmj-1044	130	51	(	(	PUNCT
ghmj-1044	130	52	dd	dd	NOUN
ghmj-1044	130	53	and	and	CCONJ
ghmj-1044	130	54	i	i	PROPN
ghmj-1044	130	55	d	d	PROPN
ghmj-1044	130	56	)	)	PUNCT
ghmj-1044	130	57	28	28	NUM
ghmj-1044	130	58	(	(	PUNCT
ghmj-1044	130	59	93.3	93.3	NUM
ghmj-1044	130	60	)	)	PUNCT
ghmj-1044	130	61	27	27	NUM
ghmj-1044	130	62	(	(	PUNCT
ghmj-1044	130	63	90.0	90.0	NUM
ghmj-1044	130	64	)	)	PUNCT
ghmj-1044	130	65	0.500a	0.500a	NOUN
ghmj-1044	130	66	1.556	1.556	NUM
ghmj-1044	130	67	(	(	PUNCT
ghmj-1044	130	68	0.241	0.241	NUM
ghmj-1044	130	69	-	-	SYM
ghmj-1044	130	70	10.049	10.049	NUM
ghmj-1044	130	71	)	)	PUNCT
ghmj-1044	130	72	no	no	DET
ghmj-1044	130	73	(	(	PUNCT
ghmj-1044	130	74	ii	ii	NOUN
ghmj-1044	130	75	)	)	PUNCT
ghmj-1044	130	76	2	2	NUM
ghmj-1044	130	77	(	(	PUNCT
ghmj-1044	130	78	6.7	6.7	NUM
ghmj-1044	130	79	)	)	PUNCT
ghmj-1044	130	80	3	3	NUM
ghmj-1044	130	81	(	(	PUNCT
ghmj-1044	130	82	10.0	10.0	NUM
ghmj-1044	130	83	)	)	PUNCT
ghmj-1044	130	84	1.00	1.00	NUM
ghmj-1044	130	85	(	(	PUNCT
ghmj-1044	130	86	ref	ref	NOUN
ghmj-1044	130	87	)	)	PUNCT
ghmj-1044	130	88	total	total	NOUN
ghmj-1044	130	89	30	30	NUM
ghmj-1044	130	90	(	(	PUNCT
ghmj-1044	130	91	100.0	100.0	NUM
ghmj-1044	130	92	)	)	PUNCT
ghmj-1044	130	93	30	30	NUM
ghmj-1044	130	94	(	(	PUNCT
ghmj-1044	130	95	100.0	100.0	NUM
ghmj-1044	130	96	)	)	PUNCT
ghmj-1044	130	97	afisher	afisher	PROPN
ghmj-1044	130	98	exact	exact	ADJ
ghmj-1044	130	99	test	test	NOUN
ghmj-1044	130	100	4	4	NUM
ghmj-1044	130	101	.	.	PUNCT
ghmj-1044	130	102	discussion	discussion	NOUN
ghmj-1044	130	103	one	one	NUM
ghmj-1044	130	104	of	of	ADP
ghmj-1044	130	105	the	the	DET
ghmj-1044	130	106	primary	primary	ADJ
ghmj-1044	130	107	contributors	contributor	NOUN
ghmj-1044	130	108	to	to	ADP
ghmj-1044	130	109	cardiovascular	cardiovascular	ADJ
ghmj-1044	130	110	disease	disease	NOUN
ghmj-1044	130	111	-	-	PUNCT
ghmj-1044	130	112	related	relate	VERB
ghmj-1044	130	113	mortality	mortality	NOUN
ghmj-1044	130	114	is	be	AUX
ghmj-1044	130	115	hypertension	hypertension	NOUN
ghmj-1044	130	116	,	,	PUNCT
ghmj-1044	130	117	a	a	DET
ghmj-1044	130	118	disorder	disorder	NOUN
ghmj-1044	130	119	characterized	characterize	VERB
ghmj-1044	130	120	by	by	ADP
ghmj-1044	130	121	elevated	elevated	ADJ
ghmj-1044	130	122	blood	blood	NOUN
ghmj-1044	130	123	pressure	pressure	NOUN
ghmj-1044	130	124	.	.	PUNCT
ghmj-1044	131	1	the	the	DET
ghmj-1044	131	2	complications	complication	NOUN
ghmj-1044	131	3	of	of	ADP
ghmj-1044	131	4	hypertension	hypertension	NOUN
ghmj-1044	131	5	can	can	AUX
ghmj-1044	131	6	affect	affect	VERB
ghmj-1044	131	7	multiple	multiple	ADJ
ghmj-1044	131	8	target	target	NOUN
ghmj-1044	131	9	organs	organ	NOUN
ghmj-1044	131	10	,	,	PUNCT
ghmj-1044	131	11	with	with	ADP
ghmj-1044	131	12	the	the	DET
ghmj-1044	131	13	extent	extent	NOUN
ghmj-1044	131	14	of	of	ADP
ghmj-1044	131	15	organ	organ	NOUN
ghmj-1044	131	16	damage	damage	NOUN
ghmj-1044	131	17	depending	depend	VERB
ghmj-1044	131	18	on	on	ADP
ghmj-1044	131	19	the	the	DET
ghmj-1044	131	20	severity	severity	NOUN
ghmj-1044	131	21	and	and	CCONJ
ghmj-1044	131	22	duration	duration	NOUN
ghmj-1044	131	23	of	of	ADP
ghmj-1044	131	24	high	high	ADJ
ghmj-1044	131	25	blood	blood	NOUN
ghmj-1044	131	26	pressure	pressure	NOUN
ghmj-1044	131	27	.	.	PUNCT
ghmj-1044	132	1	common	common	ADJ
ghmj-1044	132	2	complications	complication	NOUN
ghmj-1044	132	3	include	include	VERB
ghmj-1044	132	4	ischemic	ischemic	ADJ
ghmj-1044	132	5	heart	heart	NOUN
ghmj-1044	132	6	disease	disease	NOUN
ghmj-1044	132	7	,	,	PUNCT
ghmj-1044	132	8	heart	heart	NOUN
ghmj-1044	132	9	failure	failure	NOUN
ghmj-1044	132	10	,	,	PUNCT
ghmj-1044	132	11	stroke	stroke	NOUN
ghmj-1044	132	12	,	,	PUNCT
ghmj-1044	132	13	kidney	kidney	NOUN
ghmj-1044	132	14	failure	failure	NOUN
ghmj-1044	132	15	,	,	PUNCT
ghmj-1044	132	16	retinopathy	retinopathy	ADJ
ghmj-1044	132	17	,	,	PUNCT
ghmj-1044	132	18	and	and	CCONJ
ghmj-1044	132	19	other	other	ADJ
ghmj-1044	132	20	related	related	ADJ
ghmj-1044	132	21	disorders	disorder	NOUN
ghmj-1044	132	22	(	(	PUNCT
ghmj-1044	132	23	muhadi	muhadi	NOUN
ghmj-1044	132	24	,	,	PUNCT
ghmj-1044	132	25	2016	2016	NUM
ghmj-1044	132	26	)	)	PUNCT
ghmj-1044	132	27	.	.	PUNCT
ghmj-1044	133	1	family	family	NOUN
ghmj-1044	133	2	history	history	NOUN
ghmj-1044	133	3	or	or	CCONJ
ghmj-1044	133	4	genetic	genetic	ADJ
ghmj-1044	133	5	predisposition	predisposition	NOUN
ghmj-1044	133	6	is	be	AUX
ghmj-1044	133	7	a	a	DET
ghmj-1044	133	8	significant	significant	ADJ
ghmj-1044	133	9	non	non	ADJ
ghmj-1044	133	10	-	-	ADJ
ghmj-1044	133	11	modifiable	modifiable	ADJ
ghmj-1044	133	12	risk	risk	NOUN
ghmj-1044	133	13	factor	factor	NOUN
ghmj-1044	133	14	for	for	ADP
ghmj-1044	133	15	hypertension	hypertension	NOUN
ghmj-1044	133	16	(	(	PUNCT
ghmj-1044	133	17	rahmadhani	rahmadhani	ADJ
ghmj-1044	133	18	,	,	PUNCT
ghmj-1044	133	19	2021	2021	NUM
ghmj-1044	133	20	)	)	PUNCT
ghmj-1044	133	21	.	.	PUNCT
ghmj-1044	134	1	more	more	ADJ
ghmj-1044	134	2	than	than	ADP
ghmj-1044	134	3	150	150	NUM
ghmj-1044	134	4	genes	gene	NOUN
ghmj-1044	134	5	have	have	AUX
ghmj-1044	134	6	been	be	AUX
ghmj-1044	134	7	linked	link	VERB
ghmj-1044	134	8	to	to	ADP
ghmj-1044	134	9	hypertension	hypertension	NOUN
ghmj-1044	134	10	,	,	PUNCT
ghmj-1044	134	11	with	with	ADP
ghmj-1044	134	12	various	various	ADJ
ghmj-1044	134	13	genetic	genetic	ADJ
ghmj-1044	134	14	variations	variation	NOUN
ghmj-1044	134	15	evolving	evolve	VERB
ghmj-1044	134	16	according	accord	VERB
ghmj-1044	134	17	to	to	ADP
ghmj-1044	134	18	the	the	DET
ghmj-1044	134	19	study	study	NOUN
ghmj-1044	134	20	population	population	NOUN
ghmj-1044	134	21	(	(	PUNCT
ghmj-1044	134	22	y.	y.	PROPN
ghmj-1044	134	23	zhang	zhang	PROPN
ghmj-1044	134	24	et	et	PROPN
ghmj-1044	134	25	al	al	PROPN
ghmj-1044	134	26	.	.	PROPN
ghmj-1044	134	27	,	,	PUNCT
ghmj-1044	134	28	2019	2019	NUM
ghmj-1044	134	29	)	)	PUNCT
ghmj-1044	134	30	.	.	PUNCT
ghmj-1044	135	1	one	one	NUM
ghmj-1044	135	2	of	of	ADP
ghmj-1044	135	3	the	the	DET
ghmj-1044	135	4	most	most	ADV
ghmj-1044	135	5	critical	critical	ADJ
ghmj-1044	135	6	genes	gene	NOUN
ghmj-1044	135	7	involved	involve	VERB
ghmj-1044	135	8	in	in	ADP
ghmj-1044	135	9	hypertension	hypertension	NOUN
ghmj-1044	135	10	is	be	AUX
ghmj-1044	135	11	the	the	DET
ghmj-1044	135	12	ace	ace	NOUN
ghmj-1044	135	13	gene	gene	NOUN
ghmj-1044	135	14	,	,	PUNCT
ghmj-1044	135	15	which	which	PRON
ghmj-1044	135	16	plays	play	VERB
ghmj-1044	135	17	a	a	DET
ghmj-1044	135	18	vital	vital	ADJ
ghmj-1044	135	19	role	role	NOUN
ghmj-1044	135	20	in	in	ADP
ghmj-1044	135	21	the	the	DET
ghmj-1044	135	22	raas	raas	NOUN
ghmj-1044	135	23	(	(	PUNCT
ghmj-1044	135	24	sayed	say	VERB
ghmj-1044	135	25	-	-	PUNCT
ghmj-1044	135	26	tabatabaei	tabatabaei	NOUN
ghmj-1044	135	27	et	et	PROPN
ghmj-1044	135	28	al	al	PROPN
ghmj-1044	135	29	.	.	PROPN
ghmj-1044	135	30	,	,	PUNCT
ghmj-1044	135	31	2006	2006	NUM
ghmj-1044	135	32	)	)	PUNCT
ghmj-1044	135	33	.	.	PUNCT
ghmj-1044	136	1	in	in	ADP
ghmj-1044	136	2	this	this	DET
ghmj-1044	136	3	study	study	NOUN
ghmj-1044	136	4	,	,	PUNCT
ghmj-1044	136	5	a	a	DET
ghmj-1044	136	6	family	family	NOUN
ghmj-1044	136	7	history	history	NOUN
ghmj-1044	136	8	of	of	ADP
ghmj-1044	136	9	hypertension	hypertension	NOUN
ghmj-1044	136	10	was	be	AUX
ghmj-1044	136	11	statistically	statistically	ADV
ghmj-1044	136	12	significant	significant	ADJ
ghmj-1044	136	13	(	(	PUNCT
ghmj-1044	136	14	p<0.05	p<0.05	NOUN
ghmj-1044	136	15	)	)	PUNCT
ghmj-1044	136	16	,	,	PUNCT
ghmj-1044	136	17	with	with	ADP
ghmj-1044	136	18	an	an	DET
ghmj-1044	136	19	or	or	CCONJ
ghmj-1044	136	20	(	(	PUNCT
ghmj-1044	136	21	95	95	NUM
ghmj-1044	136	22	%	%	NOUN
ghmj-1044	136	23	ci	ci	NOUN
ghmj-1044	136	24	)	)	PUNCT
ghmj-1044	136	25	of	of	ADP
ghmj-1044	136	26	15.545	15.545	NUM
ghmj-1044	136	27	(	(	PUNCT
ghmj-1044	136	28	3.814	3.814	NUM
ghmj-1044	136	29	-	-	SYM
ghmj-1044	136	30	63.359	63.359	NUM
ghmj-1044	136	31	)	)	PUNCT
ghmj-1044	136	32	,	,	PUNCT
ghmj-1044	136	33	indicating	indicate	VERB
ghmj-1044	136	34	that	that	SCONJ
ghmj-1044	136	35	individuals	individual	NOUN
ghmj-1044	136	36	with	with	ADP
ghmj-1044	136	37	a	a	DET
ghmj-1044	136	38	family	family	NOUN
ghmj-1044	136	39	history	history	NOUN
ghmj-1044	136	40	of	of	ADP
ghmj-1044	136	41	hypertension	hypertension	NOUN
ghmj-1044	136	42	are	be	AUX
ghmj-1044	136	43	15.545	15.545	NUM
ghmj-1044	136	44	times	time	NOUN
ghmj-1044	136	45	more	more	ADV
ghmj-1044	136	46	likely	likely	ADJ
ghmj-1044	136	47	to	to	PART
ghmj-1044	136	48	develop	develop	VERB
ghmj-1044	136	49	hypertension	hypertension	NOUN
ghmj-1044	136	50	than	than	ADP
ghmj-1044	136	51	those	those	PRON
ghmj-1044	136	52	without	without	ADP
ghmj-1044	136	53	such	such	DET
ghmj-1044	136	54	a	a	DET
ghmj-1044	136	55	history	history	NOUN
ghmj-1044	136	56	.	.	PUNCT
ghmj-1044	137	1	these	these	DET
ghmj-1044	137	2	findings	finding	NOUN
ghmj-1044	137	3	are	be	AUX
ghmj-1044	137	4	consistent	consistent	ADJ
ghmj-1044	137	5	with	with	ADP
ghmj-1044	137	6	a	a	DET
ghmj-1044	137	7	study	study	NOUN
ghmj-1044	137	8	conducted	conduct	VERB
ghmj-1044	137	9	in	in	ADP
ghmj-1044	137	10	2023	2023	NUM
ghmj-1044	137	11	in	in	ADP
ghmj-1044	137	12	kendari	kendari	PROPN
ghmj-1044	137	13	,	,	PUNCT
ghmj-1044	137	14	indonesia	indonesia	PROPN
ghmj-1044	137	15	,	,	PUNCT
ghmj-1044	137	16	which	which	PRON
ghmj-1044	137	17	also	also	ADV
ghmj-1044	137	18	demonstrated	demonstrate	VERB
ghmj-1044	137	19	a	a	DET
ghmj-1044	137	20	significant	significant	ADJ
ghmj-1044	137	21	association	association	NOUN
ghmj-1044	137	22	between	between	ADP
ghmj-1044	137	23	family	family	NOUN
ghmj-1044	137	24	history	history	NOUN
ghmj-1044	137	25	and	and	CCONJ
ghmj-1044	137	26	hypertension	hypertension	NOUN
ghmj-1044	137	27	risk	risk	NOUN
ghmj-1044	137	28	,	,	PUNCT
ghmj-1044	137	29	where	where	SCONJ
ghmj-1044	137	30	subjects	subject	NOUN
ghmj-1044	137	31	with	with	ADP
ghmj-1044	137	32	a	a	DET
ghmj-1044	137	33	family	family	NOUN
ghmj-1044	137	34	history	history	NOUN
ghmj-1044	137	35	of	of	ADP
ghmj-1044	137	36	hypertension	hypertension	NOUN
ghmj-1044	137	37	were	be	AUX
ghmj-1044	137	38	12	12	NUM
ghmj-1044	137	39	times	time	NOUN
ghmj-1044	137	40	more	more	ADV
ghmj-1044	137	41	likely	likely	ADJ
ghmj-1044	137	42	to	to	PART
ghmj-1044	137	43	develop	develop	VERB
ghmj-1044	137	44	the	the	DET
ghmj-1044	137	45	condition	condition	NOUN
ghmj-1044	137	46	(	(	PUNCT
ghmj-1044	137	47	sudayasa	sudayasa	PROPN
ghmj-1044	137	48	,	,	PUNCT
ghmj-1044	137	49	husdaningsih	husdaningsih	NOUN
ghmj-1044	137	50	,	,	PUNCT
ghmj-1044	137	51	&	&	CCONJ
ghmj-1044	137	52	alifariki	alifariki	PROPN
ghmj-1044	137	53	,	,	PUNCT
ghmj-1044	137	54	2023	2023	NUM
ghmj-1044	137	55	)	)	PUNCT
ghmj-1044	137	56	.	.	PUNCT
ghmj-1044	138	1	this	this	DET
ghmj-1044	138	2	study	study	NOUN
ghmj-1044	138	3	involved	involve	VERB
ghmj-1044	138	4	30	30	NUM
ghmj-1044	138	5	hypertensive	hypertensive	ADJ
ghmj-1044	138	6	patients	patient	NOUN
ghmj-1044	138	7	and	and	CCONJ
ghmj-1044	138	8	30	30	NUM
ghmj-1044	138	9	healthy	healthy	ADJ
ghmj-1044	138	10	individuals	individual	NOUN
ghmj-1044	138	11	.	.	PUNCT
ghmj-1044	139	1	the	the	DET
ghmj-1044	139	2	significance	significance	NOUN
ghmj-1044	139	3	of	of	ADP
ghmj-1044	139	4	ethnicity	ethnicity	NOUN
ghmj-1044	139	5	was	be	AUX
ghmj-1044	139	6	observed	observe	VERB
ghmj-1044	139	7	in	in	ADP
ghmj-1044	139	8	both	both	DET
ghmj-1044	139	9	groups	group	NOUN
ghmj-1044	139	10	,	,	PUNCT
ghmj-1044	139	11	with	with	ADP
ghmj-1044	139	12	a	a	DET
ghmj-1044	139	13	p	p	NOUN
ghmj-1044	139	14	-	-	PUNCT
ghmj-1044	139	15	value	value	NOUN
ghmj-1044	139	16	of	of	ADP
ghmj-1044	139	17	0.037	0.037	NUM
ghmj-1044	139	18	(	(	PUNCT
ghmj-1044	139	19	p<0.05	p<0.05	PROPN
ghmj-1044	139	20	)	)	PUNCT
ghmj-1044	139	21	,	,	PUNCT
ghmj-1044	139	22	similar	similar	ADJ
ghmj-1044	139	23	to	to	ADP
ghmj-1044	139	24	the	the	DET
ghmj-1044	139	25	finding	finding	NOUN
ghmj-1044	139	26	from	from	ADP
ghmj-1044	139	27	a	a	DET
ghmj-1044	139	28	study	study	NOUN
ghmj-1044	139	29	conducted	conduct	VERB
ghmj-1044	139	30	in	in	ADP
ghmj-1044	139	31	india	india	PROPN
ghmj-1044	139	32	that	that	PRON
ghmj-1044	139	33	also	also	ADV
ghmj-1044	139	34	reported	report	VERB
ghmj-1044	139	35	a	a	DET
ghmj-1044	139	36	significant	significant	ADJ
ghmj-1044	139	37	association	association	NOUN
ghmj-1044	139	38	with	with	ADP
ghmj-1044	139	39	hypertension	hypertension	NOUN
ghmj-1044	139	40	in	in	ADP
ghmj-1044	139	41	both	both	CCONJ
ghmj-1044	139	42	the	the	DET
ghmj-1044	139	43	case	case	NOUN
ghmj-1044	139	44	and	and	CCONJ
ghmj-1044	139	45	control	control	NOUN
ghmj-1044	139	46	groups	group	NOUN
ghmj-1044	139	47	(	(	PUNCT
ghmj-1044	139	48	qadar	qadar	PROPN
ghmj-1044	139	49	pasha	pasha	PROPN
ghmj-1044	139	50	et	et	PROPN
ghmj-1044	139	51	al	al	PROPN
ghmj-1044	139	52	.	.	PROPN
ghmj-1044	139	53	,	,	PUNCT
ghmj-1044	139	54	2002	2002	NUM
ghmj-1044	139	55	)	)	PUNCT
ghmj-1044	139	56	.	.	PUNCT
ghmj-1044	140	1	the	the	DET
ghmj-1044	140	2	or	or	CCONJ
ghmj-1044	140	3	(	(	PUNCT
ghmj-1044	140	4	95	95	NUM
ghmj-1044	140	5	%	%	NOUN
ghmj-1044	140	6	ci	ci	NOUN
ghmj-1044	140	7	)	)	PUNCT
ghmj-1044	140	8	for	for	ADP
ghmj-1044	140	9	ethnicity	ethnicity	NOUN
ghmj-1044	140	10	was	be	AUX
ghmj-1044	140	11	0.266	0.266	NUM
ghmj-1044	140	12	(	(	PUNCT
ghmj-1044	140	13	0.073	0.073	NUM
ghmj-1044	140	14	-	-	PUNCT
ghmj-1044	140	15	0.964	0.964	NUM
ghmj-1044	140	16	)	)	PUNCT
ghmj-1044	140	17	,	,	PUNCT
ghmj-1044	140	18	suggesting	suggest	VERB
ghmj-1044	140	19	that	that	SCONJ
ghmj-1044	140	20	it	it	PRON
ghmj-1044	140	21	may	may	AUX
ghmj-1044	140	22	serve	serve	VERB
ghmj-1044	140	23	as	as	ADP
ghmj-1044	140	24	a	a	DET
ghmj-1044	140	25	protective	protective	ADJ
ghmj-1044	140	26	factor	factor	NOUN
ghmj-1044	140	27	against	against	ADP
ghmj-1044	140	28	hypertension	hypertension	NOUN
ghmj-1044	140	29	in	in	ADP
ghmj-1044	140	30	this	this	DET
ghmj-1044	140	31	study	study	NOUN
ghmj-1044	140	32	.	.	PUNCT
ghmj-1044	141	1	a	a	DET
ghmj-1044	141	2	study	study	NOUN
ghmj-1044	141	3	in	in	ADP
ghmj-1044	141	4	banyuwangi	banyuwangi	PROPN
ghmj-1044	141	5	,	,	PUNCT
ghmj-1044	141	6	east	east	PROPN
ghmj-1044	141	7	java	java	PROPN
ghmj-1044	141	8	,	,	PUNCT
ghmj-1044	141	9	indonesia	indonesia	PROPN
ghmj-1044	141	10	,	,	PUNCT
ghmj-1044	141	11	showed	show	VERB
ghmj-1044	141	12	similar	similar	ADJ
ghmj-1044	141	13	results	result	NOUN
ghmj-1044	141	14	,	,	PUNCT
ghmj-1044	141	15	indicating	indicate	VERB
ghmj-1044	141	16	that	that	SCONJ
ghmj-1044	141	17	ethnicity	ethnicity	NOUN
ghmj-1044	141	18	was	be	AUX
ghmj-1044	141	19	not	not	PART
ghmj-1044	141	20	a	a	DET
ghmj-1044	141	21	risk	risk	NOUN
ghmj-1044	141	22	factor	factor	NOUN
ghmj-1044	141	23	for	for	ADP
ghmj-1044	141	24	hypertension	hypertension	NOUN
ghmj-1044	141	25	(	(	PUNCT
ghmj-1044	141	26	astutik	astutik	PROPN
ghmj-1044	141	27	,	,	PUNCT
ghmj-1044	141	28	puspikawati	puspikawati	PROPN
ghmj-1044	141	29	,	,	PUNCT
ghmj-1044	141	30	dewi	dewi	PROPN
ghmj-1044	141	31	,	,	PUNCT
ghmj-1044	141	32	mandagi	mandagi	PROPN
ghmj-1044	141	33	,	,	PUNCT
ghmj-1044	141	34	&	&	CCONJ
ghmj-1044	141	35	sebayang	sebayang	PROPN
ghmj-1044	141	36	,	,	PUNCT
ghmj-1044	141	37	2020	2020	NUM
ghmj-1044	141	38	)	)	PUNCT
ghmj-1044	141	39	.	.	PUNCT
ghmj-1044	142	1	bmi	bmi	PROPN
ghmj-1044	142	2	characteristics	characteristics	PROPN
ghmj-1044	142	3	did	do	AUX
ghmj-1044	142	4	not	not	PART
ghmj-1044	142	5	show	show	VERB
ghmj-1044	142	6	statistical	statistical	ADJ
ghmj-1044	142	7	significance	significance	NOUN
ghmj-1044	142	8	in	in	ADP
ghmj-1044	142	9	either	either	DET
ghmj-1044	142	10	group	group	NOUN
ghmj-1044	142	11	,	,	PUNCT
ghmj-1044	142	12	with	with	ADP
ghmj-1044	142	13	a	a	DET
ghmj-1044	142	14	p	p	NOUN
ghmj-1044	142	15	-	-	PUNCT
ghmj-1044	142	16	value	value	NOUN
ghmj-1044	142	17	of	of	ADP
ghmj-1044	142	18	0.585	0.585	NUM
ghmj-1044	142	19	(	(	PUNCT
ghmj-1044	142	20	p>0.05	p>0.05	PROPN
ghmj-1044	142	21	)	)	PUNCT
ghmj-1044	142	22	,	,	PUNCT
ghmj-1044	142	23	consistent	consistent	ADJ
ghmj-1044	142	24	with	with	ADP
ghmj-1044	142	25	studies	study	NOUN
ghmj-1044	142	26	conducted	conduct	VERB
ghmj-1044	142	27	in	in	ADP
ghmj-1044	142	28	kazakh	kazakh	ADJ
ghmj-1044	142	29	populations	population	NOUN
ghmj-1044	142	30	in	in	ADP
ghmj-1044	142	31	china	china	PROPN
ghmj-1044	142	32	’s	’s	PART
ghmj-1044	142	33	barkol	barkol	PROPN
ghmj-1044	142	34	pasture	pasture	NOUN
ghmj-1044	142	35	(	(	PUNCT
ghmj-1044	142	36	x.	x.	NOUN
ghmj-1044	142	37	wang	wang	PROPN
ghmj-1044	142	38	et	et	PROPN
ghmj-1044	142	39	al	al	PROPN
ghmj-1044	142	40	.	.	PROPN
ghmj-1044	142	41	,	,	PUNCT
ghmj-1044	142	42	2004	2004	NUM
ghmj-1044	142	43	)	)	PUNCT
ghmj-1044	142	44	,	,	PUNCT
ghmj-1044	142	45	mataram	mataram	PROPN
ghmj-1044	142	46	,	,	PUNCT
ghmj-1044	142	47	indonesia	indonesia	PROPN
ghmj-1044	142	48	(	(	PUNCT
ghmj-1044	142	49	rezqi	rezqi	PROPN
ghmj-1044	142	50	,	,	PUNCT
ghmj-1044	142	51	fathana	fathana	PROPN
ghmj-1044	142	52	,	,	PUNCT
ghmj-1044	142	53	&	&	CCONJ
ghmj-1044	142	54	dirja	dirja	PROPN
ghmj-1044	142	55	,	,	PUNCT
ghmj-1044	142	56	2023	2023	NUM
ghmj-1044	142	57	)	)	PUNCT
ghmj-1044	142	58	,	,	PUNCT
ghmj-1044	142	59	and	and	CCONJ
ghmj-1044	142	60	bogor	bogor	PROPN
ghmj-1044	142	61	,	,	PUNCT
ghmj-1044	142	62	indonesia	indonesia	PROPN
ghmj-1044	142	63	(	(	PUNCT
ghmj-1044	142	64	agustiani	agustiani	PROPN
ghmj-1044	142	65	,	,	PUNCT
ghmj-1044	142	66	anggie	anggie	PROPN
ghmj-1044	142	67	nauli	nauli	PROPN
ghmj-1044	142	68	,	,	PUNCT
ghmj-1044	142	69	&	&	CCONJ
ghmj-1044	142	70	masitha	masitha	PROPN
ghmj-1044	142	71	arsyati	arsyati	PROPN
ghmj-1044	142	72	,	,	PUNCT
ghmj-1044	142	73	2023	2023	NUM
ghmj-1044	142	74	)	)	PUNCT
ghmj-1044	142	75	.	.	PUNCT
ghmj-1044	143	1	however	however	ADV
ghmj-1044	143	2	,	,	PUNCT
ghmj-1044	143	3	studies	study	NOUN
ghmj-1044	143	4	conducted	conduct	VERB
ghmj-1044	143	5	in	in	ADP
ghmj-1044	143	6	anhui	anhui	PROPN
ghmj-1044	143	7	,	,	PUNCT
ghmj-1044	143	8	china	china	PROPN
ghmj-1044	143	9	(	(	PUNCT
ghmj-1044	143	10	l.	l.	PROPN
ghmj-1044	143	11	wang	wang	PROPN
ghmj-1044	143	12	et	et	PROPN
ghmj-1044	143	13	al	al	PROPN
ghmj-1044	143	14	.	.	PROPN
ghmj-1044	143	15	,	,	PUNCT
ghmj-1044	143	16	2023	2023	NUM
ghmj-1044	143	17	)	)	PUNCT
ghmj-1044	143	18	,	,	PUNCT
ghmj-1044	143	19	lorestan	lorestan	PROPN
ghmj-1044	143	20	,	,	PUNCT
ghmj-1044	143	21	iran	iran	PROPN
ghmj-1044	143	22	(	(	PUNCT
ghmj-1044	143	23	hadian	hadian	PROPN
ghmj-1044	143	24	,	,	PUNCT
ghmj-1044	143	25	zafarmohtashami	zafarmohtashami	PROPN
ghmj-1044	143	26	,	,	PUNCT
ghmj-1044	143	27	chaghervand	chaghervand	PROPN
ghmj-1044	143	28	,	,	PUNCT
ghmj-1044	143	29	&	&	CCONJ
ghmj-1044	143	30	nouryazdan	nouryazdan	PROPN
ghmj-1044	143	31	,	,	PUNCT
ghmj-1044	143	32	2022	2022	NUM
ghmj-1044	143	33	)	)	PUNCT
ghmj-1044	143	34	,	,	PUNCT
ghmj-1044	143	35	and	and	CCONJ
ghmj-1044	143	36	yogyakarta	yogyakarta	PROPN
ghmj-1044	143	37	,	,	PUNCT
ghmj-1044	143	38	indonesia	indonesia	PROPN
ghmj-1044	143	39	(	(	PUNCT
ghmj-1044	143	40	bawazier	bawazier	X
ghmj-1044	143	41	,	,	PUNCT
ghmj-1044	143	42	sja’bani	sja’bani	PROPN
ghmj-1044	143	43	,	,	PUNCT
ghmj-1044	143	44	haryana	haryana	PROPN
ghmj-1044	143	45	,	,	PUNCT
ghmj-1044	143	46	soesatyo	soesatyo	PROPN
ghmj-1044	143	47	,	,	PUNCT
ghmj-1044	143	48	&	&	CCONJ
ghmj-1044	143	49	sadewa	sadewa	PROPN
ghmj-1044	143	50	,	,	PUNCT
ghmj-1044	143	51	2010	2010	NUM
ghmj-1044	143	52	)	)	PUNCT
ghmj-1044	143	53	reported	report	VERB
ghmj-1044	143	54	significant	significant	ADJ
ghmj-1044	143	55	associations	association	NOUN
ghmj-1044	143	56	between	between	ADP
ghmj-1044	143	57	bmi	bmi	NOUN
ghmj-1044	143	58	and	and	CCONJ
ghmj-1044	143	59	hypertension	hypertension	NOUN
ghmj-1044	143	60	.	.	PUNCT
ghmj-1044	144	1	smoking	smoking	NOUN
ghmj-1044	144	2	status	status	NOUN
ghmj-1044	144	3	in	in	ADP
ghmj-1044	144	4	this	this	DET
ghmj-1044	144	5	study	study	NOUN
ghmj-1044	144	6	also	also	ADV
ghmj-1044	144	7	did	do	AUX
ghmj-1044	144	8	not	not	PART
ghmj-1044	144	9	demonstrate	demonstrate	VERB
ghmj-1044	144	10	statistical	statistical	ADJ
ghmj-1044	144	11	significance	significance	NOUN
ghmj-1044	144	12	between	between	ADP
ghmj-1044	144	13	the	the	DET
ghmj-1044	144	14	two	two	NUM
ghmj-1044	144	15	groups	group	NOUN
ghmj-1044	144	16	,	,	PUNCT
ghmj-1044	144	17	with	with	ADP
ghmj-1044	144	18	a	a	DET
ghmj-1044	144	19	p	p	NOUN
ghmj-1044	144	20	-	-	PUNCT
ghmj-1044	144	21	value	value	NOUN
ghmj-1044	144	22	of	of	ADP
ghmj-1044	144	23	0.371	0.371	NUM
ghmj-1044	144	24	(	(	PUNCT
ghmj-1044	144	25	p>0.05	p>0.05	PROPN
ghmj-1044	144	26	)	)	PUNCT
ghmj-1044	144	27	.	.	PUNCT
ghmj-1044	145	1	this	this	DET
ghmj-1044	145	2	finding	finding	NOUN
ghmj-1044	145	3	aligns	align	VERB
ghmj-1044	145	4	with	with	ADP
ghmj-1044	145	5	studies	study	NOUN
ghmj-1044	145	6	conducted	conduct	VERB
ghmj-1044	145	7	in	in	ADP
ghmj-1044	145	8	banyuwangi	banyuwangi	NOUN
ghmj-1044	145	9	(	(	PUNCT
ghmj-1044	145	10	bawazier	bawazi	ADJ
ghmj-1044	145	11	et	et	PROPN
ghmj-1044	145	12	al	al	PROPN
ghmj-1044	145	13	.	.	PROPN
ghmj-1044	145	14	,	,	PUNCT
ghmj-1044	145	15	2010	2010	NUM
ghmj-1044	145	16	)	)	PUNCT
ghmj-1044	145	17	,	,	PUNCT
ghmj-1044	145	18	and	and	CCONJ
ghmj-1044	145	19	south	south	PROPN
ghmj-1044	145	20	hulu	hulu	PROPN
ghmj-1044	145	21	sungai	sungai	PROPN
ghmj-1044	145	22	,	,	PUNCT
ghmj-1044	145	23	kalimantan	kalimantan	PROPN
ghmj-1044	145	24	selatan	selatan	PROPN
ghmj-1044	145	25	,	,	PUNCT
ghmj-1044	145	26	indonesia	indonesia	PROPN
ghmj-1044	145	27	(	(	PUNCT
ghmj-1044	145	28	mufaidah	mufaidah	PROPN
ghmj-1044	145	29	,	,	PUNCT
ghmj-1044	145	30	2019	2019	NUM
ghmj-1044	145	31	)	)	PUNCT
ghmj-1044	145	32	,	,	PUNCT
ghmj-1044	145	33	which	which	PRON
ghmj-1044	145	34	similarly	similarly	ADV
ghmj-1044	145	35	found	find	VERB
ghmj-1044	145	36	no	no	DET
ghmj-1044	145	37	significant	significant	ADJ
ghmj-1044	145	38	association	association	NOUN
ghmj-1044	145	39	between	between	ADP
ghmj-1044	145	40	smoking	smoking	NOUN
ghmj-1044	145	41	and	and	CCONJ
ghmj-1044	145	42	the	the	DET
ghmj-1044	145	43	incidence	incidence	NOUN
ghmj-1044	145	44	of	of	ADP
ghmj-1044	145	45	hypertension	hypertension	NOUN
ghmj-1044	145	46	(	(	PUNCT
ghmj-1044	145	47	hidayat	hidayat	PROPN
ghmj-1044	145	48	&	&	CCONJ
ghmj-1044	145	49	milenia	milenia	PROPN
ghmj-1044	145	50	saputri	saputri	PROPN
ghmj-1044	145	51	,	,	PUNCT
ghmj-1044	145	52	2023	2023	NUM
ghmj-1044	145	53	)	)	PUNCT
ghmj-1044	145	54	.	.	PUNCT
ghmj-1044	146	1	likewise	likewise	ADV
ghmj-1044	146	2	,	,	PUNCT
ghmj-1044	146	3	a	a	DET
ghmj-1044	146	4	recent	recent	ADJ
ghmj-1044	146	5	study	study	NOUN
ghmj-1044	146	6	in	in	ADP
ghmj-1044	146	7	anhui	anhui	PROPN
ghmj-1044	146	8	,	,	PUNCT
ghmj-1044	146	9	china	china	PROPN
ghmj-1044	146	10	,	,	PUNCT
ghmj-1044	146	11	reported	report	VERB
ghmj-1044	146	12	no	no	DET
ghmj-1044	146	13	significant	significant	ADJ
ghmj-1044	146	14	association	association	NOUN
ghmj-1044	146	15	between	between	ADP
ghmj-1044	146	16	smoking	smoking	NOUN
ghmj-1044	146	17	and	and	CCONJ
ghmj-1044	146	18	essential	essential	ADJ
ghmj-1044	146	19	hypertension	hypertension	NOUN
ghmj-1044	146	20	(	(	PUNCT
ghmj-1044	146	21	l.	l.	PROPN
ghmj-1044	146	22	wang	wang	PROPN
ghmj-1044	146	23	et	et	PROPN
ghmj-1044	146	24	al	al	PROPN
ghmj-1044	146	25	.	.	PROPN
ghmj-1044	146	26	,	,	PUNCT
ghmj-1044	146	27	2023	2023	NUM
ghmj-1044	146	28	)	)	PUNCT
ghmj-1044	146	29	.	.	PUNCT
ghmj-1044	147	1	the	the	DET
ghmj-1044	147	2	ace	ace	PROPN
ghmj-1044	147	3	gene	gene	NOUN
ghmj-1044	147	4	influences	influence	VERB
ghmj-1044	147	5	plasma	plasma	NOUN
ghmj-1044	147	6	ace	ace	NOUN
ghmj-1044	147	7	levels	level	NOUN
ghmj-1044	147	8	and	and	CCONJ
ghmj-1044	147	9	blood	blood	NOUN
ghmj-1044	147	10	pressure	pressure	NOUN
ghmj-1044	147	11	regulation	regulation	NOUN
ghmj-1044	147	12	through	through	ADP
ghmj-1044	147	13	the	the	DET
ghmj-1044	147	14	raas	raas	NOUN
ghmj-1044	147	15	.	.	PUNCT
ghmj-1044	148	1	approximately	approximately	ADV
ghmj-1044	148	2	47	47	NUM
ghmj-1044	148	3	%	%	NOUN
ghmj-1044	148	4	of	of	ADP
ghmj-1044	148	5	the	the	DET
ghmj-1044	148	6	variation	variation	NOUN
ghmj-1044	148	7	in	in	ADP
ghmj-1044	148	8	serum	serum	NOUN
ghmj-1044	148	9	ace	ace	PROPN
ghmj-1044	148	10	levels	level	NOUN
ghmj-1044	148	11	is	be	AUX
ghmj-1044	148	12	attributed	attribute	VERB
ghmj-1044	148	13	to	to	ADP
ghmj-1044	148	14	the	the	DET
ghmj-1044	148	15	insertion	insertion	NOUN
ghmj-1044	148	16	/	/	SYM
ghmj-1044	148	17	deletion	deletion	NOUN
ghmj-1044	148	18	(	(	PUNCT
ghmj-1044	148	19	i	i	NOUN
ghmj-1044	148	20	/	/	SYM
ghmj-1044	148	21	d	d	NOUN
ghmj-1044	148	22	)	)	PUNCT
ghmj-1044	148	23	polymorphism	polymorphism	NOUN
ghmj-1044	148	24	(	(	PUNCT
ghmj-1044	148	25	sudayasa	sudayasa	PROPN
ghmj-1044	148	26	et	et	PROPN
ghmj-1044	148	27	al	al	PROPN
ghmj-1044	148	28	.	.	PROPN
ghmj-1044	148	29	,	,	PUNCT
ghmj-1044	148	30	2023	2023	NUM
ghmj-1044	148	31	)	)	PUNCT
ghmj-1044	148	32	.	.	PUNCT
ghmj-1044	149	1	in	in	ADP
ghmj-1044	149	2	this	this	DET
ghmj-1044	149	3	study	study	NOUN
ghmj-1044	149	4	,	,	PUNCT
ghmj-1044	149	5	the	the	DET
ghmj-1044	149	6	i	i	PROPN
ghmj-1044	149	7	d	d	PROPN
ghmj-1044	149	8	genotype	genotype	NOUN
ghmj-1044	149	9	was	be	AUX
ghmj-1044	149	10	the	the	DET
ghmj-1044	149	11	most	most	ADV
ghmj-1044	149	12	common	common	ADJ
ghmj-1044	149	13	among	among	ADP
ghmj-1044	149	14	both	both	DET
ghmj-1044	149	15	case	case	NOUN
ghmj-1044	149	16	and	and	CCONJ
ghmj-1044	149	17	control	control	NOUN
ghmj-1044	149	18	groups	group	NOUN
ghmj-1044	149	19	,	,	PUNCT
ghmj-1044	149	20	followed	follow	VERB
ghmj-1044	149	21	by	by	ADP
ghmj-1044	149	22	the	the	DET
ghmj-1044	149	23	dd	dd	PROPN
ghmj-1044	149	24	and	and	CCONJ
ghmj-1044	149	25	ii	ii	PROPN
ghmj-1044	149	26	genotypes	genotype	NOUN
ghmj-1044	149	27	.	.	PUNCT
ghmj-1044	150	1	the	the	DET
ghmj-1044	150	2	most	most	ADV
ghmj-1044	150	3	frequent	frequent	ADJ
ghmj-1044	150	4	allele	allele	NOUN
ghmj-1044	150	5	in	in	ADP
ghmj-1044	150	6	the	the	DET
ghmj-1044	150	7	case	case	NOUN
ghmj-1044	150	8	group	group	NOUN
ghmj-1044	150	9	was	be	AUX
ghmj-1044	150	10	allele	allele	NOUN
ghmj-1044	150	11	i	i	PRON
ghmj-1044	150	12	,	,	PUNCT
ghmj-1044	150	13	while	while	SCONJ
ghmj-1044	150	14	allele	allele	NOUN
ghmj-1044	150	15	d	d	PROPN
ghmj-1044	150	16	was	be	AUX
ghmj-1044	150	17	more	more	ADV
ghmj-1044	150	18	prevalent	prevalent	ADJ
ghmj-1044	150	19	in	in	ADP
ghmj-1044	150	20	the	the	DET
ghmj-1044	150	21	control	control	NOUN
ghmj-1044	150	22	group	group	NOUN
ghmj-1044	150	23	.	.	PUNCT
ghmj-1044	151	1	genotype	genotype	NOUN
ghmj-1044	151	2	and	and	CCONJ
ghmj-1044	151	3	allele	allele	NOUN
ghmj-1044	151	4	frequencies	frequency	NOUN
ghmj-1044	151	5	were	be	AUX
ghmj-1044	151	6	not	not	PART
ghmj-1044	151	7	significantly	significantly	ADV
ghmj-1044	151	8	associated	associate	VERB
ghmj-1044	151	9	with	with	ADP
ghmj-1044	151	10	hypertension	hypertension	NOUN
ghmj-1044	151	11	,	,	PUNCT
ghmj-1044	151	12	consistent	consistent	ADJ
ghmj-1044	151	13	with	with	ADP
ghmj-1044	151	14	findings	finding	NOUN
ghmj-1044	151	15	from	from	ADP
ghmj-1044	151	16	a	a	DET
ghmj-1044	151	17	study	study	NOUN
ghmj-1044	151	18	involving	involve	VERB
ghmj-1044	151	19	203	203	NUM
ghmj-1044	151	20	subjects	subject	NOUN
ghmj-1044	151	21	in	in	ADP
ghmj-1044	151	22	south	south	ADJ
ghmj-1044	151	23	sulawesi	sulawesi	NOUN
ghmj-1044	151	24	,	,	PUNCT
ghmj-1044	151	25	indonesia	indonesia	PROPN
ghmj-1044	151	26	(	(	PUNCT
ghmj-1044	151	27	rasyid	rasyid	NOUN
ghmj-1044	151	28	et	et	PROPN
ghmj-1044	151	29	al	al	PROPN
ghmj-1044	151	30	.	.	PROPN
ghmj-1044	151	31	,	,	PUNCT
ghmj-1044	151	32	2012	2012	NUM
ghmj-1044	151	33	)	)	PUNCT
ghmj-1044	151	34	.	.	PUNCT
ghmj-1044	152	1	similar	similar	ADJ
ghmj-1044	152	2	results	result	NOUN
ghmj-1044	152	3	were	be	AUX
ghmj-1044	152	4	observed	observe	VERB
ghmj-1044	152	5	in	in	ADP
ghmj-1044	152	6	a	a	DET
ghmj-1044	152	7	cross	cross	ADJ
ghmj-1044	152	8	-	-	ADJ
ghmj-1044	152	9	sectional	sectional	ADJ
ghmj-1044	152	10	study	study	NOUN
ghmj-1044	152	11	with	with	ADP
ghmj-1044	152	12	69	69	NUM
ghmj-1044	152	13	postmenopausal	postmenopausal	ADJ
ghmj-1044	152	14	women	woman	NOUN
ghmj-1044	152	15	in	in	ADP
ghmj-1044	152	16	java	java	PROPN
ghmj-1044	152	17	187	187	NUM
ghmj-1044	152	18	ghmj	ghmj	NOUN
ghmj-1044	152	19	(	(	PUNCT
ghmj-1044	152	20	global	global	ADJ
ghmj-1044	152	21	health	health	PROPN
ghmj-1044	152	22	management	management	NOUN
ghmj-1044	152	23	journal	journal	PROPN
ghmj-1044	152	24	)	)	PUNCT
ghmj-1044	152	25	2024	2024	NUM
ghmj-1044	152	26	,	,	PUNCT
ghmj-1044	152	27	vol	vol	NOUN
ghmj-1044	152	28	.	.	PROPN
ghmj-1044	153	1	7	7	NUM
ghmj-1044	153	2	,	,	PUNCT
ghmj-1044	153	3	no	no	INTJ
ghmj-1044	153	4	.	.	NOUN
ghmj-1044	153	5	4	4	NUM
ghmj-1044	153	6	kuswara	kuswara	NOUN
ghmj-1044	153	7	,	,	PUNCT
ghmj-1044	153	8	et	et	NOUN
ghmj-1044	153	9	.	.	PUNCT
ghmj-1044	154	1	al	al	PROPN
ghmj-1044	154	2	.	.	PUNCT
ghmj-1044	155	1	(	(	PUNCT
ghmj-1044	155	2	utami	utami	NOUN
ghmj-1044	155	3	,	,	PUNCT
ghmj-1044	155	4	simamora	simamora	PROPN
ghmj-1044	155	5	,	,	PUNCT
ghmj-1044	155	6	idawati	idawati	PROPN
ghmj-1044	155	7	,	,	PUNCT
ghmj-1044	155	8	&	&	CCONJ
ghmj-1044	155	9	widjaja	widjaja	PROPN
ghmj-1044	155	10	,	,	PUNCT
ghmj-1044	155	11	2024	2024	NUM
ghmj-1044	155	12	)	)	PUNCT
ghmj-1044	155	13	.	.	PUNCT
ghmj-1044	156	1	according	accord	VERB
ghmj-1044	156	2	to	to	ADP
ghmj-1044	156	3	that	that	DET
ghmj-1044	156	4	study	study	NOUN
ghmj-1044	156	5	,	,	PUNCT
ghmj-1044	156	6	the	the	DET
ghmj-1044	156	7	ii	ii	PROPN
ghmj-1044	156	8	genotype	genotype	NOUN
ghmj-1044	156	9	was	be	AUX
ghmj-1044	156	10	more	more	ADV
ghmj-1044	156	11	prevalent	prevalent	ADJ
ghmj-1044	156	12	among	among	ADP
ghmj-1044	156	13	healthy	healthy	ADJ
ghmj-1044	156	14	individuals	individual	NOUN
ghmj-1044	156	15	;	;	PUNCT
ghmj-1044	156	16	however	however	ADV
ghmj-1044	156	17	,	,	PUNCT
ghmj-1044	156	18	the	the	DET
ghmj-1044	156	19	dd	dd	NOUN
ghmj-1044	156	20	genotype	genotype	NOUN
ghmj-1044	156	21	was	be	AUX
ghmj-1044	156	22	exclusively	exclusively	ADV
ghmj-1044	156	23	present	present	ADJ
ghmj-1044	156	24	among	among	ADP
ghmj-1044	156	25	hypertensive	hypertensive	ADJ
ghmj-1044	156	26	patients	patient	NOUN
ghmj-1044	156	27	.	.	PUNCT
ghmj-1044	157	1	a	a	DET
ghmj-1044	157	2	study	study	NOUN
ghmj-1044	157	3	conducted	conduct	VERB
ghmj-1044	157	4	in	in	ADP
ghmj-1044	157	5	japan	japan	PROPN
ghmj-1044	157	6	similarly	similarly	ADV
ghmj-1044	157	7	reported	report	VERB
ghmj-1044	157	8	no	no	DET
ghmj-1044	157	9	significant	significant	ADJ
ghmj-1044	157	10	association	association	NOUN
ghmj-1044	157	11	between	between	ADP
ghmj-1044	157	12	genotype	genotype	NOUN
ghmj-1044	157	13	and	and	CCONJ
ghmj-1044	157	14	allele	allele	NOUN
ghmj-1044	157	15	frequencies	frequency	NOUN
ghmj-1044	157	16	among	among	ADP
ghmj-1044	157	17	case	case	NOUN
ghmj-1044	157	18	and	and	CCONJ
ghmj-1044	157	19	control	control	NOUN
ghmj-1044	157	20	groups	group	NOUN
ghmj-1044	157	21	(	(	PUNCT
ghmj-1044	157	22	ishigami	ishigami	NOUN
ghmj-1044	157	23	et	et	PROPN
ghmj-1044	157	24	al	al	PROPN
ghmj-1044	157	25	.	.	PROPN
ghmj-1044	157	26	,	,	PUNCT
ghmj-1044	157	27	1995	1995	NUM
ghmj-1044	157	28	)	)	PUNCT
ghmj-1044	157	29	.	.	PUNCT
ghmj-1044	158	1	in	in	ADP
ghmj-1044	158	2	this	this	DET
ghmj-1044	158	3	study	study	NOUN
ghmj-1044	158	4	,	,	PUNCT
ghmj-1044	158	5	the	the	DET
ghmj-1044	158	6	ii	ii	PROPN
ghmj-1044	158	7	genotype	genotype	NOUN
ghmj-1044	158	8	was	be	AUX
ghmj-1044	158	9	more	more	ADV
ghmj-1044	158	10	frequently	frequently	ADV
ghmj-1044	158	11	observed	observe	VERB
ghmj-1044	158	12	in	in	ADP
ghmj-1044	158	13	healthy	healthy	ADJ
ghmj-1044	158	14	individuals	individual	NOUN
ghmj-1044	158	15	.	.	PUNCT
ghmj-1044	159	1	the	the	DET
ghmj-1044	159	2	i	i	PROPN
ghmj-1044	159	3	allele	allele	PROPN
ghmj-1044	159	4	is	be	AUX
ghmj-1044	159	5	associated	associate	VERB
ghmj-1044	159	6	with	with	ADP
ghmj-1044	159	7	lower	low	ADJ
ghmj-1044	159	8	concentrations	concentration	NOUN
ghmj-1044	159	9	of	of	ADP
ghmj-1044	159	10	angiotensin	angiotensin	NOUN
ghmj-1044	159	11	ii	ii	PROPN
ghmj-1044	159	12	in	in	ADP
ghmj-1044	159	13	tissues	tissue	NOUN
ghmj-1044	159	14	and	and	CCONJ
ghmj-1044	159	15	reduced	reduce	VERB
ghmj-1044	159	16	enzyme	enzyme	NOUN
ghmj-1044	159	17	levels	level	NOUN
ghmj-1044	159	18	.	.	PUNCT
ghmj-1044	160	1	in	in	ADP
ghmj-1044	160	2	contrast	contrast	NOUN
ghmj-1044	160	3	,	,	PUNCT
ghmj-1044	160	4	the	the	DET
ghmj-1044	160	5	d	d	PROPN
ghmj-1044	160	6	allele	allele	NOUN
ghmj-1044	160	7	is	be	AUX
ghmj-1044	160	8	linked	link	VERB
ghmj-1044	160	9	to	to	ADP
ghmj-1044	160	10	higher	high	ADJ
ghmj-1044	160	11	serum	serum	NOUN
ghmj-1044	160	12	ace	ace	PROPN
ghmj-1044	160	13	levels	level	NOUN
ghmj-1044	160	14	,	,	PUNCT
ghmj-1044	160	15	resulting	result	VERB
ghmj-1044	160	16	in	in	ADP
ghmj-1044	160	17	increased	increase	VERB
ghmj-1044	160	18	angiotensin	angiotensin	NOUN
ghmj-1044	160	19	ii	ii	PROPN
ghmj-1044	160	20	concentration	concentration	NOUN
ghmj-1044	160	21	and	and	CCONJ
ghmj-1044	160	22	bradykinin	bradykinin	PROPN
ghmj-1044	160	23	degradation	degradation	NOUN
ghmj-1044	160	24	,	,	PUNCT
ghmj-1044	160	25	which	which	PRON
ghmj-1044	160	26	leads	lead	VERB
ghmj-1044	160	27	to	to	ADP
ghmj-1044	160	28	hypertension	hypertension	NOUN
ghmj-1044	160	29	(	(	PUNCT
ghmj-1044	160	30	barley	barley	NOUN
ghmj-1044	160	31	et	et	PROPN
ghmj-1044	160	32	al	al	PROPN
ghmj-1044	160	33	.	.	PROPN
ghmj-1044	160	34	,	,	PUNCT
ghmj-1044	160	35	1994	1994	NUM
ghmj-1044	160	36	)	)	PUNCT
ghmj-1044	160	37	.	.	PUNCT
ghmj-1044	161	1	a	a	DET
ghmj-1044	161	2	study	study	NOUN
ghmj-1044	161	3	conducted	conduct	VERB
ghmj-1044	161	4	in	in	ADP
ghmj-1044	161	5	yogyakarta	yogyakarta	PROPN
ghmj-1044	161	6	,	,	PUNCT
ghmj-1044	161	7	indonesia	indonesia	PROPN
ghmj-1044	161	8	(	(	PUNCT
ghmj-1044	161	9	bawazier	bawazi	ADJ
ghmj-1044	161	10	et	et	PROPN
ghmj-1044	161	11	al	al	PROPN
ghmj-1044	161	12	.	.	PROPN
ghmj-1044	161	13	,	,	PUNCT
ghmj-1044	161	14	2010	2010	NUM
ghmj-1044	161	15	)	)	PUNCT
ghmj-1044	161	16	found	find	VERB
ghmj-1044	161	17	that	that	SCONJ
ghmj-1044	161	18	the	the	DET
ghmj-1044	161	19	id+dd	id+dd	NOUN
ghmj-1044	161	20	genotypes	genotype	NOUN
ghmj-1044	161	21	were	be	AUX
ghmj-1044	161	22	significantly	significantly	ADV
ghmj-1044	161	23	associated	associate	VERB
ghmj-1044	161	24	with	with	ADP
ghmj-1044	161	25	hypertension	hypertension	NOUN
ghmj-1044	161	26	compared	compare	VERB
ghmj-1044	161	27	to	to	ADP
ghmj-1044	161	28	the	the	DET
ghmj-1044	161	29	ii	ii	PROPN
ghmj-1044	161	30	genotype	genotype	NOUN
ghmj-1044	161	31	.	.	PUNCT
ghmj-1044	162	1	however	however	ADV
ghmj-1044	162	2	,	,	PUNCT
ghmj-1044	162	3	the	the	DET
ghmj-1044	162	4	comparison	comparison	NOUN
ghmj-1044	162	5	between	between	ADP
ghmj-1044	162	6	id+dd	id+dd	NOUN
ghmj-1044	162	7	vs.	vs.	ADP
ghmj-1044	162	8	ii	ii	NOUN
ghmj-1044	162	9	genotypes	genotype	NOUN
ghmj-1044	162	10	in	in	ADP
ghmj-1044	162	11	this	this	DET
ghmj-1044	162	12	study	study	NOUN
ghmj-1044	162	13	was	be	AUX
ghmj-1044	162	14	not	not	PART
ghmj-1044	162	15	statistically	statistically	ADV
ghmj-1044	162	16	significant	significant	ADJ
ghmj-1044	162	17	,	,	PUNCT
ghmj-1044	162	18	although	although	SCONJ
ghmj-1044	162	19	it	it	PRON
ghmj-1044	162	20	suggested	suggest	VERB
ghmj-1044	162	21	a	a	DET
ghmj-1044	162	22	protective	protective	ADJ
ghmj-1044	162	23	effect	effect	NOUN
ghmj-1044	162	24	(	(	PUNCT
ghmj-1044	162	25	or<1	or<1	PROPN
ghmj-1044	162	26	)	)	PUNCT
ghmj-1044	162	27	.	.	PUNCT
ghmj-1044	163	1	similar	similar	ADJ
ghmj-1044	163	2	results	result	NOUN
ghmj-1044	163	3	were	be	AUX
ghmj-1044	163	4	observed	observe	VERB
ghmj-1044	163	5	in	in	ADP
ghmj-1044	163	6	a	a	DET
ghmj-1044	163	7	study	study	NOUN
ghmj-1044	163	8	conducted	conduct	VERB
ghmj-1044	163	9	in	in	ADP
ghmj-1044	163	10	burkina	burkina	PROPN
ghmj-1044	163	11	faso	faso	PROPN
ghmj-1044	163	12	,	,	PUNCT
ghmj-1044	163	13	west	west	PROPN
ghmj-1044	163	14	africa	africa	PROPN
ghmj-1044	163	15	,	,	PUNCT
ghmj-1044	163	16	where	where	SCONJ
ghmj-1044	163	17	the	the	DET
ghmj-1044	163	18	id+dd	id+dd	NOUN
ghmj-1044	163	19	vs.	vs.	ADP
ghmj-1044	163	20	ii	ii	NOUN
ghmj-1044	163	21	genotypes	genotype	NOUN
ghmj-1044	163	22	were	be	AUX
ghmj-1044	163	23	found	find	VERB
ghmj-1044	163	24	to	to	PART
ghmj-1044	163	25	be	be	AUX
ghmj-1044	163	26	protective	protective	ADJ
ghmj-1044	163	27	,	,	PUNCT
ghmj-1044	163	28	with	with	ADP
ghmj-1044	163	29	an	an	DET
ghmj-1044	163	30	or	or	CCONJ
ghmj-1044	163	31	of	of	ADP
ghmj-1044	163	32	0.34	0.34	NUM
ghmj-1044	163	33	and	and	CCONJ
ghmj-1044	163	34	a	a	DET
ghmj-1044	163	35	95	95	NUM
ghmj-1044	163	36	%	%	NOUN
ghmj-1044	163	37	ci	ci	NOUN
ghmj-1044	163	38	of	of	ADP
ghmj-1044	163	39	0.14	0.14	NUM
ghmj-1044	163	40	–	–	PUNCT
ghmj-1044	163	41	0.76	0.76	NUM
ghmj-1044	163	42	(	(	PUNCT
ghmj-1044	163	43	tchelougou	tchelougou	NOUN
ghmj-1044	163	44	et	et	PROPN
ghmj-1044	163	45	al	al	PROPN
ghmj-1044	163	46	.	.	PROPN
ghmj-1044	163	47	,	,	PUNCT
ghmj-1044	163	48	2015	2015	NUM
ghmj-1044	163	49	)	)	PUNCT
ghmj-1044	163	50	.	.	PUNCT
ghmj-1044	164	1	this	this	DET
ghmj-1044	164	2	study	study	NOUN
ghmj-1044	164	3	aimed	aim	VERB
ghmj-1044	164	4	to	to	PART
ghmj-1044	164	5	investigate	investigate	VERB
ghmj-1044	164	6	the	the	DET
ghmj-1044	164	7	association	association	NOUN
ghmj-1044	164	8	between	between	ADP
ghmj-1044	164	9	the	the	DET
ghmj-1044	164	10	risk	risk	NOUN
ghmj-1044	164	11	of	of	ADP
ghmj-1044	164	12	hypertension	hypertension	NOUN
ghmj-1044	164	13	and	and	CCONJ
ghmj-1044	164	14	ace	ace	VERB
ghmj-1044	164	15	i	i	PROPN
ghmj-1044	164	16	/	/	SYM
ghmj-1044	164	17	d	d	PROPN
ghmj-1044	164	18	gene	gene	NOUN
ghmj-1044	164	19	polymorphisms	polymorphism	NOUN
ghmj-1044	164	20	.	.	PUNCT
ghmj-1044	165	1	the	the	DET
ghmj-1044	165	2	results	result	NOUN
ghmj-1044	165	3	indicated	indicate	VERB
ghmj-1044	165	4	no	no	DET
ghmj-1044	165	5	significant	significant	ADJ
ghmj-1044	165	6	association	association	NOUN
ghmj-1044	165	7	between	between	ADP
ghmj-1044	165	8	ace	ace	PROPN
ghmj-1044	165	9	i	i	PROPN
ghmj-1044	165	10	/	/	SYM
ghmj-1044	165	11	d	d	NOUN
ghmj-1044	165	12	polymorphisms	polymorphism	NOUN
ghmj-1044	165	13	and	and	CCONJ
ghmj-1044	165	14	hypertension	hypertension	NOUN
ghmj-1044	165	15	;	;	PUNCT
ghmj-1044	165	16	however	however	ADV
ghmj-1044	165	17	,	,	PUNCT
ghmj-1044	165	18	the	the	DET
ghmj-1044	165	19	or	or	CCONJ
ghmj-1044	165	20	values	value	NOUN
ghmj-1044	165	21	suggested	suggest	VERB
ghmj-1044	165	22	that	that	SCONJ
ghmj-1044	165	23	ace	ace	VERB
ghmj-1044	165	24	i	i	PRON
ghmj-1044	165	25	/	/	SYM
ghmj-1044	165	26	d	d	NOUN
ghmj-1044	165	27	polymorphisms	polymorphism	NOUN
ghmj-1044	165	28	could	could	AUX
ghmj-1044	165	29	still	still	ADV
ghmj-1044	165	30	be	be	AUX
ghmj-1044	165	31	considered	consider	VERB
ghmj-1044	165	32	a	a	DET
ghmj-1044	165	33	risk	risk	NOUN
ghmj-1044	165	34	factor	factor	NOUN
ghmj-1044	165	35	for	for	ADP
ghmj-1044	165	36	essential	essential	ADJ
ghmj-1044	165	37	hypertension	hypertension	NOUN
ghmj-1044	165	38	.	.	PUNCT
ghmj-1044	166	1	these	these	DET
ghmj-1044	166	2	findings	finding	NOUN
ghmj-1044	166	3	are	be	AUX
ghmj-1044	166	4	consistent	consistent	ADJ
ghmj-1044	166	5	with	with	ADP
ghmj-1044	166	6	a	a	DET
ghmj-1044	166	7	study	study	NOUN
ghmj-1044	166	8	conducted	conduct	VERB
ghmj-1044	166	9	in	in	ADP
ghmj-1044	166	10	south	south	ADJ
ghmj-1044	166	11	sulawesi	sulawesi	PROPN
ghmj-1044	166	12	,	,	PUNCT
ghmj-1044	166	13	indonesia	indonesia	PROPN
ghmj-1044	166	14	,	,	PUNCT
ghmj-1044	166	15	involving	involve	VERB
ghmj-1044	166	16	99	99	NUM
ghmj-1044	166	17	non	non	ADJ
ghmj-1044	166	18	-	-	ADJ
ghmj-1044	166	19	hypertensive	hypertensive	ADJ
ghmj-1044	166	20	and	and	CCONJ
ghmj-1044	166	21	104	104	NUM
ghmj-1044	166	22	hypertensive	hypertensive	ADJ
ghmj-1044	166	23	subjects	subject	NOUN
ghmj-1044	166	24	(	(	PUNCT
ghmj-1044	166	25	rasyid	rasyid	NOUN
ghmj-1044	166	26	et	et	PROPN
ghmj-1044	166	27	al	al	PROPN
ghmj-1044	166	28	.	.	PROPN
ghmj-1044	166	29	,	,	PUNCT
ghmj-1044	166	30	2012	2012	NUM
ghmj-1044	166	31	)	)	PUNCT
ghmj-1044	166	32	.	.	PUNCT
ghmj-1044	167	1	the	the	DET
ghmj-1044	167	2	lack	lack	NOUN
ghmj-1044	167	3	of	of	ADP
ghmj-1044	167	4	significant	significant	ADJ
ghmj-1044	167	5	differences	difference	NOUN
ghmj-1044	167	6	between	between	ADP
ghmj-1044	167	7	the	the	DET
ghmj-1044	167	8	two	two	NUM
ghmj-1044	167	9	groups	group	NOUN
ghmj-1044	167	10	in	in	ADP
ghmj-1044	167	11	that	that	DET
ghmj-1044	167	12	study	study	NOUN
ghmj-1044	167	13	suggests	suggest	VERB
ghmj-1044	167	14	that	that	SCONJ
ghmj-1044	167	15	essential	essential	ADJ
ghmj-1044	167	16	hypertension	hypertension	NOUN
ghmj-1044	167	17	may	may	AUX
ghmj-1044	167	18	not	not	PART
ghmj-1044	167	19	be	be	AUX
ghmj-1044	167	20	associated	associate	VERB
ghmj-1044	167	21	with	with	ADP
ghmj-1044	167	22	the	the	DET
ghmj-1044	167	23	ace	ace	NOUN
ghmj-1044	167	24	i	i	PROPN
ghmj-1044	167	25	/	/	SYM
ghmj-1044	167	26	d	d	NOUN
ghmj-1044	167	27	polymorphism	polymorphism	NOUN
ghmj-1044	167	28	.	.	PUNCT
ghmj-1044	168	1	a	a	DET
ghmj-1044	168	2	cross	cross	ADJ
ghmj-1044	168	3	-	-	ADJ
ghmj-1044	168	4	sectional	sectional	ADJ
ghmj-1044	168	5	study	study	NOUN
ghmj-1044	168	6	in	in	ADP
ghmj-1044	168	7	the	the	DET
ghmj-1044	168	8	spanish	spanish	ADJ
ghmj-1044	168	9	-	-	PUNCT
ghmj-1044	168	10	mediterranean	mediterranean	ADJ
ghmj-1044	168	11	population	population	NOUN
ghmj-1044	168	12	also	also	ADV
ghmj-1044	168	13	found	find	VERB
ghmj-1044	168	14	no	no	DET
ghmj-1044	168	15	association	association	NOUN
ghmj-1044	168	16	between	between	ADP
ghmj-1044	168	17	the	the	DET
ghmj-1044	168	18	ace	ace	NOUN
ghmj-1044	168	19	i	i	PROPN
ghmj-1044	168	20	/	/	SYM
ghmj-1044	168	21	d	d	NOUN
ghmj-1044	168	22	gene	gene	NOUN
ghmj-1044	168	23	and	and	CCONJ
ghmj-1044	168	24	hypertension	hypertension	NOUN
ghmj-1044	168	25	,	,	PUNCT
ghmj-1044	168	26	although	although	SCONJ
ghmj-1044	168	27	the	the	DET
ghmj-1044	168	28	d	d	PROPN
ghmj-1044	168	29	allele	allele	NOUN
ghmj-1044	168	30	was	be	AUX
ghmj-1044	168	31	statistically	statistically	ADV
ghmj-1044	168	32	linked	link	VERB
ghmj-1044	168	33	to	to	ADP
ghmj-1044	168	34	increased	increase	VERB
ghmj-1044	168	35	serum	serum	NOUN
ghmj-1044	168	36	ace	ace	NOUN
ghmj-1044	168	37	activity	activity	NOUN
ghmj-1044	168	38	(	(	PUNCT
ghmj-1044	168	39	martínez	martínez	NOUN
ghmj-1044	168	40	et	et	PROPN
ghmj-1044	168	41	al	al	PROPN
ghmj-1044	168	42	.	.	PROPN
ghmj-1044	168	43	,	,	PUNCT
ghmj-1044	168	44	2000	2000	NUM
ghmj-1044	168	45	)	)	PUNCT
ghmj-1044	168	46	.	.	PUNCT
ghmj-1044	169	1	similarly	similarly	ADV
ghmj-1044	169	2	,	,	PUNCT
ghmj-1044	169	3	a	a	DET
ghmj-1044	169	4	study	study	NOUN
ghmj-1044	169	5	in	in	ADP
ghmj-1044	169	6	the	the	DET
ghmj-1044	169	7	perm	perm	NOUN
ghmj-1044	169	8	region	region	NOUN
ghmj-1044	169	9	of	of	ADP
ghmj-1044	169	10	russia	russia	PROPN
ghmj-1044	169	11	in	in	ADP
ghmj-1044	169	12	2022	2022	NUM
ghmj-1044	169	13	reported	report	VERB
ghmj-1044	169	14	a	a	DET
ghmj-1044	169	15	risk	risk	NOUN
ghmj-1044	169	16	ratio	ratio	NOUN
ghmj-1044	169	17	of	of	ADP
ghmj-1044	169	18	1.87	1.87	NUM
ghmj-1044	169	19	(	(	PUNCT
ghmj-1044	169	20	95	95	NUM
ghmj-1044	169	21	%	%	NOUN
ghmj-1044	169	22	ci	ci	NOUN
ghmj-1044	169	23	:	:	PUNCT
ghmj-1044	169	24	1.07–3.61	1.07–3.61	NUM
ghmj-1044	169	25	)	)	PUNCT
ghmj-1044	169	26	,	,	PUNCT
ghmj-1044	169	27	suggesting	suggest	VERB
ghmj-1044	169	28	that	that	SCONJ
ghmj-1044	169	29	the	the	DET
ghmj-1044	169	30	ace	ace	NOUN
ghmj-1044	169	31	i	i	PROPN
ghmj-1044	169	32	/	/	SYM
ghmj-1044	169	33	d	d	NOUN
ghmj-1044	169	34	polymorphism	polymorphism	NOUN
ghmj-1044	169	35	may	may	AUX
ghmj-1044	169	36	serve	serve	VERB
ghmj-1044	169	37	as	as	ADP
ghmj-1044	169	38	a	a	DET
ghmj-1044	169	39	potential	potential	ADJ
ghmj-1044	169	40	marker	marker	NOUN
ghmj-1044	169	41	for	for	ADP
ghmj-1044	169	42	susceptibility	susceptibility	NOUN
ghmj-1044	169	43	to	to	ADP
ghmj-1044	169	44	essential	essential	ADJ
ghmj-1044	169	45	hypertension	hypertension	NOUN
ghmj-1044	169	46	(	(	PUNCT
ghmj-1044	169	47	starkova	starkova	PROPN
ghmj-1044	169	48	,	,	PUNCT
ghmj-1044	169	49	dolgikh	dolgikh	PROPN
ghmj-1044	169	50	,	,	PUNCT
ghmj-1044	169	51	kazakova	kazakova	PROPN
ghmj-1044	169	52	,	,	PUNCT
ghmj-1044	169	53	&	&	CCONJ
ghmj-1044	169	54	legostaeva	legostaeva	PROPN
ghmj-1044	169	55	,	,	PUNCT
ghmj-1044	169	56	2022	2022	NUM
ghmj-1044	169	57	)	)	PUNCT
ghmj-1044	169	58	.	.	PUNCT
ghmj-1044	170	1	a	a	DET
ghmj-1044	170	2	large	large	ADJ
ghmj-1044	170	3	-	-	PUNCT
ghmj-1044	170	4	scale	scale	NOUN
ghmj-1044	170	5	analysis	analysis	NOUN
ghmj-1044	170	6	of	of	ADP
ghmj-1044	170	7	data	datum	NOUN
ghmj-1044	170	8	from	from	ADP
ghmj-1044	170	9	5.561	5.561	NUM
ghmj-1044	170	10	participants	participant	NOUN
ghmj-1044	170	11	in	in	ADP
ghmj-1044	170	12	the	the	DET
ghmj-1044	170	13	nhanes	nhanes	PROPN
ghmj-1044	170	14	iii	iii	PROPN
ghmj-1044	170	15	survey	survey	PROPN
ghmj-1044	170	16	found	find	VERB
ghmj-1044	170	17	limited	limited	ADJ
ghmj-1044	170	18	support	support	NOUN
ghmj-1044	170	19	for	for	ADP
ghmj-1044	170	20	an	an	DET
ghmj-1044	170	21	association	association	NOUN
ghmj-1044	170	22	between	between	ADP
ghmj-1044	170	23	the	the	DET
ghmj-1044	170	24	ace	ace	NOUN
ghmj-1044	170	25	i	i	PROPN
ghmj-1044	170	26	/	/	SYM
ghmj-1044	170	27	d	d	NOUN
ghmj-1044	170	28	variant	variant	NOUN
ghmj-1044	170	29	and	and	CCONJ
ghmj-1044	170	30	blood	blood	NOUN
ghmj-1044	170	31	pressure	pressure	NOUN
ghmj-1044	170	32	or	or	CCONJ
ghmj-1044	170	33	hypertension	hypertension	NOUN
ghmj-1044	170	34	across	across	ADP
ghmj-1044	170	35	various	various	ADJ
ghmj-1044	170	36	racial	racial	ADJ
ghmj-1044	170	37	and	and	CCONJ
ghmj-1044	170	38	ethnic	ethnic	ADJ
ghmj-1044	170	39	groups	group	NOUN
ghmj-1044	170	40	,	,	PUNCT
ghmj-1044	170	41	although	although	SCONJ
ghmj-1044	170	42	significant	significant	ADJ
ghmj-1044	170	43	genotype	genotype	NOUN
ghmj-1044	170	44	-	-	PUNCT
ghmj-1044	170	45	sex	sex	NOUN
ghmj-1044	170	46	interactions	interaction	NOUN
ghmj-1044	170	47	were	be	AUX
ghmj-1044	170	48	observed	observe	VERB
ghmj-1044	170	49	specifically	specifically	ADV
ghmj-1044	170	50	in	in	ADP
ghmj-1044	170	51	mexican	mexican	PROPN
ghmj-1044	170	52	americans	americans	PROPN
ghmj-1044	170	53	.	.	PUNCT
ghmj-1044	171	1	overall	overall	ADV
ghmj-1044	171	2	,	,	PUNCT
ghmj-1044	171	3	there	there	PRON
ghmj-1044	171	4	was	be	VERB
ghmj-1044	171	5	a	a	DET
ghmj-1044	171	6	notable	notable	ADJ
ghmj-1044	171	7	lack	lack	NOUN
ghmj-1044	171	8	of	of	ADP
ghmj-1044	171	9	significant	significant	ADJ
ghmj-1044	171	10	associations	association	NOUN
ghmj-1044	171	11	in	in	ADP
ghmj-1044	171	12	most	most	ADJ
ghmj-1044	171	13	cases	case	NOUN
ghmj-1044	171	14	(	(	PUNCT
ghmj-1044	171	15	ned	ned	NOUN
ghmj-1044	171	16	et	et	PROPN
ghmj-1044	171	17	al	al	PROPN
ghmj-1044	171	18	.	.	PROPN
ghmj-1044	171	19	,	,	PUNCT
ghmj-1044	171	20	2012	2012	NUM
ghmj-1044	171	21	)	)	PUNCT
ghmj-1044	171	22	.	.	PUNCT
ghmj-1044	172	1	in	in	ADP
ghmj-1044	172	2	contrast	contrast	NOUN
ghmj-1044	172	3	,	,	PUNCT
ghmj-1044	172	4	several	several	ADJ
ghmj-1044	172	5	previous	previous	ADJ
ghmj-1044	172	6	studies	study	NOUN
ghmj-1044	172	7	have	have	AUX
ghmj-1044	172	8	demonstrated	demonstrate	VERB
ghmj-1044	172	9	a	a	DET
ghmj-1044	172	10	strong	strong	ADJ
ghmj-1044	172	11	association	association	NOUN
ghmj-1044	172	12	between	between	ADP
ghmj-1044	172	13	essential	essential	ADJ
ghmj-1044	172	14	hypertension	hypertension	NOUN
ghmj-1044	172	15	and	and	CCONJ
ghmj-1044	172	16	the	the	DET
ghmj-1044	172	17	ace	ace	NOUN
ghmj-1044	172	18	i	i	PROPN
ghmj-1044	172	19	/	/	SYM
ghmj-1044	172	20	d	d	PROPN
ghmj-1044	172	21	gene	gene	NOUN
ghmj-1044	172	22	polymorphism	polymorphism	NOUN
ghmj-1044	172	23	.	.	PUNCT
ghmj-1044	173	1	a	a	DET
ghmj-1044	173	2	case	case	NOUN
ghmj-1044	173	3	-	-	PUNCT
ghmj-1044	173	4	control	control	NOUN
ghmj-1044	173	5	study	study	NOUN
ghmj-1044	173	6	conducted	conduct	VERB
ghmj-1044	173	7	in	in	ADP
ghmj-1044	173	8	lorestan	lorestan	PROPN
ghmj-1044	173	9	province	province	NOUN
ghmj-1044	173	10	,	,	PUNCT
ghmj-1044	173	11	iran	iran	PROPN
ghmj-1044	173	12	,	,	PUNCT
ghmj-1044	173	13	in	in	ADP
ghmj-1044	173	14	2022	2022	NUM
ghmj-1044	173	15	found	find	VERB
ghmj-1044	173	16	that	that	SCONJ
ghmj-1044	173	17	the	the	DET
ghmj-1044	173	18	ii	ii	PROPN
ghmj-1044	173	19	genotype	genotype	NOUN
ghmj-1044	173	20	increased	increase	VERB
ghmj-1044	173	21	the	the	DET
ghmj-1044	173	22	incidence	incidence	NOUN
ghmj-1044	173	23	of	of	ADP
ghmj-1044	173	24	essential	essential	ADJ
ghmj-1044	173	25	hypertension	hypertension	NOUN
ghmj-1044	173	26	among	among	ADP
ghmj-1044	173	27	102	102	NUM
ghmj-1044	173	28	hypertensive	hypertensive	ADJ
ghmj-1044	173	29	patients	patient	NOUN
ghmj-1044	173	30	and	and	CCONJ
ghmj-1044	173	31	104	104	NUM
ghmj-1044	173	32	healthy	healthy	ADJ
ghmj-1044	173	33	individuals	individual	NOUN
ghmj-1044	173	34	(	(	PUNCT
ghmj-1044	173	35	hadian	hadian	PROPN
ghmj-1044	173	36	et	et	PROPN
ghmj-1044	173	37	al	al	PROPN
ghmj-1044	173	38	.	.	PROPN
ghmj-1044	173	39	,	,	PUNCT
ghmj-1044	173	40	2022	2022	NUM
ghmj-1044	173	41	)	)	PUNCT
ghmj-1044	173	42	.	.	PUNCT
ghmj-1044	174	1	in	in	ADP
ghmj-1044	174	2	gondar	gondar	PROPN
ghmj-1044	174	3	,	,	PUNCT
ghmj-1044	174	4	ethiopia	ethiopia	PROPN
ghmj-1044	174	5	,	,	PUNCT
ghmj-1044	174	6	another	another	DET
ghmj-1044	174	7	case	case	NOUN
ghmj-1044	174	8	-	-	PUNCT
ghmj-1044	174	9	control	control	NOUN
ghmj-1044	174	10	study	study	NOUN
ghmj-1044	174	11	conducted	conduct	VERB
ghmj-1044	174	12	in	in	ADP
ghmj-1044	174	13	2022	2022	NUM
ghmj-1044	174	14	discovered	discover	VERB
ghmj-1044	174	15	a	a	DET
ghmj-1044	174	16	high	high	ADJ
ghmj-1044	174	17	association	association	NOUN
ghmj-1044	174	18	between	between	ADP
ghmj-1044	174	19	essential	essential	ADJ
ghmj-1044	174	20	hypertension	hypertension	NOUN
ghmj-1044	174	21	and	and	CCONJ
ghmj-1044	174	22	both	both	DET
ghmj-1044	174	23	the	the	DET
ghmj-1044	174	24	d	d	PROPN
ghmj-1044	174	25	allele	allele	NOUN
ghmj-1044	174	26	and	and	CCONJ
ghmj-1044	174	27	dd	dd	NOUN
ghmj-1044	174	28	genotype	genotype	NOUN
ghmj-1044	174	29	(	(	PUNCT
ghmj-1044	174	30	birhan	birhan	PROPN
ghmj-1044	174	31	et	et	PROPN
ghmj-1044	174	32	al	al	PROPN
ghmj-1044	174	33	.	.	PROPN
ghmj-1044	174	34	,	,	PUNCT
ghmj-1044	174	35	2022	2022	NUM
ghmj-1044	174	36	)	)	PUNCT
ghmj-1044	174	37	.	.	PUNCT
ghmj-1044	175	1	additionally	additionally	ADV
ghmj-1044	175	2	,	,	PUNCT
ghmj-1044	175	3	a	a	DET
ghmj-1044	175	4	study	study	NOUN
ghmj-1044	175	5	involving	involve	VERB
ghmj-1044	175	6	725	725	NUM
ghmj-1044	175	7	male	male	ADJ
ghmj-1044	175	8	steelworkers	steelworker	NOUN
ghmj-1044	175	9	in	in	ADP
ghmj-1044	175	10	china	china	PROPN
ghmj-1044	175	11	concluded	conclude	VERB
ghmj-1044	175	12	that	that	SCONJ
ghmj-1044	175	13	the	the	DET
ghmj-1044	175	14	dd	dd	NOUN
ghmj-1044	175	15	genotype	genotype	NOUN
ghmj-1044	175	16	increased	increase	VERB
ghmj-1044	175	17	the	the	DET
ghmj-1044	175	18	risk	risk	NOUN
ghmj-1044	175	19	of	of	ADP
ghmj-1044	175	20	essential	essential	ADJ
ghmj-1044	175	21	hypertension	hypertension	NOUN
ghmj-1044	175	22	(	(	PUNCT
ghmj-1044	175	23	x.	x.	NOUN
ghmj-1044	175	24	zhang	zhang	PROPN
ghmj-1044	175	25	et	et	PROPN
ghmj-1044	175	26	al	al	PROPN
ghmj-1044	175	27	.	.	PROPN
ghmj-1044	175	28	,	,	PUNCT
ghmj-1044	175	29	2022	2022	NUM
ghmj-1044	175	30	)	)	PUNCT
ghmj-1044	175	31	.	.	PUNCT
ghmj-1044	176	1	a	a	DET
ghmj-1044	176	2	meta	meta	ADJ
ghmj-1044	176	3	-	-	PUNCT
ghmj-1044	176	4	analysis	analysis	NOUN
ghmj-1044	176	5	conducted	conduct	VERB
ghmj-1044	176	6	in	in	ADP
ghmj-1044	176	7	2020	2020	NUM
ghmj-1044	176	8	on	on	ADP
ghmj-1044	176	9	the	the	DET
ghmj-1044	176	10	chinese	chinese	ADJ
ghmj-1044	176	11	population	population	NOUN
ghmj-1044	176	12	also	also	ADV
ghmj-1044	176	13	concluded	conclude	VERB
ghmj-1044	176	14	that	that	SCONJ
ghmj-1044	176	15	the	the	DET
ghmj-1044	176	16	ace	ace	NOUN
ghmj-1044	176	17	i	i	PROPN
ghmj-1044	176	18	/	/	SYM
ghmj-1044	176	19	d	d	NOUN
ghmj-1044	176	20	gene	gene	NOUN
ghmj-1044	176	21	is	be	AUX
ghmj-1044	176	22	associated	associate	VERB
ghmj-1044	176	23	with	with	ADP
ghmj-1044	176	24	the	the	DET
ghmj-1044	176	25	development	development	NOUN
ghmj-1044	176	26	of	of	ADP
ghmj-1044	176	27	essential	essential	ADJ
ghmj-1044	176	28	hypertension	hypertension	NOUN
ghmj-1044	176	29	(	(	PUNCT
ghmj-1044	176	30	xu	xu	INTJ
ghmj-1044	176	31	,	,	PUNCT
ghmj-1044	176	32	chen	chen	PROPN
ghmj-1044	176	33	,	,	PUNCT
ghmj-1044	176	34	li	li	PROPN
ghmj-1044	176	35	,	,	PUNCT
ghmj-1044	176	36	zhang	zhang	PROPN
ghmj-1044	176	37	,	,	PUNCT
ghmj-1044	176	38	&	&	CCONJ
ghmj-1044	176	39	li	li	PROPN
ghmj-1044	176	40	,	,	PUNCT
ghmj-1044	176	41	2020	2020	NUM
ghmj-1044	176	42	)	)	PUNCT
ghmj-1044	176	43	.	.	PUNCT
ghmj-1044	177	1	furthermore	furthermore	ADV
ghmj-1044	177	2	,	,	PUNCT
ghmj-1044	177	3	a	a	DET
ghmj-1044	177	4	systematic	systematic	ADJ
ghmj-1044	177	5	review	review	NOUN
ghmj-1044	177	6	and	and	CCONJ
ghmj-1044	177	7	meta	meta	ADJ
ghmj-1044	177	8	-	-	PUNCT
ghmj-1044	177	9	analysis	analysis	NOUN
ghmj-1044	177	10	found	find	VERB
ghmj-1044	177	11	that	that	SCONJ
ghmj-1044	177	12	the	the	DET
ghmj-1044	177	13	d	d	PROPN
ghmj-1044	177	14	allele	allele	NOUN
ghmj-1044	177	15	of	of	ADP
ghmj-1044	177	16	the	the	DET
ghmj-1044	177	17	ace	ace	NOUN
ghmj-1044	177	18	gene	gene	NOUN
ghmj-1044	177	19	is	be	AUX
ghmj-1044	177	20	strongly	strongly	ADV
ghmj-1044	177	21	associated	associate	VERB
ghmj-1044	177	22	as	as	ADP
ghmj-1044	177	23	a	a	DET
ghmj-1044	177	24	risk	risk	NOUN
ghmj-1044	177	25	factor	factor	NOUN
ghmj-1044	177	26	for	for	ADP
ghmj-1044	177	27	essential	essential	ADJ
ghmj-1044	177	28	hypertension	hypertension	NOUN
ghmj-1044	177	29	across	across	ADP
ghmj-1044	177	30	asian	asian	ADJ
ghmj-1044	177	31	,	,	PUNCT
ghmj-1044	177	32	caucasian	caucasian	ADJ
ghmj-1044	177	33	,	,	PUNCT
ghmj-1044	177	34	and	and	CCONJ
ghmj-1044	177	35	mixed	mixed	ADJ
ghmj-1044	177	36	populations	population	NOUN
ghmj-1044	177	37	(	(	PUNCT
ghmj-1044	177	38	liu	liu	PROPN
ghmj-1044	177	39	,	,	PUNCT
ghmj-1044	177	40	yi	yi	PROPN
ghmj-1044	177	41	,	,	PUNCT
ghmj-1044	177	42	&	&	CCONJ
ghmj-1044	177	43	tang	tang	PROPN
ghmj-1044	177	44	,	,	PUNCT
ghmj-1044	177	45	2021	2021	NUM
ghmj-1044	177	46	)	)	PUNCT
ghmj-1044	177	47	.	.	PUNCT
ghmj-1044	178	1	the	the	DET
ghmj-1044	178	2	discrepancies	discrepancy	NOUN
ghmj-1044	178	3	in	in	ADP
ghmj-1044	178	4	research	research	NOUN
ghmj-1044	178	5	findings	finding	NOUN
ghmj-1044	178	6	may	may	AUX
ghmj-1044	178	7	be	be	AUX
ghmj-1044	178	8	attributed	attribute	VERB
ghmj-1044	178	9	to	to	ADP
ghmj-1044	178	10	several	several	ADJ
ghmj-1044	178	11	factors	factor	NOUN
ghmj-1044	178	12	,	,	PUNCT
ghmj-1044	178	13	including	include	VERB
ghmj-1044	178	14	variations	variation	NOUN
ghmj-1044	178	15	in	in	ADP
ghmj-1044	178	16	sample	sample	NOUN
ghmj-1044	178	17	size	size	NOUN
ghmj-1044	178	18	,	,	PUNCT
ghmj-1044	178	19	ethnicity	ethnicity	NOUN
ghmj-1044	178	20	,	,	PUNCT
ghmj-1044	178	21	environment	environment	NOUN
ghmj-1044	178	22	,	,	PUNCT
ghmj-1044	178	23	and	and	CCONJ
ghmj-1044	178	24	lifestyle	lifestyle	NOUN
ghmj-1044	178	25	.	.	PUNCT
ghmj-1044	179	1	this	this	DET
ghmj-1044	179	2	study	study	NOUN
ghmj-1044	179	3	had	have	VERB
ghmj-1044	179	4	a	a	DET
ghmj-1044	179	5	limited	limited	ADJ
ghmj-1044	179	6	sample	sample	NOUN
ghmj-1044	179	7	size	size	NOUN
ghmj-1044	179	8	because	because	SCONJ
ghmj-1044	179	9	certain	certain	ADJ
ghmj-1044	179	10	factors	factor	NOUN
ghmj-1044	179	11	that	that	PRON
ghmj-1044	179	12	could	could	AUX
ghmj-1044	179	13	bias	bias	VERB
ghmj-1044	179	14	hypertension	hypertension	NOUN
ghmj-1044	179	15	results	result	NOUN
ghmj-1044	179	16	,	,	PUNCT
ghmj-1044	179	17	such	such	ADJ
ghmj-1044	179	18	as	as	ADP
ghmj-1044	179	19	kidney	kidney	NOUN
ghmj-1044	179	20	disease	disease	NOUN
ghmj-1044	179	21	,	,	PUNCT
ghmj-1044	179	22	diabetes	diabetes	NOUN
ghmj-1044	179	23	mellitus	mellitus	NOUN
ghmj-1044	179	24	,	,	PUNCT
ghmj-1044	179	25	and	and	CCONJ
ghmj-1044	179	26	alcohol	alcohol	NOUN
ghmj-1044	179	27	use	use	NOUN
ghmj-1044	179	28	,	,	PUNCT
ghmj-1044	179	29	were	be	AUX
ghmj-1044	179	30	excluded	exclude	VERB
ghmj-1044	179	31	.	.	PUNCT
ghmj-1044	180	1	future	future	ADJ
ghmj-1044	180	2	research	research	NOUN
ghmj-1044	180	3	should	should	AUX
ghmj-1044	180	4	involve	involve	VERB
ghmj-1044	180	5	a	a	DET
ghmj-1044	180	6	larger	large	ADJ
ghmj-1044	180	7	sample	sample	NOUN
ghmj-1044	180	8	size	size	NOUN
ghmj-1044	180	9	to	to	PART
ghmj-1044	180	10	account	account	VERB
ghmj-1044	180	11	for	for	ADP
ghmj-1044	180	12	broader	broad	ADJ
ghmj-1044	180	13	demographic	demographic	ADJ
ghmj-1044	180	14	differences	difference	NOUN
ghmj-1044	180	15	and	and	CCONJ
ghmj-1044	180	16	ethnic	ethnic	ADJ
ghmj-1044	180	17	diversity	diversity	NOUN
ghmj-1044	180	18	.	.	PUNCT
ghmj-1044	181	1	ethnic	ethnic	ADJ
ghmj-1044	181	2	diversity	diversity	NOUN
ghmj-1044	181	3	worldwide	worldwide	ADV
ghmj-1044	181	4	significantly	significantly	ADV
ghmj-1044	181	5	impacts	impact	VERB
ghmj-1044	181	6	research	research	NOUN
ghmj-1044	181	7	outcomes	outcome	NOUN
ghmj-1044	181	8	because	because	SCONJ
ghmj-1044	181	9	genetic	genetic	ADJ
ghmj-1044	181	10	variations	variation	NOUN
ghmj-1044	181	11	can	can	AUX
ghmj-1044	181	12	lead	lead	VERB
ghmj-1044	181	13	to	to	ADP
ghmj-1044	181	14	changes	change	NOUN
ghmj-1044	181	15	in	in	ADP
ghmj-1044	181	16	the	the	DET
ghmj-1044	181	17	frequency	frequency	NOUN
ghmj-1044	181	18	distribution	distribution	NOUN
ghmj-1044	181	19	of	of	ADP
ghmj-1044	181	20	ace	ace	ADJ
ghmj-1044	181	21	genotypes	genotype	NOUN
ghmj-1044	181	22	within	within	ADP
ghmj-1044	181	23	each	each	DET
ghmj-1044	181	24	community	community	NOUN
ghmj-1044	181	25	(	(	PUNCT
ghmj-1044	181	26	burchard	burchard	PROPN
ghmj-1044	181	27	et	et	PROPN
ghmj-1044	181	28	al	al	PROPN
ghmj-1044	181	29	.	.	PROPN
ghmj-1044	181	30	,	,	PUNCT
ghmj-1044	181	31	2003	2003	NUM
ghmj-1044	181	32	)	)	PUNCT
ghmj-1044	181	33	.	.	PUNCT
ghmj-1044	182	1	additionally	additionally	ADV
ghmj-1044	182	2	,	,	PUNCT
ghmj-1044	182	3	environmental	environmental	ADJ
ghmj-1044	182	4	factors	factor	NOUN
ghmj-1044	182	5	and	and	CCONJ
ghmj-1044	182	6	lifestyle	lifestyle	NOUN
ghmj-1044	182	7	variations	variation	NOUN
ghmj-1044	182	8	within	within	ADP
ghmj-1044	182	9	each	each	DET
ghmj-1044	182	10	ethnicity	ethnicity	NOUN
ghmj-1044	182	11	produce	produce	VERB
ghmj-1044	182	12	diverse	diverse	ADJ
ghmj-1044	182	13	and	and	CCONJ
ghmj-1044	182	14	complex	complex	ADJ
ghmj-1044	182	15	interactions	interaction	NOUN
ghmj-1044	182	16	that	that	PRON
ghmj-1044	182	17	can	can	AUX
ghmj-1044	182	18	affect	affect	VERB
ghmj-1044	182	19	research	research	NOUN
ghmj-1044	182	20	outcomes	outcome	NOUN
ghmj-1044	182	21	.	.	PUNCT
ghmj-1044	183	1	kuswara	kuswara	PROPN
ghmj-1044	183	2	,	,	PUNCT
ghmj-1044	183	3	et	et	PROPN
ghmj-1044	183	4	.	.	PUNCT
ghmj-1044	184	1	al	al	PROPN
ghmj-1044	184	2	.	.	PROPN
ghmj-1044	184	3	ghmj	ghmj	PROPN
ghmj-1044	184	4	(	(	PUNCT
ghmj-1044	184	5	global	global	ADJ
ghmj-1044	184	6	health	health	PROPN
ghmj-1044	184	7	management	management	NOUN
ghmj-1044	184	8	journal	journal	PROPN
ghmj-1044	184	9	)	)	PUNCT
ghmj-1044	184	10	2024	2024	NUM
ghmj-1044	184	11	,	,	PUNCT
ghmj-1044	184	12	vol	vol	NOUN
ghmj-1044	184	13	.	.	PROPN
ghmj-1044	184	14	7	7	NUM
ghmj-1044	184	15	,	,	PUNCT
ghmj-1044	184	16	no	no	INTJ
ghmj-1044	184	17	.	.	NOUN
ghmj-1044	184	18	4	4	NUM
ghmj-1044	184	19	188	188	NUM
ghmj-1044	184	20	lifestyle	lifestyle	NOUN
ghmj-1044	184	21	is	be	AUX
ghmj-1044	184	22	one	one	NUM
ghmj-1044	184	23	of	of	ADP
ghmj-1044	184	24	the	the	DET
ghmj-1044	184	25	risk	risk	NOUN
ghmj-1044	184	26	factors	factor	NOUN
ghmj-1044	184	27	for	for	ADP
ghmj-1044	184	28	hypertension	hypertension	NOUN
ghmj-1044	184	29	,	,	PUNCT
ghmj-1044	184	30	which	which	PRON
ghmj-1044	184	31	includes	include	VERB
ghmj-1044	184	32	exercise	exercise	NOUN
ghmj-1044	184	33	(	(	PUNCT
ghmj-1044	184	34	dida	dida	PROPN
ghmj-1044	184	35	,	,	PUNCT
ghmj-1044	184	36	nayoan	nayoan	PROPN
ghmj-1044	184	37	,	,	PUNCT
ghmj-1044	184	38	&	&	CCONJ
ghmj-1044	184	39	sir	sir	PROPN
ghmj-1044	184	40	,	,	PUNCT
ghmj-1044	184	41	2023	2023	NUM
ghmj-1044	184	42	)	)	PUNCT
ghmj-1044	184	43	,	,	PUNCT
ghmj-1044	184	44	diet	diet	NOUN
ghmj-1044	184	45	(	(	PUNCT
ghmj-1044	184	46	frisoli	frisoli	PROPN
ghmj-1044	184	47	,	,	PUNCT
ghmj-1044	184	48	schmieder	schmieder	NOUN
ghmj-1044	184	49	,	,	PUNCT
ghmj-1044	184	50	grodzicki	grodzicki	NOUN
ghmj-1044	184	51	,	,	PUNCT
ghmj-1044	184	52	&	&	CCONJ
ghmj-1044	184	53	messerli	messerli	PROPN
ghmj-1044	184	54	,	,	PUNCT
ghmj-1044	184	55	2012	2012	NUM
ghmj-1044	184	56	)	)	PUNCT
ghmj-1044	184	57	,	,	PUNCT
ghmj-1044	184	58	and	and	CCONJ
ghmj-1044	184	59	stress	stress	NOUN
ghmj-1044	184	60	levels	level	NOUN
ghmj-1044	184	61	(	(	PUNCT
ghmj-1044	184	62	bhelkar	bhelkar	PRON
ghmj-1044	184	63	,	,	PUNCT
ghmj-1044	184	64	deshpande	deshpande	PROPN
ghmj-1044	184	65	,	,	PUNCT
ghmj-1044	184	66	&	&	CCONJ
ghmj-1044	184	67	mankar	mankar	PROPN
ghmj-1044	184	68	,	,	PUNCT
ghmj-1044	184	69	2019	2019	NUM
ghmj-1044	184	70	)	)	PUNCT
ghmj-1044	184	71	.	.	PUNCT
ghmj-1044	185	1	aerobic	aerobic	ADJ
ghmj-1044	185	2	exercise	exercise	NOUN
ghmj-1044	185	3	influences	influence	VERB
ghmj-1044	185	4	blood	blood	NOUN
ghmj-1044	185	5	pressure	pressure	NOUN
ghmj-1044	185	6	responses	response	NOUN
ghmj-1044	185	7	differently	differently	ADV
ghmj-1044	185	8	based	base	VERB
ghmj-1044	185	9	on	on	ADP
ghmj-1044	185	10	the	the	DET
ghmj-1044	185	11	ace	ace	NOUN
ghmj-1044	185	12	i	i	PROPN
ghmj-1044	185	13	/	/	SYM
ghmj-1044	185	14	d	d	NOUN
ghmj-1044	185	15	genotype	genotype	NOUN
ghmj-1044	185	16	.	.	PUNCT
ghmj-1044	186	1	in	in	ADP
ghmj-1044	186	2	a	a	DET
ghmj-1044	186	3	study	study	NOUN
ghmj-1044	186	4	involving	involve	VERB
ghmj-1044	186	5	elderly	elderly	ADJ
ghmj-1044	186	6	hypertensive	hypertensive	ADJ
ghmj-1044	186	7	individuals	individual	NOUN
ghmj-1044	186	8	,	,	PUNCT
ghmj-1044	186	9	those	those	PRON
ghmj-1044	186	10	with	with	ADP
ghmj-1044	186	11	the	the	DET
ghmj-1044	186	12	d	d	PROPN
ghmj-1044	186	13	/	/	SYM
ghmj-1044	186	14	d	d	NOUN
ghmj-1044	186	15	genotype	genotype	NOUN
ghmj-1044	186	16	exhibited	exhibit	VERB
ghmj-1044	186	17	impaired	impaired	ADJ
ghmj-1044	186	18	mean	mean	NOUN
ghmj-1044	186	19	arterial	arterial	ADJ
ghmj-1044	186	20	pressure	pressure	NOUN
ghmj-1044	186	21	responses	response	NOUN
ghmj-1044	186	22	following	follow	VERB
ghmj-1044	186	23	exercise	exercise	NOUN
ghmj-1044	186	24	,	,	PUNCT
ghmj-1044	186	25	particularly	particularly	ADV
ghmj-1044	186	26	during	during	ADP
ghmj-1044	186	27	sleep	sleep	NOUN
ghmj-1044	186	28	,	,	PUNCT
ghmj-1044	186	29	as	as	ADV
ghmj-1044	186	30	well	well	ADV
ghmj-1044	186	31	as	as	ADP
ghmj-1044	186	32	reduced	reduce	VERB
ghmj-1044	186	33	heart	heart	NOUN
ghmj-1044	186	34	rate	rate	NOUN
ghmj-1044	186	35	variability	variability	NOUN
ghmj-1044	186	36	and	and	CCONJ
ghmj-1044	186	37	nitric	nitric	ADJ
ghmj-1044	186	38	oxide	oxide	NOUN
ghmj-1044	186	39	release	release	NOUN
ghmj-1044	186	40	(	(	PUNCT
ghmj-1044	186	41	moreira	moreira	PROPN
ghmj-1044	186	42	et	et	PROPN
ghmj-1044	186	43	al	al	PROPN
ghmj-1044	186	44	.	.	PROPN
ghmj-1044	186	45	,	,	PUNCT
ghmj-1044	186	46	2018	2018	NUM
ghmj-1044	186	47	)	)	PUNCT
ghmj-1044	186	48	.	.	PUNCT
ghmj-1044	187	1	high	high	ADJ
ghmj-1044	187	2	salt	salt	NOUN
ghmj-1044	187	3	intake	intake	NOUN
ghmj-1044	187	4	interacts	interact	VERB
ghmj-1044	187	5	with	with	ADP
ghmj-1044	187	6	the	the	DET
ghmj-1044	187	7	ace	ace	NOUN
ghmj-1044	187	8	i	i	PROPN
ghmj-1044	187	9	/	/	SYM
ghmj-1044	187	10	d	d	PROPN
ghmj-1044	187	11	polymorphism	polymorphism	NOUN
ghmj-1044	187	12	to	to	PART
ghmj-1044	187	13	affect	affect	VERB
ghmj-1044	187	14	blood	blood	NOUN
ghmj-1044	187	15	pressure	pressure	NOUN
ghmj-1044	187	16	.	.	PUNCT
ghmj-1044	188	1	a	a	DET
ghmj-1044	188	2	study	study	NOUN
ghmj-1044	188	3	on	on	ADP
ghmj-1044	188	4	japanese	japanese	ADJ
ghmj-1044	188	5	men	man	NOUN
ghmj-1044	188	6	found	find	VERB
ghmj-1044	188	7	that	that	SCONJ
ghmj-1044	188	8	high	high	ADJ
ghmj-1044	188	9	salt	salt	NOUN
ghmj-1044	188	10	intake	intake	NOUN
ghmj-1044	188	11	increased	increase	VERB
ghmj-1044	188	12	blood	blood	NOUN
ghmj-1044	188	13	pressure	pressure	NOUN
ghmj-1044	188	14	in	in	ADP
ghmj-1044	188	15	individuals	individual	NOUN
ghmj-1044	188	16	with	with	ADP
ghmj-1044	188	17	id+ii	id+ii	NOUN
ghmj-1044	188	18	genotypes	genotype	NOUN
ghmj-1044	188	19	but	but	CCONJ
ghmj-1044	188	20	not	not	PART
ghmj-1044	188	21	in	in	ADP
ghmj-1044	188	22	those	those	PRON
ghmj-1044	188	23	with	with	ADP
ghmj-1044	188	24	dd	dd	NOUN
ghmj-1044	188	25	genotypes	genotype	NOUN
ghmj-1044	188	26	.	.	PUNCT
ghmj-1044	189	1	this	this	DET
ghmj-1044	189	2	interaction	interaction	NOUN
ghmj-1044	189	3	was	be	AUX
ghmj-1044	189	4	more	more	ADV
ghmj-1044	189	5	pronounced	pronounced	ADJ
ghmj-1044	189	6	among	among	ADP
ghmj-1044	189	7	overweight	overweight	ADJ
ghmj-1044	189	8	individuals	individual	NOUN
ghmj-1044	189	9	,	,	PUNCT
ghmj-1044	189	10	leading	lead	VERB
ghmj-1044	189	11	to	to	ADP
ghmj-1044	189	12	diastolic	diastolic	ADJ
ghmj-1044	189	13	blood	blood	NOUN
ghmj-1044	189	14	pressure	pressure	NOUN
ghmj-1044	189	15	of	of	ADP
ghmj-1044	189	16	10.5	10.5	NUM
ghmj-1044	189	17	mmhg	mmhg	NOUN
ghmj-1044	189	18	in	in	ADP
ghmj-1044	189	19	those	those	PRON
ghmj-1044	189	20	with	with	ADP
ghmj-1044	189	21	id+ii	id+ii	NOUN
ghmj-1044	189	22	genotypes	genotype	NOUN
ghmj-1044	189	23	compared	compare	VERB
ghmj-1044	189	24	to	to	PART
ghmj-1044	189	25	dd	dd	VERB
ghmj-1044	189	26	genotypes	genotype	NOUN
ghmj-1044	189	27	(	(	PUNCT
ghmj-1044	189	28	l.	l.	PROPN
ghmj-1044	189	29	zhang	zhang	PROPN
ghmj-1044	189	30	et	et	PROPN
ghmj-1044	189	31	al	al	PROPN
ghmj-1044	189	32	.	.	PROPN
ghmj-1044	189	33	,	,	PUNCT
ghmj-1044	189	34	2006	2006	NUM
ghmj-1044	189	35	)	)	PUNCT
ghmj-1044	189	36	.	.	PUNCT
ghmj-1044	190	1	diets	diet	NOUN
ghmj-1044	190	2	high	high	ADJ
ghmj-1044	190	3	in	in	ADP
ghmj-1044	190	4	potassium	potassium	NOUN
ghmj-1044	190	5	,	,	PUNCT
ghmj-1044	190	6	soy	soy	NOUN
ghmj-1044	190	7	protein	protein	NOUN
ghmj-1044	190	8	,	,	PUNCT
ghmj-1044	190	9	alpha	alpha	NOUN
ghmj-1044	190	10	-	-	PUNCT
ghmj-1044	190	11	linolenic	linolenic	ADJ
ghmj-1044	190	12	acid	acid	NOUN
ghmj-1044	190	13	,	,	PUNCT
ghmj-1044	190	14	and	and	CCONJ
ghmj-1044	190	15	low	low	ADJ
ghmj-1044	190	16	in	in	ADP
ghmj-1044	190	17	sodium	sodium	NOUN
ghmj-1044	190	18	can	can	AUX
ghmj-1044	190	19	decrease	decrease	VERB
ghmj-1044	190	20	ace	ace	VERB
ghmj-1044	190	21	activity	activity	NOUN
ghmj-1044	190	22	and	and	CCONJ
ghmj-1044	190	23	potentially	potentially	ADV
ghmj-1044	190	24	reduce	reduce	VERB
ghmj-1044	190	25	hypertension	hypertension	NOUN
ghmj-1044	190	26	risk	risk	NOUN
ghmj-1044	190	27	.	.	PUNCT
ghmj-1044	191	1	conversely	conversely	ADV
ghmj-1044	191	2	,	,	PUNCT
ghmj-1044	191	3	diets	diet	NOUN
ghmj-1044	191	4	high	high	ADJ
ghmj-1044	191	5	in	in	ADP
ghmj-1044	191	6	sodium	sodium	NOUN
ghmj-1044	191	7	may	may	AUX
ghmj-1044	191	8	increase	increase	VERB
ghmj-1044	191	9	ace	ace	NOUN
ghmj-1044	191	10	activity	activity	NOUN
ghmj-1044	191	11	and	and	CCONJ
ghmj-1044	191	12	contribute	contribute	VERB
ghmj-1044	191	13	to	to	ADP
ghmj-1044	191	14	higher	high	ADJ
ghmj-1044	191	15	blood	blood	NOUN
ghmj-1044	191	16	pressure	pressure	NOUN
ghmj-1044	191	17	,	,	PUNCT
ghmj-1044	191	18	especially	especially	ADV
ghmj-1044	191	19	among	among	ADP
ghmj-1044	191	20	individuals	individual	NOUN
ghmj-1044	191	21	with	with	ADP
ghmj-1044	191	22	certain	certain	ADJ
ghmj-1044	191	23	ace	ace	NOUN
ghmj-1044	191	24	i	i	PROPN
ghmj-1044	191	25	/	/	SYM
ghmj-1044	191	26	d	d	NOUN
ghmj-1044	191	27	genotypes	genotype	NOUN
ghmj-1044	191	28	(	(	PUNCT
ghmj-1044	191	29	zambrano	zambrano	PROPN
ghmj-1044	191	30	et	et	PROPN
ghmj-1044	191	31	al	al	PROPN
ghmj-1044	191	32	.	.	PROPN
ghmj-1044	191	33	,	,	PUNCT
ghmj-1044	191	34	2023	2023	NUM
ghmj-1044	191	35	)	)	PUNCT
ghmj-1044	191	36	.	.	PUNCT
ghmj-1044	192	1	therefore	therefore	ADV
ghmj-1044	192	2	,	,	PUNCT
ghmj-1044	192	3	further	further	ADJ
ghmj-1044	192	4	research	research	NOUN
ghmj-1044	192	5	is	be	AUX
ghmj-1044	192	6	needed	need	VERB
ghmj-1044	192	7	to	to	PART
ghmj-1044	192	8	assess	assess	VERB
ghmj-1044	192	9	these	these	DET
ghmj-1044	192	10	factors	factor	NOUN
ghmj-1044	192	11	comprehensively	comprehensively	ADV
ghmj-1044	192	12	.	.	PUNCT
ghmj-1044	193	1	this	this	DET
ghmj-1044	193	2	study	study	NOUN
ghmj-1044	193	3	aims	aim	VERB
ghmj-1044	193	4	to	to	PART
ghmj-1044	193	5	provide	provide	VERB
ghmj-1044	193	6	an	an	DET
ghmj-1044	193	7	evaluation	evaluation	NOUN
ghmj-1044	193	8	for	for	ADP
ghmj-1044	193	9	future	future	ADJ
ghmj-1044	193	10	researchers	researcher	NOUN
ghmj-1044	193	11	and	and	CCONJ
ghmj-1044	193	12	create	create	VERB
ghmj-1044	193	13	opportunities	opportunity	NOUN
ghmj-1044	193	14	for	for	ADP
ghmj-1044	193	15	subsequent	subsequent	ADJ
ghmj-1044	193	16	studies	study	NOUN
ghmj-1044	193	17	to	to	PART
ghmj-1044	193	18	expand	expand	VERB
ghmj-1044	193	19	knowledge	knowledge	NOUN
ghmj-1044	193	20	on	on	ADP
ghmj-1044	193	21	related	related	ADJ
ghmj-1044	193	22	topics	topic	NOUN
ghmj-1044	193	23	.	.	PUNCT
ghmj-1044	194	1	5	5	X
ghmj-1044	194	2	.	.	X
ghmj-1044	194	3	conclusion	conclusion	NOUN
ghmj-1044	194	4	in	in	ADP
ghmj-1044	194	5	both	both	CCONJ
ghmj-1044	194	6	the	the	DET
ghmj-1044	194	7	case	case	NOUN
ghmj-1044	194	8	and	and	CCONJ
ghmj-1044	194	9	control	control	NOUN
ghmj-1044	194	10	groups	group	NOUN
ghmj-1044	194	11	,	,	PUNCT
ghmj-1044	194	12	the	the	DET
ghmj-1044	194	13	i	i	PROPN
ghmj-1044	194	14	d	d	PROPN
ghmj-1044	194	15	genotype	genotype	NOUN
ghmj-1044	194	16	was	be	AUX
ghmj-1044	194	17	the	the	DET
ghmj-1044	194	18	most	most	ADV
ghmj-1044	194	19	commonly	commonly	ADV
ghmj-1044	194	20	observed	observe	VERB
ghmj-1044	194	21	.	.	PUNCT
ghmj-1044	195	1	essential	essential	ADJ
ghmj-1044	195	2	hypertension	hypertension	NOUN
ghmj-1044	195	3	was	be	AUX
ghmj-1044	195	4	not	not	PART
ghmj-1044	195	5	associated	associate	VERB
ghmj-1044	195	6	with	with	ADP
ghmj-1044	195	7	genotype	genotype	NOUN
ghmj-1044	195	8	frequency	frequency	NOUN
ghmj-1044	195	9	.	.	PUNCT
ghmj-1044	196	1	the	the	DET
ghmj-1044	196	2	case	case	NOUN
ghmj-1044	196	3	group	group	NOUN
ghmj-1044	196	4	exhibited	exhibit	VERB
ghmj-1044	196	5	a	a	DET
ghmj-1044	196	6	higher	high	ADJ
ghmj-1044	196	7	frequency	frequency	NOUN
ghmj-1044	196	8	of	of	ADP
ghmj-1044	196	9	the	the	DET
ghmj-1044	196	10	i	i	PROPN
ghmj-1044	196	11	allele	allele	NOUN
ghmj-1044	196	12	,	,	PUNCT
ghmj-1044	196	13	while	while	SCONJ
ghmj-1044	196	14	the	the	DET
ghmj-1044	196	15	control	control	NOUN
ghmj-1044	196	16	group	group	NOUN
ghmj-1044	196	17	had	have	VERB
ghmj-1044	196	18	a	a	DET
ghmj-1044	196	19	higher	high	ADJ
ghmj-1044	196	20	frequency	frequency	NOUN
ghmj-1044	196	21	of	of	ADP
ghmj-1044	196	22	the	the	DET
ghmj-1044	196	23	d	d	PROPN
ghmj-1044	196	24	allele	allele	PROPN
ghmj-1044	196	25	.	.	PUNCT
ghmj-1044	197	1	there	there	PRON
ghmj-1044	197	2	was	be	VERB
ghmj-1044	197	3	no	no	DET
ghmj-1044	197	4	significant	significant	ADJ
ghmj-1044	197	5	association	association	NOUN
ghmj-1044	197	6	between	between	ADP
ghmj-1044	197	7	essential	essential	ADJ
ghmj-1044	197	8	hypertension	hypertension	NOUN
ghmj-1044	197	9	and	and	CCONJ
ghmj-1044	197	10	the	the	DET
ghmj-1044	197	11	frequency	frequency	NOUN
ghmj-1044	197	12	of	of	ADP
ghmj-1044	197	13	a	a	DET
ghmj-1044	197	14	specific	specific	ADJ
ghmj-1044	197	15	allele	allele	NOUN
ghmj-1044	197	16	.	.	PUNCT
ghmj-1044	198	1	polymorphisms	polymorphism	NOUN
ghmj-1044	198	2	in	in	ADP
ghmj-1044	198	3	the	the	DET
ghmj-1044	198	4	ace	ace	NOUN
ghmj-1044	199	1	i	i	PROPN
ghmj-1044	199	2	/	/	SYM
ghmj-1044	199	3	d	d	NOUN
ghmj-1044	199	4	gene	gene	NOUN
ghmj-1044	199	5	were	be	AUX
ghmj-1044	199	6	not	not	PART
ghmj-1044	199	7	significantly	significantly	ADV
ghmj-1044	199	8	associated	associate	VERB
ghmj-1044	199	9	with	with	ADP
ghmj-1044	199	10	essential	essential	ADJ
ghmj-1044	199	11	hypertension	hypertension	NOUN
ghmj-1044	199	12	.	.	PUNCT
ghmj-1044	200	1	conflict	conflict	NOUN
ghmj-1044	200	2	of	of	ADP
ghmj-1044	200	3	interest	interest	NOUN
ghmj-1044	200	4	the	the	DET
ghmj-1044	200	5	authors	author	NOUN
ghmj-1044	200	6	declare	declare	VERB
ghmj-1044	200	7	that	that	SCONJ
ghmj-1044	200	8	they	they	PRON
ghmj-1044	200	9	have	have	VERB
ghmj-1044	200	10	no	no	DET
ghmj-1044	200	11	conflicts	conflict	NOUN
ghmj-1044	200	12	of	of	ADP
ghmj-1044	200	13	interest	interest	NOUN
ghmj-1044	200	14	relevant	relevant	ADJ
ghmj-1044	200	15	to	to	ADP
ghmj-1044	200	16	the	the	DET
ghmj-1044	200	17	results	result	NOUN
ghmj-1044	200	18	presented	present	VERB
ghmj-1044	200	19	.	.	PUNCT
ghmj-1044	201	1	references	reference	NOUN
ghmj-1044	201	2	agustiani	agustiani	PROPN
ghmj-1044	201	3	,	,	PUNCT
ghmj-1044	201	4	y.	y.	PROPN
ghmj-1044	201	5	,	,	PUNCT
ghmj-1044	201	6	anggie	anggie	PROPN
ghmj-1044	201	7	nauli	nauli	PROPN
ghmj-1044	201	8	,	,	PUNCT
ghmj-1044	201	9	h.	h.	PROPN
ghmj-1044	201	10	,	,	PUNCT
ghmj-1044	201	11	&	&	CCONJ
ghmj-1044	201	12	masitha	masitha	PROPN
ghmj-1044	201	13	arsyati	arsyati	PROPN
ghmj-1044	201	14	,	,	PUNCT
ghmj-1044	201	15	a.	a.	NOUN
ghmj-1044	201	16	(	(	PUNCT
ghmj-1044	201	17	2023	2023	NUM
ghmj-1044	201	18	)	)	PUNCT
ghmj-1044	201	19	.	.	PUNCT
ghmj-1044	202	1	hubungan	hubungan	ADJ
ghmj-1044	202	2	antara	antara	NOUN
ghmj-1044	202	3	obesitas	obesita	NOUN
ghmj-1044	202	4	,	,	PUNCT
ghmj-1044	202	5	kebiasaan	kebiasaan	PROPN
ghmj-1044	202	6	merokok	merokok	PROPN
ghmj-1044	202	7	dan	dan	PROPN
ghmj-1044	202	8	aktivitas	aktivitas	PROPN
ghmj-1044	202	9	fisik	fisik	PROPN
ghmj-1044	202	10	dengan	dengan	PROPN
ghmj-1044	202	11	kejadian	kejadian	PROPN
ghmj-1044	202	12	hipertensi	hipertensi	PROPN
ghmj-1044	202	13	pada	pada	PROPN
ghmj-1044	202	14	lansia	lansia	PROPN
ghmj-1044	202	15	di	di	PROPN
ghmj-1044	202	16	wilayah	wilayah	PROPN
ghmj-1044	202	17	kerja	kerja	PROPN
ghmj-1044	202	18	puskesmas	puskesmas	PROPN
ghmj-1044	202	19	gang	gang	PROPN
ghmj-1044	202	20	kelor	kelor	PROPN
ghmj-1044	202	21	.	.	PUNCT
ghmj-1044	203	1	promotor	promotor	PROPN
ghmj-1044	203	2	,	,	PUNCT
ghmj-1044	203	3	6(2	6(2	NUM
ghmj-1044	203	4	)	)	PUNCT
ghmj-1044	203	5	,	,	PUNCT
ghmj-1044	203	6	141–149	141–149	NUM
ghmj-1044	203	7	.	.	PUNCT
ghmj-1044	204	1	https://doi.org/10.32832/pro.v6i4.277	https://doi.org/10.32832/pro.v6i4.277	PROPN
ghmj-1044	204	2	astutik	astutik	PROPN
ghmj-1044	204	3	,	,	PUNCT
ghmj-1044	204	4	e.	e.	PROPN
ghmj-1044	204	5	,	,	PUNCT
ghmj-1044	204	6	puspikawati	puspikawati	PROPN
ghmj-1044	204	7	,	,	PUNCT
ghmj-1044	204	8	s.	s.	PROPN
ghmj-1044	204	9	i.	i.	PROPN
ghmj-1044	204	10	,	,	PUNCT
ghmj-1044	204	11	dewi	dewi	PROPN
ghmj-1044	204	12	,	,	PUNCT
ghmj-1044	204	13	d.	d.	PROPN
ghmj-1044	204	14	m.	m.	PROPN
ghmj-1044	204	15	s.	s.	PROPN
ghmj-1044	204	16	k.	k.	PROPN
ghmj-1044	204	17	,	,	PUNCT
ghmj-1044	204	18	mandagi	mandagi	PROPN
ghmj-1044	204	19	,	,	PUNCT
ghmj-1044	204	20	a.	a.	NOUN
ghmj-1044	204	21	m.	m.	NOUN
ghmj-1044	204	22	,	,	PUNCT
ghmj-1044	204	23	&	&	CCONJ
ghmj-1044	204	24	sebayang	sebayang	PROPN
ghmj-1044	204	25	,	,	PUNCT
ghmj-1044	204	26	s.	s.	PROPN
ghmj-1044	204	27	k.	k.	PROPN
ghmj-1044	204	28	(	(	PUNCT
ghmj-1044	204	29	2020	2020	NUM
ghmj-1044	204	30	)	)	PUNCT
ghmj-1044	204	31	.	.	PUNCT
ghmj-1044	205	1	prevalence	prevalence	NOUN
ghmj-1044	205	2	and	and	CCONJ
ghmj-1044	205	3	risk	risk	NOUN
ghmj-1044	205	4	factors	factor	NOUN
ghmj-1044	205	5	of	of	ADP
ghmj-1044	205	6	high	high	ADJ
ghmj-1044	205	7	blood	blood	NOUN
ghmj-1044	205	8	pressure	pressure	NOUN
ghmj-1044	205	9	among	among	ADP
ghmj-1044	205	10	adults	adult	NOUN
ghmj-1044	205	11	in	in	ADP
ghmj-1044	205	12	banyuwangi	banyuwangi	PROPN
ghmj-1044	205	13	coastal	coastal	ADJ
ghmj-1044	205	14	communities	communities	PROPN
ghmj-1044	205	15	,	,	PUNCT
ghmj-1044	205	16	indonesia	indonesia	PROPN
ghmj-1044	205	17	.	.	PUNCT
ghmj-1044	206	1	ethiopian	ethiopian	PROPN
ghmj-1044	206	2	journal	journal	PROPN
ghmj-1044	206	3	of	of	ADP
ghmj-1044	206	4	health	health	PROPN
ghmj-1044	206	5	sciences	sciences	PROPN
ghmj-1044	206	6	,	,	PUNCT
ghmj-1044	206	7	30(6	30(6	NUM
ghmj-1044	206	8	)	)	PUNCT
ghmj-1044	206	9	,	,	PUNCT
ghmj-1044	206	10	941–950	941–950	NUM
ghmj-1044	206	11	.	.	PUNCT
ghmj-1044	207	1	https://doi.org/10.4314/ejhs.v30i6.12	https://doi.org/10.4314/ejhs.v30i6.12	PROPN
ghmj-1044	207	2	badan	badan	PROPN
ghmj-1044	207	3	penelitian	penelitian	PROPN
ghmj-1044	207	4	dan	dan	PROPN
ghmj-1044	207	5	pengembangan	pengembangan	PROPN
ghmj-1044	207	6	kesehatan	kesehatan	PROPN
ghmj-1044	207	7	kementerian	kementerian	PROPN
ghmj-1044	207	8	kesehatan	kesehatan	PROPN
ghmj-1044	207	9	ri	ri	PROPN
ghmj-1044	207	10	.	.	PUNCT
ghmj-1044	207	11	(	(	PUNCT
ghmj-1044	207	12	2019	2019	NUM
ghmj-1044	207	13	)	)	PUNCT
ghmj-1044	207	14	.	.	PUNCT
ghmj-1044	208	1	laporan	laporan	ADJ
ghmj-1044	208	2	riskesdas	riskesda	NOUN
ghmj-1044	208	3	2018	2018	NUM
ghmj-1044	208	4	nasional	nasional	PROPN
ghmj-1044	208	5	.	.	PUNCT
ghmj-1044	209	1	in	in	ADP
ghmj-1044	209	2	kementerian	kementerian	PROPN
ghmj-1044	209	3	kesehatan	kesehatan	PROPN
ghmj-1044	209	4	republik	republik	PROPN
ghmj-1044	209	5	indonesia	indonesia	PROPN
ghmj-1044	209	6	.	.	PUNCT
ghmj-1044	210	1	jakarta	jakarta	PROPN
ghmj-1044	210	2	:	:	PUNCT
ghmj-1044	211	1	lembaga	lembaga	PROPN
ghmj-1044	211	2	penerbit	penerbit	PROPN
ghmj-1044	211	3	badan	badan	PROPN
ghmj-1044	211	4	penelitian	penelitian	PROPN
ghmj-1044	211	5	dan	dan	PROPN
ghmj-1044	211	6	pengembangan	pengembangan	PROPN
ghmj-1044	211	7	kesehatan	kesehatan	PROPN
ghmj-1044	211	8	ri	ri	PROPN
ghmj-1044	211	9	.	.	PROPN
ghmj-1044	211	10	barley	barley	PROPN
ghmj-1044	211	11	,	,	PUNCT
ghmj-1044	211	12	j.	j.	PROPN
ghmj-1044	211	13	,	,	PUNCT
ghmj-1044	211	14	blackwood	blackwood	PROPN
ghmj-1044	211	15	,	,	PUNCT
ghmj-1044	211	16	a.	a.	PROPN
ghmj-1044	211	17	,	,	PUNCT
ghmj-1044	211	18	carter	carter	PROPN
ghmj-1044	211	19	,	,	PUNCT
ghmj-1044	211	20	n.	n.	PROPN
ghmj-1044	211	21	d.	d.	PROPN
ghmj-1044	211	22	,	,	PUNCT
ghmj-1044	211	23	crews	crew	NOUN
ghmj-1044	211	24	,	,	PUNCT
ghmj-1044	211	25	d.	d.	PROPN
ghmj-1044	211	26	e.	e.	PROPN
ghmj-1044	211	27	,	,	PUNCT
ghmj-1044	211	28	cruickshank	cruickshank	ADV
ghmj-1044	211	29	,	,	PUNCT
ghmj-1044	211	30	j.	j.	PROPN
ghmj-1044	211	31	k.	k.	PROPN
ghmj-1044	211	32	,	,	PUNCT
ghmj-1044	211	33	jeffery	jeffery	PROPN
ghmj-1044	211	34	,	,	PUNCT
ghmj-1044	211	35	s.	s.	PROPN
ghmj-1044	211	36	,	,	PUNCT
ghmj-1044	211	37	…	…	PUNCT
ghmj-1044	211	38	sagnella	sagnella	NOUN
ghmj-1044	211	39	,	,	PUNCT
ghmj-1044	211	40	g.	g.	PROPN
ghmj-1044	211	41	a.	a.	PROPN
ghmj-1044	211	42	(	(	PUNCT
ghmj-1044	211	43	1994	1994	NUM
ghmj-1044	211	44	)	)	PUNCT
ghmj-1044	211	45	.	.	PUNCT
ghmj-1044	212	1	angiotensin	angiotensin	NOUN
ghmj-1044	212	2	converting	convert	VERB
ghmj-1044	212	3	enzyme	enzyme	NOUN
ghmj-1044	212	4	insertion	insertion	NOUN
ghmj-1044	212	5	/	/	SYM
ghmj-1044	212	6	deletion	deletion	NOUN
ghmj-1044	212	7	polymorphism	polymorphism	NOUN
ghmj-1044	212	8	.	.	PUNCT
ghmj-1044	213	1	journal	journal	PROPN
ghmj-1044	213	2	of	of	ADP
ghmj-1044	213	3	hypertension	hypertension	NOUN
ghmj-1044	213	4	,	,	PUNCT
ghmj-1044	213	5	12(8	12(8	NUM
ghmj-1044	213	6	)	)	PUNCT
ghmj-1044	213	7	,	,	PUNCT
ghmj-1044	213	8	995	995	X
ghmj-1044	213	9	.	.	PUNCT
ghmj-1044	214	1	https://doi.org/10.1097/00004872199408000-00014	https://doi.org/10.1097/00004872199408000-00014	PROPN
ghmj-1044	214	2	bawazier	bawazier	PROPN
ghmj-1044	214	3	,	,	PUNCT
ghmj-1044	214	4	l.	l.	PROPN
ghmj-1044	214	5	a.	a.	PROPN
ghmj-1044	214	6	,	,	PUNCT
ghmj-1044	214	7	sja’bani	sja’bani	PROPN
ghmj-1044	214	8	,	,	PUNCT
ghmj-1044	214	9	m.	m.	NOUN
ghmj-1044	214	10	,	,	PUNCT
ghmj-1044	214	11	haryana	haryana	PROPN
ghmj-1044	214	12	,	,	PUNCT
ghmj-1044	214	13	s.	s.	PROPN
ghmj-1044	214	14	m.	m.	PROPN
ghmj-1044	214	15	,	,	PUNCT
ghmj-1044	214	16	soesatyo	soesatyo	PROPN
ghmj-1044	214	17	,	,	PUNCT
ghmj-1044	214	18	m.	m.	NOUN
ghmj-1044	214	19	h.	h.	PROPN
ghmj-1044	214	20	n.	n.	PROPN
ghmj-1044	214	21	e.	e.	PROPN
ghmj-1044	214	22	,	,	PUNCT
ghmj-1044	214	23	&	&	CCONJ
ghmj-1044	214	24	sadewa	sadewa	PROPN
ghmj-1044	214	25	,	,	PUNCT
ghmj-1044	214	26	a.	a.	PROPN
ghmj-1044	214	27	h.	h.	PROPN
ghmj-1044	214	28	(	(	PUNCT
ghmj-1044	214	29	2010	2010	NUM
ghmj-1044	214	30	)	)	PUNCT
ghmj-1044	214	31	.	.	PUNCT
ghmj-1044	215	1	relationship	relationship	NOUN
ghmj-1044	215	2	of	of	ADP
ghmj-1044	215	3	angiotensin	angiotensin	NOUN
ghmj-1044	215	4	converting	convert	VERB
ghmj-1044	215	5	enzyme	enzyme	NOUN
ghmj-1044	215	6	gene	gene	NOUN
ghmj-1044	215	7	polymorphism	polymorphism	NOUN
ghmj-1044	215	8	and	and	CCONJ
ghmj-1044	215	9	hypertension	hypertension	NOUN
ghmj-1044	215	10	in	in	ADP
ghmj-1044	215	11	yogyakarta	yogyakarta	PROPN
ghmj-1044	215	12	,	,	PUNCT
ghmj-1044	215	13	indonesia	indonesia	PROPN
ghmj-1044	215	14	.	.	PUNCT
ghmj-1044	216	1	acta	acta	PROPN
ghmj-1044	216	2	medica	medica	PROPN
ghmj-1044	216	3	indonesiana	indonesiana	PROPN
ghmj-1044	216	4	,	,	PUNCT
ghmj-1044	216	5	42(4	42(4	PROPN
ghmj-1044	216	6	)	)	PUNCT
ghmj-1044	216	7	,	,	PUNCT
ghmj-1044	216	8	192–198	192–198	NUM
ghmj-1044	216	9	.	.	PUNCT
ghmj-1044	217	1	bhelkar	bhelkar	PROPN
ghmj-1044	217	2	,	,	PUNCT
ghmj-1044	217	3	s.	s.	PROPN
ghmj-1044	217	4	,	,	PUNCT
ghmj-1044	217	5	deshpande	deshpande	PROPN
ghmj-1044	217	6	,	,	PUNCT
ghmj-1044	217	7	s.	s.	PROPN
ghmj-1044	217	8	,	,	PUNCT
ghmj-1044	217	9	&	&	CCONJ
ghmj-1044	217	10	mankar	mankar	PROPN
ghmj-1044	217	11	,	,	PUNCT
ghmj-1044	217	12	s.	s.	PROPN
ghmj-1044	217	13	(	(	PUNCT
ghmj-1044	217	14	2019	2019	NUM
ghmj-1044	217	15	)	)	PUNCT
ghmj-1044	217	16	.	.	PUNCT
ghmj-1044	218	1	association	association	NOUN
ghmj-1044	218	2	between	between	ADP
ghmj-1044	218	3	stress	stress	NOUN
ghmj-1044	218	4	and	and	CCONJ
ghmj-1044	218	5	hypertension	hypertension	NOUN
ghmj-1044	218	6	among	among	ADP
ghmj-1044	218	7	adults	adult	NOUN
ghmj-1044	218	8	more	more	ADJ
ghmj-1044	218	9	than	than	ADP
ghmj-1044	218	10	30	30	NUM
ghmj-1044	218	11	years	year	NOUN
ghmj-1044	218	12	:	:	PUNCT
ghmj-1044	218	13	a	a	DET
ghmj-1044	218	14	case	case	NOUN
ghmj-1044	218	15	-	-	PUNCT
ghmj-1044	218	16	control	control	NOUN
ghmj-1044	218	17	study	study	NOUN
ghmj-1044	218	18	.	.	PUNCT
ghmj-1044	219	1	national	national	ADJ
ghmj-1044	219	2	journal	journal	PROPN
ghmj-1044	219	3	of	of	ADP
ghmj-1044	219	4	community	community	NOUN
ghmj-1044	219	5	medicine	medicine	NOUN
ghmj-1044	219	6	│	│	NOUN
ghmj-1044	219	7	volume	volume	NOUN
ghmj-1044	219	8	,	,	PUNCT
ghmj-1044	219	9	9(6	9(6	NUM
ghmj-1044	219	10	)	)	PUNCT
ghmj-1044	219	11	,	,	PUNCT
ghmj-1044	219	12	430–433	430–433	NUM
ghmj-1044	219	13	.	.	PUNCT
ghmj-1044	220	1	birhan	birhan	PROPN
ghmj-1044	220	2	,	,	PUNCT
ghmj-1044	220	3	t.	t.	PROPN
ghmj-1044	220	4	a.	a.	PROPN
ghmj-1044	220	5	,	,	PUNCT
ghmj-1044	220	6	molla	molla	PROPN
ghmj-1044	220	7	,	,	PUNCT
ghmj-1044	220	8	m.	m.	NOUN
ghmj-1044	220	9	d.	d.	PROPN
ghmj-1044	220	10	,	,	PUNCT
ghmj-1044	220	11	abdulkadir	abdulkadir	NOUN
ghmj-1044	220	12	,	,	PUNCT
ghmj-1044	220	13	m.	m.	NOUN
ghmj-1044	220	14	,	,	PUNCT
ghmj-1044	220	15	&	&	CCONJ
ghmj-1044	220	16	tesfa	tesfa	PROPN
ghmj-1044	220	17	,	,	PUNCT
ghmj-1044	220	18	k.	k.	PROPN
ghmj-1044	220	19	h.	h.	PROPN
ghmj-1044	220	20	(	(	PUNCT
ghmj-1044	220	21	2022	2022	NUM
ghmj-1044	220	22	)	)	PUNCT
ghmj-1044	220	23	.	.	PUNCT
ghmj-1044	221	1	association	association	NOUN
ghmj-1044	221	2	of	of	ADP
ghmj-1044	221	3	angiotensin	angiotensin	NOUN
ghmj-1044	221	4	-	-	PUNCT
ghmj-1044	221	5	converting	convert	VERB
ghmj-1044	221	6	enzyme	enzyme	NOUN
ghmj-1044	221	7	gene	gene	NOUN
ghmj-1044	221	8	insertion	insertion	NOUN
ghmj-1044	221	9	/	/	SYM
ghmj-1044	221	10	deletion	deletion	NOUN
ghmj-1044	221	11	polymorphisms	polymorphism	NOUN
ghmj-1044	221	12	with	with	ADP
ghmj-1044	221	13	risk	risk	NOUN
ghmj-1044	221	14	of	of	ADP
ghmj-1044	221	15	hypertension	hypertension	NOUN
ghmj-1044	221	16	among	among	ADP
ghmj-1044	221	17	the	the	DET
ghmj-1044	221	18	ethiopian	ethiopian	ADJ
ghmj-1044	221	19	population	population	NOUN
ghmj-1044	221	20	.	.	PUNCT
ghmj-1044	222	1	plos	plos	PROPN
ghmj-1044	222	2	one	one	NUM
ghmj-1044	222	3	,	,	PUNCT
ghmj-1044	222	4	17(11	17(11	NUM
ghmj-1044	222	5	november	november	PROPN
ghmj-1044	222	6	)	)	PUNCT
ghmj-1044	222	7	,	,	PUNCT
ghmj-1044	222	8	1–14	1–14	PROPN
ghmj-1044	222	9	.	.	PUNCT
ghmj-1044	222	10	https://doi.org/10.1371/journal.pone.0276021	https://doi.org/10.1371/journal.pone.0276021	PROPN
ghmj-1044	222	11	burchard	burchard	PROPN
ghmj-1044	222	12	,	,	PUNCT
ghmj-1044	222	13	e.	e.	PROPN
ghmj-1044	222	14	g.	g.	PROPN
ghmj-1044	222	15	,	,	PUNCT
ghmj-1044	222	16	ziv	ziv	PROPN
ghmj-1044	222	17	,	,	PUNCT
ghmj-1044	222	18	e.	e.	PROPN
ghmj-1044	222	19	,	,	PUNCT
ghmj-1044	222	20	coyle	coyle	PROPN
ghmj-1044	222	21	,	,	PUNCT
ghmj-1044	222	22	n.	n.	PROPN
ghmj-1044	222	23	,	,	PUNCT
ghmj-1044	222	24	gomez	gomez	PROPN
ghmj-1044	222	25	,	,	PUNCT
ghmj-1044	222	26	s.	s.	PROPN
ghmj-1044	222	27	l.	l.	PROPN
ghmj-1044	222	28	,	,	PUNCT
ghmj-1044	222	29	tang	tang	PROPN
ghmj-1044	222	30	,	,	PUNCT
ghmj-1044	222	31	h.	h.	PROPN
ghmj-1044	222	32	,	,	PUNCT
ghmj-1044	222	33	karter	karter	PROPN
ghmj-1044	222	34	,	,	PUNCT
ghmj-1044	222	35	a.	a.	PROPN
ghmj-1044	222	36	j.	j.	PROPN
ghmj-1044	222	37	,	,	PUNCT
ghmj-1044	222	38	…	…	PUNCT
ghmj-1044	222	39	pérez	pérez	NOUN
ghmj-1044	222	40	-	-	PUNCT
ghmj-1044	222	41	stable	stable	ADJ
ghmj-1044	222	42	,	,	PUNCT
ghmj-1044	222	43	e.	e.	PROPN
ghmj-1044	222	44	j.	j.	PROPN
ghmj-1044	222	45	(	(	PUNCT
ghmj-1044	222	46	2003	2003	NUM
ghmj-1044	222	47	)	)	PUNCT
ghmj-1044	222	48	.	.	PUNCT
ghmj-1044	223	1	the	the	DET
ghmj-1044	223	2	importance	importance	NOUN
ghmj-1044	223	3	of	of	ADP
ghmj-1044	223	4	race	race	NOUN
ghmj-1044	223	5	and	and	CCONJ
ghmj-1044	223	6	ethnic	ethnic	ADJ
ghmj-1044	223	7	background	background	NOUN
ghmj-1044	223	8	in	in	ADP
ghmj-1044	223	9	biomedical	biomedical	ADJ
ghmj-1044	223	10	research	research	NOUN
ghmj-1044	223	11	and	and	CCONJ
ghmj-1044	223	12	clinical	clinical	ADJ
ghmj-1044	223	13	practice	practice	NOUN
ghmj-1044	223	14	.	.	PUNCT
ghmj-1044	224	1	the	the	DET
ghmj-1044	224	2	new	new	PROPN
ghmj-1044	224	3	england	england	PROPN
ghmj-1044	224	4	journal	journal	PROPN
ghmj-1044	224	5	of	of	ADP
ghmj-1044	224	6	medicine	medicine	NOUN
ghmj-1044	224	7	,	,	PUNCT
ghmj-1044	224	8	348(12	348(12	NUM
ghmj-1044	224	9	)	)	PUNCT
ghmj-1044	224	10	,	,	PUNCT
ghmj-1044	224	11	1170	1170	NUM
ghmj-1044	224	12	–	–	PUNCT
ghmj-1044	224	13	1175	1175	NUM
ghmj-1044	224	14	.	.	PUNCT
ghmj-1044	225	1	dida	dida	PROPN
ghmj-1044	225	2	,	,	PUNCT
ghmj-1044	225	3	g.	g.	PROPN
ghmj-1044	225	4	y.	y.	PROPN
ghmj-1044	225	5	,	,	PUNCT
ghmj-1044	225	6	nayoan	nayoan	PROPN
ghmj-1044	225	7	,	,	PUNCT
ghmj-1044	225	8	c.	c.	PROPN
ghmj-1044	225	9	r.	r.	PROPN
ghmj-1044	225	10	,	,	PUNCT
ghmj-1044	225	11	&	&	CCONJ
ghmj-1044	225	12	sir	sir	PROPN
ghmj-1044	225	13	,	,	PUNCT
ghmj-1044	225	14	a.	a.	PROPN
ghmj-1044	225	15	b.	b.	PROPN
ghmj-1044	225	16	(	(	PUNCT
ghmj-1044	225	17	2023	2023	NUM
ghmj-1044	225	18	)	)	PUNCT
ghmj-1044	225	19	.	.	PUNCT
ghmj-1044	226	1	the	the	DET
ghmj-1044	226	2	risk	risk	NOUN
ghmj-1044	226	3	factors	factor	NOUN
ghmj-1044	226	4	of	of	ADP
ghmj-1044	226	5	hypertension	hypertension	NOUN
ghmj-1044	226	6	among	among	ADP
ghmj-1044	226	7	the	the	DET
ghmj-1044	226	8	elderly	elderly	ADJ
ghmj-1044	226	9	in	in	ADP
ghmj-1044	226	10	the	the	DET
ghmj-1044	226	11	working	working	NOUN
ghmj-1044	226	12	area	area	NOUN
ghmj-1044	226	13	of	of	ADP
ghmj-1044	226	14	sikumana	sikumana	PROPN
ghmj-1044	226	15	primary	primary	ADJ
ghmj-1044	226	16	health	health	PROPN
ghmj-1044	226	17	care	care	NOUN
ghmj-1044	226	18	center	center	NOUN
ghmj-1044	226	19	.	.	PUNCT
ghmj-1044	227	1	journal	journal	NOUN
ghmj-1044	227	2	of	of	ADP
ghmj-1044	227	3	public	public	ADJ
ghmj-1044	227	4	health	health	NOUN
ghmj-1044	227	5	for	for	ADP
ghmj-1044	227	6	tropical	tropical	ADJ
ghmj-1044	227	7	and	and	CCONJ
ghmj-1044	227	8	coastal	coastal	ADJ
ghmj-1044	227	9	region	region	NOUN
ghmj-1044	227	10	,	,	PUNCT
ghmj-1044	227	11	6(1	6(1	NUM
ghmj-1044	227	12	)	)	PUNCT
ghmj-1044	227	13	,	,	PUNCT
ghmj-1044	227	14	21–29	21–29	NUM
ghmj-1044	227	15	.	.	PUNCT
ghmj-1044	228	1	https://doi.org/10.14710/jphtcr.v6i1.17541	https://doi.org/10.14710/jphtcr.v6i1.17541	PRON
ghmj-1044	228	2	https://doi.org/10.32832/pro.v6i4.277	https://doi.org/10.32832/pro.v6i4.277	PROPN
ghmj-1044	228	3	https://doi.org/10.4314/ejhs.v30i6.12	https://doi.org/10.4314/ejhs.v30i6.12	PROPN
ghmj-1044	228	4	https://doi.org/10.1097/00004872-199408000-00014	https://doi.org/10.1097/00004872-199408000-00014	NOUN
ghmj-1044	228	5	https://doi.org/10.1097/00004872-199408000-00014	https://doi.org/10.1097/00004872-199408000-00014	NOUN
ghmj-1044	228	6	https://doi.org/10.1371/journal.pone.0276021	https://doi.org/10.1371/journal.pone.0276021	NOUN
ghmj-1044	228	7	https://doi.org/10.14710/jphtcr.v6i1.17541	https://doi.org/10.14710/jphtcr.v6i1.17541	PRON
ghmj-1044	228	8	189	189	NUM
ghmj-1044	228	9	ghmj	ghmj	NOUN
ghmj-1044	228	10	(	(	PUNCT
ghmj-1044	228	11	global	global	ADJ
ghmj-1044	228	12	health	health	PROPN
ghmj-1044	228	13	management	management	NOUN
ghmj-1044	228	14	journal	journal	PROPN
ghmj-1044	228	15	)	)	PUNCT
ghmj-1044	228	16	2024	2024	NUM
ghmj-1044	228	17	,	,	PUNCT
ghmj-1044	228	18	vol	vol	NOUN
ghmj-1044	228	19	.	.	PROPN
ghmj-1044	229	1	7	7	NUM
ghmj-1044	229	2	,	,	PUNCT
ghmj-1044	229	3	no	no	INTJ
ghmj-1044	229	4	.	.	NOUN
ghmj-1044	229	5	4	4	NUM
ghmj-1044	229	6	kuswara	kuswara	NOUN
ghmj-1044	229	7	,	,	PUNCT
ghmj-1044	229	8	et	et	PROPN
ghmj-1044	229	9	.	.	PUNCT
ghmj-1044	230	1	al	al	PROPN
ghmj-1044	230	2	.	.	PUNCT
ghmj-1044	231	1	dinas	dinas	PROPN
ghmj-1044	231	2	kesehatan	kesehatan	PROPN
ghmj-1044	231	3	kabupaten	kabupaten	PROPN
ghmj-1044	231	4	cirebon	cirebon	PROPN
ghmj-1044	231	5	.	.	PUNCT
ghmj-1044	232	1	(	(	PUNCT
ghmj-1044	232	2	2021	2021	NUM
ghmj-1044	232	3	)	)	PUNCT
ghmj-1044	232	4	.	.	PUNCT
ghmj-1044	233	1	profil	profil	PROPN
ghmj-1044	233	2	kesehatan	kesehatan	PROPN
ghmj-1044	233	3	kabupaten	kabupaten	PROPN
ghmj-1044	233	4	cirebon	cirebon	PROPN
ghmj-1044	233	5	tahun	tahun	PROPN
ghmj-1044	233	6	2021	2021	NUM
ghmj-1044	233	7	.	.	PUNCT
ghmj-1044	234	1	dinas	dinas	PROPN
ghmj-1044	234	2	kesehatan	kesehatan	PROPN
ghmj-1044	234	3	kabupaten	kabupaten	PROPN
ghmj-1044	234	4	cirebon	cirebon	PROPN
ghmj-1044	234	5	.	.	PUNCT
ghmj-1044	235	1	eleni	eleni	PROPN
ghmj-1044	235	2	,	,	PUNCT
ghmj-1044	235	3	s.	s.	PROPN
ghmj-1044	235	4	,	,	PUNCT
ghmj-1044	235	5	dimitrios	dimitrio	NOUN
ghmj-1044	235	6	,	,	PUNCT
ghmj-1044	235	7	k.	k.	PROPN
ghmj-1044	235	8	,	,	PUNCT
ghmj-1044	235	9	vaya	vaya	PROPN
ghmj-1044	235	10	,	,	PUNCT
ghmj-1044	235	11	p.	p.	PROPN
ghmj-1044	235	12	,	,	PUNCT
ghmj-1044	235	13	areti	areti	ADJ
ghmj-1044	235	14	,	,	PUNCT
ghmj-1044	235	15	m.	m.	NOUN
ghmj-1044	235	16	,	,	PUNCT
ghmj-1044	235	17	norma	norma	PROPN
ghmj-1044	235	18	,	,	PUNCT
ghmj-1044	235	19	v.	v.	PROPN
ghmj-1044	235	20	,	,	PUNCT
ghmj-1044	235	21	&	&	CCONJ
ghmj-1044	235	22	magdalini	magdalini	PROPN
ghmj-1044	235	23	,	,	PUNCT
ghmj-1044	235	24	g.	g.	PROPN
ghmj-1044	235	25	(	(	PUNCT
ghmj-1044	235	26	2008	2008	NUM
ghmj-1044	235	27	)	)	PUNCT
ghmj-1044	235	28	.	.	PUNCT
ghmj-1044	236	1	angiotensin	angiotensin	NOUN
ghmj-1044	236	2	-	-	PUNCT
ghmj-1044	236	3	i	i	PRON
ghmj-1044	236	4	converting	convert	VERB
ghmj-1044	236	5	enzyme	enzyme	NOUN
ghmj-1044	236	6	gene	gene	NOUN
ghmj-1044	236	7	and	and	CCONJ
ghmj-1044	236	8	i	i	PRON
ghmj-1044	236	9	/	/	SYM
ghmj-1044	236	10	d	d	NOUN
ghmj-1044	236	11	polymorphism	polymorphism	NOUN
ghmj-1044	236	12	distribution	distribution	NOUN
ghmj-1044	236	13	in	in	ADP
ghmj-1044	236	14	the	the	DET
ghmj-1044	236	15	greek	greek	ADJ
ghmj-1044	236	16	population	population	NOUN
ghmj-1044	236	17	and	and	CCONJ
ghmj-1044	236	18	a	a	DET
ghmj-1044	236	19	comparison	comparison	NOUN
ghmj-1044	236	20	with	with	ADP
ghmj-1044	236	21	other	other	ADJ
ghmj-1044	236	22	european	european	ADJ
ghmj-1044	236	23	populations	population	NOUN
ghmj-1044	236	24	.	.	PUNCT
ghmj-1044	237	1	journal	journal	NOUN
ghmj-1044	237	2	of	of	ADP
ghmj-1044	237	3	genetics	genetic	NOUN
ghmj-1044	237	4	,	,	PUNCT
ghmj-1044	237	5	87(1	87(1	NUM
ghmj-1044	237	6	)	)	PUNCT
ghmj-1044	237	7	,	,	PUNCT
ghmj-1044	237	8	91–93	91–93	NUM
ghmj-1044	237	9	.	.	PUNCT
ghmj-1044	238	1	https://doi.org/10.1007/s12041-008-0013-7	https://doi.org/10.1007/s12041-008-0013-7	PROPN
ghmj-1044	238	2	frisoli	frisoli	PROPN
ghmj-1044	238	3	,	,	PUNCT
ghmj-1044	238	4	t.	t.	NOUN
ghmj-1044	238	5	m.	m.	NOUN
ghmj-1044	238	6	,	,	PUNCT
ghmj-1044	238	7	schmieder	schmieder	PROPN
ghmj-1044	238	8	,	,	PUNCT
ghmj-1044	238	9	r.	r.	PROPN
ghmj-1044	238	10	e.	e.	PROPN
ghmj-1044	238	11	,	,	PUNCT
ghmj-1044	238	12	grodzicki	grodzicki	NOUN
ghmj-1044	238	13	,	,	PUNCT
ghmj-1044	238	14	t.	t.	PROPN
ghmj-1044	238	15	,	,	PUNCT
ghmj-1044	238	16	&	&	CCONJ
ghmj-1044	238	17	messerli	messerli	PROPN
ghmj-1044	238	18	,	,	PUNCT
ghmj-1044	238	19	f.	f.	PROPN
ghmj-1044	238	20	h.	h.	PROPN
ghmj-1044	238	21	(	(	PUNCT
ghmj-1044	238	22	2012	2012	NUM
ghmj-1044	238	23	)	)	PUNCT
ghmj-1044	238	24	.	.	PUNCT
ghmj-1044	239	1	salt	salt	NOUN
ghmj-1044	239	2	and	and	CCONJ
ghmj-1044	239	3	hypertension	hypertension	NOUN
ghmj-1044	239	4	:	:	PUNCT
ghmj-1044	239	5	is	be	AUX
ghmj-1044	239	6	salt	salt	VERB
ghmj-1044	239	7	dietary	dietary	ADJ
ghmj-1044	239	8	reduction	reduction	NOUN
ghmj-1044	239	9	worth	worth	ADJ
ghmj-1044	239	10	the	the	DET
ghmj-1044	239	11	effort	effort	NOUN
ghmj-1044	239	12	?	?	PUNCT
ghmj-1044	240	1	american	american	ADJ
ghmj-1044	240	2	journal	journal	PROPN
ghmj-1044	240	3	of	of	ADP
ghmj-1044	240	4	medicine	medicine	NOUN
ghmj-1044	240	5	,	,	PUNCT
ghmj-1044	240	6	125(5	125(5	NUM
ghmj-1044	240	7	)	)	PUNCT
ghmj-1044	240	8	,	,	PUNCT
ghmj-1044	240	9	433–439	433–439	NUM
ghmj-1044	240	10	.	.	PUNCT
ghmj-1044	241	1	https://doi.org/10.1016/j.amjmed.2011.10.023	https://doi.org/10.1016/j.amjmed.2011.10.023	NUM
ghmj-1044	241	2	hadian	hadian	PROPN
ghmj-1044	241	3	,	,	PUNCT
ghmj-1044	241	4	b.	b.	PROPN
ghmj-1044	241	5	,	,	PUNCT
ghmj-1044	241	6	zafarmohtashami	zafarmohtashami	PROPN
ghmj-1044	241	7	,	,	PUNCT
ghmj-1044	241	8	a.	a.	NOUN
ghmj-1044	241	9	,	,	PUNCT
ghmj-1044	241	10	chaghervand	chaghervand	PROPN
ghmj-1044	241	11	,	,	PUNCT
ghmj-1044	241	12	z.	z.	PROPN
ghmj-1044	241	13	,	,	PUNCT
ghmj-1044	241	14	&	&	CCONJ
ghmj-1044	241	15	nouryazdan	nouryazdan	PROPN
ghmj-1044	241	16	,	,	PUNCT
ghmj-1044	241	17	n.	n.	NOUN
ghmj-1044	241	18	(	(	PUNCT
ghmj-1044	241	19	2022	2022	NUM
ghmj-1044	241	20	)	)	PUNCT
ghmj-1044	241	21	.	.	PUNCT
ghmj-1044	242	1	angiotensin	angiotensin	NOUN
ghmj-1044	242	2	-	-	PUNCT
ghmj-1044	242	3	converting	convert	VERB
ghmj-1044	242	4	enzyme	enzyme	NOUN
ghmj-1044	242	5	gene	gene	NOUN
ghmj-1044	242	6	insertion	insertion	NOUN
ghmj-1044	242	7	/	/	SYM
ghmj-1044	242	8	deletion	deletion	NOUN
ghmj-1044	242	9	polymorphism	polymorphism	NOUN
ghmj-1044	242	10	and	and	CCONJ
ghmj-1044	242	11	hypertension	hypertension	NOUN
ghmj-1044	242	12	disease	disease	NOUN
ghmj-1044	242	13	.	.	PUNCT
ghmj-1044	243	1	archives	archive	NOUN
ghmj-1044	243	2	of	of	ADP
ghmj-1044	243	3	physiology	physiology	NOUN
ghmj-1044	243	4	and	and	CCONJ
ghmj-1044	243	5	biochemistry	biochemistry	NOUN
ghmj-1044	243	6	,	,	PUNCT
ghmj-1044	243	7	128(5	128(5	NUM
ghmj-1044	243	8	)	)	PUNCT
ghmj-1044	243	9	,	,	PUNCT
ghmj-1044	243	10	1165–1169	1165–1169	NUM
ghmj-1044	243	11	.	.	PUNCT
ghmj-1044	244	1	https://doi.org/10.1080/13813455.2020.1762225	https://doi.org/10.1080/13813455.2020.1762225	PROPN
ghmj-1044	244	2	hidayat	hidayat	PROPN
ghmj-1044	244	3	,	,	PUNCT
ghmj-1044	244	4	t.	t.	PROPN
ghmj-1044	244	5	,	,	PUNCT
ghmj-1044	244	6	&	&	CCONJ
ghmj-1044	244	7	milenia	milenia	PROPN
ghmj-1044	244	8	saputri	saputri	PROPN
ghmj-1044	244	9	,	,	PUNCT
ghmj-1044	244	10	r.	r.	PROPN
ghmj-1044	244	11	(	(	PUNCT
ghmj-1044	244	12	2023	2023	NUM
ghmj-1044	244	13	)	)	PUNCT
ghmj-1044	244	14	.	.	PUNCT
ghmj-1044	245	1	hubungan	hubungan	PROPN
ghmj-1044	245	2	tingkat	tingkat	PROPN
ghmj-1044	245	3	ketergantungan	ketergantungan	VERB
ghmj-1044	245	4	nikotin	nikotin	PROPN
ghmj-1044	245	5	dengan	dengan	PROPN
ghmj-1044	245	6	tekanan	tekanan	PROPN
ghmj-1044	245	7	darah	darah	PROPN
ghmj-1044	245	8	pada	pada	PROPN
ghmj-1044	245	9	kelompok	kelompok	PROPN
ghmj-1044	245	10	perokok	perokok	PROPN
ghmj-1044	245	11	laki	laki	PROPN
ghmj-1044	245	12	-	-	PUNCT
ghmj-1044	245	13	laki	laki	PROPN
ghmj-1044	245	14	dengan	dengan	PROPN
ghmj-1044	245	15	hipertensi	hipertensi	PROPN
ghmj-1044	245	16	.	.	PUNCT
ghmj-1044	246	1	jurnal	jurnal	PROPN
ghmj-1044	246	2	ilmu	ilmu	PROPN
ghmj-1044	246	3	kesehatan	kesehatan	PROPN
ghmj-1044	246	4	insan	insan	PROPN
ghmj-1044	246	5	sehat	sehat	PROPN
ghmj-1044	246	6	,	,	PUNCT
ghmj-1044	246	7	11(2	11(2	NOUN
ghmj-1044	246	8	)	)	PUNCT
ghmj-1044	246	9	,	,	PUNCT
ghmj-1044	246	10	52–57	52–57	NUM
ghmj-1044	246	11	.	.	PUNCT
ghmj-1044	247	1	https://doi.org/10.54004/jikis.v11i2.135	https://doi.org/10.54004/jikis.v11i2.135	NOUN
ghmj-1044	247	2	ishigami	ishigami	NOUN
ghmj-1044	247	3	,	,	PUNCT
ghmj-1044	247	4	t.	t.	PROPN
ghmj-1044	247	5	,	,	PUNCT
ghmj-1044	247	6	iwamoto	iwamoto	ADJ
ghmj-1044	247	7	,	,	PUNCT
ghmj-1044	247	8	t.	t.	PROPN
ghmj-1044	247	9	,	,	PUNCT
ghmj-1044	247	10	tamura	tamura	PROPN
ghmj-1044	247	11	,	,	PUNCT
ghmj-1044	247	12	k.	k.	PROPN
ghmj-1044	247	13	,	,	PUNCT
ghmj-1044	247	14	yamaguchi	yamaguchi	PROPN
ghmj-1044	247	15	,	,	PUNCT
ghmj-1044	247	16	s.	s.	PROPN
ghmj-1044	247	17	,	,	PUNCT
ghmj-1044	247	18	iwasawa	iwasawa	PROPN
ghmj-1044	247	19	,	,	PUNCT
ghmj-1044	247	20	k.	k.	PROPN
ghmj-1044	247	21	,	,	PUNCT
ghmj-1044	247	22	uchino	uchino	PROPN
ghmj-1044	247	23	,	,	PUNCT
ghmj-1044	247	24	k.	k.	PROPN
ghmj-1044	247	25	,	,	PUNCT
ghmj-1044	247	26	…	…	PUNCT
ghmj-1044	247	27	ishii	ishii	PROPN
ghmj-1044	247	28	,	,	PUNCT
ghmj-1044	247	29	m.	m.	NOUN
ghmj-1044	247	30	(	(	PUNCT
ghmj-1044	247	31	1995	1995	NUM
ghmj-1044	247	32	)	)	PUNCT
ghmj-1044	247	33	.	.	PUNCT
ghmj-1044	248	1	angiotensin	angiotensin	NOUN
ghmj-1044	248	2	i	i	PRON
ghmj-1044	248	3	converting	convert	VERB
ghmj-1044	248	4	enzyme	enzyme	NOUN
ghmj-1044	248	5	(	(	PUNCT
ghmj-1044	248	6	ace	ace	NOUN
ghmj-1044	248	7	)	)	PUNCT
ghmj-1044	248	8	gene	gene	NOUN
ghmj-1044	248	9	polymorphism	polymorphism	NOUN
ghmj-1044	248	10	and	and	CCONJ
ghmj-1044	248	11	essential	essential	ADJ
ghmj-1044	248	12	hypertension	hypertension	NOUN
ghmj-1044	248	13	in	in	ADP
ghmj-1044	248	14	japan	japan	PROPN
ghmj-1044	248	15	.	.	PUNCT
ghmj-1044	249	1	7061(94	7061(94	NUM
ghmj-1044	249	2	)	)	PUNCT
ghmj-1044	249	3	,	,	PUNCT
ghmj-1044	249	4	95–97	95–97	NUM
ghmj-1044	249	5	.	.	PUNCT
ghmj-1044	250	1	kumar	kumar	PROPN
ghmj-1044	250	2	,	,	PUNCT
ghmj-1044	250	3	d.	d.	PROPN
ghmj-1044	250	4	p.	p.	PROPN
ghmj-1044	250	5	j.	j.	PROPN
ghmj-1044	250	6	,	,	PUNCT
ghmj-1044	250	7	&	&	CCONJ
ghmj-1044	250	8	clark	clark	PROPN
ghmj-1044	250	9	,	,	PUNCT
ghmj-1044	250	10	m.	m.	NOUN
ghmj-1044	250	11	l.	l.	PROPN
ghmj-1044	250	12	(	(	PUNCT
ghmj-1044	250	13	2021	2021	NUM
ghmj-1044	250	14	)	)	PUNCT
ghmj-1044	250	15	.	.	PUNCT
ghmj-1044	251	1	kumar	kumar	PROPN
ghmj-1044	251	2	and	and	CCONJ
ghmj-1044	251	3	clark	clark	PROPN
ghmj-1044	251	4	’s	’s	PART
ghmj-1044	251	5	clinical	clinical	ADJ
ghmj-1044	251	6	medicine	medicine	NOUN
ghmj-1044	251	7	(	(	PUNCT
ghmj-1044	251	8	10th	10th	ADJ
ghmj-1044	251	9	ed	ed	NOUN
ghmj-1044	251	10	;	;	PUNCT
ghmj-1044	251	11	a.	a.	NOUN
ghmj-1044	251	12	feather	feather	PROPN
ghmj-1044	251	13	,	,	PUNCT
ghmj-1044	251	14	d.	d.	PROPN
ghmj-1044	251	15	randall	randall	PROPN
ghmj-1044	251	16	,	,	PUNCT
ghmj-1044	251	17	&	&	CCONJ
ghmj-1044	251	18	m.	m.	PROPN
ghmj-1044	251	19	waterhouse	waterhouse	PROPN
ghmj-1044	251	20	,	,	PUNCT
ghmj-1044	251	21	eds	ed	NOUN
ghmj-1044	251	22	.	.	PUNCT
ghmj-1044	251	23	)	)	PUNCT
ghmj-1044	251	24	.	.	PUNCT
ghmj-1044	252	1	united	united	PROPN
ghmj-1044	252	2	kingdom	kingdom	PROPN
ghmj-1044	252	3	:	:	PUNCT
ghmj-1044	252	4	elsevier	elsevier	NOUN
ghmj-1044	252	5	.	.	PUNCT
ghmj-1044	253	1	liu	liu	PROPN
ghmj-1044	253	2	,	,	PUNCT
ghmj-1044	253	3	m.	m.	NOUN
ghmj-1044	253	4	,	,	PUNCT
ghmj-1044	253	5	yi	yi	PROPN
ghmj-1044	253	6	,	,	PUNCT
ghmj-1044	253	7	j.	j.	PROPN
ghmj-1044	253	8	,	,	PUNCT
ghmj-1044	253	9	&	&	CCONJ
ghmj-1044	253	10	tang	tang	PROPN
ghmj-1044	253	11	,	,	PUNCT
ghmj-1044	253	12	w.	w.	NOUN
ghmj-1044	253	13	(	(	PUNCT
ghmj-1044	253	14	2021	2021	NUM
ghmj-1044	253	15	)	)	PUNCT
ghmj-1044	253	16	.	.	PUNCT
ghmj-1044	254	1	association	association	NOUN
ghmj-1044	254	2	between	between	ADP
ghmj-1044	254	3	angiotensin	angiotensin	NOUN
ghmj-1044	254	4	converting	convert	VERB
ghmj-1044	254	5	enzyme	enzyme	NOUN
ghmj-1044	254	6	gene	gene	NOUN
ghmj-1044	254	7	polymorphism	polymorphism	NOUN
ghmj-1044	254	8	and	and	CCONJ
ghmj-1044	254	9	essential	essential	ADJ
ghmj-1044	254	10	hypertension	hypertension	NOUN
ghmj-1044	254	11	:	:	PUNCT
ghmj-1044	254	12	a	a	DET
ghmj-1044	254	13	systematic	systematic	ADJ
ghmj-1044	254	14	review	review	NOUN
ghmj-1044	254	15	and	and	CCONJ
ghmj-1044	254	16	meta	meta	ADJ
ghmj-1044	254	17	-	-	PUNCT
ghmj-1044	254	18	analysis	analysis	NOUN
ghmj-1044	254	19	.	.	PUNCT
ghmj-1044	255	1	jraas	jraas	ADJ
ghmj-1044	255	2	journal	journal	NOUN
ghmj-1044	255	3	of	of	ADP
ghmj-1044	255	4	the	the	DET
ghmj-1044	255	5	renin	renin	ADJ
ghmj-1044	255	6	-	-	PUNCT
ghmj-1044	255	7	angiotensin	angiotensin	NOUN
ghmj-1044	255	8	-	-	PUNCT
ghmj-1044	255	9	aldosterone	aldosterone	NOUN
ghmj-1044	255	10	system	system	NOUN
ghmj-1044	255	11	,	,	PUNCT
ghmj-1044	255	12	22(1	22(1	NUM
ghmj-1044	255	13	)	)	PUNCT
ghmj-1044	255	14	.	.	PUNCT
ghmj-1044	256	1	https://doi.org/10.1177/1470320321995074	https://doi.org/10.1177/1470320321995074	PROPN
ghmj-1044	256	2	martínez	martínez	PROPN
ghmj-1044	256	3	,	,	PUNCT
ghmj-1044	256	4	e.	e.	PROPN
ghmj-1044	256	5	,	,	PUNCT
ghmj-1044	256	6	puras	puras	PROPN
ghmj-1044	256	7	,	,	PUNCT
ghmj-1044	256	8	a.	a.	NOUN
ghmj-1044	256	9	,	,	PUNCT
ghmj-1044	256	10	escribano	escribano	PROPN
ghmj-1044	256	11	,	,	PUNCT
ghmj-1044	256	12	j.	j.	PROPN
ghmj-1044	256	13	,	,	PUNCT
ghmj-1044	256	14	sanchis	sanchis	PROPN
ghmj-1044	256	15	,	,	PUNCT
ghmj-1044	256	16	c.	c.	PROPN
ghmj-1044	256	17	,	,	PUNCT
ghmj-1044	256	18	carrión	carrión	PROPN
ghmj-1044	256	19	,	,	PUNCT
ghmj-1044	256	20	l.	l.	PROPN
ghmj-1044	256	21	,	,	PUNCT
ghmj-1044	256	22	artigao	artigao	ADJ
ghmj-1044	256	23	,	,	PUNCT
ghmj-1044	256	24	m.	m.	NOUN
ghmj-1044	256	25	,	,	PUNCT
ghmj-1044	256	26	…	…	PUNCT
ghmj-1044	256	27	fernández	fernández	PROPN
ghmj-1044	256	28	,	,	PUNCT
ghmj-1044	256	29	j.	j.	PROPN
ghmj-1044	256	30	a.	a.	PROPN
ghmj-1044	256	31	(	(	PUNCT
ghmj-1044	256	32	2000	2000	NUM
ghmj-1044	256	33	)	)	PUNCT
ghmj-1044	256	34	.	.	PUNCT
ghmj-1044	257	1	angiotensin	angiotensin	NOUN
ghmj-1044	257	2	-	-	PUNCT
ghmj-1044	257	3	converting	convert	VERB
ghmj-1044	257	4	enzyme	enzyme	NOUN
ghmj-1044	257	5	(	(	PUNCT
ghmj-1044	257	6	ace	ace	NOUN
ghmj-1044	257	7	)	)	PUNCT
ghmj-1044	257	8	gene	gene	NOUN
ghmj-1044	257	9	polymorphisms	polymorphism	NOUN
ghmj-1044	257	10	,	,	PUNCT
ghmj-1044	257	11	serum	serum	NOUN
ghmj-1044	257	12	ace	ace	NOUN
ghmj-1044	257	13	activity	activity	NOUN
ghmj-1044	257	14	and	and	CCONJ
ghmj-1044	257	15	blood	blood	NOUN
ghmj-1044	257	16	pressure	pressure	NOUN
ghmj-1044	257	17	in	in	ADP
ghmj-1044	257	18	a	a	DET
ghmj-1044	257	19	spanish	spanish	ADJ
ghmj-1044	257	20	-	-	PUNCT
ghmj-1044	257	21	mediterranean	mediterranean	ADJ
ghmj-1044	257	22	population	population	NOUN
ghmj-1044	257	23	.	.	PUNCT
ghmj-1044	258	1	journal	journal	PROPN
ghmj-1044	258	2	of	of	ADP
ghmj-1044	258	3	human	human	ADJ
ghmj-1044	258	4	hypertension	hypertension	NOUN
ghmj-1044	258	5	,	,	PUNCT
ghmj-1044	258	6	14(2	14(2	NUM
ghmj-1044	258	7	)	)	PUNCT
ghmj-1044	258	8	,	,	PUNCT
ghmj-1044	258	9	131–135	131–135	NUM
ghmj-1044	258	10	.	.	PUNCT
ghmj-1044	259	1	https://doi.org/10.1038/sj.jhh.1000958	https://doi.org/10.1038/sj.jhh.1000958	PROPN
ghmj-1044	259	2	moreira	moreira	PROPN
ghmj-1044	259	3	,	,	PUNCT
ghmj-1044	259	4	s.	s.	PROPN
ghmj-1044	259	5	r.	r.	PROPN
ghmj-1044	259	6	,	,	PUNCT
ghmj-1044	259	7	nóbrega	nóbrega	PROPN
ghmj-1044	259	8	,	,	PUNCT
ghmj-1044	259	9	o.	o.	PROPN
ghmj-1044	259	10	t.	t.	PROPN
ghmj-1044	259	11	,	,	PUNCT
ghmj-1044	259	12	santana	santana	PROPN
ghmj-1044	259	13	,	,	PUNCT
ghmj-1044	259	14	h.	h.	PROPN
ghmj-1044	259	15	a.	a.	PROPN
ghmj-1044	259	16	p.	p.	PROPN
ghmj-1044	259	17	,	,	PUNCT
ghmj-1044	259	18	sales	sale	NOUN
ghmj-1044	259	19	,	,	PUNCT
ghmj-1044	259	20	m.	m.	NOUN
ghmj-1044	259	21	m.	m.	NOUN
ghmj-1044	259	22	,	,	PUNCT
ghmj-1044	259	23	farinatti	farinatti	NOUN
ghmj-1044	259	24	,	,	PUNCT
ghmj-1044	259	25	p.	p.	NOUN
ghmj-1044	259	26	t.	t.	PROPN
ghmj-1044	260	1	v.	v.	PROPN
ghmj-1044	260	2	,	,	PUNCT
ghmj-1044	260	3	&	&	CCONJ
ghmj-1044	260	4	simões	simões	PROPN
ghmj-1044	260	5	,	,	PUNCT
ghmj-1044	260	6	h.	h.	PROPN
ghmj-1044	260	7	g.	g.	PROPN
ghmj-1044	260	8	(	(	PUNCT
ghmj-1044	260	9	2018	2018	NUM
ghmj-1044	260	10	)	)	PUNCT
ghmj-1044	260	11	.	.	PUNCT
ghmj-1044	261	1	impacto	impacto	PROPN
ghmj-1044	261	2	del	del	PROPN
ghmj-1044	261	3	polimorfismo	polimorfismo	PROPN
ghmj-1044	262	1	i	i	PRON
ghmj-1044	262	2	/	/	SYM
ghmj-1044	262	3	d	d	PROPN
ghmj-1044	262	4	del	del	X
ghmj-1044	262	5	gen	gen	PROPN
ghmj-1044	262	6	de	de	PROPN
ghmj-1044	262	7	la	la	PROPN
ghmj-1044	262	8	enzima	enzima	PROPN
ghmj-1044	262	9	conversora	conversora	PROPN
ghmj-1044	262	10	de	de	PROPN
ghmj-1044	262	11	la	la	X
ghmj-1044	262	12	angiotensina	angiotensina	X
ghmj-1044	262	13	en	en	PROPN
ghmj-1044	262	14	la	la	PROPN
ghmj-1044	262	15	presión	presión	PROPN
ghmj-1044	262	16	sanguínea	sanguínea	PROPN
ghmj-1044	262	17	,	,	PUNCT
ghmj-1044	262	18	variacion	variacion	NOUN
ghmj-1044	262	19	de	de	X
ghmj-1044	262	20	la	la	PROPN
ghmj-1044	262	21	frecuencia	frecuencia	PROPN
ghmj-1044	262	22	cardíaca	cardíaca	PROPN
ghmj-1044	262	23	y	y	PROPN
ghmj-1044	262	24	óxido	óxido	VERB
ghmj-1044	262	25	nítrico	nítrico	NOUN
ghmj-1044	262	26	en	en	ADP
ghmj-1044	262	27	respuesta	respuesta	PROPN
ghmj-1044	262	28	a	a	DET
ghmj-1044	262	29	ejercicios	ejercicio	NOUN
ghmj-1044	262	30	aeróbicos	aeróbicos	PROPN
ghmj-1044	262	31	en	en	PROPN
ghmj-1044	262	32	mayores	mayores	PROPN
ghmj-1044	262	33	hipertensos	hipertensos	PROPN
ghmj-1044	262	34	.	.	PUNCT
ghmj-1044	263	1	revista	revista	PROPN
ghmj-1044	263	2	andaluza	andaluza	PROPN
ghmj-1044	263	3	de	de	PROPN
ghmj-1044	263	4	medicina	medicina	PROPN
ghmj-1044	263	5	del	del	PROPN
ghmj-1044	263	6	deporte	deporte	PROPN
ghmj-1044	263	7	,	,	PUNCT
ghmj-1044	263	8	11(2	11(2	NUM
ghmj-1044	263	9	)	)	PUNCT
ghmj-1044	263	10	,	,	PUNCT
ghmj-1044	263	11	57	57	NUM
ghmj-1044	263	12	–	–	PUNCT
ghmj-1044	263	13	62	62	NUM
ghmj-1044	263	14	.	.	PUNCT
ghmj-1044	264	1	https://doi.org/10.1016/j.ramd.2015.10.001	https://doi.org/10.1016/j.ramd.2015.10.001	VERB
ghmj-1044	264	2	mufaidah	mufaidah	PROPN
ghmj-1044	264	3	,	,	PUNCT
ghmj-1044	264	4	s.	s.	PROPN
ghmj-1044	264	5	(	(	PUNCT
ghmj-1044	264	6	2019	2019	NUM
ghmj-1044	264	7	)	)	PUNCT
ghmj-1044	264	8	.	.	PUNCT
ghmj-1044	265	1	hubungan	hubungan	PROPN
ghmj-1044	265	2	imt	imt	PROPN
ghmj-1044	265	3	,	,	PUNCT
ghmj-1044	265	4	usia	usia	PROPN
ghmj-1044	265	5	dan	dan	PROPN
ghmj-1044	265	6	kebiasaan	kebiasaan	PROPN
ghmj-1044	265	7	merokok	merokok	PROPN
ghmj-1044	265	8	terhadap	terhadap	PROPN
ghmj-1044	265	9	kejadian	kejadian	PROPN
ghmj-1044	265	10	hipertensi	hipertensi	PROPN
ghmj-1044	265	11	pada	pada	PROPN
ghmj-1044	265	12	nelayan	nelayan	PROPN
ghmj-1044	265	13	kub	kub	PROPN
ghmj-1044	265	14	pondok	pondok	PROPN
ghmj-1044	265	15	layar	layar	PROPN
ghmj-1044	265	16	.	.	PUNCT
ghmj-1044	266	1	journal	journal	PROPN
ghmj-1044	266	2	of	of	ADP
ghmj-1044	266	3	community	community	NOUN
ghmj-1044	266	4	mental	mental	ADJ
ghmj-1044	266	5	health	health	NOUN
ghmj-1044	266	6	and	and	CCONJ
ghmj-1044	266	7	public	public	ADJ
ghmj-1044	266	8	policy	policy	NOUN
ghmj-1044	266	9	,	,	PUNCT
ghmj-1044	266	10	1(2	1(2	NUM
ghmj-1044	266	11	)	)	PUNCT
ghmj-1044	266	12	,	,	PUNCT
ghmj-1044	266	13	1–12	1–12	NOUN
ghmj-1044	266	14	.	.	PUNCT
ghmj-1044	267	1	https://doi.org/10.51602/cmhp.v1i2.29	https://doi.org/10.51602/cmhp.v1i2.29	PROPN
ghmj-1044	267	2	muhadi	muhadi	PROPN
ghmj-1044	267	3	.	.	PUNCT
ghmj-1044	268	1	(	(	PUNCT
ghmj-1044	268	2	2016	2016	NUM
ghmj-1044	268	3	)	)	PUNCT
ghmj-1044	268	4	.	.	PUNCT
ghmj-1044	269	1	jnc	jnc	PROPN
ghmj-1044	269	2	8	8	NUM
ghmj-1044	269	3	 	 	SPACE
ghmj-1044	269	4	:	:	PUNCT
ghmj-1044	269	5	evidence	evidence	NOUN
ghmj-1044	269	6	-	-	PUNCT
ghmj-1044	269	7	based	base	VERB
ghmj-1044	269	8	guideline	guideline	NOUN
ghmj-1044	269	9	penanganan	penanganan	PROPN
ghmj-1044	269	10	pasien	pasien	PROPN
ghmj-1044	269	11	hipertensi	hipertensi	PROPN
ghmj-1044	269	12	dewasa	dewasa	PROPN
ghmj-1044	269	13	.	.	PUNCT
ghmj-1044	270	1	cermin	cermin	PROPN
ghmj-1044	270	2	dunia	dunia	PROPN
ghmj-1044	270	3	kedokteran	kedokteran	PROPN
ghmj-1044	270	4	,	,	PUNCT
ghmj-1044	270	5	43(1	43(1	NOUN
ghmj-1044	270	6	)	)	PUNCT
ghmj-1044	270	7	,	,	PUNCT
ghmj-1044	270	8	54	54	NUM
ghmj-1044	270	9	–	–	SYM
ghmj-1044	270	10	59	59	NUM
ghmj-1044	270	11	.	.	PUNCT
ghmj-1044	270	12	ned	ned	PROPN
ghmj-1044	270	13	,	,	PUNCT
ghmj-1044	270	14	r.	r.	PROPN
ghmj-1044	270	15	m.	m.	PROPN
ghmj-1044	270	16	,	,	PUNCT
ghmj-1044	270	17	yesupriya	yesupriya	PROPN
ghmj-1044	270	18	,	,	PUNCT
ghmj-1044	270	19	a.	a.	PROPN
ghmj-1044	270	20	,	,	PUNCT
ghmj-1044	270	21	imperatore	imperatore	PROPN
ghmj-1044	270	22	,	,	PUNCT
ghmj-1044	270	23	g.	g.	PROPN
ghmj-1044	270	24	,	,	PUNCT
ghmj-1044	270	25	smelser	smelser	PROPN
ghmj-1044	270	26	,	,	PUNCT
ghmj-1044	270	27	d.	d.	PROPN
ghmj-1044	270	28	t.	t.	PROPN
ghmj-1044	270	29	,	,	PUNCT
ghmj-1044	270	30	moonesinghe	moonesinghe	PROPN
ghmj-1044	270	31	,	,	PUNCT
ghmj-1044	270	32	r.	r.	PROPN
ghmj-1044	270	33	,	,	PUNCT
ghmj-1044	270	34	chang	chang	PROPN
ghmj-1044	270	35	,	,	PUNCT
ghmj-1044	270	36	m.	m.	PROPN
ghmj-1044	270	37	h.	h.	PROPN
ghmj-1044	270	38	,	,	PUNCT
ghmj-1044	270	39	&	&	CCONJ
ghmj-1044	270	40	dowling	dowling	PROPN
ghmj-1044	270	41	,	,	PUNCT
ghmj-1044	270	42	n.	n.	PROPN
ghmj-1044	270	43	f.	f.	PROPN
ghmj-1044	270	44	(	(	PUNCT
ghmj-1044	270	45	2012	2012	NUM
ghmj-1044	270	46	)	)	PUNCT
ghmj-1044	270	47	.	.	PUNCT
ghmj-1044	271	1	the	the	DET
ghmj-1044	271	2	ace	ace	NOUN
ghmj-1044	271	3	i	i	PROPN
ghmj-1044	271	4	/	/	SYM
ghmj-1044	271	5	d	d	NOUN
ghmj-1044	271	6	polymorphism	polymorphism	NOUN
ghmj-1044	271	7	in	in	ADP
ghmj-1044	271	8	us	us	PROPN
ghmj-1044	271	9	adults	adult	NOUN
ghmj-1044	271	10	:	:	PUNCT
ghmj-1044	271	11	limited	limited	ADJ
ghmj-1044	271	12	evidence	evidence	NOUN
ghmj-1044	271	13	of	of	ADP
ghmj-1044	271	14	association	association	NOUN
ghmj-1044	271	15	with	with	ADP
ghmj-1044	271	16	hypertension	hypertension	NOUN
ghmj-1044	271	17	-	-	PUNCT
ghmj-1044	271	18	related	relate	VERB
ghmj-1044	271	19	traits	trait	NOUN
ghmj-1044	271	20	and	and	CCONJ
ghmj-1044	271	21	sex	sex	NOUN
ghmj-1044	271	22	-	-	PUNCT
ghmj-1044	271	23	specific	specific	ADJ
ghmj-1044	271	24	effects	effect	NOUN
ghmj-1044	271	25	by	by	ADP
ghmj-1044	271	26	race	race	NOUN
ghmj-1044	271	27	/	/	SYM
ghmj-1044	271	28	ethnicity	ethnicity	NOUN
ghmj-1044	271	29	.	.	PUNCT
ghmj-1044	272	1	american	american	PROPN
ghmj-1044	272	2	journal	journal	PROPN
ghmj-1044	272	3	of	of	ADP
ghmj-1044	272	4	hypertension	hypertension	NOUN
ghmj-1044	272	5	,	,	PUNCT
ghmj-1044	272	6	25(2	25(2	NUM
ghmj-1044	272	7	)	)	PUNCT
ghmj-1044	272	8	,	,	PUNCT
ghmj-1044	272	9	209–215	209–215	NUM
ghmj-1044	272	10	.	.	PUNCT
ghmj-1044	272	11	https://doi.org/10.1038/ajh.2011.182	https://doi.org/10.1038/ajh.2011.182	PROPN
ghmj-1044	272	12	qadar	qadar	PROPN
ghmj-1044	272	13	pasha	pasha	PROPN
ghmj-1044	272	14	,	,	PUNCT
ghmj-1044	272	15	m.	m.	NOUN
ghmj-1044	272	16	a.	a.	PROPN
ghmj-1044	272	17	,	,	PUNCT
ghmj-1044	272	18	khan	khan	PROPN
ghmj-1044	272	19	,	,	PUNCT
ghmj-1044	272	20	a.	a.	PROPN
ghmj-1044	272	21	p.	p.	PROPN
ghmj-1044	272	22	,	,	PUNCT
ghmj-1044	272	23	kumar	kumar	PROPN
ghmj-1044	272	24	,	,	PUNCT
ghmj-1044	272	25	r.	r.	PROPN
ghmj-1044	272	26	,	,	PUNCT
ghmj-1044	272	27	ram	ram	PROPN
ghmj-1044	272	28	,	,	PUNCT
ghmj-1044	272	29	r.	r.	PROPN
ghmj-1044	272	30	b.	b.	PROPN
ghmj-1044	272	31	,	,	PUNCT
ghmj-1044	272	32	grover	grover	PROPN
ghmj-1044	272	33	,	,	PUNCT
ghmj-1044	272	34	s.	s.	PROPN
ghmj-1044	272	35	k.	k.	PROPN
ghmj-1044	272	36	,	,	PUNCT
ghmj-1044	272	37	srivastava	srivastava	PROPN
ghmj-1044	272	38	,	,	PUNCT
ghmj-1044	272	39	k.	k.	PROPN
ghmj-1044	272	40	k.	k.	PROPN
ghmj-1044	272	41	,	,	PUNCT
ghmj-1044	272	42	…	…	PUNCT
ghmj-1044	272	43	brahmachari	brahmachari	X
ghmj-1044	272	44	,	,	PUNCT
ghmj-1044	272	45	s.	s.	PROPN
ghmj-1044	272	46	k.	k.	PROPN
ghmj-1044	272	47	(	(	PUNCT
ghmj-1044	272	48	2002	2002	NUM
ghmj-1044	272	49	)	)	PUNCT
ghmj-1044	272	50	.	.	PUNCT
ghmj-1044	273	1	variations	variation	NOUN
ghmj-1044	273	2	in	in	ADP
ghmj-1044	273	3	angiotensin	angiotensin	NOUN
ghmj-1044	273	4	-	-	PUNCT
ghmj-1044	273	5	converting	convert	VERB
ghmj-1044	273	6	enzyme	enzyme	NOUN
ghmj-1044	273	7	gene	gene	NOUN
ghmj-1044	273	8	insertion	insertion	NOUN
ghmj-1044	273	9	/	/	SYM
ghmj-1044	273	10	deletion	deletion	NOUN
ghmj-1044	273	11	polymorphism	polymorphism	NOUN
ghmj-1044	273	12	in	in	ADP
ghmj-1044	273	13	indian	indian	ADJ
ghmj-1044	273	14	populations	population	NOUN
ghmj-1044	273	15	of	of	ADP
ghmj-1044	273	16	different	different	ADJ
ghmj-1044	273	17	ethnic	ethnic	ADJ
ghmj-1044	273	18	origins	origin	NOUN
ghmj-1044	273	19	.	.	PUNCT
ghmj-1044	274	1	journal	journal	PROPN
ghmj-1044	274	2	of	of	ADP
ghmj-1044	274	3	biosciences	bioscience	NOUN
ghmj-1044	274	4	,	,	PUNCT
ghmj-1044	274	5	27(1	27(1	NUM
ghmj-1044	274	6	suppl	suppl	ADJ
ghmj-1044	274	7	.	.	PROPN
ghmj-1044	274	8	1	1	NUM
ghmj-1044	274	9	)	)	PUNCT
ghmj-1044	274	10	,	,	PUNCT
ghmj-1044	274	11	67–70	67–70	NUM
ghmj-1044	274	12	.	.	PUNCT
ghmj-1044	275	1	https://doi.org/10.1007/bf02703684	https://doi.org/10.1007/bf02703684	PROPN
ghmj-1044	275	2	rahmadhani	rahmadhani	ADJ
ghmj-1044	275	3	,	,	PUNCT
ghmj-1044	275	4	m.	m.	NOUN
ghmj-1044	275	5	(	(	PUNCT
ghmj-1044	275	6	2021	2021	NUM
ghmj-1044	275	7	)	)	PUNCT
ghmj-1044	275	8	.	.	PUNCT
ghmj-1044	276	1	faktor	faktor	NOUN
ghmj-1044	276	2	-	-	PUNCT
ghmj-1044	276	3	faktor	faktor	PROPN
ghmj-1044	276	4	yang	yang	PROPN
ghmj-1044	276	5	mempengaruhi	mempengaruhi	PROPN
ghmj-1044	276	6	terjadinya	terjadinya	PROPN
ghmj-1044	276	7	hipertensi	hipertensi	PROPN
ghmj-1044	276	8	pada	pada	PROPN
ghmj-1044	276	9	masyarakat	masyarakat	PROPN
ghmj-1044	276	10	di	di	PROPN
ghmj-1044	276	11	kampung	kampung	PROPN
ghmj-1044	276	12	bedagai	bedagai	PROPN
ghmj-1044	276	13	kota	kota	PROPN
ghmj-1044	276	14	pinang	pinang	PROPN
ghmj-1044	276	15	.	.	PUNCT
ghmj-1044	277	1	jurnal	jurnal	PROPN
ghmj-1044	277	2	kedokteran	kedokteran	PROPN
ghmj-1044	277	3	stm	stm	PROPN
ghmj-1044	277	4	(	(	PUNCT
ghmj-1044	277	5	sains	sains	PROPN
ghmj-1044	277	6	dan	dan	PROPN
ghmj-1044	277	7	teknologi	teknologi	PROPN
ghmj-1044	277	8	medik	medik	PROPN
ghmj-1044	277	9	)	)	PUNCT
ghmj-1044	277	10	,	,	PUNCT
ghmj-1044	277	11	iv(i	iv(i	NUM
ghmj-1044	277	12	)	)	PUNCT
ghmj-1044	277	13	,	,	PUNCT
ghmj-1044	277	14	52–62	52–62	NUM
ghmj-1044	277	15	.	.	PUNCT
ghmj-1044	278	1	https://doi.org/10.30743/stm.v4i1.132	https://doi.org/10.30743/stm.v4i1.132	PROPN
ghmj-1044	278	2	rasyid	rasyid	NOUN
ghmj-1044	278	3	,	,	PUNCT
ghmj-1044	278	4	h.	h.	PROPN
ghmj-1044	278	5	,	,	PUNCT
ghmj-1044	278	6	bakri	bakri	PROPN
ghmj-1044	278	7	,	,	PUNCT
ghmj-1044	278	8	s.	s.	PROPN
ghmj-1044	278	9	,	,	PUNCT
ghmj-1044	278	10	&	&	CCONJ
ghmj-1044	278	11	yusuf	yusuf	PROPN
ghmj-1044	278	12	,	,	PUNCT
ghmj-1044	278	13	i.	i.	PROPN
ghmj-1044	278	14	(	(	PUNCT
ghmj-1044	278	15	2012	2012	NUM
ghmj-1044	278	16	)	)	PUNCT
ghmj-1044	278	17	.	.	PUNCT
ghmj-1044	279	1	angiotensin	angiotensin	NOUN
ghmj-1044	279	2	-	-	PUNCT
ghmj-1044	279	3	converting	convert	VERB
ghmj-1044	279	4	enzyme	enzyme	NOUN
ghmj-1044	279	5	gene	gene	NOUN
ghmj-1044	279	6	polymorphisms	polymorphism	NOUN
ghmj-1044	279	7	,	,	PUNCT
ghmj-1044	279	8	blood	blood	NOUN
ghmj-1044	279	9	pressure	pressure	NOUN
ghmj-1044	279	10	and	and	CCONJ
ghmj-1044	279	11	pulse	pulse	NOUN
ghmj-1044	279	12	pressure	pressure	NOUN
ghmj-1044	279	13	in	in	ADP
ghmj-1044	279	14	subjects	subject	NOUN
ghmj-1044	279	15	with	with	ADP
ghmj-1044	279	16	essential	essential	ADJ
ghmj-1044	279	17	hypertension	hypertension	NOUN
ghmj-1044	279	18	in	in	ADP
ghmj-1044	279	19	a	a	DET
ghmj-1044	279	20	south	south	ADJ
ghmj-1044	279	21	sulawesi	sulawesi	PROPN
ghmj-1044	279	22	indonesian	indonesian	ADJ
ghmj-1044	279	23	population	population	PROPN
ghmj-1044	279	24	.	.	PUNCT
ghmj-1044	280	1	acta	acta	PROPN
ghmj-1044	280	2	medica	medica	PROPN
ghmj-1044	280	3	indonesiana	indonesiana	PROPN
ghmj-1044	280	4	,	,	PUNCT
ghmj-1044	280	5	44(4	44(4	NOUN
ghmj-1044	280	6	)	)	PUNCT
ghmj-1044	280	7	,	,	PUNCT
ghmj-1044	280	8	280–283	280–283	NUM
ghmj-1044	280	9	.	.	PUNCT
ghmj-1044	281	1	rezqi	rezqi	PROPN
ghmj-1044	281	2	,	,	PUNCT
ghmj-1044	281	3	e.	e.	PROPN
ghmj-1044	281	4	g.	g.	PROPN
ghmj-1044	281	5	,	,	PUNCT
ghmj-1044	281	6	fathana	fathana	PROPN
ghmj-1044	281	7	,	,	PUNCT
ghmj-1044	281	8	p.	p.	PROPN
ghmj-1044	281	9	b.	b.	PROPN
ghmj-1044	281	10	,	,	PUNCT
ghmj-1044	281	11	&	&	CCONJ
ghmj-1044	281	12	dirja	dirja	PROPN
ghmj-1044	281	13	,	,	PUNCT
ghmj-1044	281	14	b.	b.	PROPN
ghmj-1044	281	15	t.	t.	PROPN
ghmj-1044	281	16	(	(	PUNCT
ghmj-1044	281	17	2023	2023	NUM
ghmj-1044	281	18	)	)	PUNCT
ghmj-1044	281	19	.	.	PUNCT
ghmj-1044	282	1	hubungan	hubungan	ADJ
ghmj-1044	282	2	perilaku	perilaku	PROPN
ghmj-1044	282	3	merokok	merokok	PROPN
ghmj-1044	282	4	dan	dan	PROPN
ghmj-1044	282	5	obesitas	obesitas	PROPN
ghmj-1044	282	6	dengan	dengan	PROPN
ghmj-1044	282	7	kejadian	kejadian	PROPN
ghmj-1044	282	8	hipertensi	hipertensi	PROPN
ghmj-1044	282	9	pada	pada	PROPN
ghmj-1044	282	10	guru	guru	PROPN
ghmj-1044	282	11	sman	sman	PROPN
ghmj-1044	282	12	di	di	PROPN
ghmj-1044	282	13	kota	kota	PROPN
ghmj-1044	282	14	mataram	mataram	PROPN
ghmj-1044	282	15	.	.	PUNCT
ghmj-1044	283	1	intisari	intisari	PROPN
ghmj-1044	283	2	sains	sains	PROPN
ghmj-1044	283	3	medis	medis	PROPN
ghmj-1044	283	4	,	,	PUNCT
ghmj-1044	283	5	14(1	14(1	NUM
ghmj-1044	283	6	)	)	PUNCT
ghmj-1044	283	7	,	,	PUNCT
ghmj-1044	283	8	237–242	237–242	NUM
ghmj-1044	283	9	.	.	PUNCT
ghmj-1044	284	1	https://doi.org/10.15562/ism.v14i1.1569	https://doi.org/10.15562/ism.v14i1.1569	PROPN
ghmj-1044	284	2	sayed	say	VERB
ghmj-1044	284	3	-	-	PUNCT
ghmj-1044	284	4	tabatabaei	tabatabaei	NOUN
ghmj-1044	284	5	,	,	PUNCT
ghmj-1044	284	6	f.	f.	PROPN
ghmj-1044	284	7	a.	a.	PROPN
ghmj-1044	284	8	,	,	PUNCT
ghmj-1044	284	9	oostra	oostra	PROPN
ghmj-1044	284	10	,	,	PUNCT
ghmj-1044	284	11	b.	b.	PROPN
ghmj-1044	284	12	a.	a.	PROPN
ghmj-1044	284	13	,	,	PUNCT
ghmj-1044	284	14	isaacs	isaacs	PROPN
ghmj-1044	284	15	,	,	PUNCT
ghmj-1044	284	16	a.	a.	PROPN
ghmj-1044	284	17	,	,	PUNCT
ghmj-1044	284	18	duijn	duijn	PROPN
ghmj-1044	284	19	,	,	PUNCT
ghmj-1044	284	20	c.	c.	PROPN
ghmj-1044	284	21	m.	m.	PROPN
ghmj-1044	284	22	van	van	PROPN
ghmj-1044	284	23	,	,	PUNCT
ghmj-1044	284	24	&	&	CCONJ
ghmj-1044	284	25	witteman	witteman	PROPN
ghmj-1044	284	26	,	,	PUNCT
ghmj-1044	284	27	j.	j.	PROPN
ghmj-1044	284	28	c.	c.	PROPN
ghmj-1044	284	29	m.	m.	PROPN
ghmj-1044	284	30	(	(	PUNCT
ghmj-1044	284	31	2006	2006	NUM
ghmj-1044	284	32	)	)	PUNCT
ghmj-1044	284	33	.	.	PUNCT
ghmj-1044	285	1	ace	ace	PROPN
ghmj-1044	285	2	polymorphisms	polymorphism	NOUN
ghmj-1044	285	3	.	.	PUNCT
ghmj-1044	286	1	lippincott	lippincott	PROPN
ghmj-1044	286	2	williams	williams	PROPN
ghmj-1044	286	3	&	&	CCONJ
ghmj-1044	286	4	wilkins	wilkins	PROPN
ghmj-1044	286	5	,	,	PUNCT
ghmj-1044	286	6	1123–1133	1123–1133	NUM
ghmj-1044	286	7	.	.	PUNCT
ghmj-1044	287	1	https://doi.org/10.1161/01.res.0000223145.74217.e7	https://doi.org/10.1161/01.res.0000223145.74217.e7	PROPN
ghmj-1044	287	2	setiati	setiati	PROPN
ghmj-1044	287	3	,	,	PUNCT
ghmj-1044	287	4	s.	s.	PROPN
ghmj-1044	287	5	,	,	PUNCT
ghmj-1044	287	6	alwi	alwi	PROPN
ghmj-1044	287	7	,	,	PUNCT
ghmj-1044	287	8	i.	i.	NOUN
ghmj-1044	287	9	,	,	PUNCT
ghmj-1044	287	10	sudoyo	sudoyo	PROPN
ghmj-1044	287	11	,	,	PUNCT
ghmj-1044	287	12	a.	a.	PROPN
ghmj-1044	287	13	w.	w.	PROPN
ghmj-1044	287	14	,	,	PUNCT
ghmj-1044	287	15	simadibrata	simadibrata	PROPN
ghmj-1044	287	16	k	k	PROPN
ghmj-1044	287	17	,	,	PUNCT
ghmj-1044	287	18	m.	m.	NOUN
ghmj-1044	287	19	,	,	PUNCT
ghmj-1044	287	20	setiyohadi	setiyohadi	NOUN
ghmj-1044	287	21	,	,	PUNCT
ghmj-1044	287	22	b.	b.	PROPN
ghmj-1044	287	23	,	,	PUNCT
ghmj-1044	287	24	&	&	CCONJ
ghmj-1044	287	25	syam	syam	PROPN
ghmj-1044	287	26	,	,	PUNCT
ghmj-1044	287	27	a.	a.	PROPN
ghmj-1044	287	28	f.	f.	PROPN
ghmj-1044	287	29	(	(	PUNCT
ghmj-1044	287	30	2014	2014	NUM
ghmj-1044	287	31	)	)	PUNCT
ghmj-1044	287	32	.	.	PUNCT
ghmj-1044	288	1	buku	buku	PROPN
ghmj-1044	288	2	ajar	ajar	PROPN
ghmj-1044	288	3	ilmu	ilmu	PROPN
ghmj-1044	288	4	penyakit	penyakit	PROPN
ghmj-1044	288	5	dalam	dalam	PROPN
ghmj-1044	288	6	.	.	PUNCT
ghmj-1044	289	1	in	in	ADP
ghmj-1044	289	2	interna	interna	PROPN
ghmj-1044	289	3	publishing	publishing	PROPN
ghmj-1044	289	4	(	(	PUNCT
ghmj-1044	289	5	edisi	edisi	VERB
ghmj-1044	289	6	6	6	NUM
ghmj-1044	289	7	)	)	PUNCT
ghmj-1044	289	8	.	.	PUNCT
ghmj-1044	290	1	jakarta	jakarta	PROPN
ghmj-1044	290	2	:	:	PUNCT
ghmj-1044	290	3	interna	interna	PROPN
ghmj-1044	290	4	publishing	publishing	PROPN
ghmj-1044	290	5	.	.	PUNCT
ghmj-1044	291	1	starkova	starkova	PROPN
ghmj-1044	291	2	,	,	PUNCT
ghmj-1044	291	3	k.	k.	PROPN
ghmj-1044	291	4	g.	g.	PROPN
ghmj-1044	291	5	,	,	PUNCT
ghmj-1044	291	6	dolgikh	dolgikh	PROPN
ghmj-1044	291	7	,	,	PUNCT
ghmj-1044	291	8	о	о	PROPN
ghmj-1044	291	9	.	.	PUNCT
ghmj-1044	292	1	v.	v.	PROPN
ghmj-1044	292	2	,	,	PUNCT
ghmj-1044	292	3	kazakova	kazakova	PROPN
ghmj-1044	292	4	,	,	PUNCT
ghmj-1044	292	5	о	о	PROPN
ghmj-1044	292	6	.	.	PUNCT
ghmj-1044	293	1	а	а	PROPN
ghmj-1044	293	2	.	.	PROPN
ghmj-1044	293	3	,	,	PUNCT
ghmj-1044	293	4	&	&	CCONJ
ghmj-1044	293	5	legostaeva	legostaeva	PROPN
ghmj-1044	293	6	,	,	PUNCT
ghmj-1044	293	7	т	т	PROPN
ghmj-1044	293	8	.	.	PUNCT
ghmj-1044	293	9	а	а	PROPN
ghmj-1044	293	10	.	.	PUNCT
ghmj-1044	294	1	(	(	PUNCT
ghmj-1044	294	2	2022	2022	NUM
ghmj-1044	294	3	)	)	PUNCT
ghmj-1044	294	4	.	.	PUNCT
ghmj-1044	295	1	ace	ace	VERB
ghmj-1044	295	2	i	i	PRON
ghmj-1044	295	3	/	/	SYM
ghmj-1044	295	4	d	d	PROPN
ghmj-1044	295	5	genetic	genetic	ADJ
ghmj-1044	295	6	polymorphism	polymorphism	NOUN
ghmj-1044	295	7	as	as	ADP
ghmj-1044	295	8	a	a	DET
ghmj-1044	295	9	risk	risk	NOUN
ghmj-1044	295	10	factor	factor	NOUN
ghmj-1044	295	11	of	of	ADP
ghmj-1044	295	12	essential	essential	ADJ
ghmj-1044	295	13	hypertension	hypertension	NOUN
ghmj-1044	295	14	.	.	PUNCT
ghmj-1044	296	1	health	health	NOUN
ghmj-1044	296	2	risk	risk	NOUN
ghmj-1044	296	3	analysis	analysis	NOUN
ghmj-1044	296	4	,	,	PUNCT
ghmj-1044	296	5	7(3	7(3	NUM
ghmj-1044	296	6	)	)	PUNCT
ghmj-1044	296	7	,	,	PUNCT
ghmj-1044	296	8	169–175	169–175	NUM
ghmj-1044	296	9	.	.	PUNCT
ghmj-1044	297	1	https://doi.org/10.21668/health.risk/2022.3.16.eng	https://doi.org/10.21668/health.risk/2022.3.16.eng	X
ghmj-1044	297	2	sudayasa	sudayasa	PROPN
ghmj-1044	297	3	,	,	PUNCT
ghmj-1044	297	4	i.	i.	PROPN
ghmj-1044	297	5	p.	p.	PROPN
ghmj-1044	297	6	,	,	PUNCT
ghmj-1044	297	7	husdaningsih	husdaningsih	PROPN
ghmj-1044	297	8	,	,	PUNCT
ghmj-1044	297	9	f.	f.	PROPN
ghmj-1044	297	10	,	,	PUNCT
ghmj-1044	297	11	&	&	CCONJ
ghmj-1044	297	12	alifariki	alifariki	PROPN
ghmj-1044	297	13	,	,	PUNCT
ghmj-1044	297	14	l.	l.	PROPN
ghmj-1044	297	15	o.	o.	PROPN
ghmj-1044	297	16	(	(	PUNCT
ghmj-1044	297	17	2023	2023	NUM
ghmj-1044	297	18	)	)	PUNCT
ghmj-1044	297	19	.	.	PUNCT
ghmj-1044	298	1	polymorphism	polymorphism	NOUN
ghmj-1044	298	2	of	of	ADP
ghmj-1044	298	3	gene	gene	NOUN
ghmj-1044	298	4	ace	ace	NOUN
ghmj-1044	299	1	i	i	PROPN
ghmj-1044	299	2	/	/	SYM
ghmj-1044	299	3	d	d	PROPN
ghmj-1044	299	4	and	and	CCONJ
ghmj-1044	299	5	family	family	NOUN
ghmj-1044	299	6	history	history	NOUN
ghmj-1044	299	7	of	of	ADP
ghmj-1044	299	8	hypertension	hypertension	NOUN
ghmj-1044	299	9	as	as	ADP
ghmj-1044	299	10	the	the	DET
ghmj-1044	299	11	predisposition	predisposition	NOUN
ghmj-1044	299	12	of	of	ADP
ghmj-1044	299	13	hypertension	hypertension	NOUN
ghmj-1044	299	14	.	.	PUNCT
ghmj-1044	300	1	malaysian	malaysian	ADJ
ghmj-1044	300	2	journal	journal	PROPN
ghmj-1044	300	3	of	of	ADP
ghmj-1044	300	4	medicine	medicine	NOUN
ghmj-1044	300	5	and	and	CCONJ
ghmj-1044	300	6	health	health	NOUN
ghmj-1044	300	7	sciences	science	NOUN
ghmj-1044	300	8	,	,	PUNCT
ghmj-1044	300	9	18(2	18(2	NUM
ghmj-1044	300	10	)	)	PUNCT
ghmj-1044	300	11	,	,	PUNCT
ghmj-1044	300	12	236–241	236–241	NUM
ghmj-1044	300	13	.	.	PUNCT
ghmj-1044	301	1	https://doi.org/10.47836/mjmhs.19.2.34	https://doi.org/10.47836/mjmhs.19.2.34	PROPN
ghmj-1044	301	2	tchelougou	tchelougou	PROPN
ghmj-1044	301	3	,	,	PUNCT
ghmj-1044	301	4	d.	d.	PROPN
ghmj-1044	301	5	,	,	PUNCT
ghmj-1044	301	6	kologo	kologo	PROPN
ghmj-1044	301	7	,	,	PUNCT
ghmj-1044	301	8	j.	j.	PROPN
ghmj-1044	301	9	k.	k.	PROPN
ghmj-1044	301	10	,	,	PUNCT
ghmj-1044	301	11	karou	karou	PROPN
ghmj-1044	301	12	,	,	PUNCT
ghmj-1044	301	13	s.	s.	PROPN
ghmj-1044	301	14	d.	d.	PROPN
ghmj-1044	301	15	,	,	PUNCT
ghmj-1044	301	16	yaméogo	yaméogo	PROPN
ghmj-1044	301	17	,	,	PUNCT
ghmj-1044	301	18	v.	v.	ADP
ghmj-1044	301	19	n.	n.	NOUN
ghmj-1044	301	20	,	,	PUNCT
ghmj-1044	301	21	bisseye	bisseye	NOUN
ghmj-1044	301	22	,	,	PUNCT
ghmj-1044	301	23	c.	c.	PROPN
ghmj-1044	301	24	,	,	PUNCT
ghmj-1044	301	25	djigma	djigma	PROPN
ghmj-1044	301	26	,	,	PUNCT
ghmj-1044	301	27	f.	f.	PROPN
ghmj-1044	301	28	w.	w.	PROPN
ghmj-1044	301	29	,	,	PUNCT
ghmj-1044	301	30	…	…	PUNCT
ghmj-1044	301	31	simpore	simpore	X
ghmj-1044	301	32	,	,	PUNCT
ghmj-1044	301	33	j.	j.	PROPN
ghmj-1044	301	34	(	(	PUNCT
ghmj-1044	301	35	2015	2015	NUM
ghmj-1044	301	36	)	)	PUNCT
ghmj-1044	301	37	.	.	PUNCT
ghmj-1044	302	1	renin	renin	ADJ
ghmj-1044	302	2	-	-	PUNCT
ghmj-1044	302	3	angiotensin	angiotensin	NOUN
ghmj-1044	302	4	system	system	NOUN
ghmj-1044	302	5	genes	gene	NOUN
ghmj-1044	302	6	polymorphisms	polymorphism	NOUN
ghmj-1044	302	7	and	and	CCONJ
ghmj-1044	302	8	essential	essential	ADJ
ghmj-1044	302	9	hypertension	hypertension	NOUN
ghmj-1044	302	10	in	in	ADP
ghmj-1044	302	11	burkina	burkina	PROPN
ghmj-1044	302	12	faso	faso	PROPN
ghmj-1044	302	13	,	,	PUNCT
ghmj-1044	302	14	west	west	PROPN
ghmj-1044	302	15	africa	africa	PROPN
ghmj-1044	302	16	.	.	PUNCT
ghmj-1044	303	1	international	international	ADJ
ghmj-1044	303	2	journal	journal	PROPN
ghmj-1044	303	3	of	of	ADP
ghmj-1044	303	4	hypertension	hypertension	NOUN
ghmj-1044	303	5	,	,	PUNCT
ghmj-1044	303	6	2015	2015	NUM
ghmj-1044	303	7	.	.	PUNCT
ghmj-1044	304	1	https://doi.org/10.1155/2015/979631	https://doi.org/10.1155/2015/979631	PROPN
ghmj-1044	304	2	tortora	tortora	PROPN
ghmj-1044	304	3	,	,	PUNCT
ghmj-1044	304	4	g.	g.	PROPN
ghmj-1044	304	5	j.	j.	PROPN
ghmj-1044	304	6	,	,	PUNCT
ghmj-1044	304	7	&	&	CCONJ
ghmj-1044	304	8	derrickson	derrickson	PROPN
ghmj-1044	304	9	,	,	PUNCT
ghmj-1044	304	10	b.	b.	PROPN
ghmj-1044	304	11	(	(	PUNCT
ghmj-1044	304	12	2014	2014	NUM
ghmj-1044	304	13	)	)	PUNCT
ghmj-1044	304	14	.	.	PUNCT
ghmj-1044	305	1	principles	principle	NOUN
ghmj-1044	305	2	of	of	ADP
ghmj-1044	305	3	anatomy	anatomy	NOUN
ghmj-1044	305	4	and	and	CCONJ
ghmj-1044	305	5	physiology	physiology	NOUN
ghmj-1044	305	6	.	.	PUNCT
ghmj-1044	306	1	in	in	ADP
ghmj-1044	306	2	physiotherapy	physiotherapy	NOUN
ghmj-1044	306	3	(	(	PUNCT
ghmj-1044	306	4	14th	14th	ADJ
ghmj-1044	306	5	ed	ed	NOUN
ghmj-1044	306	6	.	.	PUNCT
ghmj-1044	306	7	,	,	PUNCT
ghmj-1044	306	8	vol	vol	NOUN
ghmj-1044	306	9	.	.	PROPN
ghmj-1044	306	10	86	86	NUM
ghmj-1044	306	11	)	)	PUNCT
ghmj-1044	306	12	.	.	PUNCT
ghmj-1044	307	1	united	united	PROPN
ghmj-1044	307	2	states	states	PROPN
ghmj-1044	307	3	of	of	ADP
ghmj-1044	307	4	america	america	PROPN
ghmj-1044	307	5	:	:	PUNCT
ghmj-1044	307	6	john	john	PROPN
ghmj-1044	307	7	wiley	wiley	PROPN
ghmj-1044	307	8	&	&	CCONJ
ghmj-1044	307	9	sons	sons	PROPN
ghmj-1044	307	10	,	,	PUNCT
ghmj-1044	307	11	inc	inc	PROPN
ghmj-1044	307	12	.	.	PROPN
ghmj-1044	307	13	https://doi.org/10.1016/s0031-9406(05)60992-3	https://doi.org/10.1016/s0031-9406(05)60992-3	PROPN
ghmj-1044	307	14	utami	utami	PROPN
ghmj-1044	307	15	,	,	PUNCT
ghmj-1044	307	16	s.	s.	PROPN
ghmj-1044	307	17	l.	l.	PROPN
ghmj-1044	307	18	,	,	PUNCT
ghmj-1044	307	19	simamora	simamora	PROPN
ghmj-1044	307	20	,	,	PUNCT
ghmj-1044	307	21	d.	d.	PROPN
ghmj-1044	307	22	,	,	PUNCT
ghmj-1044	307	23	idawati	idawati	PROPN
ghmj-1044	307	24	,	,	PUNCT
ghmj-1044	307	25	i.	i.	PROPN
ghmj-1044	307	26	,	,	PUNCT
ghmj-1044	307	27	&	&	CCONJ
ghmj-1044	307	28	widjaja	widjaja	PROPN
ghmj-1044	307	29	,	,	PUNCT
ghmj-1044	307	30	j.	j.	PROPN
ghmj-1044	307	31	h.	h.	PROPN
ghmj-1044	307	32	(	(	PUNCT
ghmj-1044	307	33	2024	2024	NUM
ghmj-1044	307	34	)	)	PUNCT
ghmj-1044	307	35	.	.	PUNCT
ghmj-1044	308	1	ace	ace	VERB
ghmj-1044	308	2	i	i	PRON
ghmj-1044	308	3	/	/	SYM
ghmj-1044	308	4	d	d	PROPN
ghmj-1044	308	5	and	and	CCONJ
ghmj-1044	308	6	a2350	a2350	PROPN
ghmj-1044	308	7	g	g	NOUN
ghmj-1044	308	8	polymorphisms	polymorphism	NOUN
ghmj-1044	308	9	are	be	AUX
ghmj-1044	308	10	correlated	correlate	VERB
ghmj-1044	308	11	with	with	ADP
ghmj-1044	308	12	body	body	NOUN
ghmj-1044	308	13	mass	mass	PROPN
ghmj-1044	308	14	index	index	NOUN
ghmj-1044	308	15	,	,	PUNCT
ghmj-1044	308	16	but	but	CCONJ
ghmj-1044	308	17	not	not	PART
ghmj-1044	308	18	with	with	ADP
ghmj-1044	308	19	body	body	NOUN
ghmj-1044	308	20	weight	weight	NOUN
ghmj-1044	308	21	and	and	CCONJ
ghmj-1044	308	22	essential	essential	ADJ
ghmj-1044	308	23	hypertension	hypertension	NOUN
ghmj-1044	308	24	:	:	PUNCT
ghmj-1044	308	25	study	study	NOUN
ghmj-1044	308	26	in	in	ADP
ghmj-1044	308	27	javanese	javanese	ADJ
ghmj-1044	308	28	postmenopausal	postmenopausal	ADJ
ghmj-1044	308	29	women	woman	NOUN
ghmj-1044	308	30	.	.	PUNCT
ghmj-1044	309	1	molecular	molecular	ADJ
ghmj-1044	309	2	and	and	CCONJ
ghmj-1044	309	3	cellular	cellular	ADJ
ghmj-1044	309	4	biomedical	biomedical	ADJ
ghmj-1044	309	5	sciences	science	NOUN
ghmj-1044	309	6	,	,	PUNCT
ghmj-1044	309	7	8(2	8(2	NUM
ghmj-1044	309	8	)	)	PUNCT
ghmj-1044	309	9	,	,	PUNCT
ghmj-1044	309	10	96	96	NUM
ghmj-1044	309	11	.	.	PUNCT
ghmj-1044	309	12	https://doi.org/10.21705/mcbs.v8i2.426	https://doi.org/10.21705/mcbs.v8i2.426	PROPN
ghmj-1044	309	13	wang	wang	PROPN
ghmj-1044	309	14	,	,	PUNCT
ghmj-1044	309	15	l.	l.	PROPN
ghmj-1044	309	16	,	,	PUNCT
ghmj-1044	309	17	song	song	NOUN
ghmj-1044	309	18	,	,	PUNCT
ghmj-1044	309	19	t.	t.	PROPN
ghmj-1044	309	20	t.	t.	PROPN
ghmj-1044	309	21	,	,	PUNCT
ghmj-1044	309	22	&	&	CCONJ
ghmj-1044	309	23	dong	dong	PROPN
ghmj-1044	309	24	,	,	PUNCT
ghmj-1044	309	25	c.	c.	PROPN
ghmj-1044	309	26	w.	w.	PROPN
ghmj-1044	309	27	(	(	PUNCT
ghmj-1044	309	28	2023	2023	NUM
ghmj-1044	309	29	)	)	PUNCT
ghmj-1044	309	30	.	.	PUNCT
ghmj-1044	310	1	association	association	NOUN
ghmj-1044	310	2	between	between	ADP
ghmj-1044	310	3	interactions	interaction	NOUN
ghmj-1044	310	4	among	among	ADP
ghmj-1044	310	5	ace	ace	ADJ
ghmj-1044	310	6	gene	gene	NOUN
ghmj-1044	310	7	polymorphisms	polymorphism	NOUN
ghmj-1044	310	8	and	and	CCONJ
ghmj-1044	310	9	essential	essential	ADJ
ghmj-1044	310	10	hypertension	hypertension	NOUN
ghmj-1044	310	11	in	in	ADP
ghmj-1044	310	12	patients	patient	NOUN
ghmj-1044	310	13	in	in	ADP
ghmj-1044	310	14	the	the	DET
ghmj-1044	310	15	hefei	hefei	PROPN
ghmj-1044	310	16	region	region	PROPN
ghmj-1044	310	17	,	,	PUNCT
ghmj-1044	310	18	anhui	anhui	PROPN
ghmj-1044	310	19	,	,	PUNCT
ghmj-1044	310	20	china	china	PROPN
ghmj-1044	310	21	.	.	PUNCT
ghmj-1044	311	1	journal	journal	PROPN
ghmj-1044	311	2	of	of	ADP
ghmj-1044	311	3	the	the	DET
ghmj-1044	311	4	renin	renin	ADJ
ghmj-1044	311	5	-	-	PUNCT
ghmj-1044	311	6	angiotensin	angiotensin	NOUN
ghmj-1044	311	7	-	-	PUNCT
ghmj-1044	311	8	aldosterone	aldosterone	NOUN
ghmj-1044	311	9	system	system	NOUN
ghmj-1044	311	10	 	 	SPACE
ghmj-1044	311	11	:	:	PUNCT
ghmj-1044	311	12	jraas	jraas	ADJ
ghmj-1044	311	13	,	,	PUNCT
ghmj-1044	311	14	2023	2023	NUM
ghmj-1044	311	15	,	,	PUNCT
ghmj-1044	311	16	1159973	1159973	NUM
ghmj-1044	311	17	.	.	PUNCT
ghmj-1044	312	1	https://doi.org/10.1155/2023/1159973	https://doi.org/10.1155/2023/1159973	PROPN
ghmj-1044	312	2	https://doi.org/10.1007/s12041-008-0013-7	https://doi.org/10.1007/s12041-008-0013-7	PROPN
ghmj-1044	312	3	https://doi.org/10.1016/j.amjmed.2011.10.023	https://doi.org/10.1016/j.amjmed.2011.10.023	PROPN
ghmj-1044	312	4	https://doi.org/10.1080/13813455.2020.1762225	https://doi.org/10.1080/13813455.2020.1762225	NOUN
ghmj-1044	312	5	https://doi.org/10.54004/jikis.v11i2.135	https://doi.org/10.54004/jikis.v11i2.135	VERB
ghmj-1044	312	6	https://doi.org/10.1177/1470320321995074	https://doi.org/10.1177/1470320321995074	X
ghmj-1044	312	7	https://doi.org/10.1038/sj.jhh.1000958	https://doi.org/10.1038/sj.jhh.1000958	PROPN
ghmj-1044	312	8	https://doi.org/10.1016/j.ramd.2015.10.001	https://doi.org/10.1016/j.ramd.2015.10.001	VERB
ghmj-1044	312	9	https://doi.org/10.51602/cmhp.v1i2.29	https://doi.org/10.51602/cmhp.v1i2.29	NOUN
ghmj-1044	312	10	https://doi.org/10.1038/ajh.2011.182	https://doi.org/10.1038/ajh.2011.182	PROPN
ghmj-1044	312	11	https://doi.org/10.1007/bf02703684	https://doi.org/10.1007/bf02703684	PROPN
ghmj-1044	313	1	https://doi.org/10.30743/stm.v4i1.132	https://doi.org/10.30743/stm.v4i1.132	PROPN
ghmj-1044	313	2	https://doi.org/10.15562/ism.v14i1.1569	https://doi.org/10.15562/ism.v14i1.1569	PROPN
ghmj-1044	313	3	https://doi.org/10.1161/01.res.0000223145.74217.e7	https://doi.org/10.1161/01.res.0000223145.74217.e7	PROPN
ghmj-1044	313	4	https://doi.org/10.21668/health.risk/2022.3.16.eng	https://doi.org/10.21668/health.risk/2022.3.16.eng	PRON
ghmj-1044	314	1	https://doi.org/10.47836/mjmhs.19.2.34	https://doi.org/10.47836/mjmhs.19.2.34	NOUN
ghmj-1044	314	2	https://doi.org/10.1155/2015/979631	https://doi.org/10.1155/2015/979631	PROPN
ghmj-1044	314	3	https://doi.org/10.1016/s0031-9406(05)60992-3	https://doi.org/10.1016/s0031-9406(05)60992-3	PROPN
ghmj-1044	314	4	https://doi.org/10.21705/mcbs.v8i2.426	https://doi.org/10.21705/mcbs.v8i2.426	PROPN
ghmj-1044	314	5	https://doi.org/10.1155/2023/1159973	https://doi.org/10.1155/2023/1159973	PROPN
ghmj-1044	314	6	kuswara	kuswara	PROPN
ghmj-1044	314	7	,	,	PUNCT
ghmj-1044	314	8	et	et	PROPN
ghmj-1044	314	9	.	.	PUNCT
ghmj-1044	315	1	al	al	PROPN
ghmj-1044	315	2	.	.	PROPN
ghmj-1044	315	3	ghmj	ghmj	PROPN
ghmj-1044	315	4	(	(	PUNCT
ghmj-1044	315	5	global	global	ADJ
ghmj-1044	315	6	health	health	PROPN
ghmj-1044	315	7	management	management	NOUN
ghmj-1044	315	8	journal	journal	PROPN
ghmj-1044	315	9	)	)	PUNCT
ghmj-1044	315	10	2024	2024	NUM
ghmj-1044	315	11	,	,	PUNCT
ghmj-1044	315	12	vol	vol	NOUN
ghmj-1044	315	13	.	.	PROPN
ghmj-1044	315	14	7	7	NUM
ghmj-1044	315	15	,	,	PUNCT
ghmj-1044	315	16	no	no	INTJ
ghmj-1044	315	17	.	.	NOUN
ghmj-1044	315	18	4	4	NUM
ghmj-1044	315	19	190	190	NUM
ghmj-1044	315	20	wang	wang	PROPN
ghmj-1044	315	21	,	,	PUNCT
ghmj-1044	315	22	x.	x.	PROPN
ghmj-1044	315	23	,	,	PUNCT
ghmj-1044	315	24	wang	wang	PROPN
ghmj-1044	315	25	,	,	PUNCT
ghmj-1044	315	26	s.	s.	PROPN
ghmj-1044	315	27	,	,	PUNCT
ghmj-1044	315	28	lin	lin	PROPN
ghmj-1044	315	29	,	,	PUNCT
ghmj-1044	315	30	r.	r.	PROPN
ghmj-1044	315	31	,	,	PUNCT
ghmj-1044	315	32	jiang	jiang	PROPN
ghmj-1044	315	33	,	,	PUNCT
ghmj-1044	315	34	x.	x.	PROPN
ghmj-1044	315	35	,	,	PUNCT
ghmj-1044	315	36	cheng	cheng	PROPN
ghmj-1044	315	37	,	,	PUNCT
ghmj-1044	315	38	z.	z.	PROPN
ghmj-1044	315	39	,	,	PUNCT
ghmj-1044	315	40	turdi	turdi	PROPN
ghmj-1044	315	41	,	,	PUNCT
ghmj-1044	315	42	j.	j.	PROPN
ghmj-1044	315	43	,	,	PUNCT
ghmj-1044	315	44	…	…	PUNCT
ghmj-1044	315	45	wen	wen	PROPN
ghmj-1044	315	46	,	,	PUNCT
ghmj-1044	315	47	h.	h.	PROPN
ghmj-1044	315	48	(	(	PUNCT
ghmj-1044	315	49	2004	2004	NUM
ghmj-1044	315	50	)	)	PUNCT
ghmj-1044	315	51	.	.	PUNCT
ghmj-1044	316	1	gnb3	gnb3	NOUN
ghmj-1044	316	2	gene	gene	NOUN
ghmj-1044	316	3	c825	c825	PROPN
ghmj-1044	316	4	t	t	NOUN
ghmj-1044	316	5	and	and	CCONJ
ghmj-1044	316	6	ace	ace	VERB
ghmj-1044	316	7	gene	gene	NOUN
ghmj-1044	316	8	i	i	PROPN
ghmj-1044	316	9	/	/	SYM
ghmj-1044	316	10	d	d	NOUN
ghmj-1044	316	11	polymorphisms	polymorphism	NOUN
ghmj-1044	316	12	in	in	ADP
ghmj-1044	316	13	essential	essential	ADJ
ghmj-1044	316	14	hypertension	hypertension	NOUN
ghmj-1044	316	15	in	in	ADP
ghmj-1044	316	16	a	a	DET
ghmj-1044	316	17	kazakh	kazakh	ADJ
ghmj-1044	316	18	genetic	genetic	ADJ
ghmj-1044	316	19	isolate	isolate	NOUN
ghmj-1044	316	20	.	.	PUNCT
ghmj-1044	317	1	journal	journal	PROPN
ghmj-1044	317	2	of	of	ADP
ghmj-1044	317	3	human	human	ADJ
ghmj-1044	317	4	hypertension	hypertension	NOUN
ghmj-1044	317	5	,	,	PUNCT
ghmj-1044	317	6	18(9	18(9	NOUN
ghmj-1044	317	7	)	)	PUNCT
ghmj-1044	317	8	,	,	PUNCT
ghmj-1044	317	9	663–668	663–668	NUM
ghmj-1044	317	10	.	.	PUNCT
ghmj-1044	318	1	https://doi.org/10.1038/sj.jhh.1001700	https://doi.org/10.1038/sj.jhh.1001700	NUM
ghmj-1044	318	2	world	world	PROPN
ghmj-1044	318	3	health	health	NOUN
ghmj-1044	318	4	organization	organization	NOUN
ghmj-1044	318	5	.	.	PUNCT
ghmj-1044	319	1	(	(	PUNCT
ghmj-1044	319	2	2023	2023	NUM
ghmj-1044	319	3	)	)	PUNCT
ghmj-1044	319	4	.	.	PUNCT
ghmj-1044	320	1	hypertension	hypertension	NOUN
ghmj-1044	320	2	.	.	PUNCT
ghmj-1044	321	1	retrieved	retrieve	VERB
ghmj-1044	321	2	january	january	PROPN
ghmj-1044	321	3	10	10	NUM
ghmj-1044	321	4	,	,	PUNCT
ghmj-1044	321	5	2024	2024	NUM
ghmj-1044	321	6	,	,	PUNCT
ghmj-1044	321	7	from	from	ADP
ghmj-1044	321	8	world	world	PROPN
ghmj-1044	321	9	health	health	NOUN
ghmj-1044	321	10	organization	organization	NOUN
ghmj-1044	321	11	website	website	NOUN
ghmj-1044	321	12	:	:	PUNCT
ghmj-1044	321	13	https://www.who.int/news-room/fact-sheets/detail/hypertension	https://www.who.int/news-room/fact-sheets/detail/hypertension	NOUN
ghmj-1044	321	14	world	world	NOUN
ghmj-1044	321	15	health	health	NOUN
ghmj-1044	321	16	organization	organization	NOUN
ghmj-1044	321	17	.	.	PUNCT
ghmj-1044	322	1	(	(	PUNCT
ghmj-1044	322	2	2024	2024	NUM
ghmj-1044	322	3	)	)	PUNCT
ghmj-1044	322	4	.	.	PUNCT
ghmj-1044	323	1	global	global	ADJ
ghmj-1044	323	2	health	health	NOUN
ghmj-1044	323	3	estimates	estimate	NOUN
ghmj-1044	323	4	:	:	PUNCT
ghmj-1044	323	5	life	life	NOUN
ghmj-1044	323	6	expectancy	expectancy	NOUN
ghmj-1044	323	7	and	and	CCONJ
ghmj-1044	323	8	leading	lead	VERB
ghmj-1044	323	9	causes	cause	NOUN
ghmj-1044	323	10	of	of	ADP
ghmj-1044	323	11	death	death	NOUN
ghmj-1044	323	12	and	and	CCONJ
ghmj-1044	323	13	disability	disability	NOUN
ghmj-1044	323	14	.	.	PUNCT
ghmj-1044	324	1	retrieved	retrieve	VERB
ghmj-1044	324	2	january	january	PROPN
ghmj-1044	324	3	10	10	NUM
ghmj-1044	324	4	,	,	PUNCT
ghmj-1044	324	5	2024	2024	NUM
ghmj-1044	324	6	,	,	PUNCT
ghmj-1044	324	7	from	from	ADP
ghmj-1044	324	8	world	world	PROPN
ghmj-1044	324	9	health	health	NOUN
ghmj-1044	324	10	organization	organization	NOUN
ghmj-1044	324	11	website	website	NOUN
ghmj-1044	324	12	:	:	PUNCT
ghmj-1044	324	13	https://www.who.int/data/gho/data/themes/mortality-andglobal-health-estimates	https://www.who.int/data/gho/data/themes/mortality-andglobal-health-estimates	AUX
ghmj-1044	325	1	xu	xu	PROPN
ghmj-1044	325	2	,	,	PUNCT
ghmj-1044	325	3	j.	j.	PROPN
ghmj-1044	325	4	,	,	PUNCT
ghmj-1044	325	5	chen	chen	PROPN
ghmj-1044	325	6	,	,	PUNCT
ghmj-1044	325	7	j.	j.	PROPN
ghmj-1044	325	8	,	,	PUNCT
ghmj-1044	325	9	li	li	PROPN
ghmj-1044	325	10	,	,	PUNCT
ghmj-1044	325	11	y.	y.	PROPN
ghmj-1044	325	12	,	,	PUNCT
ghmj-1044	325	13	zhang	zhang	PROPN
ghmj-1044	325	14	,	,	PUNCT
ghmj-1044	325	15	d.	d.	PROPN
ghmj-1044	325	16	,	,	PUNCT
ghmj-1044	325	17	&	&	CCONJ
ghmj-1044	325	18	li	li	PROPN
ghmj-1044	325	19	,	,	PUNCT
ghmj-1044	325	20	x.	x.	PROPN
ghmj-1044	325	21	(	(	PUNCT
ghmj-1044	325	22	2020	2020	NUM
ghmj-1044	325	23	)	)	PUNCT
ghmj-1044	325	24	.	.	PUNCT
ghmj-1044	326	1	association	association	NOUN
ghmj-1044	326	2	of	of	ADP
ghmj-1044	326	3	angiotensin	angiotensin	NOUN
ghmj-1044	326	4	-	-	PUNCT
ghmj-1044	326	5	converting	convert	VERB
ghmj-1044	326	6	enzyme	enzyme	NOUN
ghmj-1044	326	7	gene	gene	NOUN
ghmj-1044	326	8	insertion	insertion	NOUN
ghmj-1044	326	9	/	/	SYM
ghmj-1044	326	10	deletion	deletion	NOUN
ghmj-1044	326	11	polymorphism	polymorphism	NOUN
ghmj-1044	326	12	and	and	CCONJ
ghmj-1044	326	13	obstructive	obstructive	ADJ
ghmj-1044	326	14	sleep	sleep	NOUN
ghmj-1044	326	15	apnoea	apnoea	NOUN
ghmj-1044	326	16	in	in	ADP
ghmj-1044	326	17	a	a	DET
ghmj-1044	326	18	chinese	chinese	ADJ
ghmj-1044	326	19	population	population	NOUN
ghmj-1044	326	20	:	:	PUNCT
ghmj-1044	326	21	a	a	DET
ghmj-1044	326	22	meta	meta	ADJ
ghmj-1044	326	23	-	-	PUNCT
ghmj-1044	326	24	analysis	analysis	NOUN
ghmj-1044	326	25	.	.	PUNCT
ghmj-1044	327	1	jraas	jraas	ADJ
ghmj-1044	327	2	journal	journal	NOUN
ghmj-1044	327	3	of	of	ADP
ghmj-1044	327	4	the	the	DET
ghmj-1044	327	5	reninangiotensin	reninangiotensin	NOUN
ghmj-1044	327	6	-	-	PUNCT
ghmj-1044	327	7	aldosterone	aldosterone	NOUN
ghmj-1044	327	8	system	system	NOUN
ghmj-1044	327	9	,	,	PUNCT
ghmj-1044	327	10	21(2	21(2	NUM
ghmj-1044	327	11	)	)	PUNCT
ghmj-1044	327	12	.	.	PUNCT
ghmj-1044	328	1	https://doi.org/10.1177/1470320320934716	https://doi.org/10.1177/1470320320934716	DET
ghmj-1044	328	2	zambrano	zambrano	PROPN
ghmj-1044	328	3	,	,	PUNCT
ghmj-1044	328	4	a.	a.	PROPN
ghmj-1044	328	5	k.	k.	PROPN
ghmj-1044	328	6	,	,	PUNCT
ghmj-1044	328	7	cadena	cadena	PROPN
ghmj-1044	328	8	-	-	PUNCT
ghmj-1044	328	9	ullauri	ullauri	PROPN
ghmj-1044	328	10	,	,	PUNCT
ghmj-1044	328	11	s.	s.	PROPN
ghmj-1044	328	12	,	,	PUNCT
ghmj-1044	328	13	guevara	guevara	NOUN
ghmj-1044	328	14	-	-	PUNCT
ghmj-1044	328	15	ramírez	ramírez	NOUN
ghmj-1044	328	16	,	,	PUNCT
ghmj-1044	328	17	p.	p.	NOUN
ghmj-1044	328	18	,	,	PUNCT
ghmj-1044	328	19	ruiz	ruiz	NOUN
ghmj-1044	328	20	-	-	PUNCT
ghmj-1044	328	21	pozo	pozo	PROPN
ghmj-1044	328	22	,	,	PUNCT
ghmj-1044	328	23	v.	v.	PROPN
ghmj-1044	328	24	a.	a.	NOUN
ghmj-1044	328	25	,	,	PUNCT
ghmj-1044	328	26	tamayo	tamayo	PROPN
ghmj-1044	328	27	-	-	PUNCT
ghmj-1044	328	28	trujillo	trujillo	PROPN
ghmj-1044	328	29	,	,	PUNCT
ghmj-1044	328	30	r.	r.	PROPN
ghmj-1044	328	31	,	,	PUNCT
ghmj-1044	328	32	paz	paz	PROPN
ghmj-1044	328	33	-	-	PUNCT
ghmj-1044	328	34	cruz	cruz	PROPN
ghmj-1044	328	35	,	,	PUNCT
ghmj-1044	328	36	e.	e.	PROPN
ghmj-1044	328	37	,	,	PUNCT
ghmj-1044	328	38	…	…	PUNCT
ghmj-1044	328	39	doménech	doménech	NOUN
ghmj-1044	328	40	,	,	PUNCT
ghmj-1044	328	41	n.	n.	NOUN
ghmj-1044	328	42	(	(	PUNCT
ghmj-1044	328	43	2023	2023	NUM
ghmj-1044	328	44	)	)	PUNCT
ghmj-1044	328	45	.	.	PUNCT
ghmj-1044	329	1	genetic	genetic	ADJ
ghmj-1044	329	2	diet	diet	NOUN
ghmj-1044	329	3	interactions	interaction	NOUN
ghmj-1044	329	4	of	of	ADP
ghmj-1044	329	5	ace	ace	NOUN
ghmj-1044	329	6	:	:	PUNCT
ghmj-1044	329	7	the	the	DET
ghmj-1044	329	8	increased	increase	VERB
ghmj-1044	329	9	hypertension	hypertension	NOUN
ghmj-1044	329	10	predisposition	predisposition	NOUN
ghmj-1044	329	11	in	in	ADP
ghmj-1044	329	12	the	the	DET
ghmj-1044	329	13	latin	latin	ADJ
ghmj-1044	329	14	american	american	ADJ
ghmj-1044	329	15	population	population	NOUN
ghmj-1044	329	16	.	.	PUNCT
ghmj-1044	330	1	frontiers	frontier	NOUN
ghmj-1044	330	2	in	in	ADP
ghmj-1044	330	3	nutrition	nutrition	NOUN
ghmj-1044	330	4	,	,	PUNCT
ghmj-1044	330	5	10(october	10(october	NUM
ghmj-1044	330	6	)	)	PUNCT
ghmj-1044	330	7	.	.	PUNCT
ghmj-1044	331	1	https://doi.org/10.3389/fnut.2023.1241017	https://doi.org/10.3389/fnut.2023.1241017	PROPN
ghmj-1044	331	2	zhang	zhang	PROPN
ghmj-1044	331	3	,	,	PUNCT
ghmj-1044	331	4	l.	l.	PROPN
ghmj-1044	331	5	,	,	PUNCT
ghmj-1044	331	6	miyaki	miyaki	PROPN
ghmj-1044	331	7	,	,	PUNCT
ghmj-1044	331	8	k.	k.	PROPN
ghmj-1044	331	9	,	,	PUNCT
ghmj-1044	331	10	araki	araki	PROPN
ghmj-1044	331	11	,	,	PUNCT
ghmj-1044	331	12	j.	j.	PROPN
ghmj-1044	331	13	,	,	PUNCT
ghmj-1044	331	14	song	song	NOUN
ghmj-1044	331	15	,	,	PUNCT
ghmj-1044	331	16	y.	y.	PROPN
ghmj-1044	331	17	,	,	PUNCT
ghmj-1044	331	18	kimura	kimura	NOUN
ghmj-1044	331	19	,	,	PUNCT
ghmj-1044	331	20	t.	t.	PROPN
ghmj-1044	331	21	,	,	PUNCT
ghmj-1044	331	22	omae	omae	PROPN
ghmj-1044	331	23	,	,	PUNCT
ghmj-1044	331	24	k.	k.	PROPN
ghmj-1044	331	25	,	,	PUNCT
ghmj-1044	331	26	&	&	CCONJ
ghmj-1044	331	27	muramatsu	muramatsu	PROPN
ghmj-1044	331	28	,	,	PUNCT
ghmj-1044	331	29	m.	m.	NOUN
ghmj-1044	331	30	(	(	PUNCT
ghmj-1044	331	31	2006	2006	NUM
ghmj-1044	331	32	)	)	PUNCT
ghmj-1044	331	33	.	.	PUNCT
ghmj-1044	332	1	interaction	interaction	NOUN
ghmj-1044	332	2	of	of	ADP
ghmj-1044	332	3	angiotensin	angiotensin	NOUN
ghmj-1044	332	4	i	i	PRON
ghmj-1044	332	5	-	-	PUNCT
ghmj-1044	332	6	converting	convert	VERB
ghmj-1044	332	7	enzyme	enzyme	NOUN
ghmj-1044	332	8	insertion	insertion	NOUN
ghmj-1044	332	9	-	-	PUNCT
ghmj-1044	332	10	deletion	deletion	NOUN
ghmj-1044	332	11	polymorphism	polymorphism	NOUN
ghmj-1044	332	12	and	and	CCONJ
ghmj-1044	332	13	daily	daily	ADJ
ghmj-1044	332	14	salt	salt	NOUN
ghmj-1044	332	15	intake	intake	NOUN
ghmj-1044	332	16	influences	influence	NOUN
ghmj-1044	332	17	hypertension	hypertension	NOUN
ghmj-1044	332	18	in	in	ADP
ghmj-1044	332	19	japanese	japanese	ADJ
ghmj-1044	332	20	men	man	NOUN
ghmj-1044	332	21	.	.	PUNCT
ghmj-1044	333	1	hypertension	hypertension	NOUN
ghmj-1044	333	2	research	research	NOUN
ghmj-1044	333	3	,	,	PUNCT
ghmj-1044	333	4	29(10	29(10	NOUN
ghmj-1044	333	5	)	)	PUNCT
ghmj-1044	333	6	,	,	PUNCT
ghmj-1044	333	7	751–758	751–758	NUM
ghmj-1044	333	8	.	.	PUNCT
ghmj-1044	334	1	https://doi.org/10.1291/hypres.29.751	https://doi.org/10.1291/hypres.29.751	PROPN
ghmj-1044	334	2	zhang	zhang	PROPN
ghmj-1044	334	3	,	,	PUNCT
ghmj-1044	334	4	x.	x.	PROPN
ghmj-1044	334	5	,	,	PUNCT
ghmj-1044	334	6	wang	wang	PROPN
ghmj-1044	334	7	,	,	PUNCT
ghmj-1044	334	8	y.	y.	PROPN
ghmj-1044	334	9	,	,	PUNCT
ghmj-1044	334	10	zheng	zheng	PROPN
ghmj-1044	334	11	,	,	PUNCT
ghmj-1044	334	12	y.	y.	PROPN
ghmj-1044	334	13	,	,	PUNCT
ghmj-1044	334	14	yuan	yuan	PROPN
ghmj-1044	334	15	,	,	PUNCT
ghmj-1044	334	16	j.	j.	PROPN
ghmj-1044	334	17	,	,	PUNCT
ghmj-1044	334	18	tong	tong	PROPN
ghmj-1044	334	19	,	,	PUNCT
ghmj-1044	334	20	j.	j.	PROPN
ghmj-1044	334	21	,	,	PUNCT
ghmj-1044	334	22	xu	xu	PROPN
ghmj-1044	334	23	,	,	PUNCT
ghmj-1044	334	24	j.	j.	PROPN
ghmj-1044	334	25	,	,	PUNCT
ghmj-1044	334	26	…	…	PUNCT
ghmj-1044	334	27	li	li	PROPN
ghmj-1044	334	28	,	,	PUNCT
ghmj-1044	334	29	x.	x.	NOUN
ghmj-1044	334	30	(	(	PUNCT
ghmj-1044	334	31	2022	2022	NUM
ghmj-1044	334	32	)	)	PUNCT
ghmj-1044	334	33	.	.	PUNCT
ghmj-1044	335	1	effect	effect	NOUN
ghmj-1044	335	2	of	of	ADP
ghmj-1044	335	3	ace	ace	NOUN
ghmj-1044	335	4	,	,	PUNCT
ghmj-1044	335	5	ace2	ace2	NOUN
ghmj-1044	335	6	and	and	CCONJ
ghmj-1044	335	7	cyp11b2	cyp11b2	NOUN
ghmj-1044	335	8	gene	gene	NOUN
ghmj-1044	335	9	polymorphisms	polymorphism	NOUN
ghmj-1044	335	10	and	and	CCONJ
ghmj-1044	335	11	noise	noise	NOUN
ghmj-1044	335	12	on	on	ADP
ghmj-1044	335	13	essential	essential	ADJ
ghmj-1044	335	14	hypertension	hypertension	NOUN
ghmj-1044	335	15	among	among	ADP
ghmj-1044	335	16	steelworkers	steelworker	NOUN
ghmj-1044	335	17	in	in	ADP
ghmj-1044	335	18	china	china	PROPN
ghmj-1044	335	19	:	:	PUNCT
ghmj-1044	335	20	a	a	DET
ghmj-1044	335	21	case	case	NOUN
ghmj-1044	335	22	–	–	PUNCT
ghmj-1044	335	23	control	control	NOUN
ghmj-1044	335	24	study	study	NOUN
ghmj-1044	335	25	.	.	PUNCT
ghmj-1044	336	1	bmc	bmc	PROPN
ghmj-1044	336	2	medical	medical	ADJ
ghmj-1044	336	3	genomics	genomic	NOUN
ghmj-1044	336	4	,	,	PUNCT
ghmj-1044	336	5	15(1	15(1	NUM
ghmj-1044	336	6	)	)	PUNCT
ghmj-1044	336	7	,	,	PUNCT
ghmj-1044	336	8	1–10	1–10	NOUN
ghmj-1044	336	9	.	.	PUNCT
ghmj-1044	337	1	https://doi.org/10.1186/s12920-022-01177-0	https://doi.org/10.1186/s12920-022-01177-0	NUM
ghmj-1044	338	1	zhang	zhang	PROPN
ghmj-1044	338	2	,	,	PUNCT
ghmj-1044	338	3	y.	y.	PROPN
ghmj-1044	338	4	,	,	PUNCT
ghmj-1044	338	5	shi	shi	PROPN
ghmj-1044	338	6	,	,	PUNCT
ghmj-1044	338	7	f.	f.	PROPN
ghmj-1044	338	8	,	,	PUNCT
ghmj-1044	338	9	yu	yu	PROPN
ghmj-1044	338	10	,	,	PUNCT
ghmj-1044	338	11	z.	z.	PROPN
ghmj-1044	338	12	,	,	PUNCT
ghmj-1044	338	13	yang	yang	PROPN
ghmj-1044	338	14	,	,	PUNCT
ghmj-1044	338	15	a.	a.	PROPN
ghmj-1044	338	16	,	,	PUNCT
ghmj-1044	338	17	zeng	zeng	PROPN
ghmj-1044	338	18	,	,	PUNCT
ghmj-1044	338	19	m.	m.	NOUN
ghmj-1044	338	20	,	,	PUNCT
ghmj-1044	338	21	wang	wang	PROPN
ghmj-1044	338	22	,	,	PUNCT
ghmj-1044	338	23	j.	j.	PROPN
ghmj-1044	338	24	,	,	PUNCT
ghmj-1044	338	25	…	…	PUNCT
ghmj-1044	338	26	ma	ma	PROPN
ghmj-1044	338	27	,	,	PUNCT
ghmj-1044	338	28	x.	x.	NOUN
ghmj-1044	338	29	(	(	PUNCT
ghmj-1044	338	30	2019	2019	NUM
ghmj-1044	338	31	)	)	PUNCT
ghmj-1044	338	32	.	.	PUNCT
ghmj-1044	339	1	a	a	DET
ghmj-1044	339	2	cross	cross	ADJ
ghmj-1044	339	3	-	-	ADJ
ghmj-1044	339	4	sectional	sectional	ADJ
ghmj-1044	339	5	study	study	NOUN
ghmj-1044	339	6	on	on	ADP
ghmj-1044	339	7	factors	factor	NOUN
ghmj-1044	339	8	associated	associate	VERB
ghmj-1044	339	9	with	with	ADP
ghmj-1044	339	10	hypertension	hypertension	NOUN
ghmj-1044	339	11	and	and	CCONJ
ghmj-1044	339	12	genetic	genetic	ADJ
ghmj-1044	339	13	polymorphisms	polymorphism	NOUN
ghmj-1044	339	14	of	of	ADP
ghmj-1044	339	15	renin	renin	ADJ
ghmj-1044	339	16	-	-	PUNCT
ghmj-1044	339	17	angiotensinaldosterone	angiotensinaldosterone	NOUN
ghmj-1044	339	18	system	system	NOUN
ghmj-1044	339	19	in	in	ADP
ghmj-1044	339	20	chinese	chinese	PROPN
ghmj-1044	339	21	hui	hui	PROPN
ghmj-1044	339	22	pilgrims	pilgrim	NOUN
ghmj-1044	339	23	to	to	ADP
ghmj-1044	339	24	hajj	hajj	PROPN
ghmj-1044	339	25	.	.	PUNCT
ghmj-1044	340	1	bmc	bmc	VERB
ghmj-1044	340	2	public	public	ADJ
ghmj-1044	340	3	health	health	NOUN
ghmj-1044	340	4	,	,	PUNCT
ghmj-1044	340	5	19(1223	19(1223	NUM
ghmj-1044	340	6	)	)	PUNCT
ghmj-1044	340	7	,	,	PUNCT
ghmj-1044	340	8	1–11	1–11	PROPN
ghmj-1044	340	9	.	.	PUNCT
ghmj-1044	341	1	https://doi.org/10.1186/s12889-019-7357-1	https://doi.org/10.1186/s12889-019-7357-1	PROPN
ghmj-1044	341	2	cite	cite	VERB
ghmj-1044	341	3	this	this	DET
ghmj-1044	341	4	article	article	NOUN
ghmj-1044	341	5	as	as	ADP
ghmj-1044	341	6	:	:	PUNCT
ghmj-1044	341	7	kuswara	kuswara	PROPN
ghmj-1044	341	8	,	,	PUNCT
ghmj-1044	341	9	h.	h.	PROPN
ghmj-1044	341	10	n.	n.	PROPN
ghmj-1044	341	11	,	,	PUNCT
ghmj-1044	341	12	nauphar	nauphar	PROPN
ghmj-1044	341	13	,	,	PUNCT
ghmj-1044	341	14	d.	d.	PROPN
ghmj-1044	341	15	,	,	PUNCT
ghmj-1044	341	16	&	&	CCONJ
ghmj-1044	341	17	sari	sari	NOUN
ghmj-1044	341	18	,	,	PUNCT
ghmj-1044	341	19	a.	a.	PROPN
ghmj-1044	341	20	i.	i.	PROPN
ghmj-1044	341	21	p.	p.	PROPN
ghmj-1044	341	22	(	(	PUNCT
ghmj-1044	341	23	2024	2024	NUM
ghmj-1044	341	24	)	)	PUNCT
ghmj-1044	341	25	.	.	PUNCT
ghmj-1044	342	1	angiotensin	angiotensin	NOUN
ghmj-1044	342	2	-	-	PUNCT
ghmj-1044	342	3	converting	convert	VERB
ghmj-1044	342	4	enzyme	enzyme	NOUN
ghmj-1044	342	5	insertion	insertion	NOUN
ghmj-1044	342	6	/	/	SYM
ghmj-1044	342	7	deletion	deletion	NOUN
ghmj-1044	342	8	(	(	PUNCT
ghmj-1044	342	9	ace	ace	VERB
ghmj-1044	342	10	i	i	PROPN
ghmj-1044	342	11	/	/	SYM
ghmj-1044	342	12	d	d	NOUN
ghmj-1044	342	13	)	)	PUNCT
ghmj-1044	342	14	gene	gene	NOUN
ghmj-1044	342	15	polymorphism	polymorphism	NOUN
ghmj-1044	342	16	as	as	ADP
ghmj-1044	342	17	a	a	DET
ghmj-1044	342	18	risk	risk	NOUN
ghmj-1044	342	19	factor	factor	NOUN
ghmj-1044	342	20	for	for	ADP
ghmj-1044	342	21	essential	essential	ADJ
ghmj-1044	342	22	hypertension	hypertension	NOUN
ghmj-1044	342	23	.	.	PUNCT
ghmj-1044	343	1	ghmj	ghmj	PROPN
ghmj-1044	343	2	(	(	PUNCT
ghmj-1044	343	3	global	global	ADJ
ghmj-1044	343	4	health	health	PROPN
ghmj-1044	343	5	management	management	NOUN
ghmj-1044	343	6	journal	journal	PROPN
ghmj-1044	343	7	)	)	PUNCT
ghmj-1044	343	8	,	,	PUNCT
ghmj-1044	343	9	7(4	7(4	NUM
ghmj-1044	343	10	)	)	PUNCT
ghmj-1044	343	11	,	,	PUNCT
ghmj-1044	343	12	180–190	180–190	NUM
ghmj-1044	343	13	.	.	PUNCT
ghmj-1044	344	1	https://doi.org/10.35898/ghmj-741044	https://doi.org/10.35898/ghmj-741044	PROPN
ghmj-1044	344	2	https://doi.org/10.1038/sj.jhh.1001700	https://doi.org/10.1038/sj.jhh.1001700	PROPN
ghmj-1044	344	3	https://www.who.int/news-room/fact-sheets/detail/hypertension	https://www.who.int/news-room/fact-sheets/detail/hypertension	NOUN
ghmj-1044	344	4	https://doi.org/10.1177/1470320320934716	https://doi.org/10.1177/1470320320934716	VERB
ghmj-1044	344	5	https://doi.org/10.3389/fnut.2023.1241017	https://doi.org/10.3389/fnut.2023.1241017	PROPN
ghmj-1044	344	6	https://doi.org/10.1291/hypres.29.751	https://doi.org/10.1291/hypres.29.751	PROPN
ghmj-1044	344	7	https://doi.org/10.1186/s12920-022-01177-0	https://doi.org/10.1186/s12920-022-01177-0	NUM
ghmj-1044	344	8	https://doi.org/10.1186/s12889-019-7357-1	https://doi.org/10.1186/s12889-019-7357-1	NUM
ghmj-1044	344	9	https://doi.org/10.35898/ghmj-741044	https://doi.org/10.35898/ghmj-741044	PROPN